0001651717-24-000031.txt : 20240509 0001651717-24-000031.hdr.sgml : 20240509 20240509064543 ACCESSION NUMBER: 0001651717-24-000031 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 73 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240509 DATE AS OF CHANGE: 20240509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nomad Foods Ltd CENTRAL INDEX KEY: 0001651717 STANDARD INDUSTRIAL CLASSIFICATION: FOOD & KINDRED PRODUCTS [2000] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37669 FILM NUMBER: 24928434 BUSINESS ADDRESS: STREET 1: 1 NEW SQUARE STREET 2: BEDFONT LAKES BUSINESS PARK CITY: FELTHAM STATE: X0 ZIP: TW14 8HA BUSINESS PHONE: 00442089183200 MAIL ADDRESS: STREET 1: 1 NEW SQUARE STREET 2: BEDFONT LAKES BUSINESS PARK CITY: FELTHAM STATE: X0 ZIP: TW14 8HA 6-K 1 nomd-2024331x6k.htm 6-K Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_______________________________________________
FORM 6-K
_______________________________________________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 _______________________________________________
For the month of May 2024
Commission File Number: 001-37669
_______________________________________________
Nomad Foods Limited
(Translation of registrant’s name in English)
 
_______________________________________________
Forge, 43 Church Street West
Woking, GU21 6HT
+ (44) 208 918 3200
(Address of Principal Executive Offices)
_______________________________________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F  x           Form 40-F  o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  o
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  o
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.




Financial Results
On May 9, 2024, Nomad Foods Limited (the “Company”) issued a press release announcing its financial results for the three month period ended March 31, 2024 (“1Q 2024”). The press release is furnished as Exhibit 99.1 to this Report on Form 6-K. The Company also issued Condensed Consolidated Interim Financial Statements for 1Q 2024. The Condensed Consolidated Interim Financial Statements for 1Q 2024 are filed as Exhibit 99.2 to this Report on Form 6-K and are incorporated by reference into the registration statements on (i) Form S-8 filed with the Securities and Exchange Commission (the “Commission”) on May 3, 2016 (File No. 333-211095), (ii) Form F-3, initially filed with the Commission on March 30, 2017 and declared effective on May 2, 2017 (File No. 333-217044) and (iii) Form F-3 filed with the Commission on March 1, 2023, which was automatically effective upon filing with the Commission (File No. 333-270190).





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
NOMAD FOODS LIMITED
By: /s/ Samy Zekhout
Name: Samy Zekhout
Title: Chief Financial Officer
Dated: May 9, 2024



Exhibit Index
Exhibit
Number
  Exhibit Title
  Press Release issued by Nomad Foods Limited on May 9, 2024 relating to the Company’s financial results for the three month period ended March 31, 2024.
  Condensed Consolidated Interim Financial Statements (unaudited) for the three months ended March 31, 2024.




EX-99.1 2 ex991pressrelease20240331.htm PRESS RELEASE Document
Exhibit 99.1
nomadlogoa15.jpg
Nomad Foods Reports First Quarter 2024 Financial Results

Volume recovery on-track; Revenue growth of +1.1% with Adjusted EPS of €0.37

Reiterates full year 2024 financial guidance
WOKING, England - May 9, 2024 - Nomad Foods Limited (NYSE: NOMD), today reported financial results for the three month period ended March 31, 2024. Key operating highlights and financial performance for the first quarter 2024, when compared to the first quarter 2023, include:
 
Reported revenue increased 1.1% to €784 million
Organic revenue growth of 0.3%
Adjusted EBITDA decreased 16.4% to €122 million
Adjusted EPS of €0.37
Management Comments
Stéfan Descheemaeker, Nomad Foods’ Chief Executive Officer, stated, “I am pleased with the solid start to the year as our first quarter's results demonstrated tangible progress on our key growth initiatives. Our volume and market share trends improved sequentially as targeted investments and exceptional execution at retail is driving accelerated growth in our core must-win-battles. Looking ahead, I am excited about our building momentum as our growth flywheel starts to spin faster, fueled by our outstanding progress on productivity initiatives and a more favorable costs environment.”

He continued, "As a result, we are maintaining our full year guidance to deliver revenue growth of 3%-4%, Adjusted EBITDA growth of 4%-6%, and Adjusted EPS of €1.75-€1.80."

Noam Gottesman, Nomad Foods’ Co-Chairman and Founder, commented, “We are delighted with the trajectory of the business as our strategies to return to volume growth in 2024 are working. Frozen food categories remain healthy and we are well-positioned to leverage our strong brands, impactful innovation, and excellent supply-chain into delivering sustained, top-tier sales and profit growth in 2024 and beyond. Our attractive organic growth outlook coupled with strong cash generation, and disciplined capital allocation gives us the confidence that we will continue to generate superior returns for our shareholders.”

First Quarter of 2024 results compared to the First Quarter of 2023
Revenue increased 1.1% to €784 million. Organic revenue growth of 0.3% was driven by favorable price/mix of 2.5%. Quarterly volume declines moderated to -2.2%, a marked improvement from -8.0% in 4Q23.
Gross profit decreased 5.9% to €211 million. Gross margin decreased 200 basis points to 26.9% as anticipated impact from balance sheet inventory revaluation due to lower inflation more than offset positive contribution from favorable mix and higher productivity.
Adjusted operating expenses increased 11.5% to €112 million due to the planned increase in A&P investments, ongoing investments in building capabilities, and inflationary headwinds.
Adjusted EBITDA decreased 16.4% to €122 million due to the aforementioned factors.
Adjusted Profit for the period decreased 25% to €61 million, and as a result, Adjusted EPS decreased by €0.09 to €0.37. Reported EPS decreased €0.03 to €0.21.
2024 Guidance
For the full year 2024, the Company continues to expect organic revenue growth of 3%-4%, driven by positive volume/mix, Adjusted EBITDA growth of 4%-6%, and Adjusted EPS of €1.75-€1.80, implying growth of 9-12%. Based on USD/EUR exchange rate as of May 1st, this translates into 2024 Adjusted EPS of $1.87-$1.93. The Company expects full year cash flow conversion in the range of 90% to 95%.

1


Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results today, Thursday, May 9, 2024 at 1:30 p.m. BST (8:30 a.m. Eastern Daylight Time). To participate on the live call, listeners in North America
may dial +1-877-451-6152 and international listeners may dial +1-201-389-0879. Additionally, there will be a presentation to
accompany the conference call and the call is being webcast. Both can be accessed at the Nomad Foods website at
www.nomadfoods.com under Investor Relations. A replay of the conference call will be available on the Company website for two
weeks following the event and can be accessed by listeners in North America by dialing +1-844-512-2921 and by international
listeners by dialing +1-412-317-6671; the replay pin number is 13745160.

Enquiries
Investor Relations Contact
Amit Sharma, Head of Investor Relations
amit.sharma@nomadfoods.com

About Nomad Foods
Nomad Foods (NYSE: NOMD) is Europe’s leading frozen food company. The Company’s portfolio of iconic brands, which includes Birds Eye, Findus, iglo, Ledo and Frikom, have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.

Non-IFRS Financial Information
Nomad Foods is presenting Adjusted and Organic financial information, which is considered non-IFRS financial information, for the three months ended March 31, 2024 and for comparative purposes, the three months ended March 31, 2023.

Adjusted financial information for the three months ended March 31, 2024 and 2023 presented in this press release reflects the historical reported financial statements of Nomad Foods, adjusted primarily for share based payment expenses and related employer payroll taxes, non-operating M&A related costs, acquisition purchase price adjustments, exceptional items and foreign currency translation charges/gains.

Adjusted EBITDA is profit or loss for the period before taxation, net financing costs, depreciation and amortization, adjusted to exclude, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges and other unusual or non-recurring items. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EBITDA provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.

Adjusted EBITDA should not be considered as an alternative to profit/(loss) for the period, determined in accordance with IFRS, as an indicator of the Company’s operating performance.

Adjusted Profit for the period is defined as profit for the period excluding, when they occur, the impacts of exited markets, acquisition purchase price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, unissued preferred share dividends, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted Profit after tax provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.

Adjusted EPS is defined as basic earnings per share excluding, when they occur, the impacts of exited markets, acquisition purchase
price adjustments and exceptional items such as restructuring charges, goodwill and intangible asset impairment charges, as well as certain other items considered unusual or non-recurring in nature. In addition, we exclude other adjustments such as the impact of share based payment expenses and related employer payroll taxes, and non-operating M&A related costs, because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance. The Company believes Adjusted EPS provides important comparability of underlying operating results, allowing investors and management to assess operating performance on a consistent basis.

2


Organic revenue growth/(decline) is an adjusted measurement of our operating results. The comparison for the three months ended March 31, 2024 and 2023 presented in this press release takes into consideration only those activities that were in effect during both time periods. Organic revenue growth/(decline) reflects reported revenue adjusted for currency translation and non-comparable trading items such as expansion, acquisitions, disposals, closures, trading day impacts or any other event that artificially impacts the comparability of our results period over period.

Adjustments for currency translation are calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.

Adjusted Free Cash Flow – Adjusted free cash flow is the amount of cash generated from operating activities before cash flows related to exceptional items (as described above), non-operating M&A related costs and working capital movements on employer taxes associated with share based payment awards, but after capital expenditure (on property, plant and equipment and intangible assets), net interest paid, proceeds/(payments) on settlement of derivatives where hedge accounting is not applied and payments of lease liabilities. Adjusted free cash flow reflects cash flows that could be used for payment of dividends, repayment of debt or to fund acquisitions or other strategic objectives. Cash flow conversion is Adjusted Free Cash Flow as percentage of Adjusted Profit for the period.

Adjusted and Organic non-IFRS financial information should be read in conjunction with the unaudited financial statements of Nomad Foods included in this press release as well as the historical financial statements of the Company previously filed with the SEC.

Nomad Foods believe its non-IFRS financial measures provide an important additional measure with which to monitor and evaluate
the Company’s ongoing financial results, as well as to reflect its acquisitions. Nomad Foods’ calculation of these financial measures
may be different from the calculations used by other companies and comparability may therefore be limited. The Adjusted and
Organic financial information presented herein is based upon certain assumptions that Nomad Foods believes to be reasonable and is
presented for informational purposes only and is not necessarily indicative of any anticipated financial position or future results of
operations that the Company will experience. You should not consider the Company’s non-IFRS financial measures an alternative or
substitute for the Company’s reported results and are cautioned not to place undue reliance on these results and information as they
may not be representative of our actual or future results as a Company.

Please see on pages 7 to 11, the non-IFRS reconciliation tables attached hereto and the schedules accompanying this release for an explanation and reconciliation of the Adjusted and Organic financial information to the most directly comparable IFRS measure. The
Company is unable to reconcile, without unreasonable efforts, Organic Growth, Adjusted EBITDA and Adjusted EPS guidance to the most directly comparable IFRS measure.



3


Nomad Foods Limited As Reported
Condensed Consolidated Interim Statements of Profit or Loss (unaudited)
Three months ended March 31, 2024 and March 31, 2023
Three months ended March 31, 2024Three months ended March 31, 2023
€m€m
Revenue783.7 775.1 
Cost of sales(572.8)(550.9)
Gross profit210.9 224.2 
Other operating expenses(115.4)(114.5)
Exceptional items(23.5)(30.1)
Operating profit72.0 79.6 
Finance income5.9 1.1 
Finance costs(36.0)(30.1)
Net financing costs(30.1)(29.0)
Profit before tax41.9 50.6 
Taxation(7.4)(9.4)
Profit for the period34.5 41.2 
Basic & diluted earnings per share in €0.21 0.24 

4


Nomad Foods Limited As Reported
Condensed Consolidated Interim Statements of Financial Position
As at March 31, 2024 (unaudited) and December 31, 2023 (audited)
As at March 31, 2024As at December 31, 2023
 €m €m
Non-current assets
Goodwill2,103.2 2,105.0 
Intangibles2,467.0 2,468.2 
Property, plant and equipment563.4 563.7 
Other non-current assets7.3 7.1 
Derivative financial instruments1.4 0.7 
Deferred tax assets106.1 106.9 
Total non-current assets5,248.4 5,251.6 
Current assets
Cash and cash equivalents390.7 412.9 
Inventories432.6 446.4 
Trade and other receivables343.8 263.4 
Current tax receivable39.7 40.7 
Indemnification assets0.5 0.5 
Derivative financial instruments6.0 1.2 
Total current assets1,213.3 1,165.1 
Total assets6,461.7 6,416.7 
Current liabilities
Trade and other payables810.3 769.8 
Current tax payable189.3 189.5 
Provisions31.5 35.1 
Loans and borrowings26.2 21.4 
Derivative financial instruments8.9 12.2 
Total current liabilities1,066.2 1,028.0 
Non-current liabilities
Loans and borrowings2,126.9 2,113.7 
Employee benefits152.1 158.3 
Other non-current liabilities0.5 0.5 
Provisions1.4 1.4 
Derivative financial instruments69.8 97.8 
Deferred tax liabilities425.6 425.1 
Total non-current liabilities2,776.3 2,796.8 
Total liabilities3,842.5 3,824.8 
Net assets2,619.2 2,591.9 
Equity attributable to equity holders
Share capital and capital reserve1,419.0 1,426.1 
Share-based compensation reserve34.5 31.4 
Translation reserve104.6 101.0 
Other reserves(11.8)(24.6)
Retained earnings1,072.9 1,058.0 
Total equity2,619.2 2,591.9 

5


Nomad Foods Limited As Reported
Condensed Consolidated Interim Statements of Cash Flows (unaudited)
For the three months ended March 31, 2024 and the three months ended March 31, 2023
For the three months ended March 31, 2024For the three months ended March 31, 2023
 €m €m
Cash flows from operating activities
Profit for the period34.5 41.2 
Adjustments for:
Exceptional items23.5 30.1 
Share based payment expense3.1 12.3 
Depreciation and amortization23.1 22.3 
Loss on disposal of property, plant and equipment0.4 0.5 
Net finance costs30.1 29.0 
Taxation7.4 9.4 
Operating cash flow before changes in working capital, provisions and exceptional items
122.1 144.8 
Decrease/(increase) in inventories14.2 (34.3)
Increase in trade and other receivables(81.3)(53.7)
Increase in trade and other payables77.1 20.6 
(Decrease)/increase in employee benefits and other provisions(0.2)1.9 
Cash generated from operations before tax and exceptional items131.9 79.3 
Cash flows relating to exceptional items(24.0)(14.0)
Tax paid(8.9)(10.0)
Net cash generated from operating activities99.0 55.3 
Cash flows from investing activities
Purchase of property, plant and equipment and intangibles(18.8)(20.6)
Interest received2.0 1.1 
Cash used in investing activities(16.8)(19.5)
Cash flows from financing activities
Repurchase of ordinary shares(7.1)— 
Payment of lease liabilities(7.2)(7.0)
Dividends paid(22.3)— 
Payment of financing fees(0.5)(0.5)
Interest paid(50.4)(19.3)
Net cash used in financing activities(87.5)(26.8)
Net (decrease)/increase in cash and cash equivalents(5.3)9.0 
Cash and cash equivalents at beginning of period399.7 366.8 
Effect of exchange rate fluctuations(3.7)(4.9)
Cash and cash equivalents at end of period390.7 370.9 

6


Nomad Foods Limited
Adjusted Financial Information
(In € millions, except per share data)
Reconciliation of Non-IFRS Financial Measures
The following table reconciles adjusted financial information for the three months ended March 31, 2024 to the reported results of Nomad Foods for such period.
Adjusted Statement of Profit or Loss (unaudited)
Three Months Ended March 31, 2024
€ in millions, except per share dataAs reported for the three months ended March 31, 2024AdjustmentsAs adjusted for the three months ended March 31, 2024
Revenue783.7 — 783.7 
Cost of sales(572.8)— (572.8)
Gross profit210.9  210.9 
Other operating expenses(115.4)3.7 (a)(111.7)
Exceptional items(23.5)23.5 (b)— 
Operating profit72.0 27.2 99.2 
Finance income5.9 (4.1)1.8 
Finance costs(36.0)10.4 (25.6)
Net financing costs(30.1)6.3 (c)(23.8)
Profit before tax41.9 33.5 75.4 
Taxation(7.4)(7.4)(d)(14.8)
Profit for the period34.5 26.1 60.6 
Weighted average shares outstanding in millions - basic163.2 163.2 
Basic earnings per share0.21 0.37 
Weighted average shares outstanding in millions - diluted163.3 163.3 
Diluted earnings per share0.21 0.37 

(a)Represents share based payment charge including employer payroll taxes of €3.4 million and non-operating M&A transaction costs of €0.3 million.
(b)Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within ‘Exhibit 99.2 - Condensed Consolidated Interim Financial Statements’ for a detailed list of exceptional items.
(c)Elimination of €4.1 million net gains on repricing of debt, €10.2 million of foreign exchange translation losses and €0.2 million of foreign exchange losses on derivatives.
(d)Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises.




7


Reconciliation of Non-IFRS Financial Measures (continued)
The following table reconciles adjusted financial information for the three months ended March 31, 2023 to the reported results of Nomad Foods for such period.
Adjusted Statement of Profit or Loss (unaudited)
Three Months Ended March 31, 2023
€ in millions, except per share dataAs reported for the three months ended March 31, 2023AdjustmentsAs adjusted for the three months ended March 31, 2023
Revenue775.1 — 775.1 
Cost of sales(550.9)— (550.9)
Gross profit224.2  224.2 
Other operating expenses(114.5)14.3 (a)(100.2)
Exceptional items(30.1)30.1 (b)— 
Operating profit79.6 44.4 124.0 
Finance income1.1 — 1.1 
Finance costs(30.1)5.9 (24.2)
Net financing costs(29.0)5.9 (c)(23.1)
Profit before tax50.6 50.3 100.9 
Taxation(9.4)(10.9)(d)(20.3)
Profit for the period41.2 39.4 80.6 
Weighted average shares outstanding in millions - basic174.5 174.5 
Basic earnings per share0.24 0.46 
Weighted average shares outstanding in millions - diluted
174.5 174.5 
Diluted earnings per share0.24 0.46 

(a)Represents share based payment charge including employer payroll taxes of €13.9 million and non-operating M&A transaction costs of €0.4 million.
(b)Represents exceptional items which management believes are non-recurring and do not have a continuing impact. See Note 6, Exceptional items, within ‘Exhibit 99.2 - Condensed Consolidated Interim Financial Statements’ for a detailed list of exceptional items.
(c)Elimination of €5.8 million of foreign exchange translation losses and €0.1 million of foreign exchange losses on derivatives.
(d)Represents tax impact of the above at the applicable tax rate for each adjustment, determined by the nature of the item and the jurisdiction in which it arises.
8


Reconciliation of Non-IFRS Financial Measures (continued)
Reconciliation of Profit for the period to Adjusted EBITDA (unaudited)
Three months ended
€ in millionsMarch 31, 2024March 31, 2023
Profit for the period34.5 41.2 
Taxation7.4 9.4 
Net financing costs30.1 29.0 
Depreciation & amortization23.1 22.3 
Exceptional items (a)
23.5 30.1 
Other add-backs (b)
3.7 14.3 
Adjusted EBITDA122.3 146.3 
Revenue783.7 775.1 
Adjusted EBITDA margin (c)
15.6 %18.9 %

(a)Adjustment to add back exceptional items. See Note 6, Exceptional items, within ‘Exhibit 99.2 - Condensed Consolidated Interim Financial Statements’ for a detailed list of exceptional items.
(b)Represents the elimination of share-based payment charges including employer payroll taxes for the three month period to March 31, 2024 of €3.4 million (2023: €13.9 million) as well as the elimination of non-operating M&A transaction costs for the three month period to March 31, 2024 of €0.3 million (2023: €0.4 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.
(c)Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by Revenue.


9


Nomad Foods Limited
Adjusted Financial Information (continued)

Appendix 1: Reconciliation from reported to organic revenue growth/(decline)
Year on Year Growth - March 31, 2024 compared with March 31, 2023:
Three Months Ended March 31, 2024
YoY change
Reported Revenue Growth1.1 %
Of which:
Organic Revenue Growth/(Decline)0.3 %
Translational FX (a)0.8 %
Total1.1 %

(a)Translational FX is calculated by translating data of the current and comparative periods using a budget foreign exchange rate that is set once a year as part of the Company's internal annual forecast process.

10


Nomad Foods Limited
Adjusted Financial Information (continued)

Appendix 2: Historical Year on Year Organic revenue growth/(decline) split by volume and Price/Mix


YoY changeThree Months Ended March 31, 2024
Volume(2.2)%
Price/Mix2.5 %
Organic Revenue Growth/(decline)0.3 %

YoY changeTwelve Months Ended December 31, 2023Three Months Ended December 31, 2023Three Months Ended September 30, 2023Three Months Ended June 30, 2023Three Months Ended March 31, 2023
Volume(10.9)%(8.0)%(12.7)%(12.0)%(9.7)%
Price/Mix15.8 %9.9 %14.3 %20.6 %17.7 %
Organic Revenue Growth/(decline)4.9 %1.9 %1.6 %8.6 %8.0 %

YoY changeTwelve Months Ended December 31, 2022Three Months Ended December 31, 2022Three Months Ended September 30, 2022Three Months Ended June 30, 2022Three Months Ended March 31, 2022
Volume(6.9)%(8.3)%(5.6)%(7.3)%(6.3)%
Price/Mix8.7 %16.0 %12.8 %4.1 %1.8 %
Organic Revenue Growth/(decline)1.8 %7.7 %7.2 %(3.2)%(4.5)%

YoY changeTwelve Months Ended December 31, 2021Three Months Ended December 31, 2021Three Months Ended September 30, 2021Three Months Ended June 30, 2021Three Months Ended March 31, 2021
Volume(2.4)%(4.4)%(0.3)%(3.2)%(1.6)%
Price/Mix0.3 %(0.1)%(1.1)%(1.3)%3.4 %
Organic Revenue Growth/(decline)(2.1)%(4.5)%(1.4)%(4.5)%1.8 %









11


Forward-Looking Statements
Forward-Looking Statements and Disclaimers

Certain statements in this announcement are forward-looking statements which are based on the Company’s expectations, intentions
and projections regarding its future performance, anticipated events or trends and other matters that are not historical facts, including
the Company’s expectations regarding (i) its future operating and financial performance, including its reiterated guidance with respect
to organic net revenue growth, Adjusted EBITDA growth, free cash flow conversion, Adjusted EPS, and Adjusted EPS growth for
2024; (ii) its ability to generate stronger bottom-line growth and superior shareholder returns; and (iii) its success in 2024 and beyond.

These statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: (i) the Company’s ability to effectively mitigate factors that negatively impact its supply of raw materials, including the conflict in Ukraine; (ii) the Company’s ability to successfully mitigate inflationary changes in the market; (iii) the Company’s ability to successfully identify suitable acquisition targets and adequately evaluate the potential performance of such acquisition targets; (iv) the Company’s ability to successfully implement its strategies (including its M&A strategy) and strategic initiatives and to recognize the anticipated benefits of such strategic initiatives; (v) the Company’s ability to accurately predict the performance of its Green Cuisine brand and the Findus Switzerland and Fortenova's frozen food businesses' and their impact on the Company’s growth; (vi) the Company’s ability to effectively compete in its markets, including the ability of Green Cuisine to effectively compete in Continental Europe; (vii) changes in consumer preferences, such as meat substitutes, and the Company’s failure to anticipate and respond to such changes or to successfully develop and renovate products; (viii) the effects of reputational damage from unsafe or poor quality food products; (ix) the risk that securities markets will react negatively to actions by the Company; (x) the adequacy of the Company’s cash resources to achieve its anticipated growth agenda; (xi) increases in operating costs, including labor costs, and the Company’s ability to manage its cost structure; (xii) fluctuations in the availability of food ingredients and packaging materials that the Company uses in its products; (xiii) the Company’s ability to protect its brand names and trademarks; (xiv) the Company’s ability to prevent, or remediate, any future cybersecurity incidents; (xv) loss of the Company’s financial arrangements with respect to receivables factoring; (xvi) the loss of any of the Company’s major customers or a decrease in demand for its products; (xvii) economic conditions that may affect the Company’s future performance including exchange rate fluctuations; (xviii) the Company’s ability to successfully interpret and respond to key industry trends and to realize the expected benefits of its responsive actions; (xix) the Company’s failure to comply with, and liabilities related to, environmental, health and safety laws and regulations; (xx) changes in applicable laws or regulations; and (xxi) the other risks and uncertainties disclosed in the Company’s public filings and any other public disclosures by the Company. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date of such statements and, except as required by applicable law, the Company does not undertake any obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

No Offer or Solicitation

This release and referenced conference call is provided for informational purposes only and does not constitute an offer to sell, or an invitation to subscribe for, purchase or exchange, any securities or the solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance, exchange or transfer of the securities referred to in this press release in any jurisdiction in contravention of applicable law.

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.


12
EX-99.2 3 nomd-20240331.htm CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS nomd-20240331
6-Kfalse2024-03-312024Q1Nomad Foods Ltd.000165171712/31iso4217:EURiso4217:EURxbrli:sharesutr:Ratexbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:shares00016517172024-01-012024-03-3100016517172024-03-3100016517172023-12-3100016517172023-01-012023-03-310001651717ifrs-full:CapitalReserveMember2023-12-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2023-12-310001651717ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-12-310001651717ifrs-full:ReserveOfCashFlowHedgesMember2023-12-310001651717ifrs-full:RetainedEarningsMember2023-12-310001651717ifrs-full:EquityAttributableToOwnersOfParentMember2023-12-310001651717ifrs-full:RetainedEarningsMember2024-01-012024-03-310001651717ifrs-full:EquityAttributableToOwnersOfParentMember2024-01-012024-03-310001651717ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2024-01-012024-03-310001651717ifrs-full:ReserveOfCashFlowHedgesMember2024-01-012024-03-310001651717ifrs-full:CapitalReserveMember2024-01-012024-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2024-01-012024-03-310001651717ifrs-full:CapitalReserveMember2024-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2024-03-310001651717ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2024-03-310001651717ifrs-full:ReserveOfCashFlowHedgesMember2024-03-310001651717ifrs-full:RetainedEarningsMember2024-03-310001651717ifrs-full:EquityAttributableToOwnersOfParentMember2024-03-310001651717ifrs-full:CapitalReserveMember2022-12-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2022-12-310001651717ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-12-310001651717ifrs-full:ReserveOfCashFlowHedgesMember2022-12-310001651717ifrs-full:RetainedEarningsMember2022-12-310001651717ifrs-full:EquityAttributableToOwnersOfParentMember2022-12-310001651717ifrs-full:RetainedEarningsMember2023-01-012023-03-310001651717ifrs-full:EquityAttributableToOwnersOfParentMember2023-01-012023-03-310001651717ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-01-012023-03-310001651717ifrs-full:ReserveOfCashFlowHedgesMember2023-01-012023-03-310001651717ifrs-full:CapitalReserveMember2023-01-012023-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2023-01-012023-03-310001651717ifrs-full:CapitalReserveMember2023-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2023-03-310001651717ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2023-03-310001651717ifrs-full:ReserveOfCashFlowHedgesMember2023-03-310001651717ifrs-full:RetainedEarningsMember2023-03-310001651717ifrs-full:EquityAttributableToOwnersOfParentMember2023-03-3100016517172022-12-3100016517172023-03-310001651717ifrs-full:MaterialReconcilingItemsMember2024-01-012024-03-310001651717ifrs-full:MaterialReconcilingItemsMember2023-01-012023-03-310001651717country:GB2024-01-012024-03-310001651717country:GB2023-01-012023-03-310001651717country:DE2024-01-012024-03-310001651717country:DE2023-01-012023-03-310001651717country:IT2024-01-012024-03-310001651717country:IT2023-01-012023-03-310001651717country:FR2024-01-012024-03-310001651717country:FR2023-01-012023-03-310001651717country:SE2024-01-012024-03-310001651717country:SE2023-01-012023-03-310001651717country:HR2024-01-012024-03-310001651717country:HR2023-01-012023-03-310001651717country:AT2024-01-012024-03-310001651717country:AT2023-01-012023-03-310001651717country:NO2024-01-012024-03-310001651717country:NO2023-01-012023-03-310001651717country:RS2024-01-012024-03-310001651717country:RS2023-01-012023-03-310001651717country:ES2024-01-012024-03-310001651717country:ES2023-01-012023-03-310001651717country:CH2024-01-012024-03-310001651717country:CH2023-01-012023-03-310001651717nomd:RestOfEuropeMember2024-01-012024-03-310001651717nomd:RestOfEuropeMember2023-01-012023-03-310001651717nomd:SeniorEurDebtMember2024-03-3100016517172023-04-012023-04-010001651717ifrs-full:KeyManagementPersonnelOfEntityOrParentMember2024-01-012024-03-310001651717ifrs-full:DerivativesMember2024-03-310001651717ifrs-full:TradeReceivablesMember2024-03-310001651717nomd:CashAndCashEquivalents1Member2024-03-310001651717ifrs-full:DerivativesMember2024-03-310001651717nomd:TradePayablesMember2024-03-310001651717nomd:LoansandBorrowingsExcludingDeferredBorrowingCostsMember2024-03-310001651717nomd:LiabilityrelatingtoIFRS16Member2024-03-310001651717ifrs-full:DerivativesMember2023-12-310001651717ifrs-full:TradeReceivablesMember2023-12-310001651717nomd:CashAndCashEquivalents1Member2023-12-310001651717ifrs-full:DerivativesMember2023-12-310001651717nomd:TradePayablesMember2023-12-310001651717nomd:LoansandBorrowingsExcludingDeferredBorrowingCostsMember2023-12-310001651717nomd:LiabilityrelatingtoIFRS16Member2023-12-310001651717nomd:SeniorUSDDebtMember2022-11-080001651717nomd:SeniorUSDDebtMember2024-03-310001651717nomd:SeniorEURODebtMember2024-03-310001651717nomd:SeniorUSDDebtMember2024-01-012024-03-310001651717nomd:SeniorUSDDebtMember2022-12-3100016517172022-11-080001651717nomd:SeniorEURODebtMember2022-11-082022-11-080001651717nomd:SeniorUSDDebtMember2023-12-3100016517172023-01-012023-12-310001651717nomd:SeniorEURUSDLoansMembernomd:LoansandBorrowingsMemberifrs-full:Level2OfFairValueHierarchyMember2024-03-310001651717nomd:SeniorEURUSDLoansMembernomd:LoansandBorrowingsMemberifrs-full:Level2OfFairValueHierarchyMember2023-12-310001651717nomd:SeniorEURUSDLoansMembernomd:LoansandBorrowingsMember2024-03-310001651717nomd:SeniorEURUSDLoansMembernomd:LoansandBorrowingsMember2023-12-310001651717nomd:OtherborrowingsDomainnomd:LoansandBorrowingsMember2024-03-310001651717nomd:OtherborrowingsDomainnomd:LoansandBorrowingsMember2023-12-310001651717nomd:LoansandBorrowingsMemberifrs-full:Level1OfFairValueHierarchyMembernomd:TwentyTwentyEightFixedRateSeniorSecuredNotesMember2024-03-310001651717nomd:LoansandBorrowingsMemberifrs-full:Level1OfFairValueHierarchyMembernomd:TwentyTwentyEightFixedRateSeniorSecuredNotesMember2023-12-310001651717nomd:LoansandBorrowingsMembernomd:TwentyTwentyEightFixedRateSeniorSecuredNotesMember2024-03-310001651717nomd:LoansandBorrowingsMembernomd:TwentyTwentyEightFixedRateSeniorSecuredNotesMember2023-12-310001651717nomd:DeferredFinancingCostsMembernomd:LoansandBorrowingsMember2024-03-310001651717nomd:DeferredFinancingCostsMembernomd:LoansandBorrowingsMember2023-12-310001651717nomd:LoansandBorrowingsMember2024-03-310001651717nomd:LoansandBorrowingsMember2023-12-310001651717ifrs-full:RestructuringProvisionMember2023-12-310001651717ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember2023-12-310001651717ifrs-full:MiscellaneousOtherProvisionsMember2023-12-310001651717ifrs-full:RestructuringProvisionMember2024-01-012024-03-310001651717ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember2024-01-012024-03-310001651717ifrs-full:MiscellaneousOtherProvisionsMember2024-01-012024-03-310001651717ifrs-full:RestructuringProvisionMember2024-03-310001651717ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember2024-03-310001651717ifrs-full:MiscellaneousOtherProvisionsMember2024-03-310001651717country:DE2023-12-310001651717country:DE2024-03-310001651717country:SE2024-03-310001651717nomd:RestrictedStock1Membernomd:January12021Member2023-12-310001651717nomd:January12022Membernomd:RestrictedStock1Member2023-12-310001651717nomd:RestrictedStock1Membernomd:January12023Member2023-12-310001651717nomd:January12024Membernomd:RestrictedStock1Member2023-12-310001651717nomd:OtherAwardsMembernomd:RestrictedStock1Member2023-12-310001651717nomd:RestrictedStock1Member2023-12-310001651717nomd:RestrictedStock1Membernomd:January12021Member2024-01-012024-03-310001651717nomd:January12022Membernomd:RestrictedStock1Member2024-01-012024-03-310001651717nomd:RestrictedStock1Membernomd:January12023Member2024-01-012024-03-310001651717nomd:January12024Membernomd:RestrictedStock1Member2024-01-012024-03-310001651717nomd:OtherAwardsMembernomd:RestrictedStock1Member2024-01-012024-03-310001651717nomd:RestrictedStock1Member2024-01-012024-03-310001651717nomd:RestrictedStock1Membernomd:January12021Member2024-03-310001651717nomd:January12022Membernomd:RestrictedStock1Member2024-03-310001651717nomd:RestrictedStock1Membernomd:January12023Member2024-03-310001651717nomd:January12024Membernomd:RestrictedStock1Member2024-03-310001651717nomd:OtherAwardsMembernomd:RestrictedStock1Member2024-03-310001651717nomd:RestrictedStock1Member2024-03-310001651717nomd:January12018Membernomd:RestrictedStock1Member2022-12-310001651717nomd:January12019Membernomd:RestrictedStock1Member2022-12-310001651717nomd:January12020Membernomd:RestrictedStock1Member2022-12-310001651717nomd:RestrictedStock1Membernomd:January12021Member2022-12-310001651717nomd:January12022Membernomd:RestrictedStock1Member2022-12-310001651717nomd:OtherAwardsMembernomd:RestrictedStock1Member2022-12-310001651717nomd:RestrictedStock1Member2022-12-310001651717nomd:January12018Membernomd:RestrictedStock1Member2023-01-012023-03-310001651717nomd:January12019Membernomd:RestrictedStock1Member2023-01-012023-03-310001651717nomd:January12020Membernomd:RestrictedStock1Member2023-01-012023-03-310001651717nomd:RestrictedStock1Membernomd:January12021Member2023-01-012023-03-310001651717nomd:January12022Membernomd:RestrictedStock1Member2023-01-012023-03-310001651717nomd:OtherAwardsMembernomd:RestrictedStock1Member2023-01-012023-03-310001651717nomd:RestrictedStock1Member2023-01-012023-03-310001651717nomd:January12018Membernomd:RestrictedStock1Member2023-03-310001651717nomd:January12019Membernomd:RestrictedStock1Member2023-03-310001651717nomd:January12020Membernomd:RestrictedStock1Member2023-03-310001651717nomd:RestrictedStock1Membernomd:January12021Member2023-03-310001651717nomd:January12022Membernomd:RestrictedStock1Member2023-03-310001651717nomd:OtherAwardsMembernomd:RestrictedStock1Member2023-03-310001651717nomd:RestrictedStock1Member2023-03-310001651717nomd:January12021Membernomd:RestrictedStock1Member2021-01-012021-01-310001651717nomd:January12021Membernomd:RestrictedStock1Member2024-01-012024-03-310001651717nomd:January12021Membernomd:RestrictedStock1Member2021-01-010001651717nomd:January12022Membernomd:RestrictedStock1Member2022-01-012022-01-010001651717nomd:January12022Membernomd:RestrictedStock1Member2024-01-012024-03-310001651717nomd:January12023Membernomd:RestrictedStock1Member2023-01-012023-01-010001651717nomd:OtherAwardsMembernomd:RestrictedStock1Member2023-01-012023-01-010001651717nomd:RestrictedStock1Membernomd:January12024Member2024-01-012024-01-010001651717nomd:January12018Membernomd:RestrictedStock1Member2023-01-012023-01-010001651717nomd:January12018Membernomd:RestrictedStock1Member2023-01-010001651717nomd:January12018Memberifrs-full:OrdinarySharesMembernomd:RestrictedStock1Member2023-01-012023-01-010001651717nomd:ManagementAward2019Membernomd:RestrictedStock1Member2023-01-012023-01-010001651717nomd:ManagementAward2019Membernomd:RestrictedStock1Member2023-01-010001651717nomd:ManagementAward2019Memberifrs-full:OrdinarySharesMembernomd:RestrictedStock1Member2023-01-012023-01-010001651717nomd:ManagementAward2020Membernomd:RestrictedStock1Member2023-02-012023-02-010001651717nomd:ManagementAward2020Membernomd:RestrictedStock1Member2023-02-010001651717ifrs-full:OrdinarySharesMembernomd:ManagementAward2020Membernomd:RestrictedStock1Member2023-02-012023-02-010001651717nomd:ManagementAward2021Membernomd:RestrictedStock1Member2024-03-012024-03-010001651717nomd:ManagementAward2021Membernomd:RestrictedStock1Member2024-03-010001651717ifrs-full:OrdinarySharesMembernomd:ManagementAward2020Membernomd:RestrictedStock1Member2024-03-012024-03-010001651717nomd:January12021Member2021-01-010001651717nomd:January12022Member2022-01-010001651717nomd:January12023Member2023-01-010001651717nomd:January12023Member2024-01-010001651717nomd:OtherAwardsMember2023-01-010001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMembernomd:RestrictedStock1Member2024-01-012024-03-310001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember2022-07-012022-07-010001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMembernomd:RestrictedStock1Member2022-07-010001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember2023-01-012023-12-310001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember2023-07-062023-07-060001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMembernomd:RestrictedStock1Member2023-07-060001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMembernomd:RestrictedStock1Member2023-01-012023-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2023-12-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2022-12-310001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMemberifrs-full:ReserveOfSharebasedPaymentsMember2024-01-012024-03-310001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMemberifrs-full:ReserveOfSharebasedPaymentsMember2023-01-012023-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMemberifrs-full:KeyManagementPersonnelOfEntityOrParentMember2024-01-012024-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMemberifrs-full:KeyManagementPersonnelOfEntityOrParentMember2023-01-012023-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMembernomd:KeyManagementPersonnelOfEntityOrParentReclassificationToTaxLiabilityMember2024-01-012024-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMembernomd:KeyManagementPersonnelOfEntityOrParentReclassificationToTaxLiabilityMember2023-01-012023-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2024-03-310001651717ifrs-full:ReserveOfSharebasedPaymentsMember2023-03-3100016517172021-08-052021-08-050001651717ifrs-full:OrdinarySharesMember2021-08-052021-12-310001651717ifrs-full:OrdinarySharesMember2021-12-310001651717ifrs-full:OrdinarySharesMember2022-01-012022-12-310001651717ifrs-full:OrdinarySharesMember2022-12-310001651717ifrs-full:OrdinarySharesMember2023-01-012023-12-310001651717ifrs-full:OrdinarySharesMember2023-12-3100016517172023-11-062023-11-060001651717ifrs-full:OrdinarySharesMember2024-01-012024-03-310001651717ifrs-full:OrdinarySharesMember2024-03-310001651717ifrs-full:OrdinarySharesMembernomd:IssuedCapitalAndCapitalReserveMember2024-03-310001651717ifrs-full:OrdinarySharesMembernomd:IssuedCapitalAndCapitalReserveMember2023-12-310001651717ifrs-full:CashFlowHedgesMember2024-03-310001651717ifrs-full:CashFlowHedgesMember2023-12-310001651717nomd:CostOfHedgingReserveMember2024-03-310001651717nomd:CostOfHedgingReserveMember2023-12-310001651717nomd:MariposaCapitalandTOMSCapitalMembernomd:AffiliateOfFounderEntitiesMember2022-01-012022-01-010001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember2024-01-012024-03-310001651717nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember2023-01-012023-03-31

Exhibit 99.2

Nomad Foods Limited
Condensed Consolidated Interim Financial Statements (unaudited)
For the three months ended March 31, 2024



Nomad Foods Limited—Interim management report
General information

Nomad Foods Limited (NYSE: NOMD) is Europe's leading frozen foods company. Nomad Foods Limited's (the “Company” or “Nomad”) portfolio of iconic brands, which includes Birds Eye, Findus, iglo, Ledo and Frikom, have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad Foods is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.

Nomad was incorporated in the British Virgin Islands on April 1, 2014. The address of Nomad’s registered office is Ritter House, Wickhams Cay II, Road Town, Tortola, VG1110 British Virgin Islands. The Company is domiciled for tax in the United Kingdom.
Results for the three months ended March 31, 2024
The Company’s financial results are discussed within the press release which accompanies these unaudited condensed consolidated interim financial statements.
Liquidity review
 For the three months ended March 31,
20242023
 €m€m
Net cash generated from operating activities99.055.3
Cash used in investing activities(16.8)(19.5)
Net cash used in financing activities(87.5)(26.8)
Net (decrease)/increase in cash and cash equivalents(5.3)9.0
Cash and cash equivalents at end of period390.7370.9

Cash and cash equivalents decreased during the three months ended March 31, 2024, compared to an increase in the three months ended March 31, 2023.

Net cash provided by operating activities increased by €43.7 million compared to the three months ended March 31, 2023, primarily driven by changes in working capital. The net cash inflow from changes in working capital was €9.8 million in the three months ended March 31, 2024, compared to a net cash outflow of €65.5 million in the three months ended March 31, 2023.

Net cash used in investing activities decreased by €2.7 million compared to the three months ended March 31, 2023. Payments for property, plant and equipment and intangibles of €18.8 million were offset by interest received of €2.0 million in the three months ended March 31, 2024, compared to payments for property, plant and equipment and intangibles of €20.6 million and €1.1 million interest received in the three months ended March 31, 2023.

Net cash used in financing activities increased by €60.7 million compared to the three months ended March 31, 2023. The net cash outflow in the three months ended March 31, 2024 included interest payments of €50.4 million, dividend payments of €22.3 million, payments for the repurchase of ordinary shares of €7.1 million and lease payments of €7.2 million. The net cash outflow in the three months ended March 31, 2023 included interest payments of €19.3 million and lease payments of €7.0 million.
2


Nomad Foods Limited—Risk Factors

An investment in our ordinary shares carries a significant degree of risk. You should carefully consider the following risks and other information in this interim report, including our condensed consolidated interim financial statements and related notes included in this document, before you decide to purchase our ordinary shares. Additional risks and uncertainties of which we are not presently aware or that we currently deem immaterial could also affect our business operations and financial condition. If any of these risks actually occur, our business, financial condition, results of operations or prospects could be materially affected. As a result, the trading price of our ordinary shares could decline, and you could lose part or all of your investment.
i.Risk Factor Summary
The risks described below include, but are not limited to, the following:
Risks Related to Our Business and Industry
We operate in a highly competitive market.
Sales of our products are subject to changing consumer preferences and trends.
Our future results and competitive position are dependent on the successful development of new products and improvement of existing products.
The ongoing conflict between Ukraine and Russia and the wider geopolitical impact of conflict could materially and adversely affect our business.
We may not be able to increase prices to offset inflationary pressures on costs for materials or other inputs.
Pandemics could have a material adverse impact on our business, results of operations and financial condition.
We are exposed to macroeconomic and other trends that could adversely impact our operations in our Key Markets.
We may not be able to source raw materials or other inputs of an acceptable type or quality.
We rely on sales to a limited number of large food retailers.
We may be subject to increased distribution costs or disruption of transportation services.
Failure to protect our brand names and trademarks could materially affect our business.
Our business is dependent on third-party suppliers.
Health concerns or adverse developments with respect to the safety or quality of our products may damage our reputation, increase our costs of operations and decrease demand for our products.
A failure in our cold chain could lead to unsafe food conditions and increased costs.
Potential liabilities and costs from litigation could adversely affect our business.
We are exposed to local business and tax risks in many different countries.
The price of energy and other raw materials we consume in the manufacture, storage and distribution of our products are subject to volatile market conditions.
Our supply network and manufacturing and distribution facilities could be disrupted by climate-related factors and other factors beyond our control.
Seasonality impacts our business, and our revenue and working capital levels may vary quarter to quarter.
We may be unable to realize the expected benefits of actions taken to align our resources, operate more efficiently and control costs.
We may be subject to significant disruption in our workforce or the workforce of our suppliers.
Labor shortages and higher labor costs could adversely affect our business and financial results.
We are dependent upon key executives and highly qualified managers and we cannot assure their retention.
Failure to adequately address current and emerging sustainability risks, including environmental, social and governance matters, could have an impact on our business.
Risks Related to Our Acquisition Strategy
We may not be able to consummate future acquisitions or successfully integrate acquisitions into our business.
We may be subject to antitrust regulations with respect to future acquisition opportunities.
We may face significant competition for acquisition opportunities.
Any due diligence by us in connection with agreed acquisitions or potential future acquisitions may not reveal all relevant considerations or liabilities of the target business.
Risks Related to Regulations
We could incur material costs for violations of, or liabilities under applicable directives, regulations and laws.
We are subject to complying with a variety of regulatory schemes.
European privacy and data protection regulations could expose us to compliance risks and costs.
3


Risks Related to Financial Management
We have risks related to our indebtedness, including our ability to withstand adverse business conditions and to meet our debt service obligations.
Our variable rate indebtedness subjects us to interest rate risk.
We are exposed to exchange rate risks.
Changes to our payment terms with customers and suppliers may materially adversely affect our cash flows.
Dividend payments and purchases made pursuant to announced share repurchase programs may have an impact on our cash flows and our ability to meet our debt service obligations.
An impairment of the carrying value of goodwill or other intangible assets could negatively affect our consolidated operating results and net worth.
We are exposed to risks in connection with our treasury and cash management activities.
We face risks associated with certain pension obligations.
We are exposed to risks related to our financial arrangements with respect to receivables factoring, reverse factoring and supply chain financing.
We are a holding company whose principal source of operating cash is the income received from our subsidiaries.
The Founders and/or the Founder Entities may in the future enter into related party transactions with us.
General Risk Factors
We are subject to the risk of disruptions, failures or security breaches of our information technology systems.
Changes in accounting standards and subjective assumptions, estimates and judgments by management related to accounting matters could significantly affect our financial results.
We may incur liabilities that are not covered by insurance.
If we fail to or are unable to maintain effective internal controls over financial reporting, the accuracy and timeliness of our financial reporting may be adversely affected.
In connection with the preparation of our 2023 financial statements, we identified a material weakness in our internal control over financial reporting.
Risks Related to our Ordinary Shares
Outstanding equity award grants under our LTIP could require us to issue additional ordinary shares.
Our ordinary share price may be volatile.
Securities or industry analysts may not or may cease publishing research reports about us.
As a foreign private issuer, we are subject to different U.S. securities laws and NYSE governance standards.
We may lose our foreign private issuer status in the future.
The rights of shareholders under British Virgin Islands law differ from those under United States law.
The laws of the British Virgin Islands provide limited protection for minority shareholders.
British Virgin Islands companies may not be able to initiate shareholder derivative actions.
Shareholders may experience a dilution of their percentage ownership.
Risks Related to Taxation
Changes in tax law and practice may reduce any net returns for shareholders.
Failure to maintain our tax status may negatively affect our financial and operating results and shareholders.
Taxation of returns from subsidiaries may reduce any net return to shareholders.
If any dividend is declared in the future and paid in a foreign currency, U.S. holders may be taxed on a larger amount in U.S. Dollars than the U.S. Dollar amount actually received.
4


ii. Details of our Risk Factors
Risks Related to Our Business and Industry
We operate in a highly competitive market and our failure to compete effectively could adversely affect our results of operations.
The market for frozen food is highly competitive, and further consolidation in the industry would likely increase competition. Our competitors include retailers who promote private label products and well-established branded producers that operate on both a national and an international basis across single or multiple frozen food categories. We also face competition more generally from distributors and retailers of chilled and fresh products, baked goods and ready-made meals. We may not successfully compete with our existing competitors and new competitors may enter the market.
It is difficult to accurately predict the pricing or promotional actions of our competitors or their effect on consumer perceptions or the success of our own advertising and promotional efforts. Our competitors develop and launch products targeted to compete directly with our products. In order to effectively compete, our products must provide higher value and/or quality than alternatives, particularly during periods of economic uncertainty and rising prices. If they do not, consumers may be more likely to purchase private label products. Our retail customers, most of which promote their own private label products, control the shelf space allocations within their stores and they may allocate more shelf space to private label products, their own branded products or to our branded competitors’ products in accordance with their respective promotional or pricing strategies. Decreases in shelf space allocated to our products, increases in competitor promotional activity, aggressive marketing strategies by competitors, changes to the strategies deployed by retailers or other factors may require us to reduce our prices or invest greater amounts in advertising and promotion of our products to ensure our products remain competitive.
In addition, shoppers may move to other channels such as discounters. Discounters are supermarket retailers which offer a narrow range of food and grocery products at discounted prices and which typically focus more on non-branded rather than branded products. A continued increase in discounter sales may adversely affect the sales of our branded products. Market dynamics continue to evolve and growth rates might change by channel and over time. For example, during the COVID-19 pandemic we saw a shift in consumer behavior to online shopping. The growth in eCommerce has encouraged the entry of new competitors and business models, intensifying competition in the food industry.
Furthermore, some of our competitors may have substantially greater financial, marketing and other resources than we have. This creates competitive pressures that could cause us to lose market share or require us to lower prices, increase advertising expenditures or increase the use of discounting or promotional campaigns. These competitive factors may also restrict our ability to increase prices, including in response to commodity and other cost increases. If we are unable to continue to respond effectively to these and other competitive pressures, our customers may reduce orders of our products, may insist on prices that erode our margins or may allocate less shelf space and fewer displays for our products. These or other developments could materially and adversely affect our sales volumes and margins and result in a decrease in our operating results, which could have a material adverse effect on our business and financial condition.
Sales of our products are subject to changing consumer preferences and trends; if we do not correctly anticipate such changes, our sales and profitability may decline.
There are a number of trends in consumer preferences which have an impact on us and the frozen food industry as a whole. These include, among others, preferences for speed; convenience and ease of food preparation; value for money at a time when consumers are subject to increased inflationary pressure on household spending; natural, nutritious and well-proportioned meals; products that are sustainably sourced and produced and are otherwise environmentally friendly; and the recent trend towards meat substitutes. Concerns as to the health impacts and nutritional value of certain foods may increasingly result in food producers being encouraged or required to produce products with reduced levels of salt, sugar and fat and to eliminate trans-fatty acids and certain other ingredients, including gluten and animal products. Consumer preferences are also shaped by concern over waste reduction, the level of processing of certain products and the environmental impact of products.
The success of our business depends on both the continued appeal of our products and, given the varied backgrounds and tastes of our customer base, our ability to offer a sufficient range of products to satisfy a broad spectrum of preferences. Any shift in consumer preferences in the UK, Italy, Germany, France, Serbia or Austria (the “Key Markets”, based on sales of branded goods) could have a material adverse effect on our business.
Our competitiveness depends on our ability to predict and quickly adapt to consumer preferences and trends and to exploit profitable opportunities for product development without alienating our existing consumer base or focusing excessive resources or attention on unprofitable or short-lived trends. All of these efforts require significant research and development and marketing investments. If we are unable to respond in a timely and appropriate way to changes in demand or consumer preferences and trends, our sales volumes and margins could be materially adversely affected.
5


Our future results and competitive position are dependent on the successful development of new products and improvement of existing products.
We aim to introduce new products and re-launch and extend existing product lines on a timely basis in order to counteract obsolescence and decreases in sales of existing products as well as to increase overall sales of our products. The launch and success of new or modified products are inherently uncertain, especially as to the products’ appeal to consumers, and there can be no assurance as to our continuing ability to develop and launch successful new products or variations of existing products. The failure to launch a product successfully can give rise to inventory write-offs and other costs, can affect consumer perception of our other products and can lead to erosion of brand equity. Market factors and the need to develop and provide modified or alternative products may also increase costs. In addition, launching new or modified products can result in cannibalization of sales of our existing products if consumers purchase the new product in place of our existing products. If we are unsuccessful in developing new products in response to changing consumer demands or preferences in an efficient and economical manner, or if our competitors respond more effectively than we do, demand for our products may decrease, which could materially and adversely affect our business, financial condition and results of operations.
The ongoing conflict between Ukraine and Russia and the wider geopolitical impact of conflict could materially and adversely affect our business.
On February 24, 2022, Russian forces invaded Ukraine. While we do not have any direct operations or sales in either Russia or Ukraine, these countries are responsible for the supply of many commonly used raw materials and resources used in, or in the manufacturing of products such as ours, including, but not limited to some species of fish, wheat and energy. The ongoing conflict in the Ukraine, and the imposition of economic sanctions and additional tariffs could result in considerable reductions in the availability or increase the cost of such raw materials and resources. In particular, both before and following the invasion, the U.S., the EU and the UK have imposed economic sanctions and tariffs on Russia. It is not clear to what extent such sanctions and tariffs could continue to proliferate and increase, what raw materials and resources may be affected, nor for how long they will be in place. Our inability, and the inability of our suppliers, to source certain raw materials, particularly fish, and provide certain products to customers and consumers could materially and adversely affect our business. In addition, sanctions and tariffs are intended to and will have an impact on international trade and the global economy. Further steps that might be taken in response to the crisis and their consequences are unknown but could include further sanctions, tariffs, embargoes, regional instability, adverse effects on macroeconomic conditions and adverse effects on exchange rates and financial markets.
Should there be additional sanctions, tariffs or restrictions on the supply of fish from Russian waters that impact our supply chain or specific products, it would not be possible to replace entirely the required volumes of MSC certified fish in the short-to-medium term. Furthermore, should there be a reduction in availability we may also face higher costs for the raw materials and resources available. In anticipation of that possibility, we are continually seeking clarity from governments on the issue and diversifying our supply sources for raw materials and resources. For example, we are continuing the diversification of our fish supply by looking into alternative species, geographies and product formats. However, these efforts are subject to negotiation of acceptable contractual terms, availability of alternative species at comparable prices and the conformity of any alternatives to our standards. Where additional sanctions or tariffs are being considered, we are asking for a realistic transition period. There is no guarantee that any such transition period will be provided.
Our factories in Europe use energy for which a proportion is sourced from Russia. If sanctions, tariffs or restrictions were to be implemented by Russia or the EU on the use of such resources this could materially and adversely affect our business.
Additionally, the invasion of Ukraine by Russian forces and the impact of wider geopolitical conflicts could impact many of the other risk factors listed in these Risk Factors. In particular, but not limited to, the conflicts could have an effect on our profitability, fluctuations on our future borrowings, fluctuations on the foreign currency market, the cost of borrowings, the prevailing rate of inflation, the creditworthiness of our customers and our suppliers, the laws and regulations affecting our business and the carrying value of goodwill and other assets in our business. To the extent conflicts are ongoing, the potential for related sanctions, potential government actions and economic impact remain uncertain. At this time it is not possible to predict the extent or nature of these impacts on our business although we expect the current conflicts to continue for some time. Any change or movement in any of the elements listed in this section could materially and adversely affect our business.
6


We may not be able to increase prices to fully offset inflationary pressures on costs for materials or other inputs.
Our ability to pass through increases in the prices of raw materials, energy, packaging or freight and logistics costs to our customers depends, among others, on prevailing competitive conditions and pricing methods in the markets in which we operate, and we may not be able to pass through such price increases to our customers. Even if we are able to pass through increases in prices, there is typically a time lag between cost increases impacting our business and implementation of product price increases during which time our profit margin may be negatively impacted. Recovery of cost inflation, driven by both commodity cost increases or changes in the foreign exchange rate of the currency the commodity is denominated in, can also lead to disparities in retailers’ shelf-prices between different brands and private label products which can result in a competitive disadvantage and volume decline. During our negotiations to increase our prices to recover cost increases, customers may take actions which exacerbate the impact of such cost increases, for example by ceasing to offer our products or deferring orders until negotiations have ended. Our inability to pass through price increases in raw materials, energy, packaging or freight and logistics and preserve our profit margins in the future could materially adversely affect our business, financial condition and results of operations.
Pandemics and other contagious outbreaks and government actions in response, could have a material adverse impact on our business, results of operations and financial condition.
The ultimate impact that a pandemic, such as COVID-19, or other contagious outbreaks will have on our business, results of operations and financial condition is uncertain. Restrictions, as well as prevention and mitigation measures, that may arise as a result of pandemic or contagious outbreak may have an adverse impact on global economic conditions.
We operate production space in facilities across Europe. We could, in the future, be forced to close our facilities or reduce operations due to government responses to any pandemic or employee illness or health concerns, including as a result of sustained periods of employees working from home. If a significant percentage of our workforce is unable to work, including because of illness or travel or government restrictions in connection with any pandemic or contagious outbreak, or if we are required to shut down one or more of our facilities, this could have a material adverse effect on our revenue, operations and results of operations.
The extent of a pandemic's effect on our operational and financial performance will depend on many factors, including the duration, spread, seasonality and intensity of further outbreaks, the emergence of new variants, the availability and effectiveness of vaccines and government responses to the pandemic (including any further lockdowns, mandatory social distancing or other restrictive measures), all of which are uncertain and difficult to predict. If a pandemic evolves in such a way that its effects are similar to the COVID-19 pandemic, the disease could exacerbate other risks we face, and also have a material adverse effect on our business, results of operations, financial condition and cash flows and adversely impact the trading price of our ordinary shares. Examples of trends which we saw as a result of COVID-19 restrictions included, supply chain pressures and delays as a result of localized lockdowns in China, increases in the cost of energy and raw materials, shortage of labor across Europe, and shortages of commercial truck drivers. A substantial supply of our fish is processed in China, and as such, any lockdowns or other incidents in China could have a material impact on our business if they increase or continue for a longer period than anticipated.

7


We are exposed to macroeconomic and other trends that could adversely impact our operations in our Key Markets.
We conduct operations in our Key Markets from which approximately 69% of our revenue was generated during the year ended December 31, 2023. We are particularly influenced by economic developments and changes in consumer habits in those countries.
The geographic markets in which we compete have been affected by negative macroeconomic trends which have affected consumer confidence. For example, inflation and resulting increases in the cost of living have created political and economic uncertainty both in the UK and the other geographies in which we operate. Additionally, the continuing conflict in Ukraine and wider geopolitical conflict will also affect different geographies in different ways. A deterioration in economic conditions could result in increased inflationary pressure, increased raw material and energy cost, increased unemployment rates, increased short and long-term interest rates, consumer and commercial bankruptcy filings, a decline in the strength of national and local economies, and other results that negatively impact household incomes. This can result in changes to consumers' purchasing habits, for example by purchasing more promoted products, purchasing cheaper private label products instead of equivalent branded products, switching to cheaper proteins and switching to discounter stores. Such macroeconomic trends could, among other things, negatively impact global demand for branded and premium food products, which could result in a reduction of sales or pressure on margins of our branded products or cause an increasing transfer to lower priced product categories.
We may not be able to source raw materials or other inputs of an acceptable type or quality.
We use significant quantities of food ingredients and packaging materials and are therefore vulnerable to fluctuations in the availability and price of such food ingredients, packaging materials and other supplies. In particular, raw materials have historically represented a significant portion of our cost of sales, and accordingly, adverse changes in raw material prices have in the past and may in the future, negatively impact our results of operations.
Specifically, the availability and the price of fish, vegetables and other agricultural commodities, including poultry and meat, can be volatile. The current conflict in Ukraine is also causing continuous changes in the global supply chain with fish, poultry, energy, fuel, edible oils, wheat, vegetables and packaging materials affected among others. We are also affected by the availability of quality raw materials, most notably fish, which can be impacted by the fishing and agricultural policies of the UK, US, European Union and other countries including national or international quotas that can limit the volume of raw materials.
General economic conditions, economic sanctions or tariffs, whether due to regional conflict or otherwise, unanticipated demand, problems in manufacturing or distribution, natural disasters, pandemics, weather conditions during the growing and harvesting seasons, farmers choosing to grow different crops due to changing economic conditions and commodity prices, plant, fish and livestock diseases, the availability of sustainably sourced raw materials, or national or international quarantines can all also adversely affect availability and prices of commodities and transportation costs in the long and short term.
While we attempt to negotiate fixed prices for certain materials with our suppliers for periods ranging from one month to a full year, we cannot guarantee that our strategy will be successful in managing input costs if prices increase for extended periods of time. Additionally, by entering fixed price agreements we may potentially be limiting our ability to benefit from possible price decreases. Moreover, there is no market for hedging against price volatility for certain raw materials and accordingly such materials are bought at the spot rate in the market.
Our ability to avoid the adverse effects of a pronounced, sustained price increase in raw materials is limited. Any increases in prices or scarcity of ingredients or packaging materials required for our products could increase our costs and disrupt our operations. If the availability of any of our inputs is constrained for any reason, we may not be able to obtain sufficient supplies or supplies of a suitable quality on favorable terms or at all. Such shortages could materially adversely affect our market share, business, financial condition and results of operations.
Lastly, activist groups have in the past, and may in the future, use pressure tactics to influence our decisions regarding commodities, raw materials and supply chains based on their stances regarding, for example, inhumane treatment of animals, human right abuses and deforestation by our suppliers. These groups may be able to coordinate their actions with other groups, threaten strikes or boycotts or enlist the support of well-known persons or organizations in order to increase the pressure on us to achieve their stated aims. In the future, these actions or the threat of these actions may force us to change our business practices or pricing policies, which may have a material adverse effect on our business, results of operations and financial condition.
8


We rely on sales to a limited number of large food retailers and should they perform poorly or the buying power of these large retailers increase, our business could be adversely affected.
Our retail customers include supermarkets and large chain food retailers. Throughout our markets, the food retail segments are highly concentrated. For the year ended December 31, 2023, our top 10 retail customers accounted for 32% of revenue. In recent years, the major multiple (multi-channel) retailers in Key Markets have increased their share of the grocery market and price competition between retailers has intensified. The strength of the major multiple retailers’ bargaining position gives them significant leverage over their suppliers in negotiating pricing, product specification and the level of supplier participation in promotional campaigns and offers, which can reduce our margins. International alliances among retailers continue to become stronger, and the trend for consolidation in Europe at a local level and across borders is ongoing, for example, there is an increasing establishment of cross border buying groups between retailers. Further consolidation among the major multiple retailers or disproportionate growth in relation to their competitors could increase their relative negotiating power and allow them to force a negative shift in our trade terms. Our results of operations could also be adversely affected if these retailers suffer a significant deterioration in sales performance, if we are required to reduce our prices or increase our promotional spending activity as a consequence, if we lose business from a major retail customer or if our relationship with a major retail customer deteriorates.
Our retail customers also offer private label products that compete directly with our products for retail shelf space and consumer purchases. Private label products typically have higher margins for retailers than other branded products. Accordingly, there is a risk that our retail customers may give higher priority to private label products, retailer owned brands or the branded products of our competitors as a result of a change in pricing strategy or a change in economic conditions which would adversely affect sales of our products. Our major multiple retail customers are also expanding into non-food product lines in their stores, thereby exerting pressure on available shelf space for other categories including our products. We may be unable to adequately respond to these trends and, as a result, the volume of our sales may decrease, or we may need to lower the prices of our products.
As is typical in our industry, sales to our retail customers in our markets are made on a daily demand basis. We generally do not have long-term contractual commitments to supply such customers and must renegotiate supply and pricing terms of our products on a regular basis. Customarily, trade terms are renegotiated annually or more frequently in periods of high inflation or deflation. It is not always the case that our retail customers accept more frequent negotiations of price increases or decreases nor the amount of them. In addition, ad hoc changes are often made on an informal basis, such as by email, to reflect discounts and promotional arrangements. Amounts paid can be subject to end of period reconciliations to reflect these informal arrangements. In some cases, our retail customers seek to claim reimbursement for informal discount arrangements going back multiple periods. In addition, we do not have written contractual arrangements with a number of our other retail customers. Most of our retail customer relationships or arrangements could be terminated or renegotiated at any time and, in some cases, without reasonable notice.
Our business is subject to the risks of non-payment and non-performance by our retail customers. We manage our exposure to credit risk through credit analysis and monitoring procedures, and sometimes use letters of credit, prepayments and guarantees. However, these procedures and policies cannot fully eliminate retail customer credit risk, and to the extent our policies and procedures prove to be inadequate, it could negatively affect our financial condition and results of operations. In addition, some of our retail customers may be highly leveraged and subject to their own operating and regulatory risks and, even if our credit review and analysis mechanisms work properly, we may experience financial losses in our dealings with such parties. Any future financial market disruptions or tightening of the credit markets could result in some of our retail customers experiencing a significant decline in profits and/or reduced liquidity. A significant adverse change in the financial position of a retail customer could require us to assume greater credit risk relating to that retail customer and could limit our ability to collect receivables. We do not maintain credit insurance to insure against retail customer credit risk.
Any of the above risk factors in relation to our retail customers could have a material adverse effect on our business, financial condition and results of operations.
We may be subject to increased distribution costs or disruption of transportation services.
We are dependent on third parties for almost all of our transportation and distribution requirements and distribution costs have historically fluctuated significantly over time. Increases in such costs could result in reduced profits. In addition, certain factors affecting distribution costs are controlled by our third-party carriers. To the extent that the market price for fuel or freight or the number or availability of carriers fluctuates, our distribution costs could be affected. Furthermore, temporary or long-term disruption of transportation services due to weather-related problems, pandemic related impacts, increased energy and fuel costs as a result of conflict, strikes or other events could impair our ability to supply products affordably and in a timely manner or at all. Failure to receive our raw materials or to deliver our food products promptly could also result in inventory spoilage. These factors could impact our commercial reputation and result in our customers reducing their orders or ceasing to order our products. We require the use of refrigerated vehicles to ship our products and such distribution costs represent an important element of our cost structure. If we change the transportation services we use, we could face logistical difficulties that could delay deliveries, and we could incur costs and expend resources in connection with such change. Any increases in the cost of transportation, energy or fuel, and any disruption in
9


transportation, including the availability of suitable transportation (including the availability of suitable refrigerated transport, freight containers or lorry drivers), could have a material adverse effect on our business, financial condition and results of operations.
Failure to protect our brand names and trademarks could materially affect our business.
Our principal brand names and trademarks (including but not limited to Birds Eye, iglo, Findus, Aunt Bessie's, Goodfella's, Ledo and Frikom) are key assets of our business and our success depends upon our ability to protect our intellectual property rights. We rely upon trademark and other intellectual property laws to establish and protect our intellectual property rights but cannot be certain that the actions we have taken or will take in the future will be adequate to prevent violation of our proprietary rights. Litigation may be necessary to enforce our trademark or proprietary rights. In addition, the Birds Eye brand, which we use in the UK, is used by other producers in the United States and Australia. Even though the brands have different logos, adverse publicity from such other markets may negatively impact the perception of our brands in our respective markets. Adverse publicity, legal action or other factors could lead to substantial erosion in the value of our brands, which could lead to decreased consumer demand and could have a material adverse effect on our business, financial condition and results of operations.
There is also a risk that other parties may have intellectual property rights covering some of our brands, products or technology. If any third parties bring a claim of intellectual property infringement against us, we may be subject to costly and time-consuming litigation, diverting the attention of management and our employees. If we are unsuccessful in defending against such claims, we may be subject to, among other things, significant damages, injunctions against development and sale of certain products, or we may be required to enter into costly licensing agreements, any of which could have an adverse impact on our business, financial condition, and results of operations.
Our business is dependent on third-party suppliers.
We outsource some of our business functions to third-party suppliers, such as the processing and supply of certain vegetables and other products, the manufacturing of certain products and packaging materials and distribution of our products. Our suppliers are subject to their own operational, sustainability and financial risks, which are out of our control. Our suppliers may fail to meet timelines or contractual obligations or fail to provide us with sufficient products or services, which may adversely affect our business. For example, if a third-party supplier is impacted by increased costs or unavailability of energy and raw materials as a result of the conflict in Ukraine, is prevented from supplying as a result of changes in the international sanctions or customs regimes, or fails to take adequate steps to operate their business sustainably with respect to environmental or social issues, this could negatively affect the price and availability of our ingredients, products and/or packaging materials and may adversely impact our supply chain, operations and corporate reputation. Moreover, there may be delays or shortages in procuring alternative suppliers, co-manufacturing capacity, or distribution capability.
Certain of our contracts with key suppliers, such as for the raw materials we use in our products, are short term, can be terminated by the supplier upon giving notice within a certain period and restrict us from using other suppliers. Also, a number of our supply contracts, including for fish and vegetables, may be terminated by the supplier upon a change in our ownership. Failure to appropriately structure or adequately manage our agreements with third parties may adversely affect our supply of raw materials or our supply of products to our customers. We are also subject to credit risk with respect to our third-party suppliers. If any such suppliers become insolvent, an appointed trustee could potentially ignore the service contracts we have in place with such party, resulting in increased charges or the termination of the service contracts. We may not be able to replace a service provider within a reasonable period of time, on as favorable terms or without disruption to our operations.
Any adverse changes to our relationships with third-party suppliers could have a material adverse effect on our image, brand and reputation, as well as on our business, financial condition and results of operations.
In addition, to the extent that our creditworthiness is impaired, or general economic conditions decline, certain of our key suppliers may demand different or onerous payment terms that could materially adversely affect our working capital position, or such suppliers may refuse to continue to supply to us or seek to re-negotiate the contracts they have with us. A number of our key suppliers have taken out trade credit insurance on our ability to pay them. To the extent that such trade credit insurance becomes unobtainable or more expensive due to market conditions, we may face adverse changes to payment terms by our key suppliers or they may refuse to continue to supply us.
10


Health concerns or adverse developments with respect to the safety or quality of products of the food industry may damage our reputation, increase our costs of operations and decrease demand for our products.
Food safety and the public’s perception that our products are safe and healthy are essential to our image and business. We sell food products for human consumption, which subjects us to safety risks such as product contamination, spoilage, misbranding or product tampering. Product contamination, including the presence of foreign objects, undeclared allergens, substances, chemicals or other agents or residues or the introduction of genetically modified organisms, could require product withdrawals or recalls or the destruction of inventory, and could result in negative publicity, reputational harm, temporary plant closures and substantial costs of compliance or remediation. We may also be impacted by publicity concerning any assertion that our products caused illness, injury or death. In addition, we could be subject to claims or lawsuits relating to an actual or alleged illness stemming from product contamination or any other incidents that compromise the safety and quality of our products. Any significant lawsuit or widespread product recall or other events leading to the loss of consumer confidence in the safety and quality of our products could damage our brand, reputation and image and negatively impact our sales, profitability and prospects for growth.
We could also be adversely affected if consumers lose confidence in the safety and quality of certain food products or ingredients, the sustainability credentials of certain products or ingredients, for example, palm oil or soy, the frozen category or the food safety system generally. If another company recalls or experiences negative publicity related to a product in a category in which we compete, consumers might reduce their overall consumption of products in this category or confuse our products with those of such company. Adverse publicity about these types of concerns, whether valid or not, may discourage consumers from buying our products or cause production and delivery disruptions. In addition, product recalls are difficult to foresee and prepare for and, in the event we are required to recall one or more of our products, such recall may result in loss of sales due to unavailability of our products and may take up a significant amount of our management’s time and attention. We cannot guarantee that our efforts to monitor food safety risks and such efforts of our suppliers will be successful or that such risks will not materialize. In addition, we cannot guarantee that our efforts, through contractual relationships and regular inspections, to control the risk of contamination caused by third parties, including in relation to the several manufacturing and distribution processes we outsource, will be successful or that contamination of our products by third parties will not materialize and have a material adverse effect on our business, financial condition and results of operations.
We are also subject to further risks affecting the food industry generally, including risks posed by widespread contamination and evolving nutritional, environmental/sustainability, animal welfare, social and health-related concerns. For example, we could be affected by overfishing in the seafood supply chain which poses a risk to current and future fish stocks, ecosystems, and communities. Further damage is being done by careless fishing practices, including avoidable by-catch of non-target species and fishing equipment left in the ocean (known as Ghost Gear), which is a significant contributor to plastic pollution. Seafood supply chains are also at risk of a range of human rights abuses, including modern slavery. Overfishing risks are compounded by the negative consequences of climate change, including ocean heating and acidification. All or any of these factors could give rise to a negative perception of the seafood supply chain and lead to reduced sales, higher prices and consumers choosing alternative products. Regulatory authorities may limit the supply of or place prohibitive charges on certain types of food products in response to public health concerns and consumers may perceive certain products to be unsafe, unsustainable, unhealthy or otherwise undesirable. In addition, governmental regulations may require us to discontinue certain offerings or limit the range of products we offer, for example by limiting the amount of certain nutrients in our products as is currently the case with regard to High in Fat, Salt and Sugar ("HFSS") nutrients in the UK. We may be unable to find substitutes that are as appealing to our customer base, or such substitutes may not be widely available or may be available only at increased costs. Such substitutions or limitations could also reduce demand for our products.
We could also be subject to claims or lawsuits relating to an actual or alleged illness or injury or death stemming from the consumption of a misbranded, altered, contaminated or spoiled product, even where such misbranding, alteration, contamination or spoilage is out of our control, which could negatively affect our reputation and business. Awards of damages, settlement amounts and fees and expenses resulting from such claims and the public relations implications of any such claims could be significant and have an adverse effect on our business. The availability and price of insurance to cover claims for damages are subject to market forces that we do not control, and such insurance may not cover all the costs of such claims and would not cover damage to our reputation. Even if product liability claims against us are not successful or fully pursued, these claims could be costly and time consuming, increase our insurance premiums and divert our management’s time and resources towards defending them rather than operating our business. In addition, any adverse publicity concerning such claims, even if unfounded, could cause customers to lose confidence in the safety and quality of our products and damage our reputation and brand image.
11


A failure in our cold chain could lead to unsafe food conditions and increased costs.
“Cold chain” requirements setting out the temperatures at which our ingredients and products are stored are established both by statute and by us to help guarantee the safety of our food products. The cold chain is maintained from the moment the ingredients arrive at, or are frozen by, our suppliers, through our manufacturing and transportation of products and ultimately to the time of sale in retail stores. These standards ensure the quality, freshness and safety of our products. A failure in the cold chain could lead to wastage, increased costs, food contamination, risks to the health of consumers, fines and damage to our brands and reputation, each of which could have a material adverse effect on our business, financial condition and results of operations.
Potential liabilities and costs from litigation could adversely affect our business.
We are subject to litigation, arbitration and regulatory proceedings, audits and investigations from time to time. There is no guarantee that we will be successful in defending ourselves in civil, criminal or regulatory actions, including under general, commercial, employment, intellectual property, food quality and safety, anti-trust and trade, tax, advertising and claims, and environmental laws and regulations, or in asserting our rights under various new and existing laws and regulations. For example, we could face allegations of false, misleading or deceptive advertising, claims or marketing, allegations or investigations of anti-competitive practices or other criticisms which could result in litigation, arbitration or regulatory proceedings and result in potential liabilities or costs which may be significant and/or may damage our reputation. In addition, the defense of these lawsuits may divert our management’s attention from other business matters. The costs and other effects of potential and pending litigation and administrative actions against us, and new legal requirements, cannot be determined with certainty and may differ from expectations and may have a material adverse effect on our reputation, business, financial condition and results of operations.
We are exposed to local business and tax risks in many different countries.
Our business is subject to risks resulting from differing legal, political, social and regulatory requirements, economic conditions and unforeseeable developments in our markets, all or any of which could result in disruption of our activities. These risks include, among others, political instability, differing economic cycles, tariffs, duties and adverse economic conditions, changes in regulatory and legislative environments, currency exchange rate fluctuations, inability to collect payments or seek recourse under or comply with ambiguous or vague commercial or other laws, changes in distribution and supply channels, foreign exchange controls and restrictions on repatriation of funds, and difficulties in attracting and retaining qualified management and employees. Our overall success in the markets in which we operate depends, to a considerable extent, on our ability to effectively manage differing legal, political, social and regulatory requirements, economic conditions and both foreseeable and unforeseeable developments. We cannot guarantee that we will succeed in developing and implementing policies and strategies which will be effective in each location where we do business.
We must comply with complex and evolving tax regulations in the various jurisdictions in which we operate, which subjects us to international tax compliance risks. Some tax jurisdictions in which we operate have complex and subjective rules regarding income tax, value-added tax, sales or excise tax, tariffs, duties and transfer tax. From time to time, our foreign subsidiaries are subject to tax audits and may be required to pay additional taxes, interest or penalties should the taxing authority assert different interpretations, or different allocations or valuations of our services which could be material and could reduce our income and cash flow from our international subsidiaries. We currently have several pending tax assessments and audits in various jurisdictions including Germany. The agreements by which we acquired certain businesses provide for certain indemnifications of tax liabilities which may arise in certain jurisdictions which we believe are sufficient to address these specific tax matters as far as they relate to those businesses but our belief that these indemnities are sufficient may prove incorrect. We have also established, where appropriate, reserves and provisions for tax assessments which we believe to be adequate to address potential tax liabilities, where management assesses that it is probable that the liability will arise, but our belief that these reserves and provisions are adequate may prove incorrect. However, it is possible that the tax audits referred to above could result in the volatility of timings of cash tax payment and recoveries. In addition, it is possible that countries will increase tax rates in the future to address rising costs following the COVID-19 pandemic and global economic pressures.
12


The price of energy and other raw materials we consume in the manufacture, storage and distribution of our products are subject to volatile market conditions.
The price and availability of electricity and other energy resources required in the manufacture, storage and distribution of our products is subject to volatile market conditions. These market conditions are often affected by political and economic factors beyond our control, including, for instance, the energy policies of the countries in which we operate. For example, the current conflict in Ukraine is resulting in volatility in the markets for energy and fuel as a result of the widespread usage of gas, oil and coal from Russia throughout Europe. Any sustained increases in energy costs, or disruptions to or limitations in supply as a result of wider geopolitical conflict or otherwise, could have an adverse effect on our business, financial conditions and results of operations and could affect our competitive position if our competitors’ energy costs do not increase at the same rate as ours or if they do not suffer the same disruptions to or limitations in supply. Such disruptions may also occur as a result of the loss of energy supply contracts or the inability to enter into new energy supply contracts on commercially attractive terms. Furthermore, natural catastrophes, regional conflicts or similar events could affect the electricity grid. Any such disruptions or increases in energy costs as a result of the aforementioned factors or otherwise, could have a material adverse effect on our business, financial condition and results of operations.
Our supply network and manufacturing and distribution facilities could be disrupted by factors beyond our control.
Severe weather conditions and natural disasters, such as storms, floods, droughts, frosts, earthquakes or pestilence, may affect the supply of the raw materials and energy resources that we use for the manufacturing of our products. For example, climate change may increase the frequency of adverse weather events such as flooding or droughts in crop growing areas or changes in sea temperature that may adversely affect marine biomass, fishing catch rates and overall fishing conditions. In addition, drought or floods may affect the feed supply for red meat and poultry, which in turn may affect the quality and availability of protein sources for our products. Adverse weather conditions and natural disasters can reduce crop size and crop quality, which in turn can reduce our supplies of raw materials, lower recoveries of usable raw materials, increase the prices of our raw materials, increase our cost of transporting and storing raw materials and finished goods, or disrupt our production schedules. Competing food producers can be affected differently by weather conditions and natural disasters depending on the location of their supply sources. If our climate continues to change, whether as a result of increased greenhouse gas emissions or otherwise, and leads to increasingly severe weather conditions, shortages of raw materials, local water scarcity, soil health deterioration, ocean heating and acidification, increased price volatility, increased regulation, and impacts the quality of raw materials, together with any resulting social unrest, it could have a material adverse effect on our business, financial condition and results of operation.
In addition, our manufacturing and distribution facilities may be subject to damage, disruption or closure resulting from conflict, fire, terrorist activity, natural disasters, health epidemics or other causes. For example, our Lowestoft and Bremerhaven manufacturing facilities are situated in regions which have historically been prone to flooding. Extensive damage to any of our major manufacturing facilities as a result of any of the foregoing reasons, could, to the extent that lost production could not be compensated for by unaffected facilities, severely affect our ability to conduct our business operations and, as a result, adversely affect our business, financial condition and results of operations.
Furthermore, as we lease parts of our Boulogne, Bremerhaven, Lowestoft, and Tonsberg manufacturing sites, the use of these properties is subject to certain terms and conditions, the breach of which could affect our ability to continue use of these properties which in turn may disrupt our operations and may materially adversely affect our results of operations.
Also, while we do not have any direct operations or sales in either Russia or Ukraine, these countries are responsible for many commonly used raw materials and resources such as fish, edible oils, wheat and energy. The ongoing conflict in Ukraine could see considerable reductions in the availability or cost of such raw materials and resources, for example if the crops are not planted in as great a quantity in any year, and if we are not able to source or find suitable alternatives in a cost effective manner, then this may adversely affect our business, financial condition, and results of operations.
Seasonality impacts our business, and our revenue and working capital levels may vary quarter to quarter.
Our sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for savory frozen food are slightly higher in cold or winter months, partly because there are fewer fresh alternatives available for vegetables and because our customers typically allocate more freezer space to the ice cream segment in summer or hotter months. The one exception is our "Adriatic business", defined as those entities acquired in the Fortenova Acquisition in 2021, which follows a different seasonality pattern with stronger performance through the summer months as a result of the ice-cream business. In addition, variable production costs, including costs for seasonal staff, and working capital requirements associated with the keeping of inventories, vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, inventory (and therefore net working capital) levels typically peak in August to September just after the pea harvest. If seasonal fluctuations are greater than anticipated, our business, financial condition and results of operations could be adversely affected.
13


We may be unable to realize the expected benefits of actions taken to align our resources, operate more efficiently and control costs.
When required we take actions, such as workforce reductions, plant closures and consolidations, and other cost reduction initiatives, to align our resources with our growth strategies in order to operate more efficiently and control costs. As these plans and actions are complex, unforeseen factors could result in expected savings and benefits to be delayed or not realized to the full extent planned, could negatively impact labor relations, including causing work stoppages, and could lead to disruptions in our business and operations and higher short-term costs related to severance and related capital expenditures.
We may be subject to significant disruption in our workforce or the workforce of our suppliers, which could adversely affect our business, financial condition and results of operations.
As of December 31, 2023, we employed approximately 7,894 employees, of which approximately 1,557 were located in the UK, 1,370 were located in Serbia, 1,269 were located in Germany, 1,073 were located in Croatia, 449 were located in Italy, 365 were located in Sweden/Norway, 323 were located in Bosnia & Herzegovina, 306 were located in France and 1,182 employees in other locations. As of December 31, 2023, approximately 62% of our employees worked in our manufacturing operations. We have in the past, and may in the future, experience labor disputes and work stoppages at one or more of our manufacturing sites due to localized strikes or strikes in the larger retail food industry sector. We have also been involved in negotiations on collective bargaining agreements. A labor stoppage or other interruption at one of our eighteen manufacturing sites (or at the site of any of our suppliers) would impact our ability to supply our customers and could have a material adverse effect on such facility’s operations and, potentially, on our business, financial condition and results of operations.
Labor shortages and higher labor costs could adversely affect our business and financial results.
A sustained labor shortage or increased turnover rate within our workforce, caused by macroeconomic factors beyond our control, have led, and could in the future lead, to production delays and increased costs, such as increased overtime costs to meet demand. Such labor shortages and increased costs could adversely affect our business and financial results.
Additionally, we compete with other producers for good and dependable employees. The supply of such employees is limited and competition to hire and retain them may result in higher labor costs, for example as a result of higher wages negotiated in response to inflationary pressure and cost of living increases. Furthermore, a number of our employees are subject to national minimum wage requirements. If legislation is enacted that has the effect of raising national minimum wage requirements, requires additional mandatory employee benefits or affects our ability to hire or dismiss employees, we could face substantially higher labor costs. High labor costs could adversely affect our profitability if we are not able to pass them on to our customers.
We are dependent upon key executives and highly qualified managers and we cannot assure their retention.
Our success depends, in part, upon the continued services of key members of our management. Our executives’ and managers’ knowledge of the market, our business and our Company represents a key strength of our business, which cannot be easily replicated. The success of our business strategy and our future growth also depend on our ability to attract, train, retain and motivate skilled managerial, sales, administration, development and operating personnel. There can be no assurance that our existing personnel will be adequate or qualified to carry out our strategy, or that we will be able to hire or retain experienced, qualified employees to carry out our strategy. The loss of one or more of our key management or operating personnel, or the failure to attract and retain additional key personnel, could have a material adverse effect on our business, financial condition and results of operations.

14


Failure to adequately address current and emerging sustainability risks, including environmental, social and governance (“ESG”) matters, could have a material adverse effect on our business, financial condition and results of operations.
Our ability to ensure a resilient business that delivers long-term sustainable growth, is reliant on our ability to identify current and emerging sustainability risks and legislative requirements that could adversely impact our business and ensure appropriate strategies are in place to manage such risks and requirements. Some of the key risks and requirements include:
Growing expectations of how businesses respond to and address sustainability issues from customers, consumers, non-governmental organizations, and ESG-focused investors. Failure to meet this expectation can have adverse consequences, such as: active product delisting, negative non-governmental organization campaigns, loss of market share and omission from high profile sustainability indices.
Increased mandatory sustainability due-diligence and non-financial reporting and disclosure obligations, requiring businesses to take appropriate action or face regulatory penalties. This includes the U.S. Securities and Exchange Commission's climate disclosure rules, as well as local legislation in the countries we operate, such as the EU Corporate Sustainability Due Diligence Directive, EU Corporate Sustainability Reporting Directive, German Supply Chain Due Diligence Act, Task Force on Climate Related Financial Disclosures (TCFD) and proposed Task Force on Nature Related Financial Disclosures (TNFD).
Physical risks of climate change, such as increased frequency of adverse weather events (droughts, floods, storms) impacting the availability of agricultural commodities or causing damage to physical assets within our operations and wider supply chain.
Any of the above risks, together with any others which relate to our inability to address increased and emerging sustainability risks could have a material adverse effect on our business, financial condition and results of operations.
Risks Related to Our Acquisition Strategy
We may not be able to consummate future acquisitions or successfully integrate acquisitions into our business, which could result in unanticipated expenses and losses.
Our acquisitions strategy is largely based on our ability to grow through acquisitions of additional businesses to build an integrated group. Consummating acquisitions of businesses, or our failure to integrate such businesses successfully into our existing businesses, could result in unanticipated expenses and losses. Furthermore, we may not be able to realize all of the anticipated benefits from completed acquisitions, including the Findus Switzerland and Fortenova acquisitions.
We anticipate that any future acquisitions we may pursue as part of our business strategy may be partially financed through additional debt or equity. Any future financial market disruptions or tightening of the credit markets may make it more difficult for us to obtain financing for acquisitions or increase the cost of obtaining financing. If new debt is added to current debt levels, or if we incur other liabilities, including contingent liabilities, in connection with an acquisition, the debt or liabilities could impose additional constraints and requirements on our business and operations, which could materially adversely affect our financial condition and results of operation. In addition, to the extent our ordinary shares are used for all or a portion of the consideration to be paid for future acquisitions, dilution may be experienced by existing shareholders.
In connection with our completed and future acquisitions, the process of integrating acquired operations into our existing group operations may result in unforeseen operating difficulties and may require significant financial resources that would otherwise be available for the ongoing development or expansion of existing operations. Some of the risks associated with acquisitions include:
unexpected losses of key employees or customers of the acquired company;
challenges with conforming the acquired company's standards, processes, procedures and controls with our operations;
difficulties with coordinating new product and process development;
hiring additional management and other critical personnel;
inheriting historic legacy business decisions and risks together with the potential for litigation, arbitration and regulatory proceedings associated with them;
negotiating with labor unions; and
increasing the scope, geographic diversity and complexity of our current operations.
We may encounter unforeseen obstacles or costs in the integration of businesses that we may acquire. For example, an acquisition may trigger change of control clauses entered into by the previous owner in which case the counterparties to such agreements may terminate their agreements requiring the acquired business to enter into new contracts, potentially on less favorable terms. In addition, general economic and market conditions or other factors outside of our control could make our operating strategies difficult or impossible to implement. Any such unforeseen obstacles or costs or failure to implement operational improvements successfully and/or the failure of any operational improvements to deliver the anticipated benefits could have a material adverse effect on our results of operations and financial condition.
15


Typically, when acquiring a business, the seller will provide certain warranties regarding its ownership of the acquired business as well as warranties regarding the business and operations of the acquired business. We may also obtain a warranty & indemnity insurance policy which provides coverage in respect of certain of these warranties. Any unexpected liabilities, individually or in the aggregate, which are not subject to such warranties or which are not recoverable under such insurance policy, could have a material adverse effect on the business, financial condition and results of operations of the acquired business following the acquisition, whether or not such liabilities result from breaches of warranties. There can be no assurance that we will be able to enforce any claims against the seller relating to breaches of such warranties or successfully claim under our insurance policy. Moreover, even if we are ultimately able to recover any amounts from the seller or the insurer, we may be required to temporarily bear some or all of the losses which may arise from any breaches of warranties, which could have a material adverse effect on our financial condition and results of operations.
We may be subject to antitrust regulations with respect to future acquisition opportunities.
Many jurisdictions in which we operate have antitrust regulations which involve governmental filings for certain acquisitions, impose waiting periods and require approvals by government regulators. Governmental authorities may seek to challenge potential acquisitions or impose conditions, terms, obligations or restrictions that may delay completion of the acquisition or materially reduce the anticipated benefits (financial or otherwise) as a result of applying the relevant antitrust regulations. Our inability to consummate potential future acquisitions or to receive the full benefits of such acquisitions because of antitrust regulations could limit our ability to execute on our acquisition strategy which could have a material adverse effect on our financial condition and results of operations.
We may face significant competition for acquisition opportunities.
There may be significant competition in some or all of the acquisition opportunities that we may explore. Such competition may for example come from strategic buyers, sovereign wealth funds, special purpose acquisition companies and public and private investment funds, many of which are well established and have extensive experience in identifying and completing acquisitions. Such competition may cause us to be unsuccessful in executing any acquisition or may result in a successful acquisition being made at a significantly higher price than would otherwise have been the case.
Any due diligence by us in connection with potential future acquisitions may not reveal all relevant considerations or liabilities of the target business, which could have a material adverse effect on our financial condition or results of operations.
We intend to conduct such due diligence as we deem reasonably practicable and appropriate based on the facts and circumstances applicable to any potential acquisition. The objective of the due diligence process will be to identify material issues which may affect the decision to proceed with any one particular acquisition target or the consideration payable for an acquisition. We also intend to use information revealed during the due diligence process to formulate our business and operational planning for, and our valuation of, any target company or business. While conducting due diligence and assessing a potential acquisition, we may rely on publicly available information, if any, information provided by the relevant target company to the extent such company is willing or able to provide such information and, in some circumstances, third party investigations where certain of our diligence efforts may be delayed or prohibited due to government or practical restrictions.
There can be no assurance that the due diligence undertaken with respect to an acquisition will reveal all relevant facts that may be necessary to evaluate such an acquisition including the determination of the price we may pay for an acquisition target or to formulate a business strategy. Furthermore, the information provided during due diligence may be incomplete, inadequate or inaccurate. As part of the due diligence process, we will also make subjective judgments regarding the results of operations, financial condition and prospects of a potential target. If the due diligence investigation fails to correctly identify material issues and liabilities that may be present in a target company or business, or if we consider such material risks to be commercially acceptable relative to the opportunity, and we proceed with an acquisition, we may subsequently incur substantial impairment charges or other losses.
In addition, following any acquisition, we may be subject to significant, previously undisclosed liabilities of the acquired business that were not identified during due diligence and which could contribute to poor operational performance, undermine any attempt to restructure the acquired company or business in line with our business plan and have a material adverse effect on our financial condition and results of operations.

16


Risks Related to Regulations
We could incur material costs to address violations of, or liabilities under all applicable directives, regulations and laws.
As a producer of food products for human consumption, we are subject to extensive regulation in our Key Markets and other countries in which we operate, at both a national and European Union level, that governs production, composition, manufacturing, animal welfare, sustainability, storage, transport, advertising, packaging, quality, marketing, including marketing to children, labeling, and distribution standards. Any failure to comply with applicable laws and regulations could subject us to civil remedies, including fines, injunctions, product recalls or asset seizures, as well as potential criminal sanctions.
In addition, our facilities and our suppliers’ facilities are subject to licensing, reporting requirements and official quality controls by numerous governmental authorities. These governmental authorities include European, national and local health, environmental, labor relations, sanitation, building, zoning, and fire and safety departments. Difficulties in obtaining or failure to obtain the necessary licenses or approval could delay or prevent the development, expansion or operation of a given production or warehouse facility. Any changes in those regulations may require us or our suppliers to implement new quality controls and possibly invest in new equipment, which could delay the development of new products and increase our operating costs.
All of our products and production facilities must comply with strict national and international hygiene regulations. Our facilities and our suppliers’ facilities are subject to regular inspection by authorities for compliance with hygiene regulations applicable to the sale, storage and manufacturing of foodstuffs and the traceability of genetically modified organisms, meats and other raw materials. Additionally, in certain jurisdictions, food business operators, including those in the food storage, processing and distribution sectors, are required to trace all food, animal feed, and food-producing animals under their control using registration systems that track the source of the products through the supply chain. Despite the precautions we undertake, should any non-compliance with such regulations be discovered during an inspection or otherwise, authorities may temporarily shut down any of our facilities, demand a product recall and/or levy a fine for such non-compliance.
Our facilities and operations are subject to numerous health, safety and environmental regulations, including local and national laws, European directives and regulations governing, among other things, water supply and use, water discharges, air emissions, chemical safety, solid and hazardous waste management and disposal, clean-up of contamination, energy use, noise pollution, and workplace health and safety together with globally recognized health and safety standards, including ISO compliance. Health, safety and environmental legislation and standards in Europe and elsewhere has generally become more comprehensive and restrictive and more rigid over time and enforcement has become more stringent. Failure to comply with applicable requirements, or the terms of required permits, can result in penalties or fines, clean-up costs, third party property damage, personal injury claims and damage to our reputation and relationships with our suppliers and retail customers. In addition, if health, safety and environmental laws and regulations in our Key Markets and the other countries in which we operate or from which we source raw materials and ingredients become more stringent in the future, the extent and timing of investments required to maintain compliance may exceed our budgets or estimates and may limit the availability of funding for other investments.
Furthermore, under some environmental laws, we could be liable for costs incurred in investigating or remediating contamination at properties we own or occupy, even if the contamination was caused by a party unrelated to us, and even if the activity which caused the contamination was legal at the time it occurred. The discovery of previously unknown contamination, or the imposition of new or more burdensome obligations to investigate or remediate contamination at our properties or at third-party sites, could result in substantial unanticipated costs.
In certain jurisdictions, we are also subject to legislation designed to significantly reduce industrial energy use, water use, carbon dioxide emissions and the emission of ozone depleting compounds more generally. If we fail to meet applicable standards for energy use reduction or are unable to decrease, and in some cases eliminate, certain emissions within the applicable period required by relevant laws and regulations, we could be subject to significant penalties or fines and temporary or long-term disruptions to production at our facilities. We are also subject to increasing pressure to reduce waste in our supply chains and to reduce packaging overall, reduce the use of certain substances in our packaging, for example non-recyclable plastic and increase the recyclability of our products. Any failure to do so could see a reduction in our sales, the imposition of penalties or fines, retailers destocking as a result of not meeting increased standards all or any of which could have a material adverse effect on our business, financial condition, reputation and results of operations.
Any failure to comply with any of the applicable directives, regulations and laws as set out in this section could have a material adverse effect on our business, financial condition, reputation and results of operations.

17


We are subject to a variety of regulatory schemes; failure to comply with applicable rules and regulations could adversely affect our business, results of operations and reputation.
Our operations are subject to a variety of regulatory schemes which require us to implement processes, procedures and controls to provide reasonable assurance that we are operating in compliance with applicable regulations, including the UK Bribery Act, the Modern Slavery Act 2015, the Foreign Corrupt Practices Act of 1977, the Trade Sanctions and Export Controls and the General Data Protection Regulation ("GDPR"). In addition, our business, including our ability to operate and continue to expand internationally, could be adversely affected if local and foreign laws or regulations are adopted, interpreted, or implemented in a manner that is inconsistent with our current business practices and that require rapid changes to these practices or our products, services, policies and procedures. For example, if we are prevented from purchasing certain products and raw materials as a result of the increasing sanctions currently being imposed on Russia and Belarus. If we are not able to adapt our business practices or strategies to changes in laws or regulations, it could subject us to liability, increased costs and reduced product demand. Additionally, the costs of compliance with laws and regulations may increase in the future as a result of changes in interpretation. Failure to comply (or any alleged failure to comply) with the regulations referenced above or any other regulations could result in civil and criminal, monetary and non-monetary penalties, and any such failure or alleged failure (or becoming subject to a regulatory enforcement investigation) could also damage our reputation, disrupt our business, result in loss of customers and cause us to incur significant legal and investigatory fees.
European privacy and data protection regulations could expose us to compliance risks and costs.
On May 25, 2018, the EU’s GDPR became enforceable. The GDPR relates to the collection, use, retention, security, processing and transfer of personally identifiable information of residents of European Economic Area (EEA) countries, and we are subject to these heightened standards. The GDPR created a range of new compliance obligations and imposes substantial fines for breaches and violations (up to the greater of €20 million or 4% of our annual global revenue). Furthermore, there is uncertainty with respect to compliance with privacy and data protection laws and regulations, including the GDPR, because such laws and regulations are continuously evolving and developing and may be interpreted and applied differently from country to country and may create inconsistent or conflicting requirements. Our efforts to comply with privacy and data protection laws in all our markets may impose significant costs and challenges that are likely to increase over time, in particular with the UK, Switzerland and other non-EU countries in which we operate. Since January 1, 2021 the GDPR has ceased to have direct effect in the UK but the Data Protection Act 2018 alongside the UK GDPR ensures that the UK has in effect the same high standards for data protection in place as under the GDPR. As with other EU-origin laws, how these are interpreted and applied by the UK might change and differ from the EU approach over time.
Risks Related to Financial Management
We have risks related to our indebtedness, including our ability to withstand adverse business conditions and to meet our debt service obligations.
Our ability to make payments on and to refinance our indebtedness, and to fund our operations, working capital and capital expenditures, depends on our ability to generate cash. To a certain extent, our cash flow is subject to general economic, industry, financial, competitive, operating, legislative, regulatory and other factors, many of which are beyond our control.
We cannot assure you that our business will generate sufficient cash flow from operations or that future sources of cash will be available to us in an amount sufficient to enable us to pay amounts due on our indebtedness or to fund our other liquidity needs.
Additionally, if we incur additional indebtedness in connection with any future acquisitions or development projects or for any other purpose, our debt service obligations could increase. We may need to refinance all or a portion of our indebtedness before maturity. Our ability to refinance our indebtedness or obtain additional financing will depend on, among other things:
• our financial condition and market conditions at the time;
• restrictions in the agreements governing our indebtedness;
• general economic and capital market conditions;
• the availability of credit from banks or other lenders;
• investor confidence in us; and
• our results of operations.
In addition, a significant part of our indebtedness includes provisions with respect to maintaining and complying with certain financial and operational covenants. Our ability to comply with these covenants may be affected by events beyond our control. A breach of one or more of these covenants could result in an event of default and may give rise to an acceleration of the debt. In the longer term, such breach of covenants could have a material adverse effect on our operations and cash flows.
18


Our variable rate indebtedness subjects us to interest rate risk, which could cause our debt service obligations to increase significantly.
An increase in market interest rates may increase our interest expense arising on our existing and future floating rate indebtedness. Pursuant to the terms of the amended and restated Senior Facilities Agreement dated April 29, 2024, the interest rate paid on indebtedness incurred under our senior loans and primary revolving credit facility varies based on a fixed margin over a base reference rate, term SOFR for the USD denominated term loans or EURIBOR for the EUR denominated term loans. If interest rates increase, our debt service obligations on the variable rate indebtedness will increase even though the amount borrowed remains the same, and our net income and cash flows, including cash available for operational or strategic purposes, will correspondingly decrease. Pursuant to our interest rate hedging policy, we may enter into interest rate derivatives that may involve the exchange of floating for fixed rate interest payments in order to reduce interest rate volatility. However, we may not maintain interest rate swaps with respect to all of our variable rate indebtedness, and any swaps we enter into may not fully mitigate our interest rate risk. If any reference rate ceases to exist, we will need to renegotiate the interest rate payable on our Senior Facilities Agreement with our lenders.
We are exposed to exchange rate risks.
We are exposed to exchange rate risk. Our reporting currency is the Euro. We are exposed to foreign exchange translation risk as we convert the results of our non-Euro businesses into our reporting currency of Euro. Pursuant to Company foreign exchange hedging policy, we have converted our USD term loan to EUR designated as a cash flow hedge. We are exposed to transactional exchange rate risk as many of our raw material purchases may be denominated in non-functional currencies of the purchasing entity, predominantly U.S. Dollars and Euro. Company policy is to reduce this risk by using foreign exchange forward contracts that are designated as cash flow hedges. Hedging arrangements are subject to changes in Company policy, may not fully protect us against currency fluctuations and may or not achieve hedge effectiveness. Fluctuations and sustained strengthening of non-functional currencies against the functional currency of the operating entities may materially adversely affect our business, financial condition and results of operations.
Changes to our payment terms with customers and suppliers may materially adversely affect our cash flows.
We may experience significant pressure from our key suppliers to reduce trade payable terms. At the same time, we may experience pressure from our customers to extend trade receivable terms. European and country legislation can also set conditions and restrictions related to payment terms between suppliers and purchasers at different levels of the supply chain, for example, Directive 2019/633 on unfair trading practices in business to business relationships in the agricultural and food supply chain, which has been widely implemented across the European Union. Any failure to comply with applicable laws and regulations could subject us to civil remedies, including fines, which could have a material adverse effect on our business, financial condition and results of operations. Any such changes in commercial arrangements regarding trade payable and trade receivable payment terms, as a result of changes in legislation or otherwise, may have a material adverse effect on our business, financial condition and results of operations.
Dividend payments and purchases made pursuant to announced share repurchase programs may have an impact on our cash flows and our ability to meet our debt service obligations.
We intend to pay dividends on our ordinary shares only at such times, if any, and in such amounts, if any, as the board determines appropriate and in accordance with applicable law, and then only if we receive dividends from our operating subsidiaries. The board from time to time has announced share repurchase programs as set out further in the Financing and Acquisition section below. Our ability to make payments on and to refinance our indebtedness, and to fund our operations, working capital and capital expenditures, depends on cash flows. A significant part of our indebtedness includes provisions with respect to maintaining and complying with certain financial and operational covenants. In the event that we were to pay any dividends or to repurchase shares pursuant to any announced share repurchase programs, such dividends and share repurchases may have an impact on our cash flows and on our ability to make repayments on and refinance our indebtedness and to comply with those financial covenants.
19


An impairment of the carrying value of goodwill or other intangible assets could negatively affect our consolidated operating results and net worth.
Goodwill represents amounts arising from acquisitions and is the difference between the cost of the acquisition and the fair value of the net identifiable assets acquired. Intangible assets can include computer software, brands, customer relationships and other acquired intangibles as of the acquisition date. Goodwill and other intangibles expected to contribute indefinitely to our cash flows are not amortized but must be evaluated by management at least annually for impairment. If carrying value exceeds its recoverable amount, the intangible is considered impaired and is reduced to recoverable amount via a charge to earnings. Factors outside of our control which could result in an impairment include, but are not limited to: (i) reduced demand for our products; (ii) higher commodity prices; (iii) lower prices for our products or increased marketing as a result of increased competition; and (iv) significant disruptions to our operations as a result of both internal and external events. Should the value of one or more of the acquired intangibles become impaired, our consolidated profit or loss and net assets may be materially adversely affected. As of December 31, 2023, the carrying value of intangible assets totaled €4,573.2 million, of which €2,105.0 million was goodwill and €2,468.2 million represented brands, computer software, customer relationships and other acquired intangibles compared to total assets of €6,416.7 million.
We are exposed to risks in connection with our treasury and cash management activities.
From time to time we may acquire various investment securities as part of our cash management and treasury activities. Factors beyond our control can significantly and adversely influence the fair value of our investment securities, including, but not limited to, the risk that the counterparty may not return the funds and that movements in financial, currency or interest rate markets may have an impact on the value of the investment securities. For example, fixed-rate securities are generally subject to decreases in market value when interest rates rise. Additional factors include, but are not limited to, rating agency downgrades of the securities, defaults by the issuer or individual borrowers with respect to the underlying securities, and instability in the credit markets. Any of the foregoing factors could cause a significant or prolonged decline in the fair value of an investment.
In the ordinary course of treasury activities, whether entering into derivative hedging arrangements, cash account deposits or otherwise, we are exposed to the risk that the financial counterparty with whom we have conducted dealings will not be able to perform the agreed services and as a result may have a material adverse effect on our business, financial condition and results of operation.
We face risks associated with certain pension obligations.
The Company has a mixture of partially funded and unfunded post-employment defined benefit plans in Germany, Sweden, Switzerland and Austria as well as defined benefit indemnity arrangements in Italy and France. Deterioration in the value or lower than expected returns on investments may lead to an increase in our obligation to make contributions to these plans.
The obligations that arise from these plans are calculated using actuarial valuations which are based on assumptions linked to the performance of financial markets, interest rates and legislation which changes over time. Adverse changes to these assumptions will impact the obligations recognized and would lead to higher cash payments in the long term.
Our obligation to make contributions to the pension plans could reduce the cash available for operational and other corporate uses and may have a materially adverse impact on our operations, financial condition and liquidity.
We are exposed to risks related to our financial arrangements with respect to receivables factoring, reverse factoring and supply chain financing.
We may enter into factoring, reverse factoring or supply chain financing arrangements with financial institutions from time to time to sell certain of our accounts receivables from customers without recourse or to otherwise finance aspects of our supply chain. If we were to cease entering into such arrangements, our operating results, financial condition and cash flows could be adversely impacted. However, by entering into these arrangements we are exposed to additional risks. If any of these financial institutions or other counterparties experiences financial difficulties or is otherwise unable to honor the terms of our factoring, reverse factoring or supply chain financing arrangements with them, we may experience material financial losses due to the failure of such arrangements which could have an adverse impact upon our operating results, financial condition and cash flows.
20


We are a holding company whose principal source of operating cash is the income received from our subsidiaries.
We are a holding company and rely on the earnings and cash flows of our subsidiaries, which are paid to us by our subsidiaries in the form of dividends and other payments or distributions, to meet our debt service and other obligations, or, if applicable, to pay dividends on our ordinary shares. The ability of our subsidiaries to pay dividends or make other payments or distributions to us will depend on their respective operating results and may be restricted by, among other things, the laws of their jurisdiction of organization (which may limit the amount of funds available for the payment of dividends and other distributions to us), their constitutional documents, documents governing any existing indebtedness and the covenants of any future outstanding indebtedness that our subsidiaries incur, and other factors which may be outside our control.
The Founders and/or the Founder Entities may in the future enter into and/or amend related party transactions with us, which may give rise to conflicts of interest between us and some or all of the Founders and/or the Directors.
Our founders, Sir Martin Franklin and Noam Gottesman (the “Founders”) and/or one or more of their affiliates, including Mariposa Acquisition II, LLC and TOMS Acquisition I LLC (the “Founder Entities”) may in the future enter into and/or amend agreements with us that are not currently under contemplation. While we have implemented procedures to ensure we will not enter into any related party transaction without the approval of our Audit Committee, it is possible that the entering into of such an agreement might raise conflicts of interest between us and some or all of the Founders and/or the directors.
General Risk Factors
We are subject to the risk of disruptions, failures or security breaches of our information technology systems, or those of third parties on which we rely.
We are increasingly dependent upon our information technology systems for communication among our suppliers, manufacturing plants, distribution functions, headquarters and customers. Our performance depends on the availability of accurate and timely data and other information from key software applications to aid day-to-day business and decision-making processes. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology infrastructure and to maintain the related automated and manual control processes, we could be subject to adverse effects including billing and collection errors, business disruptions, in particular concerning our manufacturing and logistics functions, issues with or errors in system's maintenance and security and migration of applications to the cloud and security breaches. We may be adversely affected if our controls designed to manage information technology operational risks fail to contain such risks. Any disruption caused by failings in our information technology infrastructure equipment or of communication networks, could delay or otherwise impact our day-to-day business and decision-making processes and negatively impact our performance. In addition, we are reliant on third parties to service our IT infrastructure. Failure on their part to provide good and timely service may have an adverse impact on our information technology network. We rely on third parties for the support and maintenance of our software solutions and furthermore we do not control the facilities or operations of our suppliers or third parties. An interruption of operations at any of their or our facilities or any failure by them to deliver on their contractual commitments may have a material adverse effect on our business, financial condition and results of operations.
Although our information technology systems are protected through physical and software safeguards, it is difficult to protect against the possibility of damage or breach created by cyber-attacks or other security attacks in every potential circumstance that may arise. In addition, governmental authorities have warned that cybercriminals will take advantage of the uncertainty created by COVID-19, national and regional mandated quarantines and recent international conflicts to launch cybersecurity attacks. The risks could include more frequent malicious cybersecurity and fraudulent activities, as well as schemes which attempt to take advantage of employees’ use of various technologies to enable remote work activities. We believe the COVID-19 outbreak and conflict in Ukraine have increased our cyber risk profile, but we are unable to predict the extent or impacts of those risks at this time. As cyber-attacks are increasing in frequency and sophistication, it becomes even more difficult to protect against a breach of our information technology systems. Cybersecurity incidents including malfeasance, security breaches, computer viruses or other malicious codes, ransomware, unauthorized access attempts, denial of service attacks, phishing, hacking, and other cyberattacks that impact the availability, reliability, speed, accuracy, or other proper functioning of these information technology systems could have a significant impact on our operations. Furthermore, there is increasing market use and availability of third party Artificial Intelligence (AI) software and whilst we have policies and procedures in place to manage their use, there is the risk of inadvertent use of 3rd party AI engines through sharing of data into an AI tool which then becomes public domain. If we are unable to prevent physical and electronic break-ins, cyber-attacks and other information security breaches, we may suffer financial and reputational damage, be subject to litigation or incur remediation costs or penalties because of the unauthorized disclosure of confidential information belonging to us or to our customers, suppliers or employees. The mishandling or inappropriate disclosure of non-public sensitive or protected information could lead to the loss of intellectual property, negatively impact planned corporate transactions or damage our reputation and brand image. Misuse, leakage or falsification of legally protected information could also result in a violation of data privacy laws and regulations and have a negative impact on our reputation, business, financial condition and results of operations.
21


While, to date, we have not had a significant cybersecurity breach or attack that had a material impact on our business or operations, there can be no assurance that our efforts to maintain the security and integrity of our information technology systems will be effective or that attempted breach would not be successful in the future.
Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect our financial results.
Generally accepted accounting principles and related accounting pronouncements, implementation guidelines and interpretations with regard to a wide range of matters that are relevant to our business, including but not limited to revenue recognition, leases, estimating valuation allowances and accrued liabilities (including allowances for returns, doubtful accounts and obsolete and damaged inventory), accounting for income taxes, valuation of long-lived and intangible assets and goodwill, stock-based compensation and loss contingencies, are highly complex and involve many subjective assumptions, estimates and judgments by our management. Changes in these rules or their interpretation or changes in underlying assumptions, estimates or judgments by our management could significantly change our reported or expected financial performance, and could have a material adverse effect on our business.
Management continues to assess new accounting pronouncements and their impact on the Company prior to their adoption dates.
We may incur liabilities that are not covered by insurance.
While we seek to maintain appropriate levels of insurance, not all claims are insurable, and we may experience major incidents of a nature that are not covered by insurance. Our insurance policies cover, among other things, employee-related accidents and injuries, property damage and liability deriving from our activities. In particular, our Lowestoft and Bremerhaven manufacturing facilities are situated in regions that have historically been affected by flooding. We may not be able to obtain flood insurance on reasonable terms or at all with respect to those facilities. We maintain an amount of insurance protection that we believe is adequate, but there can be no assurance that such insurance will continue to be available on acceptable terms or that our insurance coverage will be sufficient or effective under all circumstances and against all liabilities to which we may be subject. We could, for example, be subject to substantial claims for damages upon the occurrence of several events within one calendar year. In addition, our insurance costs may increase over time in response to any negative development in our claims history or due to material price increases in the insurance market in general which could have a material impact on our business.
If we fail to or are unable to maintain effective internal controls over financial reporting, the accuracy and timeliness of our financial reporting may be adversely affected.
We are subject to reporting obligations under U.S. securities laws. The SEC, as required under Section 404 of the Sarbanes-Oxley Act of 2002, has adopted rules requiring every public company to include a report of management on the effectiveness of such company's internal control over financial reporting in its annual report. In addition, an independent registered public accounting firm must issue an attestation report on the effectiveness of the company's internal control over financial reporting.
We recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives. If we fail to maintain effective internal control over financial reporting in the future, we and our independent registered public accounting firm may not be able to conclude that we have effective internal control over financial reporting at a reasonable assurance level. Please see the risk factor below titled, “In connection with the preparation of our 2023 financial statements, we have identified a material weakness in our internal control over financial reporting” for more information. This could in turn result in the loss of investor confidence and a decline in the reliability of our financial statements. Furthermore, we have incurred and anticipate that we will continue to incur considerable costs and use significant management time and other resources in an effort to comply with Section 404 and other requirements of the Sarbanes-Oxley Act. If we are not able to continue to meet the requirements of Section 404 in a timely manner or with adequate compliance, we might be subject to sanctions or investigation by the SEC, the NYSE or other regulatory authorities. Any such action could adversely affect the accuracy and timeliness of our financial reporting.
In connection with the preparation of our 2023 financial statements, we identified a material weakness in our internal control over financial reporting
As of December 31, 2023, our management assessed the effectiveness of our internal control over financial reporting. We concluded that there was a material weakness in our internal control over financial reporting, related to the operation of effective control over the review of supporting information to determine the completeness and accuracy of the consolidated statement of cash flows for the year ended December 31, 2023. The material weakness did not result in any material misstatement of our consolidated financial statements as of and for the year ended December 31, 2023 or prior periods; however, if it is not remediated, it
22


could result in a material misstatement of our consolidated financial statements that would not be prevented or detected on a timely basis.
A “material weakness” is a deficiency, or combination of deficiencies, in internal controls such that there is a reasonable possibility that a material misstatement in financial statements will not be prevented or detected in a timely basis.
Our failure to correct this material weakness or our failure to discover and address any other material weaknesses could result in inaccuracies in our financial statements and could also impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis. As a result, our business, financial condition, results of operations and prospects, as well as the trading price of our Ordinary Shares, may be materially and adversely affected. Moreover, ineffective internal control over financial reporting significantly hinders our ability to prevent fraud. Should this material weakness not be remediated, our management may conclude that our internal control over financial reporting is not effective. In addition, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may issue an adverse report if it is not satisfied with our internal controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us.
Risks Related to our Ordinary Shares
Outstanding equity award grants under our LTIP could require us to issue additional ordinary shares. Therefore, you may experience significant dilution of your ownership interests and the future issuance of additional ordinary shares, or the anticipation of such issuances, could have an adverse effect on our share price.
We currently have 9,809,623 ordinary shares available for issuance under our LTIP. Additionally, as of May 3, 2023, we have 6,488,175 equity awards that have either been issued to participants or been granted and are outstanding under the LTIP, which may be converted into ordinary shares subject, in most cases, to meeting certain performance conditions.
Our ordinary share price may be volatile, and as a result, you could lose a significant portion or all of your investment.
The market price of the ordinary shares on the NYSE may fluctuate as a result of several factors, including the following:
variations in our quarterly operating results;
volatility in our industry, the industries of our customers and suppliers and the global securities markets;
risks relating to our business and industry, including those discussed above;
strategic actions by us or our competitors;
reputational damage from unsafe or poor-quality food products;
actual or expected changes in our growth rates or our competitors’ growth rates;
investor perception of us, the industry in which we operate, the investment opportunity associated with the ordinary shares and our future performance;
addition or departure of our executive officers;
changes in financial estimates or publication of research reports by analysts regarding our ordinary shares, other comparable companies or our industry generally;
trading volume of our ordinary shares;
future issuances or purchases of our ordinary shares by us or our shareholders;
domestic and international economic, legal and regulatory factors unrelated to our performance; or
the release or expiration of lock-up or other transfer restrictions on our outstanding ordinary shares.
23


Furthermore, the stock markets often experience significant price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions or interest rate changes may cause the market price of ordinary shares to decline.
If securities or industry analysts do not publish or cease publishing research reports about us, if they adversely change their recommendations regarding our ordinary shares or if our operating results do not meet their expectations, the price of our ordinary shares could decline.
The trading market for our ordinary shares will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market or our competitors. Securities and industry analysts currently publish limited research on us. If there is limited or no securities or industry analyst coverage of our company, the market price and trading volume of our ordinary shares would likely be negatively impacted. Moreover, if any of the analysts who may cover us downgrade our ordinary shares, provide more favorable relative recommendations about our competitors or if our operating results or prospects do not meet their expectations, the market price of our ordinary shares could decline. If any of the analysts who may cover us were to cease coverage or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our share price or trading volume to decline.
As a foreign private issuer, we are subject to different U.S. securities laws and NYSE governance standards than domestic U.S. issuers, which may afford less protection to holders of our ordinary shares.
As a foreign private issuer, the rules governing the information that we disclose differ from those governing U.S. corporations pursuant to the Exchange Act. Although we report quarterly financial results and certain material events, we are not required to file quarterly reports on Form 10-Q or provide current reports on Form 8-K disclosing significant events within four days of their occurrence and our quarterly or current reports may contain less information than required for domestic issuers. In addition, we are exempt from the SEC’s proxy rules, and proxy statements that we distribute will not be subject to review by the SEC. Our exemption from Section 16 rules regarding sales of ordinary shares by insiders means that you will have less data in this regard than shareholders of U.S. companies that are subject to the Exchange Act. As a result, you may not have all the data that you are accustomed to having when making investment decisions with respect to U.S. public companies.
As a foreign private issuer, we are exempt from complying with certain corporate governance requirements of the NYSE applicable to a U.S. issuer, including the requirement that a majority of our board of directors consist of independent directors. As the corporate governance standards applicable to us are different from those applicable to domestic U.S. issuers, you may not have the same protections afforded under U.S. law and the NYSE rules as shareholders of companies that do not have such exemptions.
24


We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.
We could cease to be a foreign private issuer if a majority of our outstanding voting securities are directly or indirectly held of record by U.S. residents and we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. The regulatory and compliance costs to us under U.S. securities laws as a U.S. domestic issuer may be significantly higher than costs we incur as a foreign private issuer, which could have a material adverse effect on our business and financial results.
The rights of shareholders under British Virgin Islands law differ from those under United States law, you may have fewer protections as a shareholder.
Our corporate affairs are governed by our Memorandum and Articles of Association, the BVI Business Companies Act, 2004 (as amended, the “BVI Act”) and the common law of the British Virgin Islands. The rights of shareholders to take legal action against our directors, actions by minority shareholders and the fiduciary responsibilities of our directors under British Virgin Islands law are to a large extent governed by the common law of the British Virgin Islands and by the BVI Act. The common law of the British Virgin Islands is derived in part from comparatively limited judicial precedent in the British Virgin Islands as well as from English common law, which has persuasive, but not binding, authority on a court in the British Virgin Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under British Virgin Islands law are not as clearly established as they would be under statutes or judicial precedents in some jurisdictions in the United States. In particular, the British Virgin Islands has a less developed body of securities laws as compared to the United States, and some states (such as Delaware) have more fully developed and judicially interpreted bodies of corporate law. As a result of the foregoing, holders of our ordinary shares may have more difficulty in protecting their interests through actions against our management, directors or major shareholders than they would as shareholders of a U.S. company.
The laws of the British Virgin Islands provide limited protection for minority shareholders. Minority shareholders will have limited or no recourse if they are dissatisfied with the conduct of our affairs.
Under the laws of the British Virgin Islands, there is limited statutory law for the protection of minority shareholders other than the provisions of the BVI Act dealing with shareholder remedies. The principal protection under statutory law is that shareholders may bring an action to enforce the constituent documents of the Company and are entitled to have the affairs of the Company conducted in accordance with the BVI Act and the memorandum and articles of association of the Company. As such, if those who control the Company have persistently disregarded the requirements of the BVI Act or the provisions of the Company’s memorandum and articles of association, then the courts will likely grant relief. Generally, the areas in which the courts will intervene are the following: (i) an act complained of which is outside the scope of the authorized business or is illegal or not capable of ratification by the majority; (ii) acts that constitute fraud on the minority where the wrongdoers control the Company; (iii) acts that infringe on the personal rights of the shareholders, such as the right to vote; and (iv) acts where the Company has not complied with provisions requiring approval of a special or extraordinary majority of shareholders, which are more limited than the rights afforded minority shareholders under the laws of many states in the United States.
To the extent allowed by law, the rights and obligations among or between us, any of our current or former directors, officers and employees and any current or former shareholder will be governed exclusively by the laws of the British Virgin Islands and subject to the jurisdiction of the British Virgin Islands courts, unless those rights or obligations do not relate to or arise out of their capacities as such. Although there is doubt as to whether United States courts would enforce these provisions in an action brought in the United States under United States securities laws, these provisions could make judgments obtained outside of the British Virgin Islands more difficult to enforce against our assets in the British Virgin Islands or jurisdictions that would apply British Virgin Islands law.
25


British Virgin Islands companies may not be able to initiate shareholder derivative actions, thereby depriving shareholders of one avenue to protect their interests.
British Virgin Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States. The circumstances in which any such action may be brought, and the procedures and defenses that may be available in respect of any such action, may result in the rights of shareholders of a British Virgin Islands company being more limited than those of shareholders of a company organized in the United States. Accordingly, shareholders may have fewer alternatives available to them if they believe that corporate wrongdoing has occurred. The British Virgin Islands courts are also unlikely to recognize or enforce judgments of courts in the United States based on certain liability provisions of United States securities law or to impose liabilities, in original actions brought in the British Virgin Islands, based on certain liability provisions of the United States securities laws that are penal in nature. There is no statutory recognition in the British Virgin Islands of judgments obtained in the United States, although the courts of the British Virgin Islands will generally recognize and enforce the non-penal judgment of a foreign court of competent jurisdiction without retrial on the merits. This means that even if shareholders were to sue us successfully, they may not be able to recover anything to make up for the losses suffered.
Shareholders may experience a dilution of their percentage ownership if we make non-pre-emptive offers of ordinary shares in the future.
We have opted-out of statutory pre-emptive rights pursuant to the terms of our Memorandum and Articles of Association. No pre-emption rights therefore exist in respect of future issuance of ordinary shares whether or not for cash. Should we decide to offer additional ordinary shares on a non-pre-emptive basis in the future, this could dilute the interests of shareholders and/or have an adverse effect on the market price of the ordinary shares.
Risks Related to Taxation
Changes in tax law and practice may reduce any net returns for shareholders.
The tax treatment of the Company, our shareholders and any subsidiary of ours, any special purpose vehicle that we may establish and any other company which we may acquire are all subject to changes in tax laws or practices in the British Virgin Islands, the UK, the U.S. and any other relevant jurisdiction. Any change may reduce the value of your investment in our ordinary shares.
Failure to maintain our tax status may negatively affect our financial and operating results and shareholders.
If we were to be considered to be resident in or to carry on a trade or business within the United States for U.S. taxation purposes or in any other country in which we are not currently treated as having a taxable presence, we could be subject to U.S. income tax or taxes in such other country on all or a portion of our profits, as the case may be, which may negatively affect our financial and operating results.
Taxation of returns from subsidiaries may reduce any net return to shareholders.
We and our subsidiaries are subject to taxes in a number of jurisdictions. It is possible that any return we receive from any present or future subsidiary may be reduced by irrecoverable withholding or other local taxes, including those arising from future changes in legislation and other local rules and this may reduce the value of your investment in our ordinary shares.
If any dividend is declared in the future and paid in a foreign currency, U.S. holders may be taxed on a larger amount in U.S. Dollars than the U.S. Dollar amount actually received.
U.S. holders will be taxed on the U.S. Dollar value of dividends at the time they are received, even if they are not converted to U.S. Dollars or are converted at a time when the U.S. Dollar value of the dividends has fallen. The U.S. Dollar value of the payments made in the foreign currency will be determined for tax purposes at the spot rate of the foreign currency to the U.S. Dollar on the date the dividend distribution is deemed included in such U.S. holder’s income, regardless of whether or when the payment is in fact converted into U.S. Dollars.


26


Nomad Foods Limited—Unaudited Condensed Consolidated Interim Statements of Financial Position
As of March 31, 2024 (unaudited) and December 31, 2023 (audited)
March 31, 2024December 31, 2023
Note€m€m
Non-current assets
Goodwill2,103.2 2,105.0 
Intangibles2,467.0 2,468.2 
Property, plant and equipment563.4 563.7 
Other non-current assets7.3 7.1 
Derivative financial instruments111.4 0.7 
Deferred tax assets106.1 106.9 
Total non-current assets5,248.4 5,251.6 
Current assets
Cash and cash equivalents10390.7 412.9 
Inventories432.6 446.4 
Trade and other receivables343.8 263.4 
Current tax receivable39.7 40.7 
Indemnification assets0.5 0.5 
Derivative financial instruments116.0 1.2 
Total current assets1,213.3 1,165.1 
Total assets6,461.7 6,416.7 
Current liabilities
Trade and other payables810.3 769.8 
Current tax payable189.3 189.5 
Provisions1231.5 35.1 
Loans and borrowings1126.2 21.4 
Derivative financial instruments118.9 12.2 
Total current liabilities1,066.2 1,028.0 
Non-current liabilities
Loans and borrowings112,126.9 2,113.7 
Employee benefits13152.1 158.3 
Other non-current liabilities0.5 0.5 
Provisions121.4 1.4 
Derivative financial instruments1169.8 97.8 
Deferred tax liabilities425.6 425.1 
Total non-current liabilities2,776.3 2,796.8 
Total liabilities3,842.5 3,824.8 
Net assets2,619.2 2,591.9 
Equity attributable to equity holders
Share capital and capital reserve151,419.0 1,426.1 
Share based compensation reserve1434.5 31.4 
Translation reserve104.6 101.0 
Other reserves15(11.8)(24.6)
Retained earnings1,072.9 1,058.0 
Total equity2,619.2 2,591.9 
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Interim Financial Statements.
27


Nomad Foods Limited—Unaudited Condensed Consolidated Interim Statements of Profit or Loss
For the three months ended March 31, 2024 and March 31, 2023
 For the three months ended March 31,
20242023
 Note€m€m
Revenue783.7 775.1 
Cost of sales(572.8)(550.9)
Gross profit210.9 224.2 
Other operating expenses(115.4)(114.5)
Exceptional items6(23.5)(30.1)
Operating profit72.0 79.6 
Finance income75.9 1.1 
Finance costs7(36.0)(30.1)
Net financing costs(30.1)(29.0)
Profit before tax41.9 50.6 
Taxation8(7.4)(9.4)
Profit for the period34.5 41.2 
Earnings per share
Basic and diluted earnings per share90.21 0.24 
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Interim Financial Statements.
28


Nomad Foods Limited—Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss)
For the three months ended March 31, 2024 and March 31, 2023
 For the three months ended March 31,
20242023
 Note€m€m
Profit for the period34.5 41.2 
Other comprehensive income:
Actuarial gains/(losses) on defined benefit pension plans133.9 (4.3)
Taxation (charge)/credit on measurement of defined benefit pension plans(1.2)1.7 
Items not reclassified to the Statement of Profit or Loss
2.7 (2.6)
Exchange differences on translation of foreign operations3.6  
Cash flow hedges12.3 (13.6)
Taxation (charge)/credit relating to components of other comprehensive income(3.8)4.7 
Items that may be subsequently reclassified to the Statement of Profit or Loss
12.1 (8.9)
Other comprehensive income/(loss) for the period, net of tax14.8 (11.5)
Total comprehensive income for the period
49.3 29.7 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Interim Financial Statements.
29


Nomad Foods Limited—Unaudited Condensed Consolidated Interim Statements of Changes in Equity
For the three months ended March 31, 2024
Share capital and capital
reserve
Share based
compensation
reserve
Translation
reserve
Other reservesRetained earningsTotal equity
Note€m€m€m€m€m€m
Balance as of January 1, 20241,426.1 31.4 101.0 (24.6)1,058.0 2,591.9 
Profit for the period— — — — 34.5 34.5 
Other comprehensive income for the period— — 3.6 8.5 2.7 14.8 
Total comprehensive income for the period  3.6 8.5 37.2 49.3 
Deferred hedging losses and costs of hedging transferred to the carrying value of inventory— — — 4.3 — 4.3 
Transactions with owners, recognized directly in equity:
Share based payment charge14 — 3.1 — — — 3.1 
Repurchase of ordinary shares15 (7.1)— — — — (7.1)
Dividends15 — — — — (22.3)(22.3)
Total transactions with owners, recognized directly in equity(7.1)3.1   (22.3)(26.3)
Balance as of March 31, 20241,419.0 34.5 104.6 (11.8)1,072.9 2,619.2 
    
The accompanying notes are an integral part of these Unaudited Condensed Consolidated Interim Financial Statements.

30


Nomad Foods Limited—Unaudited Condensed Consolidated Interim Statements of Changes in Equity (continued)
For the three months ended March 31, 2023
Share capital and capital
reserve
Share based
compensation
reserve
Translation
reserve
Other reservesRetained earningsTotal equity
Note€m€m€m€m€m€m
Balance as of January 1, 20231,596.7 13.8 89.3 19.8 886.6 2,606.2 
Profit for the period    41.2 41.2 
Other comprehensive (loss)/income for the period— —  (8.9)(2.6)(11.5)
Total comprehensive (loss)/income for the period   (8.9)38.6 29.7 
Deferred hedging gains and costs of hedging transferred to the carrying value of inventory— — — (0.1)— (0.1)
Transactions with owners, recognized directly in equity
Share based payment charge14  12.3 — — — 12.3 
Reclassification of awards for settlement of tax liabilities14 — (4.0)— — (0.5)(4.5)
Total transactions with owners, recognized directly in equity 8.3   (0.5)7.8 
Balance as of March 31, 20231,596.7 22.1 89.3 10.8 924.7 2,643.6 

The accompanying notes are an integral part of these Unaudited Condensed Consolidated Interim Financial Statements.    
31


Nomad Foods Limited—Unaudited Condensed Consolidated Interim Statements of Cash Flows
For the three months ended March 31, 2024 and March 31, 2023
 For the three months ended March 31,
  20242023
Note€m€m
Cash flows from operating activities
Profit for the period34.5 41.2 
Adjustments for:
Exceptional items623.5 30.1 
Share based payments expense143.1 12.3 
Depreciation and amortization523.1 22.3 
Loss on disposal and impairment of property, plant and equipment0.4 0.5 
Net finance costs730.1 29.0 
Taxation87.4 9.4 
Operating cash flow before changes in working capital, provisions and exceptional items122.1 144.8 
Decrease/(increase) in inventories14.2 (34.3)
Increase in trade and other receivables(81.3)(53.7)
Increase in trade and other payables77.1 20.6 
(Decrease)/increase in employee benefits and other provisions(0.2)1.9 
Cash generated from operations before tax and exceptional items131.9 79.3 
Payments relating to exceptional items6(24.0)(14.0)
Tax paid(8.9)(10.0)
Net cash generated from operating activities99.0 55.3 
Cash flows from investing activities
Purchase of property, plant and equipment and intangibles(18.8)(20.6)
Interest received2.0 1.1 
Cash used in investing activities(16.8)(19.5)
Cash flows from financing activities
Repurchase of ordinary shares15(7.1) 
Dividends paid15(22.3) 
Payment of lease liabilities(7.2)(7.0)
Payment of financing fees(0.5)(0.5)
Interest paid(50.4)(19.3)
Net cash used in financing activities(87.5)(26.8)
Net (decrease)/increase in cash and cash equivalents(5.3)9.0 
Cash and cash equivalents at beginning of period10399.7 366.8 
Effect of exchange rate fluctuations(3.7)(4.9)
Cash and cash equivalents at end of period10390.7 370.9 
The accompanying notes are an integral part of these unaudited Condensed Consolidated Interim Financial Statements.
32


Nomad Foods Limited—Notes to the Unaudited Condensed Consolidated Interim Financial Statements
1.    General information

These unaudited condensed consolidated interim financial statements (“interim financial statements”) as at and for the three months ended March 31, 2024 comprise the results and financial position of Nomad Foods Limited and its subsidiaries (together referred to as the “Company” or “Nomad”). Nomad (NYSE: NOMD) is Europe's leading frozen foods company. Nomad's portfolio of iconic brands, which includes Birds Eye, Findus, iglo, Ledo and Frikom, have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.

The Company’s sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for savory frozen food are slightly higher in colder or winter months and variable production costs and working capital will vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, inventory levels typically peak in August to September just after the pea harvest and as a result, more working capital is required during those months. The one exception to this is in our Adriatic business, which follows a different seasonality pattern with stronger performance through the summer months behind the ice-cream business.
Nomad is a company registered in the British Virgin Islands and domiciled for tax in the United Kingdom.
2.     Basis of preparation
These unaudited condensed consolidated interim financial statements for the three months ended March 31, 2024 have been prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, as issued by the IASB. They do not include all the information required for a complete set of IFRS financial statements. The financial information consolidates the Company and the subsidiaries it controls and includes selected notes to explain events and transactions that are significant to an understanding of the changes in Nomad’s financial position and performance since the last annual consolidated financial statements. Therefore the unaudited condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended December 31, 2023, which have been prepared in accordance with International Financial Reporting Standards as issued by the IASB.
These unaudited condensed consolidated interim financial statements were authorized for issue by the Company’s Board of Directors on May 7, 2024.
The accounting policies used by management in preparing these condensed consolidated financial statements were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023, except for taxes on income. Taxes on income are provided for based on management's estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the period. It also reflects the tax impact of exceptional items accounted for in the period.
The preparation of our consolidated interim financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as supply chain disruptions, high inflation and ongoing conflicts, including that between Ukraine and Russia. Actual results could differ from these estimates. The Directors, at the time of approving these interim financial statements, have a reasonable expectation that the Company has adequate resources to continue in operational existence for at least 12 months from the date of signing these interim financial statements given the cash funds available and the current forecast cash flows. In preparing cash flow forecasts, management considers severe but plausible downside scenarios taking into consideration the Company's key risks, including the current economic climate which may adversely impact the Company. Having considered these risks the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these interim financial statements.

33


Recently issued and not yet adopted accounting pronouncements under IFRS
On April 9, 2024, the IASB issued IFRS 18 'Presentation and Disclosure in Financial Statements'. IFRS 18 replaces IAS 1 'Presentation of Financial Statements'. The new Accounting Standard introduces a number of changes to the structure of the Statement of Profit or Loss, more transparency in the presentation of management's own performance measures and more granularity in reporting of financial information. The main impacts of the new Accounting Standard include:
•    Improved comparability in the Statement of Profit or Loss by introducing a set of clearly defined categories based on main business activities (i.e. operating, investing and financing);
•    Requiring disclosure about management-defined performance measures; and
•    Adding new principles for aggregation and disaggregation of information.
IFRS 18 applies for annual reporting periods beginning on or after January 1, 2027. Earlier application is permitted. The Company is still assessing the full impact of the standard.
There are no other accounting pronouncements with a material impact on the Company.
3.    Critical accounting estimates and judgments

The preparation of financial statements in accordance with IFRS requires the use of judgment in applying the accounting policies and estimation that affect the reported amounts of assets and liabilities and results. Actual results could differ from those estimates and the financial statements will be impacted by key judgments taken. In preparing the condensed consolidated interim financial statements, the key sources of estimation uncertainty for the interim period ended March 31, 2024, continue to be the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023.
Key Judgments
Judgments are made in the process of applying accounting policies. Those judgments which are considered key are listed below.
a)     Business Combinations
Business combinations are recognized using the acquisition method. At the acquisition date, the Company is required to recognize separately the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified, the useful economic life of assets and in selecting an appropriate valuation methodology. Furthermore, judgment is applied in allocating business combinations to operating segments, as well as allocating Goodwill to cash generating units.
b)     Discounts and trade promotions
Management uses judgment when considering when accruals for discounts and trade promotions can be released. Management makes the judgment based on the principle that accruals are reversed only to the extent that it is highly probable that a significant reversal will not occur.
c)    Uncertain tax positions
Management uses judgment when identifying and determining whether it is appropriate to provide for uncertain tax positions and for how long provisions for uncertain tax positions are retained, based on assessment as to whether it is probable that a risk would crystallize or not. Management considers tax laws which are in place in making that assessment determining whether it is appropriate to release.
d)    Cash generating units
When performing goodwill impairment testing, management applies judgment to the allocation of goodwill to cash generating units. Management has determined goodwill is monitored at the operating segment level of “Frozen”.
34


e)    Operating segments
Management applies judgment in determining the Chief Operating Decision Maker (“CODM”), and the nature and extent of the financial information which is reviewed by the CODM. Management has considered how resources are allocated in determining the single reporting and operating segment of “Frozen”. Please refer to Note 5 for further information.
Significant estimates
Information about estimates and assumptions that have significant effects on the amounts reported in the condensed consolidated interim financial statements are listed below. In forming these estimates, management has taken into account the impact and potential future impact of supply chain disruptions, high inflation as well as the ongoing conflict between Ukraine and Russia. Management will continue to assess the impact of future developments in relation to these matters as it relates to estimates, especially around the carrying value of goodwill, brands and other intangibles, as well as on property, plant and equipment.

In particular, management will focus on the impact of a long-term conflict in Ukraine. While we do not have any direct operations or sales in either Russia or Ukraine, these countries are responsible for many commonly used raw materials and resources such as fish, wheat and energy. The ongoing conflict and economic sanctions could see considerable reductions in the availability or increase in cost of such raw materials and resources. At this time it is not possible to predict the extent or nature of future impacts on our business although we expect the current conflict to continue for some time.
a)    Discounts and trade promotions
Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has bespoke agreements that are governed by a combination of observable and unobservable performance conditions.
Trade promotions comprise of amounts paid to retailers for programs designed to promote Company products and include pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The estimated ultimate cost of the program is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends.
At each financial year end date, any discount or trade promotion incurred but not yet invoiced is estimated and accrued for. In certain cases, the estimate for discounts and trade promotions requires the use of forecast information for future trading periods and therefore a degree of estimation uncertainty exists. These estimates are sensitive to variances between actual results and forecasts. The estimate is based on accumulated experience. It is impracticable to disclose the extent of the possible effects of estimation uncertainty, however, it is reasonably possible that outcomes within the next financial period from these agreements are materially different in aggregate to those estimated.
The accruals are presented as ‘trade terms’ and offset against trade receivables due to the same customer, or as trade term payables where there is no receivable to be offset. The balance of the reduction in trade receivables for trade terms as of March 31, 2024 is disclosed in Note 11.
b)    Employee benefit obligations
The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each scheme has an actuarial valuation performed and is dependent on a series of assumptions to estimate the projected obligations. The assumptions include variables which are revised periodically, that include discount rates, expected salary increases, inflation, employee turnover, retirement age, mortality and medical care costs. Our assumptions reflect historical experience and management's best judgment regarding future obligations. The assumptions used affect the current service cost and interest expense as well as changes in the obligation recognized. Net actuarial gains or losses arising from changes in assumptions and from experience are recognized in other comprehensive income/(loss).
Since defined benefit pension schemes and post-employment benefit schemes are measured on a discounted basis, the discount rate applied has an impact on the expense and obligation recognized. These discount rates are determined by reference to market yields at the end of the reporting period on high quality corporate bonds, except for Sweden where a deep market does not exist, where mortgage bonds are used. See Note 13 for details of material changes, if any, to assumptions since December 31, 2023.
35


c)    Provisions for uncertain tax positions
The Company operates in many different jurisdictions and in some of these there are certain tax matters which are under discussion with local tax authorities, including as part of tax audits. Management considers these tax audits and discussions with local tax authorities as well as the local tax legislation relative to their tax positions in those jurisdictions when identifying uncertain tax positions. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments, appeals and refunds.
Where tax exposures can be quantified, and management assesses that the risk of an exposure crystallizing is probable, a provision for uncertain tax positions is made based on management's estimates which include judgments with regard to the amounts expected to be paid to the relevant tax authority. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these provisions. The factors considered in estimating the provision include the progress of discussions with the tax authorities, the complexity of respective tax legislation, valuations of assets for tax purposes and the level of documentary support for historical positions taken by previous owners. The provisions are made on the basis of a probability-weighted average of potential outcomes. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these provisions.
Other estimates
a)    Carrying value of goodwill and brands
The Company's goodwill and indefinite life brand values have been allocated based on the enterprise value at acquisition of each cash generating unit. Goodwill is monitored at an operating segment level for which the Company has one reporting and operating segment. Determining whether goodwill and indefinite life brands are impaired requires an estimation of the value in use. The review is performed using a discounted cash flow model to calculate the value in use of the Frozen segment. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. This requires us to make assumptions and estimates regarding historical information, future plans and external sources. Future cash flows for the purposes of the value in use calculation are taken from approved budgets.
b)    Business combinations
The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable estimation in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following estimates and assumptions can materially affect our financial position and profit:
•    The fair value and expected useful economic life of acquired intangible and tangible assets that are subject to depreciation or amortization in future periods.
•    Future changes to the assumptions over forecast future profitability used in estimating the value of intangible assets and goodwill may result in additional expenses or income.
•    Future changes to the assumptions used in estimating the value of uncertain tax positions may result in additional expenses or income.
c)    Fair value of derivative financial instruments
Note 11 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations. These inputs may be readily observable, market corroborated, or generally unobservable inputs and are further discussed in Note 11.
4.    Acquisitions
None.
36


5.    Segment reporting

The Chief Operating Decision Maker (“CODM”) of the Company considers there to be one reporting and operating segment, being “Frozen” and is reflected in the segment presentation below for the periods presented. The CODM primarily uses “Adjusted EBITDA”, as the key measure of the segment’s results, which is considered non-IFRS financial information.

Segment Adjusted EBITDA
  For the three months ended March 31,
20242023
 Note€m€m
Profit for the period34.5 41.2 
Taxation7.4 9.4 
Net financing costs730.1 29.0 
Depreciation & amortization23.1 22.3 
Exceptional items623.5 30.1 
Other add-backs3.7 14.3 
Adjusted EBITDA122.3 146.3 

Other add-backs include the elimination of share-based payment expense and related employer payroll tax expense of €3.4 million for the three months ended March 31, 2024 (2023: €13.9 million), as well as the elimination of non-operating M&A related costs, professional fees and transaction costs of €0.3 million for the three months ended March 31, 2024 (2023: €0.4 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

No information on segment assets or liabilities is presented to the CODM.

External revenue by geography
For the three months ended March 31,
20242023
 €m€m
United Kingdom225.3216.4
Germany112.6117.6
Italy110.6109.1
France53.952.9
Sweden35.838.1
Croatia20.819.6
Austria38.537.9
Norway30.833.7
Serbia19.018.4
Spain22.320.6
Switzerland21.621.2
Rest of Europe92.589.6
Total external revenue by geography783.7775.1
37


6.    Exceptional items
 For the three months ended March 31,
 20242023
€m€m
Business transformation program (1)20.5 28.1 
Fortenova Acquisition integration costs (2) 1.8 
Information Technology transformation program (3) 0.2 
Settlement of legacy matters (4)3.0  
Total exceptional items23.5 30.1 

We do not consider these items to be indicative of our ongoing operating performance.

(1)    Business transformation program
In 2020, the Company launched the first phase of a multi-year, enterprise-wide transformation and optimization program which continued to progress in the current year. Over the next few years, additional transformation phases will be implemented. Progress of the project is ongoing and there remain certain phases to be implemented. The program aims to standardize, simplify and automate end-to-end business processes. This will enable key decision making and analytical capability, building a platform and organization to support future growth and provide better value for shareholders. Execution of the business transformation program includes the evaluation and implementation of a new ERP system.
Expenses incurred to date consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees.

(2)    Fortenova Acquisition integration costs

The Company completed the acquisition of the Fortenova Group’s Frozen Food Business Group on September 30, 2021, following which the Company began an integration project which was completed in 2023. Integration expenses incurred relate to external consultancy costs, organizational structure alignment to Nomad design, systems configuration and roll-out of our controls environment to the acquired business.

(3)    Information Technology transformation program
In 2021, the Company launched a program to transform the Information Technology (“IT”) operating model, specifically to modernize the end-to-end technology estate to support current and future complex and evolving business needs driven by acquisitions and organic growth. Among the many changes made, the program moved our operating model to a cloud-hosted solution, which better deploys new services to the business and end user, including application management, supporting a diverse workforce across multiple locations and languages, as well as deploying artificial Intelligence assisted tools. Other key components of the program included the Company’s cyber security services to adapt to rapidly changing threats and a change of IT service partners to enable one-off renovation and uplift of capabilities across the business. The program was completed in 2023.

(4)    Settlement of legacy matters
A net expense has been recognized associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional.

Tax impact of exceptional items
The tax impact of the exceptional items for the three months ended March 31, 2024 amounted to a credit of 5.7 million (2023: €7.0 million).
Cash flow impact of exceptional items
Included in the Condensed Consolidated Interim Statements of Cash Flows for the three months ended March 31, 2024 is €24.0 million (2023: €14.0 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items in addition to the cash impact of the settlement of provisions brought forward from previous accounting periods.
38


7.    Finance income and costs
 For the three months ended March 31,
20242023
 €m€m
Finance income
Interest income1.8 1.1 
Net financing gain recognized on debt transactions (a)4.1  
Total finance income5.9 1.1 
Interest expense (b)(22.7)(21.5)
Net foreign exchange losses arising on translation of financial assets and liabilities(10.2)(5.8)
Net pension interest costs(1.2)(1.1)
Amortization of debt discounts and borrowing costs(1.7)(1.6)
Net fair value losses on derivatives held at fair value through profit or loss(0.2)(0.1)
Total finance costs(36.0)(30.1)
Net finance costs(30.1)(29.0)
(a) Net income for the three months ended March 31, 2024 of €4.1 million has been recognized from the repricing of the EUR denominated Term Loan B of 130.0 million in February 2024, representing a modification gain net of transaction costs.
(b) Interest expense includes interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss and is shown net of gains recycled from the cash flow hedge reserve on cross currency interest rate swaps.
8.    Taxation

Income tax expense of €7.4 million for the three months ended March 31, 2024 (2023: €9.4 million) is provided for based on management’s estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the periods. This estimate reflects the tax impact of exceptional items accounted for in the periods. The UK statutory rate of corporation tax increased from 19% to 25% with effect from April 1, 2023.
The Company’s subsidiaries, which are subject to tax, operate in many different jurisdictions and, in some of these, certain tax matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments appeals and refunds. The Company actively seeks to manage the associated risks by proactively engaging with tax authorities and applying for Advanced Pricing Agreements where appropriate. Provisions for uncertain tax positions require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision, including releases of provisions when those exposures become time-barred.
Notwithstanding this, management believes that the Company’s tax position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided.
39


9.    Earnings per share
 For the three months ended March 31,
 20242023
Basic earnings per share
Profit for the period attributable to equity owners of the parent (€m)
34.5 41.2 
Weighted average Ordinary Shares and shares issuable solely after the passage of time in millions163.2 174.5 
Basic earnings per share0.21 0.24 

For the three months period ended March 31, 2024, the number of shares in both basic and diluted earnings per share calculations has been adjusted to include 292,687 shares to be issued in future periods as performance conditions have been met. The diluted earnings per share calculation also includes an estimate of 109,322 potential ordinary shares, calculated using the treasury method, on long term incentive plans contingent on service only. There are no adjustments to the profit for the period attributable to equity owners of the parent.
 For the three months ended March 31,
20242023
Diluted earnings per share
Profit for the period attributable to equity owners of the parent (€m)34.5 41.2 
Weighted average Ordinary Shares, shares issuable solely after the passage of time and potential ordinary shares in millions163.3 174.5 
Diluted earnings per share0.21 0.24 
10.    Cash and cash equivalents
March 31, 2024December 31, 2023
€m€m
Cash and cash equivalents in the Statement of Financial Position390.7 412.9 
Bank overdraft (13.2)
Cash and cash equivalents per Statement of Cash Flows390.7 399.7 

‘Cash and cash equivalents’ comprise cash balances and deposits. Bank overdrafts that are repayable on demand and form an integral part of the Company's cash management are included as a component of cash and cash equivalents for the purposes of the Consolidated Statement of Cash Flows.
40


11.     Financial instruments
The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 “Financial Instruments”.
Financial assets at amortized costFinancial assets at fair value through profit or lossDerivatives designated in hedge relationshipsFinancial
liabilities at
amortized
cost
Total
March 31, 2024€m€m€m€m€m
Assets
Derivative financial instruments— — 7.4 — 7.4 
Trade and other receivables292.3 — — — 292.3 
Cash and cash equivalents255.5 135.2 — — 390.7 
Liabilities
Derivative financial instruments— — (78.7) (78.7)
Trade and other payables excluding non-financial liabilities— —  (755.7)(755.7)
Loans and borrowings— —  (2,153.1)(2,153.1)
Total547.8 135.2 (71.3)(2,908.8)(2,297.1)
Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €227.6 million.

Loans and borrowings includes €84.1 million relating to lease liabilities.

Financial assets at amortized costFinancial assets at fair value through profit or lossDerivatives designated in hedge relationships Financial
liabilities at
amortized
cost
Total
December 31, 2023€m€m€m€m€m
Assets
Derivative financial instruments— — 1.9 — 1.9 
Trade and other receivables226.9 — — — 226.9 
Cash and cash equivalents275.1 137.8 — — 412.9 
Liabilities
Derivative financial instruments— — (110.0) (110.0)
Trade and other payables excluding non-financial liabilities— —  (719.1)(719.1)
Loans and borrowings— —  (2,135.1)(2,135.1)
Total502.0 137.8 (108.1)(2,854.2)(2,322.5)
Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €231.4 million.
Loans and borrowings includes €78.8 million relating to lease liabilities.
The Company has determined that the carrying amounts of trade receivables, trade payables and cash and cash equivalents are a reasonable approximation of fair value.
41


Derivative financial instruments
The financial instruments are not traded in an active market and so the fair value of these instruments is determined from the implied forward rate. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 “Fair value measurement”.
Interest bearing loans and borrowings
The fair value of the senior secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the period end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities.
Syndicated loans includes the Senior U.S. Dollar debt of $700.0 million (€642.3 million) (the “Senior USD Loan”) and Senior EUR debt of €130.0 million (a "Senior EUR Loan") both repayable in November 2029, as well as the Senior EUR debt of €553.2 million (a "Senior EUR Loan") repayable in June 2028. The Senior USD Loan includes an annual amortization repayment, equivalent to 1.0% of the original issuance value or $7.0 million (€6.5 million) in October each year until maturity. The Senior EUR Loans are repayable only upon maturity. As required under the Senior Facilities Agreement, the Company is also required to undertake an annual excess cash flow calculation whereby additional principal could be repaid.
On November 8, 2022, the Company amended and restated the Senior Facilities Agreement to issue both a $700.0 million (€700.6 million) term loan bearing interest at a rate per annum equal to the term SOFR rate plus 3.75% with a 0.5% floor and a €130.0 million term loan bearing interest at a rate per annum equal to EURIBOR plus 3.5% with a zero floor, both due November 10, 2029. The net proceeds from these loans were used to repay and extinguish the Company's existing Senior Secured U.S. Dollar term loan due in 2024 in full, and for transaction expenses and general corporate purposes. The new term loans were issued at a discount of €31.3 million, which together with eligible transaction costs of €5.1 million have been capitalized and are being amortized over the life of the debt. Concurrently with the closing of this refinancing, the Company closed out its existing cross currency interest rate swaps and has entered into a number of new 5-year cross-currency and interest rate swaps for the new Term Loans.
On September 22, 2023, the Company completed a repricing of its $693.0 million term loan due 2029 which reduced the interest rate from SOFR plus 3.75% to SOFR plus 3.00%. There are no changes to the maturity of the Term Loan as a result of this repricing. The repricing represents a modification of a financial liability, such that a modification gain of €17.2 million has been recognized, representing the difference between the remaining original contractual cash flows and the modified cash flows, both discounted at the original effective interest rate. Eligible transaction costs associated with the modification of €2.4 million were added to the loan carrying amount and amortized over the remaining loan term. The carrying amount of the loan was revised to reflect the new cash outflows at the date of modification. In October 2023, our cross-currency and interest rate swaps were amended, effective October 10, 2023 to align more closely with the amended cash flows of our USD term loan following the repricing.
On February 2, 2024, the Company completed on the repricing of its existing EUR denominated Term Loan B of 130.0 million principal due 2029 (the “Term Loan”). Following the closing, the margin on the Term Loan has been reduced by 75 basis points to EURIBOR plus 2.75%. There are no changes to the maturity of the Term Loan as a result of this repricing. The repricing represents a modification of a financial liability, such that a net modification gain of 4.1 million has been recognized, representing the difference between the remaining original contractual cash flows and the modified cash flows, both discounted at the original effective interest rate. On April 10, 2024, our interest rate swaps were amended to align more closely with the amended cash flows of our EUR term loan following the repricing.
On April 29, 2024, the Company completed on the repricing of its existing USD denominated Term Loan B of €693.0 million principal due 2029 (the “Term Loan”), subject to customary closing conditions. Following the closing, the margin on the Term Loan will be reduced by 50 basis points to SOFR plus 2.5% effective from May 7, 2024. There are no changes to the maturity of the Term Loan as a result of this repricing. Our cross currency interest rate swaps have also been amended to more closely align with this change, also taking effect in May 2024.
The Senior Loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries.
42


 
 Fair valueCarrying value
March 31, 2024December 31, 2023March 31, 2024December 31, 2023
 €m€m€m€m
Senior EUR/USD loans1,328.5 1,314.5 1,304.8 1,293.8 
Other external debt0.3 0.3 0.3 0.3 
2028 fixed rate senior secured notes748.0 752.8 800.0 800.0 
Less capitalized debt discounts and borrowing costs  (36.1)(37.8)
2,076.8 2,067.6 2,069.0 2,056.3 
12.    Provisions
RestructuringProvisions
related to
other taxes
OtherTotal
€m€m€m€m
Balance as of January 1, 202412.7 7.6 16.2 36.5 
Additional provision in the period0.6  0.8 1.4 
Release of provision(0.5)(0.2)(0.7)(1.4)
Utilization of provision(3.6) (0.1)(3.7)
Foreign exchange(0.1) 0.2 0.1 
Balance as of March 31, 20249.1 7.4 16.4 32.9 
Analysis of total provisions:March 31, 2024December 31, 2023
Current31.5 35.1 
Non-current1.4 1.4 
Total32.9 36.5 
Updates since December 31, 2023
Restructuring
The €9.1 million (December 31, 2023: €12.7 million) provision relates to committed plans for certain restructuring activities of an exceptional nature. The increase in the provision during the period relates to the business transformation program as detailed in Note 6, which are due to be completed within the next 12 months. €3.6 million has been utilized in the three months ended March 31, 2024, which relates to reorganizational activities across the Company.
13.    Employee benefits

The Company operates partially funded defined benefit pension plans in Germany and Austria, an unfunded defined benefit pension plan in Sweden and defined benefit indemnity arrangements in Italy and Austria, as well as various contribution plans in other countries. Pension benefits in Switzerland are met via a contract with a collective foundation that offers a fully insured solution to provide a contribution-based cash balance retirement plan, which is classified as a defined benefit plan. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy, long term service awards are in operation and various other countries provide other employee benefits. There were no changes in the nature of any schemes in the three months ended March 31, 2024.

43


The total net employee benefit obligations as at March 31, 2024 is as follows:
 €m
Balance as of January 1, 2024158.3 
Service cost0.5 
Net interest expense1.2 
Actuarial gain on pension scheme valuations(3.9)
Benefits paid(0.9)
Other movements(1.0)
Foreign exchange differences on translation(2.1)
Balance as of March 31, 2024152.1 
The principal assumptions applied for the valuation at March 31, 2024 were the same as those applied at December 31, 2023, except for the German plan, which is the most significant in terms of plan assets and liabilities to the Company. The discount rate applied to the German defined benefit obligations increased from 3.4% to 3.5% and the discount rate applied to the Swedish defined benefit obligations, which is also material, was unchanged at 3.2%.
14.    Share based compensation reserve

During 2015, the Company established a discretionary share award scheme, the LTIP, which enables the Company’s Compensation Committee to make grants (“Awards”) in the form of rights over ordinary shares, to any Director, Non-Executive Director or employee of the Company. The Compensation Committee currently awards grants to Senior Management, including those that are Directors and Non-Executive Directors.
All Awards are to be settled by physical delivery of shares.
Director and Senior Management Share Awards

As part of its long term incentive initiatives, the Company has awarded restricted shares to the management team (the “Management Share Awards”) as of the following award dates.

 January 1, 2021 AwardJanuary 1, 2022 AwardJanuary 1, 2023 AwardJanuary 1, 2024 AwardOther AwardsTotal
Number of awards outstanding at January 1, 2024605,600730,5941,003,808  163,000 2,503,002
New awards granted in the period   1,112,4601,112,460
Forfeitures in the period(9,222)(11,301)(7,000)(27,523)
Awards lapsed in the period(129,048)  (129,048)
Number of awards outstanding at March 31, 2024476,552721,372992,5071,112,460156,0003,458,891


44


 January 1, 2018 AwardJanuary 1, 2019 AwardJanuary 1, 2020 AwardJanuary 1, 2021 AwardJanuary 1, 2022 AwardOther AwardsTotal
Number of awards outstanding at January 1, 2023193,990152,695598,173 683,549 894,750 176,000 2,699,157
Forfeitures in the period(11,735)(40,620)(92,583)(65,000)(209,938)
Awards lapsed in the period(171,579)   (171,579)
Awards vested and issued in period(193,990)(152,695)(414,859)   (761,544)
Number of awards outstanding at March 31, 2023642,929802,167111,0001,556,096

By April 2024, the 2018, 2019, 2020 and 2021 Management Share Awards previously granted have all vested in accordance with satisfaction of their respective performance conditions and have been issued to participants.

In late 2021, 820,202 restricted share awards were granted as part of the 2021 Management Share Award. The performance period associated with the award began on January 1, 2021. The Share awards will vest upon the Company achieving a range of performance conditions including cumulative EBITDA, cumulative net sales, and Company share price performance measures over a three-year period. The cumulative EBITDA and Cumulative Net Sales tranches of shares are equally weighted, being worth 37.5% of the total award each. The Share Price Tranche is worth 25% of the total award. All shares vest, subject to satisfaction of the award conditions.
In January 2022, 1,140,518 restricted share awards were granted as part of the 2022 Management Share Award and two new restricted share award plans ("Other awards"). The performance period associated with the awards began either on January 1, 2022 or January 1, 2023. All shares vest, subject to satisfaction of a range of award conditions from January 2025 to January 2026, with the majority of shares vesting January 1, 2025, subject to certain Company performance conditions.
In the first quarter 2023, a revision to the January 1, 2021 and 2022 Management Share Award schemes occurred, resulting in changes to how EBITDA performance is used to measure the number of shares able to vest over the entire scheme. The incremental fair value granted as a result of the modifications made to the January 1, 2021 and 2022 Management Share Awards was $9.0 million (€8.5 million) and $11.4 million (€10.8 million), respectively.
In September 2023, 1,209,137 restricted share awards were granted as part of the 2023 Management Share Award. The performance period associated with the awards began on January 1, 2023. All shares vest, subject solely to the satisfaction of Company cumulative EBITDA performance conditions, on January 1, 2026. Also in the second quarter, 87,000 restricted share awards were granted ("Other awards"). The performance period associated with these awards began on January 1, 2023 and vests on January 1, 2026, subject to certain Company performance conditions.
In February 2024, 1,112,460 restricted share awards were granted as part of the 2024 Management Share Award. The performance period associated with the awards began on January 1, 2024. All shares vest, subject to satisfaction of a range of award performance conditions, on January 1, 2027.
In January 2023, the remaining 193,990 restricted shares granted as part of the 2018 Management Share Awards vested as a result of the satisfaction of the previously achieved applicable Share Price Performance Condition (based on a share price of $17.24), resulting in the issuance of 110,781 ordinary shares to participants in the LTIP (net of 83,209 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In January 2023, 152,695 restricted shares granted as part of the 2019 Management Share Awards vested as a result of the satisfaction of the applicable EBITDA Performance Condition (based on a share price of $17.24 at time of vesting), resulting in the issuance of 79,575 ordinary shares to participants in the LTIP (net of 73,120 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

In February 2023, 414,859 restricted shares granted as part of the 2020 Management Share Awards vested as a result of the satisfaction of the applicable EBITDA Performance Condition (based on a share price of $17.77 at time of vesting), resulting in the issuance of 222,780 ordinary shares to participants in the LTIP (net of 192,079 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares).

45


476,552 restricted shares granted as part of the 2021 Management Share Awards vested as a result of the satisfaction of the applicable Performance Condition (based on a share price of $18.89). Due to the timing of the vesting, the resulting issuance of 256,687 ordinary shares to participants in the LTIP (net of 219,865 ordinary shares held back from issue by the Company as settlement towards personal tax liabilities arising on the vested ordinary shares) occurred in April 2024.

The stock compensation charge reported within the Consolidated Statement of Profit or Loss for the three months ended March 31, 2024 related to the Director and Senior Management Share Awards is €3.0 million (three months ended March 31, 2023: €12.2 million).

The Company calculates the cost of the Management Share Awards based upon their fair value using the Monte Carlo Model, which is considered to be the most appropriate methodology considering the restricted shares only vest once the market performance conditions have been satisfied, as well as expected exercise period and the payment of dividends by the Company. Based on the latest revision to schemes, the inputs and assumptions underlying the Monte Carlo models for all awards outstanding as of valuation date are as follows:

 January 1, 2021 AwardJanuary 1, 2022 Award *January 1, 2023 Award *January 1, 2024 Award *
Grant date price$25.42 $25.39 $17.24 $16.95 
Exercise price$ $ $ $ 
Expected life of restricted share3.00 years3.00 years3.00 years3.00 years
Expected volatility of the share price30.0 %28.0 %N/AN/A
Dividend yield expected % %N/AN/A
Risk free rate0.24 %1.15 %N/AN/A
Employee exit rate14.0 %14.0 %18.0 %15.0 %
EBITDA Performance Target Conditions35.0 %35.0 %75.0 %75.0 %
*Note: The table above does not include details on awards that only require continued employment over the vesting period and have only non-company wide specific performance conditions.
The expected volatility of the share price inputs above were estimated by referencing selected quoted companies which are considered to exhibit some degree of comparability with the Company, as the Company has been listed since 2016. Based on the revised assessment in the current period of fair value and the number of shares expected to vest, the total fair value in respect of the Restricted Shares outstanding are:

2021 award - $16.0 million (€15.1 million)
2022 award - $19.0 million (€17.9 million)
2023 award - $7.5 million (€7.0 million)
2024 award - $8.8 million (€8.0 million)
Other awards - $3.8 million (€3.4 million)
Non-Executive Director Restricted Share Awards
In accordance with the Board approved independent Non-Executive Director compensation guidelines, each independent Non-Executive Director is entitled to a grant of $100,000 of restricted shares annually on the date of the annual general meeting, valued at the closing market price for such shares on this date. The restricted shares vest on the earlier of thirteen months from the date of grant or the date of the Company’s next annual meeting of shareholders.
On July 1, 2022, after the Company's annual general meeting of shareholders, the then current Non-Executive Directors were granted 29,676 restricted stock awards at a share price of $20.22. These Non-Executive Directors restricted share awards vested on July 6, 2023 and 18,450 were issued. Of the total 29,676 number of shares vesting, 11,226 shares were held back from issue by the Company as settlement towards personal tax liabilities arising on the vested shares.
On July 6, 2023, after the Company's annual general meeting of shareholders, the current Non-Executive Directors were granted 35,082 restricted stock awards at a share price of $17.10.
The total charge for Non-Executive Directors' grants within the Statement of Consolidated Profit or Loss for the three months ended March 31, 2024 for the stock compensation awards was €0.1 million (three months ended March 31, 2023: €0.1 million).
46


Share based compensation reserve
20242023
 €m€m
Balance as of January 131.4 13.8 
Non-Executive Directors' restricted share awards charge0.1 0.1 
Directors' and Senior Management share awards charge3.0 12.2 
Reclassification of awards for settlement of tax liabilities (4.0)
Balance as of March 3134.5 22.1 

In many jurisdictions, tax authorities levy taxes on share-based payment transactions with employees that give rise to a personal tax liability for the employee. In some cases, the Company is required to withhold the tax due and to settle it with the tax authority on behalf of the employees. To fulfill this obligation, the terms of the Management Share Awards permit the Company to withhold the number of shares that are equal to the monetary value of the employee’s tax obligation from the total number of shares that otherwise would have been issued to the employee upon vesting. The monetary value of the employee’s tax obligation is recorded as a deduction from the Share based compensation reserve for the shares withheld.

15.    Share capital and capital reserve, other reserves and dividends
Ordinary Shares
On August 5, 2021, the Company announced that its Board of Directors authorized a share repurchase program to purchase up to an aggregate of $500 million of the Company’s ordinary shares. Acquisitions pursuant to the share repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions, at the Company's discretion, as permitted by securities laws and other legal requirements. Pursuant to the program, as at December 31, 2021, 3,090,082 ordinary shares had been repurchased and canceled at an average price of $24.50, for aggregate gross costs of $75.8 million (€67.1 million). Directly attributed transaction costs of €0.1 million were incurred. During 2022, a further 1,160,547 ordinary shares were repurchased and canceled in open market transactions at an average price of $26.23 for aggregate gross costs of $30.5 million (€26.8 million) under this authorization. Directly attributable transaction costs were immaterial. During 2023, a further 11,314,705 ordinary shares were repurchased and canceled in open market transactions at an average price of $16.33 for aggregate gross costs of $185.0 million (€170.9 million) under this authorization. Directly attributable costs of €0.2 million were incurred.
On November 6, 2023, the Company's Board of Directors authorized a new share repurchase program to purchase up to an aggregate of $500 million of the Company’s ordinary shares. Acquisitions pursuant to the share repurchase program may be made from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions, at the Company's discretion, as permitted by securities laws and other legal requirements. This new program replaces the previous authorization which was established in August 2021 and finished at the end of 2023. The new program will expire at the end of 2026. Pursuant to this program, as at March 31, 2024, 447,962 ordinary shares had been repurchased and canceled in open market transactions at an average price of $17.31. The aggregate gross costs were $7.8 million (€7.1 million) and directly attributable transaction costs were immaterial.
See Note 14 for further information on restricted shares vested as part of the 2018, 2019, 2020 and 2021 Management Share Awards.
The authorized share capital available to the Company consists of an unlimited number of Ordinary Shares with $nil nominal value issued at $10.00 per share.

 SharesMarch 31, 2024December 31, 2023
March 31, 2024December 31, 2023€m€m
Authorized Share Capital issued and fully paid:
Ordinary Shares with nil nominal value162,719,172 163,167,134 1,446.3 1,453.4 
Total share capital and capital reserve1,446.3 1,453.4 
Listing and share transaction costs(27.3)(27.3)
Total net share capital and capital reserve1,419.0 1,426.1 

47


Other Reserves
Other reserves as at March 31, 2024, include a cash flow hedging reserve of €(14.8) million (December 31, 2023: €(27.5) million) and a cost of hedging reserve with a surplus of €3.0 million (December 31, 2023: surplus of €2.9 million).
Dividends
A dividend of $0.15 per share for the quarter ended December 31, 2023 was approved by the Board of Directors on January 29, 2024 and a total of $24.4 million (€22.3 million) was paid February 26, 2024.
A dividend of $0.15 per share for the quarter ended March 31, 2024 was approved by the Board of Directors on April 30, 2024 and will be paid May 28, 2024 based on a record date of May 9, 2024. As this was approved after the date of the Consolidated Statement of Financial Position, the dividend has not been recorded as a liability in these consolidated financial statements.
16.    Related parties
As of January 1, 2022, the Company amended its Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of Sir Martin Franklin, and TOMS Capital LLC, an affiliate of Mr. Gottesman. Pursuant to the terms of the Amended and Restated Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC will continue to provide high-level strategic advice and guidance to the Company for an aggregate annual fee equal to $4.0 million, payable in quarterly installments.

Key management personnel comprise the Directors and Executive Officers. The Executive Officers continue to be remunerated for their services to the Company through their employment contracts. Non-executive Directors continue to receive fees for their services as board members and to certain committees and are settled through payroll. Director fees are payable quarterly in arrears. Total non-executive Director fees and expenses for the three months ended March 31, 2024 were €0.1 million (three months ended March 31, 2023: €0.1 million). In addition, certain non-executive Directors received grants under the LTIP as discussed in Note 14.

17.    Subsequent events after the Statement of Financial Position date
Details of the repricing of the Company's USD denominated Term Loan B and changes to interest rate swaps subsequent to March 31, 2024 are included within Note 11.
Details of dividends declared after March 31, 2024 can be found in Note 15.

48
EX-101.SCH 4 nomd-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Unaudited Condensed Consolidated Interim Statements of Financial Position link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Unaudited Condensed Consolidated Interim Statements of Profit or Loss link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Unaudited Condensed Consolidated Interim Statements of Profit or Loss link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Unaudited Condensed Consolidated Interim Statements of Changes in Equity link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Unaudited Condensed Consolidated Interim Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Cash and cash equivalents link:presentationLink link:calculationLink link:definitionLink 0000008 - Statement - Cash and cash equivalents (Tables) link:presentationLink link:calculationLink link:definitionLink 0000009 - Statement - Cash and cash equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - General information link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Basis of preparation link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Accounting estimates and judgments link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Segment reporting link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Exceptional items link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Finance income and costs link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Taxation link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Earnings per share link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Financial instruments link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Provisions link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Employee benefits link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Share based compensation reserve link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Share Capital and Capital reserve link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Related parties link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Subsequent events after the Statement of Financial Position date link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Basis of preparation (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Accounting estimates and judgments (Policies) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Segment reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Exceptional items (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Finance income and costs (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Earnings per share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Financial instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Provisions (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Employee benefits (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Share based compensation reserve (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Share Capital and Capital reserve (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - General information (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Basis of preparation (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Segment reporting - Segment as Adjusted EBITDA (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Segment reporting - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Segment reporting - Geographical information (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Exceptional Items - Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Exceptional items - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Finance income and costs (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Taxation (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Earnings per share - Computation (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Earnings per share - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Financial instruments - Categories of financial instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Financial Instruments - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Financial Instruments - Interest bearing loans and borrowings (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Provisions - Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Provisions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Employee Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Share based compensation reserve - Director and Senior Management Share Awards (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Share based compensation reserve - Director and Senior Management Share Awards (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Share based compensation reserve - Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Share based compensation reserve - Non-Executive Director Restricted Share Awards (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Share based compensation reserve - Reserve Summary (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Share Capital and Capital reserve - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Share Capital and Capital reserve - Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Share Capital and Capital reserve (Dividends) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Related parties (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 nomd-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 6 nomd-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 7 nomd-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Dilutive effect of share options on number of ordinary shares Dilutive effect of share options on weighted average number of ordinary shares Vesting1 [Axis] Vesting1 [Axis] Vesting1 [Axis] Current liabilities Current liabilities [abstract] January 1, 2016 January 1, 2016 [Member] January 1, 2016 [Member] Common Table Line Items [Line Items] Common Table Line Items [Line Items] Common Table Line Items Disclosure of defined benefit plans [table] Disclosure of defined benefit plans [table] Management Award 2020 Management Award 2020 [Member] Management Award 2020 Trade and other payables excluding non-financial liabilities Trade Payables [Member] Trade Payable [Member] Treasury shares Treasury shares [member] Schedule of Finance income and costs Disclosure of Finance Income and Costs [Table Text Block] Disclosure of Finance Income and Costs Tax paid Income taxes paid (refund), classified as operating activities Weighted average fair value at measurement date, other equity instruments granted Weighted average fair value at measurement date, other equity instruments granted Senior USD Debt Senior USD Debt [Member] Senior USD Debt [Member] Non-current liabilities Non-current liabilities [abstract] Share capital [member] Share capital [member] EBITDA Performance Target Conditions EBITDA Performance Target Condition, Other Equity Instruments Granted EBITDA Performance Target Condition, Other Equity Instruments Granted Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity1 Line of Credit Facility, Maximum Borrowing Capacity Expected life of restricted share Other Equity Instruments Life, Other Equity Instruments Granted Other Equity Instruments Life, Other Equity Instruments Granted Borrowing costs capitalised Borrowing costs capitalised Provisions Current Current provisions Restricted shares Restricted Stock1 [Member] Restricted Stock1 [Member] Depreciation and amortization Adjustments for depreciation and amortisation expense Operating profit Profit (loss) from operating activities Disclosure of share capital, reserves and other equity interest [Abstract] Disclosure of share capital, reserves and other equity interest [Abstract] Disclosure of share capital, reserves and other equity interest [Abstract] Repayment of loan principal Repayments of borrowings, classified as financing activities Incremental fair value granted, modified share-based payment arrangements Incremental fair value granted, modified share-based payment arrangements Number of other equity instruments expired in share-based payment arrangement Number of other equity instruments expired in share-based payment arrangement Taxation Taxation Tax expense Tax expense (income) Weighted average Ordinary Shares, shares issuable solely after the passage of time and potential ordinary shares in millions Weighted Average Number Of Ordinary and Preferred Shares Outstanding, Diluted Weighted Average Number Of Ordinary and Preferred Shares Outstanding, Diluted Actuarial assumption of discount rates Actuarial assumption of discount rates Geographical [Axis] Geographical [Axis] Financial Liabilities At Fair Value Through Other Comprehensive Income Financial Liabilities At Fair Value Through Other Comprehensive Income Financial Liabilities At Fair Value Through Other Comprehensive Income Non-current assets Non-current assets [abstract] Management Award 2019 Management Award 2019 [Member] Management Award 2019 Share based compensation reserve Disclosure of reserves within equity [text block] Total transactions with owners, recognized directly in equity Increase (decrease) through transactions with owners, equity Other financing cash flows Other inflows (outflows) of cash, classified as financing activities January 1, 2024 January 1, 2024 [Member] January 1, 2024 Customer [Axis] Customer [Axis] Actuarial gains/(losses) on defined benefit pension plans Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans Vesting1 [Domain] Vesting1 [Domain] [Domain] for Vesting1 [Axis] Range [axis] Range [axis] LTIP vesting LTIP vesting [Member] LTIP vesting Provisions Non-current Non-current provisions Services Agreement, Annual Fee, Related Party Transactions Services Agreement, Annual Fee, Related Party Transactions Services Agreement, Annual Fee, Related Party Transactions Reserve of change in value of forward elements of forward contracts Reserve of change in value of forward elements of forward contracts Trade and other receivables Trade and other current receivables Information Technology transformation program (3) Expenses From Supply Chain Reconfiguration Expenses From Supply Chain Reconfiguration Taxation (charge)/credit on measurement of defined benefit pension plans Income tax relating to remeasurements of defined benefit plans included in other comprehensive income Earnings per share Disclosure of earnings per share [text block] Finance income Total finance income Finance income Risk free rate Risk Free Interest Rate, Other Equity Instruments Granted Risk Free Interest Rate, Other Equity Instruments Granted Financial instruments, class [member] Financial instruments, class [member] Service cost Increase in net defined benefit liability (asset) resulting from current service cost Net defined benefit liability (asset) at beginning of period Net defined benefit liability (asset) at end of period Net defined benefit liability (asset) Basic earnings (loss) per share from continuing operations Basic earnings (loss) per share from continuing operations Exceptional items Exceptional Items Exceptional Items Aunt Bessie's Aunt Bessie's [Member] Aunt Bessie's Analysis of income and expense [abstract] Analysis of income and expense [abstract] Classes of other provisions [axis] Classes of other provisions [axis] Swap contract Swap contract [member] Disclosure of transactions between related parties [table] Disclosure of transactions between related parties [table] All Currencies [Domain] All Currencies [Domain] Founder Preferred shares Preference shares [member] Operating cash flow before changes in working capital, provisions and exceptional items Cash flows from (used in) operations before changes in working capital Other add-backs Adjustments For Other Items Adjustments For Other Items Effect of exchange rate fluctuations Effect of exchange rate changes on cash and cash equivalents Utilization of provision Provision used, other provisions Provision used, other provisions Exceptional items Disclosure Of Exceptional Items Explanatory [Text Block] Disclosure Of Exceptional Items Explanatory [Text Block] Goodfella's Pizza [Member] Goodfella's Pizza [Member] Goodfella's Pizza [Member] Preference shares, dividend payment terms, weighted average share price, minimum term required Preference Shares, Dividend Payment Terms, Weighted Average Share Price, Minimum Term Required Preference Shares, Dividend Payment Terms, Weighted Average Share Price, Minimum Term Required Schedule of Share Capital and Capital Reserve Disclosure of classes of share capital [text block] Number of shares repurchased Number of shares repurchased Number of shares repurchased Fortenova Acquisition integration costs (2) Fortenova Group Integration Costs Fortenova Group Integration Costs Basic earnings per share Basic earnings (loss) per share Common [Table] Common [Table] Other non-current assets Other non-current assets Payments related to shares withheld for taxes Income taxes paid (refund), classified as financing activities Cumulative translation difference on Croatia adopting the Euro Cumulative translation difference on Croatia adopting the Euro Cumulative translation difference on Croatia adopting the Euro Segment As Adjusted EBITDA Disclosure of operating segments [text block] Other provisions at beginning of period Other provisions at end of period Other provisions Other provisions Repayments Of Non-current Borrowings - percentage of original issued notional Repayments Of Non-current Borrowings - percentage of original issued notional Repayments Of Non-current Borrowings - percentage of original issued notional Equity attributable to owners of the parent (restated) Equity attributable to owners of the parent (restated) Equity attributable to owners of the parent (restated) Equity attributable to owners of the parent (restated) Gains (Losses) on Restructuring of previous debt Gains (Losses) on Restructuring of previous debt Gains (Losses) on Restructuring of previous debt Issued Capital and Capital Reserve Issued Capital And Capital Reserve [Member] Issued Capital And Capital Reserve [Member] Release of indemnification assets (4) Contingent Consideration Arrangements And Indemnification Assets Recognised As Of Acquisition Date, Release of Provision Contingent Consideration Arrangements And Indemnification Assets Recognised As Of Acquisition Date, Release of Provision Financial assets at fair value through profit or loss Financial assets at fair value through profit or loss Total share capital and capital reserve Issued Capital and Capital Reserve, Gross Issued Capital and Capital Reserve, Gross Share based payments expense Adjustments for share-based payments Findus Switzerland integration costs (2) Findus Switzerland Integration Costs Findus Switzerland Integration Costs Disclosure of detailed information about financial instruments [abstract] Disclosure of detailed information about financial instruments [abstract] Key Management Personnel Of Entity Or Parent, Reclassification to tax liability Key Management Personnel Of Entity Or Parent, Reclassification to tax liability [Member] Key Management Personnel Of Entity Or Parent, Reclassification to tax liability 2024 fixed rate senior secured notes Twenty Twenty-Four Fixed Rate Senior Secured Notes [Member] Twenty Twenty-Four Fixed Rate Senior Secured Notes [Member] Short-term investments [Member] Short-term investments [Member] Short-term deposits [Member] Non-controlling interests Non-controlling interests [member] Summary of Provisions Disclosure of other provisions [text block] External Credit Rating, Fitch [Domain] External Credit Rating, Fitch [Domain] Disclosure Of Financial Assets And Liabilities [Table] [Line Items] Disclosure Of Financial Assets And Liabilities [Table] [Line Items] [Line Items] for Disclosure Of Financial Assets And Liabilities [Table] [Table] Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash and cash equivalents in the Statement of Financial Position Financial assets at amortized cost Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents1 Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents1 Financial assets, class [member] Financial assets, class [member] Expected volatility of the share price Expected Volatility, Other Equity Instruments Granted Expected Volatility, Other Equity Instruments Granted Number of other equity instruments exercised or vested in share-based payment arrangement Awards vested and issued in period (in shares) Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) Number of other equity instruments exercised or vested in share-based payment arrangement Aircraft Type [Axis] Aircraft Type [Axis] Total current liabilities Current liabilities Loss on disposal and impairment of property, plant and equipment Adjustments for gain (loss) on disposals, property, plant and equipment Expense from share-based payment transactions with employees Expense from share-based payment transactions with employees Current assets Current assets [abstract] Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share Preferred Stock, Shares Issued1 Preferred Stock, Shares Issued1 Preferred Stock, Shares Issued1 Categories of related parties [axis] Categories of related parties [axis] Earnings per share [table] Earnings per share [table] Founder preferred shares annual dividend amount (in shares) Dividends Recognised As Distributions To Owners, Shares Dividends Recognised As Distributions To Owners, Shares EBITDA and cumulative net sales tranches as percent of total award EBITDA and Cumulative Net Sales tranches as Percent of Total Award EBITDA and Cumulative Net Sales tranches as Percent of Total Award Geographical areas [axis] Geographical areas [axis] Statement of changes in equity [line items] Statement of changes in equity [line items] Taxation (charge)/credit relating to components of other comprehensive income Income tax relating to components of other comprehensive income that will be reclassified to profit or loss Provision for employer taxes on share based payments Provision for employer taxes on share based payments [Member] Provision for employer taxes on share based payments [Member] Classes of financial assets [axis] Classes of financial assets [axis] Other comprehensive income: Other comprehensive income [abstract] Fair value of derivative financial instruments Description of accounting policy for fair value measurement [text block] Benefits paid Decrease (increase) in net defined benefit liability (asset) resulting from payments in respect of settlements Schedule of Net Employee Benefit Obligations Disclosure of net defined benefit liability (asset) [text block] Cash flow hedges Other comprehensive income, before tax, cash flow hedges Reclassification of awards for settlement of tax liabilities Reclassification of awards for settlement of tax liabilities Reclassification of awards for settlement of tax liabilities Exceptional Items, Tax Expense (Income), Continuing Operations Exceptional Items, Tax Expense (Income), Continuing Operations Exceptional Items, Tax Expense (Income), Continuing Operations Cash flows from investing activities Cash flows from (used in) investing activities [abstract] Profit for the period Profit for the period Profit (loss) Par value per share (in usd per share) Par value per share Proceeds from sale or issue of treasury shares Proceeds from sale or issue of treasury shares Austria AUSTRIA Total non-current assets Non-current assets Founder preferred shares [Axis] Founder preferred shares [Axis] Founder preferred shares [Axis] Increase (decrease) through transfers, intangible assets other than goodwill Increase (decrease) through transfers, intangible assets other than goodwill Non-cash loss recognized in relation to cross currency interest rate swaps Non-cash loss recognized in relation to cross currency interest rate swaps Non-cash loss recognized in relation to cross currency interest rate swaps Disclosure of other provisions [line items] Disclosure of other provisions [line items] Uncertain tax positions Description of accounting policy for income tax [text block] (Decrease)/increase in employee benefits and other provisions Adjustments for increase (decrease) in employee benefit liabilities Equity attributable to owners of parent Equity attributable to owners, beginning balance Equity attributable to owners, ending balance Equity attributable to owners of parent Translation reserve Reserve of exchange differences on translation Current tax receivable Current tax assets, current Cash flow hedges Cash flow hedges [member] Disclosure of expected impact of initial application of new standards or interpretations [text block] Disclosure of expected impact of initial application of new standards or interpretations [text block] Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity Key management personnel compensation Key management personnel compensation Operating Segments [Abstract] Operating Segments [Abstract] Operating Segments [Abstract] Decrease/(increase) in inventories Adjustments for decrease (increase) in inventories Disclosure of detailed information about borrowings [table] Disclosure of detailed information about borrowings [table] Statement of changes in equity [abstract] Statement of changes in equity [abstract] Dividends recognised as distributions to owners per share (in dollars per share) Dividends recognised as distributions to owners per share Contract liabilities Contract liabilities Share issuance costs Payments for share issue costs Counterparties [axis] Counterparties [axis] Document Type Document Type Gross profit Gross profit Basis Of Presentation [Abstract] Basis Of Presentation [Abstract] Basis Of Presentation Applicable tax rate Applicable tax rate External Credit Rating, Standard & Poor's [Domain] External Credit Rating, Standard & Poor's [Domain] Schedule of Reserves within Equity Disclosure Of Detailed Information About Reserves Within Equity [Table Text Block] Disclosure Of Detailed Information About Reserves Within Equity [Table Text Block] Basis of preparation Disclosure of basis of preparation of financial statements [text block] Net impairment loss on short term investments Impairment loss recognised in profit or loss, loans and advances Restructuring Restructuring provision [member] Other reserves Other reserves Segment reporting Disclosure of entity's operating segments [text block] Finance costs Total finance costs Finance costs Indemnification assets Indemnification assets recognized as of acquisition date Indemnification assets recognized as of acquisition date Fair value gain (loss) that would have been recognised in profit or loss or other comprehensive income if financial assets had not been reclassified as measured at amortised cost, initial application of IFRS 9 Fair value gain (loss) that would have been recognised in profit or loss or other comprehensive income if financial assets had not been reclassified as measured at amortised cost, initial application of IFRS 9 Other operating expenses Other operating income (expense) Repurchase of ordinary shares Payments to acquire or redeem entity's shares Payments to acquire or redeem entity's shares Liability relating to IFRS 16 Liability relating to IFRS 16 [Member] Liability relating to IFRS 16 [Member] Award Type1 [Axis] Award Type1 [Axis] Award Type1 [Axis] Transaction costs Transaction costs Transaction costs incurred with regards to share repurchase Total net share capital and capital reserve Issued Capital and Capital Reserve Issued Capital and Capital Reserve Organizational Design (5) Distribution network integration Distribution network integration Non-controlling interests Profit (loss), attributable to non-controlling interests Foreign exchange differences on translation Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset) Acquisition purchase price adjustments Business Combination, Purchase Price Adjustment, Inventory Step Up Business Combination, Purchase Price Adjustment, Inventory Step Up Share based payment charge Increase (decrease) through share-based payment transactions, equity Disclosure of detailed information about borrowings [line items] Disclosure of detailed information about borrowings [line items] Vesting 2 [Axis] [Axis] Vesting 2 [Axis] [Axis] Vesting 2 [Axis] [Axis] Other Miscellaneous other provisions [member] Profit or loss [abstract] Profit or loss [abstract] Share-based Compensation Award, Tranche Two Share-based Compensation Award, Tranche Two1 [Member] Share-based Compensation Award, Tranche Two1 [Member] Disclosure of detailed information about business combination [table] Disclosure of detailed information about business combination [table] Top of range Top of range [member] Fees and expenses Fees And Expenses, Related Party Transactions Fees And Expenses, Related Party Transactions Interest paid Interest paid, classified as financing activities Share-based payments Description of accounting policy for share-based payment transactions [text block] Disclosure Of Financial Assets And Liabilities [Table] Disclosure Of Financial Assets And Liabilities [Table] Disclosure Of Financial Assets And Liabilities [Table] Other reserves Reserve of cash flow hedges Acquired through business combinations Increase (decrease) in net defined benefit liability (asset) resulting from business combinations and disposals Cash flows from operating activities Cash flows from (used in) operating activities [abstract] Information Technology transformation program (3) Information Technology Transformation program Information Technology Transformation program Financial liabilities at fair value through profit or loss Financial liabilities at fair value through profit or loss Related Party [Abstract] Related Party [Abstract] Related Party [Abstract] Onerous/ unfavorable contracts Onerous contracts provision [member] Short-term investments Short-term deposits, not classified as cash equivalents Total current assets Current assets Acquisition related costs Adjustments For Acquisition Related Costs Adjustments For Acquisition Related Costs Equity (restated) Equity (restated) Equity (restated) Equity (restated) Spain SPAIN Loans and borrowings Current portion of non-current borrowings Award Date1 [Domain] Award Date1 [Domain] Award Date1 [Domain] Level 1 Level 1 of fair value hierarchy [member] Disclosure of classes of share capital [table] Disclosure of classes of share capital [table] Payment of financing fees Payments for debt issue costs General Information About Financial Statements [Abstract] General Information About Financial Statements [Abstract] General Information About Financial Statements [Abstract] Equity owners of the parent Profit for the period attributable to equity owners of the parent (€m) Profit (loss), attributable to owners of parent Other provisions [member] Other provisions [member] Rest of Europe Rest Of Europe [Member] Rest Of Europe [Member] Classes of ordinary shares [axis] Classes of ordinary shares [axis] Acquisitions Disclosure of business combinations [text block] Management Award 2021 Management Award 2021 [Member] Management Award 2021 Related parties Disclosure of related party [text block] Increase (decrease) in net defined benefit liability (asset) resulting from other changes Increase (decrease) in net defined benefit liability (asset) resulting from other changes Interest rate Borrowings, interest rate Exercise price Exercise Price, Other Equity Instruments Granted Exercise Price, Other Equity Instruments Granted Hedges [member] Hedges [member] Other reserves Reserve of cash flow hedges [member] Taxation Disclosure of income tax [text block] Schedule of Diluted Earnings per Share diluted earnings per share [Text Block] diluted earnings per share [Text Block] Classes of financial instruments [axis] Classes of financial instruments [axis] Trade and other receivables Trade receivables [member] Equity Equity Equity Equity Items not reclassified to the Statement of Profit or Loss Other comprehensive income that will not be reclassified to profit or loss, net of tax Acquired through business combinations Acquisitions through business combinations, other provisions Bank overdraft Bank overdrafts Senior EUR/USD loans Senior EUR/USD Loans [Member] Senior EUR/USD Loans [Member] Federal Home Loan Bank Branch [Domain] Federal Home Loan Bank Branch [Domain] Income Taxes [Abstract] Income Taxes [Abstract] Income Taxes [Abstract] Customer [Domain] Customer [Domain] Credit Rating, Moody's [Axis] Credit Rating, Moody's [Axis] Total comprehensive income for the period Equity owners of the parent Comprehensive income, attributable to owners of parent Germany GERMANY Management Award 2016 Management Award 2016 [Member] Management Award 2016 [Member] Senior Eur Debt Senior Eur Debt [Member] Senior Eur Debt Shares issued, price per share (in dollars per share) Shares Issued, Price Per Share1 Shares Issued, Price Per Share1 Issue of ordinary shares Issue of equity Earnings per share [line items] Earnings per share [line items] Disclosure of defined benefit plans [line items] Disclosure of defined benefit plans [line items] Components of equity [axis] Components of equity [axis] Schedule of Exceptional Items Disclosure Of Detailed Information For Exceptional Items Explanatory [Table Text Block] Disclosure Of Detailed Information For Exceptional Items Explanatory [Table Text Block] Events after Reporting Period [Axis] Events after Reporting Period [Axis] Events after Reporting Period Net interest expense Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income) Deferred tax liabilities Deferred tax liabilities Increase (decrease) in number of shares outstanding Increase (decrease) in number of shares outstanding Mariposa Capital and TOMS Capital Mariposa Capital and TOMS Capital [Member] Mariposa Capital and TOMS Capital [Member] Business Combinations Description of accounting policy for business combinations [text block] External Credit Rating, Moody's [Domain] External Credit Rating, Moody's [Domain] Issuance of new loan principal Proceeds from borrowings, classified as financing activities Founder Entities Founder Entities [Member] Founder Entities [Member] Total liabilities Liabilities Issued and fully paid (in shares) Number of shares issued and fully paid Items that may be subsequently reclassified to the Statement of Profit or Loss Other comprehensive income that will be reclassified to profit or loss, net of tax SWITZERLAND SWITZERLAND Management Award 2017 Management Award 2017 [Member] Management Award 2017 [Member] Management Award 2017 [Member] Cost of sales Cost of sales Listing and share transaction costs Share Issue Related Cost, Accumulated Share Issue Related Cost, Accumulated Hedges of net investment in foreign operations Hedges of net investment in foreign operations [member] Types of share-based payment arrangements [axis] Types of share-based payment arrangements [axis] Bottom of range Bottom of range [member] Payment of lease liabilities Payments of lease liabilities, classified as financing activities Weighted average Ordinary Shares and shares issuable solely after the passage of time in millions Weighted Average Number Of Ordinary and Preferred Shares Outstanding, Basic Weighted Average Number Of Ordinary and Preferred Shares Outstanding, Basic Loans and borrowings Loans and Borrowings Excluding Deferred Borrowing Costs [Member] Loans and Borrowings Excluding Deferred Borrowing Costs [Member] Common Domain Members [Abstract] Accounting Policies, Changes in Accounting Estimates and Errors [Abstract] Accounting Policies, Changes in Accounting Estimates and Errors [Abstract] Accounting Policies, Changes in Accounting Estimates and Errors [Abstract] Indemnification asset liability with customers Indemnification asset liability with customers [Member] Indemnification asset liability with customers Interest expense (b) Interest expense Diluted earnings per share Diluted earnings per share [abstract] Ordinary shares Ordinary shares [member] Repayments of non-current borrowings Repayments of non-current borrowings Provisions Disclosure of provisions [text block] Current Fiscal Year End Date Current Fiscal Year End Date Share-based Compensation Award, Tranche One Share-based Compensation Award, Tranche One1 [Member] Share-based Compensation Award, Tranche One1 [Member] Financial liabilities at amortised cost Financial liabilities at amortised cost Net cash used in financing activities Cash flows from (used in) financing activities Retained earnings Retained earnings [member] Adjustments for: Adjustments to reconcile profit (loss) [abstract] Exceptional items Exceptional items Adjustments For Exceptional Items Adjustments For Exceptional Items Increase in reserves recognized of applying IFRS 16 Increase in reserves recognized of applying IFRS 16 Increase in reserves recognized of applying IFRS 16 Cost of hedging reserve Cost of hedging reserve [Member] Cost of hedging reserve Net fair value losses on derivatives held at fair value through profit or loss Losses on change in fair value of derivatives Share repurchase programme Share repurchase programme Share repurchase programme Italy ITALY Share Capital and Capital reserve Disclosure of share capital, reserves and other equity interest [text block] Other reserves [member] Other reserves [member] Loans and borrowings Non-current portion of non-current borrowings Increase (decrease) through acquisition of subsidiary, equity Increase (decrease) through acquisition of subsidiary, equity Settlement of legacy matters (4) Settlement Of Legacy Matters Settlement Of Legacy Matters Classes of financial liabilities [axis] Classes of financial liabilities [axis] Increase (decrease) due to changes in accounting policy [member] Increase (decrease) due to changes in accounting policy [member] January 1, 2017 January 1, 2017 [Member] January 1, 2017 [Member] Disclosure of operating segments [line items] Disclosure of operating segments [line items] Other borrowings [Domain] Other borrowings [Domain] Other borrowings [Domain] Financial liabilities, class [member] Financial liabilities, class [member] Issued price of Senior Secured Notes (2028) Issued price of Senior Secured Notes (2028) Issued price of Senior Secured Notes (2028) CROATIA CROATIA Earnings per share Earnings per share [abstract] France FRANCE Other comprehensive income/(loss) for the period, net of tax Other comprehensive income for the period Other comprehensive income Net finance costs Adjustments for finance costs Credit Rating, Standard & Poor's [Axis] Credit Rating, Standard & Poor's [Axis] Levels of fair value hierarchy [axis] Levels of fair value hierarchy [axis] United Kingdom UNITED KINGDOM Grant date price Grant Date Price, Other Equity Instruments Granted Grant Date Price, Other Equity Instruments Granted Other Provisions, Contingent Liabilities and Contingent Assets [Abstract] Other Provisions, Contingent Liabilities and Contingent Assets [Abstract] Other Provisions, Contingent Liabilities and Contingent Assets [Abstract] Voluntary changes in accounting policy [member] Voluntary changes in accounting policy [member] Dividends paid, classified as financing activities Dividends paid, classified as financing activities Statement of changes in equity [table] Statement of changes in equity [table] Adjusted EBITDA Earnings Before Interest, Tax, Depreciation and Amortization, Adjusted Earnings Before Interest, Tax, Depreciation and Amortization, Adjusted Proceeds from issuance of ordinary shares Proceeds from issue of ordinary shares Statement of financial position [abstract] Statement of financial position [abstract] Summary of Cash and Cash Equivalents Disclosure of Cash and Cash Equivalents [Table Text Block] Disclosure of Cash and Cash Equivalents January 1, 2023 January 1, 2023 [Member] January 1, 2023 Discount on issuance of debt Discount on issuance of debt Discount on issuance of debt Net cash generated from operating activities Cash flows from (used in) operating activities Document Fiscal Period Focus Document Fiscal Period Focus Classes of share capital [axis] Classes of share capital [axis] External Revenue by Geography Disclosure of geographical areas [text block] Net financing costs Net financing costs Finance income (cost) Inventories Current inventories Derivative financial instruments Current derivative financial assets Redemption of investments Other inflows (outflows) of cash, classified as investing activities Ranges [member] Ranges [member] Derivative financial assets held for hedging Derivative financial assets held for hedging Cash and cash equivalents Cash And Cash Equivalents1 [Member] Cash And Cash Equivalents [Member] Norway NORWAY Credit Rating, Fitch [Axis] Credit Rating, Fitch [Axis] Loans and Borrowings Loans and Borrowings [Member] Loans and Borrowings [Member] Other equity instruments granted in share-based payment arrangement, per director Other Equity Instruments Granted In Share-based Payment Arrangement, Per Director Other Equity Instruments Granted In Share-based Payment Arrangement, Per Director Share based compensation reserve Reserve of share-based payments Reserve of share-based payments Reserve of share-based payments Borrowings by name [axis] Borrowings by name [axis] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Share Capital, Reserves and Other Equity Interest [Abstract] Share Capital, Reserves and Other Equity Interest [Abstract] Share Capital, Reserves and Other Equity Interest [Abstract] Title of Individual1 [Axis] Title of Individual1 [Axis] Title of Individual1 [Axis] Derivative financial instruments Current derivative financial liabilities Relationship to Entity1 [Domain] Relationship to Entity1 [Domain] Relationship to Entity1 [Domain] Non-Executive Director Key Management Personnel Of Entity Or Parent, Non-Executive Director [Member] Key Management Personnel Of Entity Or Parent, Non-Executive Director [Member] Disclosure of Financial Liabilities Disclosure of financial liabilities [text block] Hedging instruments [axis] Hedging instruments [axis] Taxation Adjustments for income tax expense Derivatives Derivative financial instruments Derivatives [member] Dilutive effect of restricted share awards on number of ordinary shares (in shares) Dilutive Effect of Restricted Share Awards on Number of Ordinary Shares Dilutive Effect of Restricted Share Awards on Number of Ordinary Shares Percentage increase in dividend price Preference Shares, Dividend Rate, Percentage Preference Shares, Dividend Rate, Percentage Dividends Dividends recognised as distributions to owners Equity attributable to equity holders Equity [abstract] Interest income Interest income Award vesting rights, percentage Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Percentage1 Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Percentage1 Depreciation & amortization Depreciation and amortisation expense Non-cash fair value purchase price adjustment of inventory Purchases, fair value measurement, assets Share capital and capital reserve Capital reserve Disclosure of non-adjusting events after reporting period [text block] Disclosure of non-adjusting events after reporting period [text block] Share-based payment arrangements [member] Share-based payment arrangements [member] Disclosure of Financial Assets Disclosure of financial assets [text block] Borrowings by name [member] Borrowings by name [member] Share based compensation reserve Reserve of share-based payments [member] Currency [Axis] Currency [Axis] Revolving Credit Facility Revolving Credit Facility (existing - replaced) [Member] Revolving Credit Facility [Member] Revenue Revenue Events after Reporting Period [Domain] Events after Reporting Period [Domain] Events after Reporting Period Voluntary changes in accounting policy [axis] Voluntary changes in accounting policy [axis] Purchase of subsidiaries, net of cash acquired Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities Affiliate of Founder Entities Affiliate Of Founder Entities [Member] Affiliate Of Founder Entities [Member] Actuarial gain on pension scheme valuations Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income Disclosure of other provisions [table] Disclosure of other provisions [table] Increase in trade and other receivables Adjustments for decrease (increase) in trade and other receivables Award Type1 [Domain] Award Type1 [Domain] Award Type1 [Domain] Currently stated [member] Currently stated [member] Lease liabilities Lease liabilities Financial liabilities Carrying value Financial liabilities Reversal of impairment loss on short term investments (a) Reversal of impairment loss recognised in profit or loss, loans and advances Disclosure of geographical areas [line items] Disclosure of geographical areas [line items] Retrospective application and retrospective restatement [axis] Retrospective application and retrospective restatement [axis] Business Combinations1 [Abstract] Business Combinations1 [Abstract] Business Combinations1 [Abstract] Current tax payable Current tax liabilities, current Cash generated from operations before tax and exceptional items Net Cash Flows From (Used In) Operating Activities, Before Income Taxes Paid And Cash Flows Related To Exceptional Items Net Cash Flows From (Used In) Operating Activities, Before Income Taxes Paid And Cash Flows Related To Exceptional Items Financial Instruments [Abstract] Financial Instruments [Abstract] Financial Instruments [Abstract] New awards granted in the period (in shares) Number of other equity instruments granted in share-based payment arrangement Entity's total for related parties [member] Entity's total for related parties [member] Types of hedges [axis] Types of hedges [axis] Total equity Equity attributable to owners of parent [member] Provisions related to other taxes Provision for taxes other than income tax [member] Level 2 Level 2 of fair value hierarchy [member] Other Awards Other Awards [Member] Other Awards Financial assets (liabilities) at fair value through profit or loss Financial Assets (Financial Liabilities) At Fair Value Through Profit Or Loss Financial Assets (Financial Liabilities) At Fair Value Through Profit Or Loss Release of provision Unused provision reversed, other provisions Diluted earnings per share Diluted earnings (loss) per share General information Disclosure of general information about financial statements [text block] Additional provision in the period Additional provisions, other provisions Schedule of Earnings per Share Earnings per share [text block] Non controlling interest through acquisition of subsidiary Non controlling interest through acquisition of subsidiary Non controlling interest through acquisition of subsidiary January 1, 2019 January 1, 2019 [Member] January 1, 2019 Employee Benefits [Abstract] Employee Benefits [Abstract] Employee Benefits [Abstract] Amortization of debt discounts and borrowing costs Amortization Of Debt Issuance Costs Amortization Of Debt Issuance Costs SERBIA SERBIA Segment consolidation items [axis] Segment consolidation items [axis] Summary of Management Share Awards Disclosure of number and weighted average exercise prices of other equity instruments [text block] Foreign exchange Increase (decrease) through net exchange differences, other provisions Subclassifications of assets, liabilities and equities [abstract] Subclassifications of assets, liabilities and equities [abstract] Disclosure of transactions between related parties [line items] Disclosure of transactions between related parties [line items] Reserves within equity [axis] Reserves within equity [axis] Basis of Presentation Description of accounting policy for changes in accounting policies, accounting estimates and errors [Policy Text Block] Description of accounting policy for changes in accounting policies, accounting estimates and errors Reduction of issued capital Repurchase of ordinary shares Reduction of issued capital Recognised assets representing continuing involvement in derecognised financial assets Recognised assets representing continuing involvement in derecognised financial assets Disclosure of operating segments [table] Disclosure of operating segments [table] Other non-current liabilities Other non-current liabilities Weighted average exercise price of other equity instruments granted in share-based payment arrangement Weighted average exercise price of other equity instruments granted in share-based payment arrangement Events after Reporting Period Events after Reporting Period [Member] Events after Reporting Period Net foreign exchange gains on translation of financial assets and liabilities Net Foreign Exchange Gains On Financial Assets And Liabilities Net Foreign Exchange Gains On Financial Assets And Liabilities Purchase of property, plant and equipment and intangibles Purchase of property, plant and equipment, classified as investing activities Goodwill Goodwill Net gain on refinancing Net gain on refinancing Net gain on refinancing Dividend yield expected Expected Dividend As Percentage, Other Equity Instruments Granted Expected Dividend As Percentage, Other Equity Instruments Granted Entity Registrant Name Entity Registrant Name Description of nature of impending change in accounting policy Description of nature of impending change in accounting policy Key management personnel of entity or parent Key management personnel of entity or parent [member] Document Period End Date Document Period End Date Entity's total for segment consolidation items [member] Entity's total for segment consolidation items [member] Counterparties [member] Counterparties [member] Trade and other payables Trade and other current payables Entity Central Index Key Entity Central Index Key Impairment of property, plant and equipment Description of accounting policy for impairment of assets [text block] Disclosure of classes of share capital [line items] Disclosure of classes of share capital [line items] Asset retirement obligation Asset retirement obligation [Member] Asset retirement obligation Employee benefits Non-current net defined benefit liability Number of countries in which entity operates Number Of Countries In Which Entity Operates1 Number Of Countries In Which Entity Operates1 Payments relating to exceptional items Inflows (Outflows) Of Cash Due To Exceptional Items, Classified As Operating Activities Inflows (Outflows) Of Cash Due To Exceptional Items, Classified As Operating Activities Finance income and costs Disclosure of finance income (cost) [text block] Estimated completion of activities Other Provisions, Estimated Completion Of Activities Other Provisions, Estimated Completion Of Activities Disclosure of geographical areas [table] Disclosure of geographical areas [table] Interest rate floor Interest rate floor Interest rate floor Financial assets (liabilities) at fair value through other comprehensive income Financial Assets (Financial Liabilities) At Fair Value Through Other Comprehensive Income Financial Assets (Financial Liabilities) At Fair Value Through Other Comprehensive Income Property, plant and equipment Property, plant and equipment Geographical areas [member] Geographical areas [member] Number of shares issued (in shares) Number of shares issued Hedging instruments [member] Hedging instruments [member] Equity [member] Equity [member] Amendment Flag Amendment Flag Purchase of treasury shares Purchase of treasury shares January 1, 2018 January 1, 2018 [Member] January 1, 2018 Accounting estimates and judgments Disclosure of accounting judgements and estimates [text block] Net (decrease)/increase in cash and cash equivalents Increase (decrease) in cash and cash equivalents before effect of exchange rate changes Financial instruments Disclosure of financial instruments [text block] Carrying value of goodwill and brands Description of accounting policy for intangible assets and goodwill [text block] Vesting 2 [Axis] [Domain] Vesting 2 [Axis] [Domain] [Domain] for Vesting 2 [Axis] [Axis] Total Financial Assets (Liabilities), Net Financial Assets (Liabilities), Net Award vesting period Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Period2 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Deferred tax assets Deferred tax assets Disclosure of other provisions, contingent liabilities and contingent assets [Abstract] Disclosure of other provisions, contingent liabilities and contingent assets [Abstract] Disclosure of other provisions, contingent liabilities and contingent assets [Abstract] Adjustments for share based payments including employer tax adjustments for share based payments including employer tax adjustments for share based payments including employer tax Net assets Assets (liabilities) January 1, 2022 January 1, 2022 [Member] January 1, 2022 Exchange differences on translation of foreign operations Other comprehensive income, before tax, hedges of net investments in foreign operations Factory optimization (6) Factory Optimization Factory Optimization Weighted average exercise price of share options exercised in share-based payment arrangement Weighted average exercise price of share options exercised in share-based payment arrangement Award Date1 [Axis] Award Date1 [Axis] Award Date1 [Axis] Fair value Financial liabilities, at fair value Employee benefits Disclosure of employee benefits [text block] Restricted cash Restricted cash and cash equivalents Statement of cash flows [abstract] Statement of cash flows [abstract] Senior EURO Debt Senior EURO Debt [Member] Senior EURO Debt [Member] Total comprehensive income for the period Comprehensive income Comprehensive income Cash balances and deposits Cash and cash equivalents Number of other equity instruments outstanding (in shares) at beginning of period Number of other equity instruments outstanding (in shares) at end of period Number of other equity instruments outstanding (in shares) Number of other equity instruments outstanding in share-based payment arrangement Liabilities from share-based payment transactions (in shares) Liabilities From Share-based Payment Transactions, Shares Liabilities From Share-based Payment Transactions, Shares Carrying amount [member] Carrying amount [member] Aircraft [Domain] Aircraft [Domain] Total non-current liabilities Non-current liabilities Summary of Management Share Award Inputs and Assumptions Disclosure of indirect measurement of fair value of goods or services received, other equity instruments granted during period [text block] Cover [Abstract] Cover [Abstract] Material reconciling items Material reconciling items [member] Total assets Assets Borrowings Borrowings Founder preferred shares [Domain] Founder preferred shares [Domain] Founder preferred shares [Domain] Basic earnings per share Basic earnings per share [abstract] Cash and cash equivalents Disclosure of cash and cash equivalents [text block] Deferred hedging losses and costs of hedging transferred to the carrying value of inventory Amount removed from reserve of cash flow hedges and included in initial cost or other carrying amount of non-financial asset (liability) or firm commitment for which fair value hedge accounting is applied Disclosure of terms and conditions of share-based payment arrangement [table] Disclosure of terms and conditions of share-based payment arrangement [table] Financing costs incurred on new or amended debt (d) Gains (Losses) on Restructuring of Debt1 Gains (Losses) on Restructuring of Debt1 Translation reserve Reserve of exchange differences on translation [member] Forfeitures in the period (in shares) Number of other equity instruments forfeited in share-based payment arrangement Notional amount Notional amount Employee benefit obligation Description of accounting policy for employee benefits [text block] Cash flows from financing activities Cash flows from (used in) financing activities [abstract] January 1, 2021 January 1, 2021 [Member] January 1, 2021 Cash and cash equivalents at beginning of period Cash and cash equivalents per Statement of Cash Flows Cash and cash equivalents if different from statement of financial position Disclosure of Share Based Compensation Reserve Disclosure of Share Based Compensation Reserve [Text Block] Disclosure of Share Based Compensation Reserve Share capital and capital reserve Capital reserve [member] Derivative financial instruments Non-current derivative financial assets Net pension interest costs Net Pension Interest Costs Net Pension Interest Costs Scenario [Axis] Scenario [Axis] Deferred borrowing costs Deferred Financing Costs [Member] Deferred Financing Costs [Member] Discounts and trade promotions Description of accounting policy for discounts and rebates [text block] Profit before tax Profit (loss) before tax Retained earnings Retained earnings Dividends paid, ordinary shares Dividends paid, ordinary shares Federal Home Loan Bank Branch [Axis] Federal Home Loan Bank Branch [Axis] Employee exit rate Employee Exit Rate, Other Equity Instruments Granted Employee Exit Rate, Other Equity Instruments Granted Share price tranche as percent of total award Share Price Tranche as Percent of Total Award Share Price Tranche as Percent of Total Award Cash used in investing activities Cash flows from (used in) investing activities Net foreign exchange losses arising on translation of financial assets and liabilities Net Foreign Exchange Losses On Financial Assets And Liabilities Net Foreign Exchange Losses On Financial Assets And Liabilities Sweden SWEDEN Intangibles Intangible assets other than goodwill Dividends paid, ordinary shares per share Dividends paid, ordinary shares per share January 1, 2020 January 1, 2020 [Member] January 1, 2020 Twenty Twenty-Eight Fixed Rate Senior Secured Notes Twenty Twenty-Eight Fixed Rate Senior Secured Notes [Member] Twenty Twenty-Eight Fixed Rate Senior Secured Notes Derivative financial instruments Non-current derivative financial liabilities All levels of fair value hierarchy [member] All levels of fair value hierarchy [member] Financial assets at amortised cost Financial assets at amortised cost Business transformation program (1) Business transformation program Business transformation program Statement of comprehensive income [abstract] Statement of comprehensive income [abstract] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Financial assets Financial assets Disclosure of terms and conditions of share-based payment arrangement [line items] Disclosure of terms and conditions of share-based payment arrangement [line items] Interest received Interest received, classified as investing activities Scenario [Domain] Scenario [Domain] Provisions Provisions Increase in trade and other payables Adjustments for increase (decrease) in trade and other payables Revolving Credit Facility (new) Revolving Credit Facility (new) [Member] Revolving Credit Facility (new) EX-101.PRE 8 nomd-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 9 nomadlogoa15.jpg begin 644 nomadlogoa15.jpg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end XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cover
3 Months Ended
Mar. 31, 2024
Cover [Abstract]  
Document Type 6-K
Amendment Flag false
Document Period End Date Mar. 31, 2024
Document Fiscal Year Focus 2024
Document Fiscal Period Focus Q1
Entity Registrant Name Nomad Foods Ltd.
Entity Central Index Key 0001651717
Current Fiscal Year End Date --12-31
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Unaudited Condensed Consolidated Interim Statements of Financial Position - EUR (€)
€ in Millions
Mar. 31, 2024
Dec. 31, 2023
Non-current assets    
Goodwill € 2,103.2 € 2,105.0
Intangibles 2,467.0 2,468.2
Property, plant and equipment 563.4 563.7
Other non-current assets 7.3 7.1
Derivative financial instruments 1.4 0.7
Deferred tax assets 106.1 106.9
Total non-current assets 5,248.4 5,251.6
Current assets    
Cash and cash equivalents 390.7 412.9
Inventories 432.6 446.4
Trade and other receivables 343.8 263.4
Current tax receivable 39.7 40.7
Indemnification assets 0.5 0.5
Derivative financial instruments 6.0 1.2
Total current assets 1,213.3 1,165.1
Total assets 6,461.7 6,416.7
Current liabilities    
Trade and other payables 810.3 769.8
Current tax payable 189.3 189.5
Provisions 31.5 35.1
Loans and borrowings 26.2 21.4
Derivative financial instruments 8.9 12.2
Total current liabilities 1,066.2 1,028.0
Non-current liabilities    
Loans and borrowings 2,126.9 2,113.7
Employee benefits 152.1 158.3
Other non-current liabilities 0.5 0.5
Provisions 1.4 1.4
Derivative financial instruments 69.8 97.8
Deferred tax liabilities 425.6 425.1
Total non-current liabilities 2,776.3 2,796.8
Total liabilities 3,842.5 3,824.8
Net assets 2,619.2 2,591.9
Equity attributable to equity holders    
Share capital and capital reserve 1,419.0 1,426.1
Share based compensation reserve 34.5 31.4
Translation reserve 104.6 101.0
Other reserves (11.8) (24.6)
Retained earnings 1,072.9 1,058.0
Equity attributable to owners of parent € 2,619.2 € 2,591.9
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Unaudited Condensed Consolidated Interim Statements of Profit or Loss - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Profit or loss [abstract]    
Revenue € 783.7 € 775.1
Cost of sales (572.8) (550.9)
Gross profit 210.9 224.2
Other operating expenses (115.4) (114.5)
Exceptional items (23.5) (30.1)
Operating profit 72.0 79.6
Finance income 5.9 1.1
Finance costs (36.0) (30.1)
Net financing costs (30.1) (29.0)
Profit before tax 41.9 50.6
Taxation (7.4) (9.4)
Profit for the period € 34.5 € 41.2
Basic earnings per share € 0.21 € 0.24
Equity owners of the parent € 34.5 € 41.2
Earnings per share    
Diluted earnings per share € 0.21 € 0.24
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Statement of comprehensive income [abstract]    
Profit for the period € 34.5 € 41.2
Other comprehensive income:    
Actuarial gains/(losses) on defined benefit pension plans 3.9 (4.3)
Taxation (charge)/credit on measurement of defined benefit pension plans (1.2) 1.7
Items not reclassified to the Statement of Profit or Loss 2.7 (2.6)
Exchange differences on translation of foreign operations 3.6 0.0
Cash flow hedges 12.3 (13.6)
Taxation (charge)/credit relating to components of other comprehensive income (3.8) 4.7
Items that may be subsequently reclassified to the Statement of Profit or Loss 12.1 (8.9)
Other comprehensive income/(loss) for the period, net of tax 14.8 (11.5)
Total comprehensive income for the period € 49.3 € 29.7
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Unaudited Condensed Consolidated Interim Statements of Changes in Equity - EUR (€)
€ in Millions
Total
Share capital and capital reserve
Share based compensation reserve
Translation reserve
Other reserves
Retained earnings
Total equity
Equity attributable to owners of the parent (restated)   € 1,596.7 € 13.8 € 89.3 € 19.8 € 886.6 € 2,606.2
Equity attributable to owners of the parent (restated)   1,596.7 13.8 89.3 19.8 886.6 2,606.2
Equity owners of the parent € 41.2         41.2 41.2
Profit for the period 41.2            
Other comprehensive income for the period (11.5)     0.0 (8.9) (2.6) (11.5)
Total comprehensive income for the period       0.0 (8.9) 38.6 29.7
Deferred hedging losses and costs of hedging transferred to the carrying value of inventory         (0.1)   (0.1)
Comprehensive income 29.7            
Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity   0.0 (4.0)     (0.5) (4.5)
Share based payment charge     12.3       12.3
Total transactions with owners, recognized directly in equity   0.0 8.3 0.0 0.0 (0.5) 7.8
Equity attributable to owners, ending balance at Mar. 31, 2023   1,596.7 22.1 89.3 10.8 924.7 2,643.6
Equity owners of the parent 41.2         41.2 41.2
Profit for the period 41.2            
Other comprehensive income for the period (11.5)     0.0 (8.9) (2.6) (11.5)
Equity owners of the parent       0.0 (8.9) 38.6 29.7
Comprehensive income 29.7            
Share based payment charge     12.3       12.3
Total transactions with owners, recognized directly in equity   0.0 8.3 0.0 0.0 (0.5) 7.8
Equity attributable to owners of parent   1,596.7 22.1 89.3 10.8 924.7 2,643.6
Equity attributable to owners of parent 2,591.9 1,426.1 31.4 101.0 (24.6) 1,058.0 2,591.9
Equity attributable to owners, beginning balance at Dec. 31, 2023 2,591.9 1,426.1 31.4 101.0 (24.6) 1,058.0 2,591.9
Equity owners of the parent 34.5         34.5 34.5
Profit for the period 34.5            
Other comprehensive income for the period 14.8     3.6 8.5 2.7 14.8
Total comprehensive income for the period   0.0 0.0 3.6 8.5 37.2 49.3
Deferred hedging losses and costs of hedging transferred to the carrying value of inventory         4.3   4.3
Comprehensive income 49.3            
Dividends           (22.3) (22.3)
Reduction of issued capital   (7.1)         (7.1)
Share based payment charge     3.1       3.1
Total transactions with owners, recognized directly in equity   (7.1) 3.1 0.0 0.0 (22.3) (26.3)
Equity attributable to owners, ending balance at Mar. 31, 2024 2,619.2 1,419.0 34.5 104.6 (11.8) 1,072.9 2,619.2
Equity owners of the parent 34.5         34.5 34.5
Profit for the period 34.5            
Other comprehensive income for the period 14.8     3.6 8.5 2.7 14.8
Equity owners of the parent   0.0 0.0 3.6 8.5 37.2 49.3
Comprehensive income 49.3            
Dividends           (22.3) (22.3)
Share based payment charge     3.1       3.1
Repurchase of ordinary shares   7.1         7.1
Total transactions with owners, recognized directly in equity   (7.1) 3.1 0.0 0.0 (22.3) (26.3)
Equity attributable to owners of parent € 2,619.2 € 1,419.0 € 34.5 € 104.6 € (11.8) € 1,072.9 € 2,619.2
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Unaudited Condensed Consolidated Interim Statements of Cash Flows - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities    
Profit for the period € 34.5 € 41.2
Adjustments for:    
Exceptional items 23.5 30.1
Share based payments expense 3.1 12.3
Depreciation and amortization 23.1 22.3
Loss on disposal and impairment of property, plant and equipment 0.4 0.5
Net finance costs 30.1 29.0
Taxation 7.4 9.4
Operating cash flow before changes in working capital, provisions and exceptional items 122.1 144.8
Decrease/(increase) in inventories 14.2 (34.3)
Increase in trade and other receivables (81.3) (53.7)
Increase in trade and other payables 77.1 20.6
(Decrease)/increase in employee benefits and other provisions (0.2) 1.9
Cash generated from operations before tax and exceptional items 131.9 79.3
Payments relating to exceptional items (24.0) (14.0)
Tax paid (8.9) (10.0)
Net cash generated from operating activities 99.0 55.3
Cash flows from investing activities    
Purchase of property, plant and equipment and intangibles (18.8) (20.6)
Interest received 2.0 1.1
Cash used in investing activities (16.8) (19.5)
Cash flows from financing activities    
Repurchase of ordinary shares (7.1) 0.0
Dividends paid, classified as financing activities (22.3) 0.0
Payment of lease liabilities (7.2) (7.0)
Payment of financing fees (0.5) (0.5)
Interest paid (50.4) (19.3)
Net cash used in financing activities (87.5) (26.8)
Net (decrease)/increase in cash and cash equivalents (5.3) 9.0
Cash and cash equivalents at beginning of period 390.7  
Cash and cash equivalents at beginning of period 412.9 366.8
Effect of exchange rate fluctuations (3.7) (4.9)
Cash and cash equivalents at end of period € 390.7 € 370.9
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash and cash equivalents
3 Months Ended
Mar. 31, 2024
Subclassifications of assets, liabilities and equities [abstract]  
Cash and cash equivalents Cash and cash equivalents
March 31, 2024December 31, 2023
€m€m
Cash and cash equivalents in the Statement of Financial Position390.7 412.9 
Bank overdraft— (13.2)
Cash and cash equivalents per Statement of Cash Flows390.7 399.7 
‘Cash and cash equivalents’ comprise cash balances and deposits.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash and cash equivalents (Tables)
3 Months Ended
Mar. 31, 2024
Subclassifications of assets, liabilities and equities [abstract]  
Summary of Cash and Cash Equivalents
March 31, 2024December 31, 2023
€m€m
Cash and cash equivalents in the Statement of Financial Position390.7 412.9 
Bank overdraft— (13.2)
Cash and cash equivalents per Statement of Cash Flows390.7 399.7 
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Cash and cash equivalents (Details) - EUR (€)
€ in Millions
Mar. 31, 2024
Dec. 31, 2023
Subclassifications of assets, liabilities and equities [abstract]    
Cash and cash equivalents in the Statement of Financial Position € 390.7 € 412.9
Bank overdraft 0.0 (13.2)
Cash and cash equivalents per Statement of Cash Flows € 390.7 € 399.7
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
General information
3 Months Ended
Mar. 31, 2024
General Information About Financial Statements [Abstract]  
General information General information
These unaudited condensed consolidated interim financial statements (“interim financial statements”) as at and for the three months ended March 31, 2024 comprise the results and financial position of Nomad Foods Limited and its subsidiaries (together referred to as the “Company” or “Nomad”). Nomad (NYSE: NOMD) is Europe's leading frozen foods company. Nomad's portfolio of iconic brands, which includes Birds Eye, Findus, iglo, Ledo and Frikom, have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.

The Company’s sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for savory frozen food are slightly higher in colder or winter months and variable production costs and working capital will vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, inventory levels typically peak in August to September just after the pea harvest and as a result, more working capital is required during those months. The one exception to this is in our Adriatic business, which follows a different seasonality pattern with stronger performance through the summer months behind the ice-cream business.
Nomad is a company registered in the British Virgin Islands and domiciled for tax in the United Kingdom.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of preparation
3 Months Ended
Mar. 31, 2024
Basis Of Presentation [Abstract]  
Basis of preparation Basis of preparation
These unaudited condensed consolidated interim financial statements for the three months ended March 31, 2024 have been prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, as issued by the IASB. They do not include all the information required for a complete set of IFRS financial statements. The financial information consolidates the Company and the subsidiaries it controls and includes selected notes to explain events and transactions that are significant to an understanding of the changes in Nomad’s financial position and performance since the last annual consolidated financial statements. Therefore the unaudited condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended December 31, 2023, which have been prepared in accordance with International Financial Reporting Standards as issued by the IASB.
These unaudited condensed consolidated interim financial statements were authorized for issue by the Company’s Board of Directors on May 7, 2024.
The accounting policies used by management in preparing these condensed consolidated financial statements were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023, except for taxes on income. Taxes on income are provided for based on management's estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the period. It also reflects the tax impact of exceptional items accounted for in the period.
The preparation of our consolidated interim financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as supply chain disruptions, high inflation and ongoing conflicts, including that between Ukraine and Russia. Actual results could differ from these estimates. The Directors, at the time of approving these interim financial statements, have a reasonable expectation that the Company has adequate resources to continue in operational existence for at least 12 months from the date of signing these interim financial statements given the cash funds available and the current forecast cash flows. In preparing cash flow forecasts, management considers severe but plausible downside scenarios taking into consideration the Company's key risks, including the current economic climate which may adversely impact the Company. Having considered these risks the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these interim financial statements.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounting estimates and judgments
3 Months Ended
Mar. 31, 2024
Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]  
Accounting estimates and judgments Critical accounting estimates and judgments
The preparation of financial statements in accordance with IFRS requires the use of judgment in applying the accounting policies and estimation that affect the reported amounts of assets and liabilities and results. Actual results could differ from those estimates and the financial statements will be impacted by key judgments taken. In preparing the condensed consolidated interim financial statements, the key sources of estimation uncertainty for the interim period ended March 31, 2024, continue to be the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023.
Key Judgments
Judgments are made in the process of applying accounting policies. Those judgments which are considered key are listed below.
a)     Business Combinations
Business combinations are recognized using the acquisition method. At the acquisition date, the Company is required to recognize separately the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified, the useful economic life of assets and in selecting an appropriate valuation methodology. Furthermore, judgment is applied in allocating business combinations to operating segments, as well as allocating Goodwill to cash generating units.
b)     Discounts and trade promotions
Management uses judgment when considering when accruals for discounts and trade promotions can be released. Management makes the judgment based on the principle that accruals are reversed only to the extent that it is highly probable that a significant reversal will not occur.
c)    Uncertain tax positions
Management uses judgment when identifying and determining whether it is appropriate to provide for uncertain tax positions and for how long provisions for uncertain tax positions are retained, based on assessment as to whether it is probable that a risk would crystallize or not. Management considers tax laws which are in place in making that assessment determining whether it is appropriate to release.
d)    Cash generating units
When performing goodwill impairment testing, management applies judgment to the allocation of goodwill to cash generating units. Management has determined goodwill is monitored at the operating segment level of “Frozen”.
e)    Operating segments
Management applies judgment in determining the Chief Operating Decision Maker (“CODM”), and the nature and extent of the financial information which is reviewed by the CODM. Management has considered how resources are allocated in determining the single reporting and operating segment of “Frozen”. Please refer to Note 5 for further information.
Significant estimates
Information about estimates and assumptions that have significant effects on the amounts reported in the condensed consolidated interim financial statements are listed below. In forming these estimates, management has taken into account the impact and potential future impact of supply chain disruptions, high inflation as well as the ongoing conflict between Ukraine and Russia. Management will continue to assess the impact of future developments in relation to these matters as it relates to estimates, especially around the carrying value of goodwill, brands and other intangibles, as well as on property, plant and equipment.

In particular, management will focus on the impact of a long-term conflict in Ukraine. While we do not have any direct operations or sales in either Russia or Ukraine, these countries are responsible for many commonly used raw materials and resources such as fish, wheat and energy. The ongoing conflict and economic sanctions could see considerable reductions in the availability or increase in cost of such raw materials and resources. At this time it is not possible to predict the extent or nature of future impacts on our business although we expect the current conflict to continue for some time.
a)    Discounts and trade promotions
Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has bespoke agreements that are governed by a combination of observable and unobservable performance conditions.
Trade promotions comprise of amounts paid to retailers for programs designed to promote Company products and include pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The estimated ultimate cost of the program is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends.
At each financial year end date, any discount or trade promotion incurred but not yet invoiced is estimated and accrued for. In certain cases, the estimate for discounts and trade promotions requires the use of forecast information for future trading periods and therefore a degree of estimation uncertainty exists. These estimates are sensitive to variances between actual results and forecasts. The estimate is based on accumulated experience. It is impracticable to disclose the extent of the possible effects of estimation uncertainty, however, it is reasonably possible that outcomes within the next financial period from these agreements are materially different in aggregate to those estimated.
The accruals are presented as ‘trade terms’ and offset against trade receivables due to the same customer, or as trade term payables where there is no receivable to be offset. The balance of the reduction in trade receivables for trade terms as of March 31, 2024 is disclosed in Note 11.
b)    Employee benefit obligations
The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each scheme has an actuarial valuation performed and is dependent on a series of assumptions to estimate the projected obligations. The assumptions include variables which are revised periodically, that include discount rates, expected salary increases, inflation, employee turnover, retirement age, mortality and medical care costs. Our assumptions reflect historical experience and management's best judgment regarding future obligations. The assumptions used affect the current service cost and interest expense as well as changes in the obligation recognized. Net actuarial gains or losses arising from changes in assumptions and from experience are recognized in other comprehensive income/(loss).
Since defined benefit pension schemes and post-employment benefit schemes are measured on a discounted basis, the discount rate applied has an impact on the expense and obligation recognized. These discount rates are determined by reference to market yields at the end of the reporting period on high quality corporate bonds, except for Sweden where a deep market does not exist, where mortgage bonds are used. See Note 13 for details of material changes, if any, to assumptions since December 31, 2023.
c)    Provisions for uncertain tax positions
The Company operates in many different jurisdictions and in some of these there are certain tax matters which are under discussion with local tax authorities, including as part of tax audits. Management considers these tax audits and discussions with local tax authorities as well as the local tax legislation relative to their tax positions in those jurisdictions when identifying uncertain tax positions. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments, appeals and refunds.
Where tax exposures can be quantified, and management assesses that the risk of an exposure crystallizing is probable, a provision for uncertain tax positions is made based on management's estimates which include judgments with regard to the amounts expected to be paid to the relevant tax authority. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these provisions. The factors considered in estimating the provision include the progress of discussions with the tax authorities, the complexity of respective tax legislation, valuations of assets for tax purposes and the level of documentary support for historical positions taken by previous owners. The provisions are made on the basis of a probability-weighted average of potential outcomes. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these provisions.
Other estimates
a)    Carrying value of goodwill and brands
The Company's goodwill and indefinite life brand values have been allocated based on the enterprise value at acquisition of each cash generating unit. Goodwill is monitored at an operating segment level for which the Company has one reporting and operating segment. Determining whether goodwill and indefinite life brands are impaired requires an estimation of the value in use. The review is performed using a discounted cash flow model to calculate the value in use of the Frozen segment. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. This requires us to make assumptions and estimates regarding historical information, future plans and external sources. Future cash flows for the purposes of the value in use calculation are taken from approved budgets.
b)    Business combinations
The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable estimation in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following estimates and assumptions can materially affect our financial position and profit:
•    The fair value and expected useful economic life of acquired intangible and tangible assets that are subject to depreciation or amortization in future periods.
•    Future changes to the assumptions over forecast future profitability used in estimating the value of intangible assets and goodwill may result in additional expenses or income.
•    Future changes to the assumptions used in estimating the value of uncertain tax positions may result in additional expenses or income.
c)    Fair value of derivative financial instruments
Note 11 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations. These inputs may be readily observable, market corroborated, or generally unobservable inputs and are further discussed in Note 11.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Acquisitions
3 Months Ended
Mar. 31, 2024
Business Combinations1 [Abstract]  
Acquisitions None
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment reporting
3 Months Ended
Mar. 31, 2024
Operating Segments [Abstract]  
Segment reporting Segment reporting
The Chief Operating Decision Maker (“CODM”) of the Company considers there to be one reporting and operating segment, being “Frozen” and is reflected in the segment presentation below for the periods presented. The CODM primarily uses “Adjusted EBITDA”, as the key measure of the segment’s results, which is considered non-IFRS financial information.

Segment Adjusted EBITDA
  For the three months ended March 31,
20242023
 Note€m€m
Profit for the period34.5 41.2 
Taxation7.4 9.4 
Net financing costs730.1 29.0 
Depreciation & amortization23.1 22.3 
Exceptional items623.5 30.1 
Other add-backs3.7 14.3 
Adjusted EBITDA122.3 146.3 

Other add-backs include the elimination of share-based payment expense and related employer payroll tax expense of €3.4 million for the three months ended March 31, 2024 (2023: €13.9 million), as well as the elimination of non-operating M&A related costs, professional fees and transaction costs of €0.3 million for the three months ended March 31, 2024 (2023: €0.4 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.

No information on segment assets or liabilities is presented to the CODM.

External revenue by geography
For the three months ended March 31,
20242023
 €m€m
United Kingdom225.3216.4
Germany112.6117.6
Italy110.6109.1
France53.952.9
Sweden35.838.1
Croatia20.819.6
Austria38.537.9
Norway30.833.7
Serbia19.018.4
Spain22.320.6
Switzerland21.621.2
Rest of Europe92.589.6
Total external revenue by geography783.7775.1
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Exceptional items
3 Months Ended
Mar. 31, 2024
Analysis of income and expense [abstract]  
Exceptional items Exceptional items
 For the three months ended March 31,
 20242023
€m€m
Business transformation program (1)20.5 28.1 
Fortenova Acquisition integration costs (2)— 1.8 
Information Technology transformation program (3)— 0.2 
Settlement of legacy matters (4)3.0 — 
Total exceptional items23.5 30.1 

We do not consider these items to be indicative of our ongoing operating performance.

(1)    Business transformation program
In 2020, the Company launched the first phase of a multi-year, enterprise-wide transformation and optimization program which continued to progress in the current year. Over the next few years, additional transformation phases will be implemented. Progress of the project is ongoing and there remain certain phases to be implemented. The program aims to standardize, simplify and automate end-to-end business processes. This will enable key decision making and analytical capability, building a platform and organization to support future growth and provide better value for shareholders. Execution of the business transformation program includes the evaluation and implementation of a new ERP system.
Expenses incurred to date consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees.

(2)    Fortenova Acquisition integration costs

The Company completed the acquisition of the Fortenova Group’s Frozen Food Business Group on September 30, 2021, following which the Company began an integration project which was completed in 2023. Integration expenses incurred relate to external consultancy costs, organizational structure alignment to Nomad design, systems configuration and roll-out of our controls environment to the acquired business.

(3)    Information Technology transformation program
In 2021, the Company launched a program to transform the Information Technology (“IT”) operating model, specifically to modernize the end-to-end technology estate to support current and future complex and evolving business needs driven by acquisitions and organic growth. Among the many changes made, the program moved our operating model to a cloud-hosted solution, which better deploys new services to the business and end user, including application management, supporting a diverse workforce across multiple locations and languages, as well as deploying artificial Intelligence assisted tools. Other key components of the program included the Company’s cyber security services to adapt to rapidly changing threats and a change of IT service partners to enable one-off renovation and uplift of capabilities across the business. The program was completed in 2023.

(4)    Settlement of legacy matters
A net expense has been recognized associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional.

Tax impact of exceptional items
The tax impact of the exceptional items for the three months ended March 31, 2024 amounted to a credit of €5.7 million (2023: €7.0 million).
Cash flow impact of exceptional items
Included in the Condensed Consolidated Interim Statements of Cash Flows for the three months ended March 31, 2024 is €24.0 million (2023: €14.0 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items in addition to the cash impact of the settlement of provisions brought forward from previous accounting periods.
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Finance income and costs
3 Months Ended
Mar. 31, 2024
Analysis of income and expense [abstract]  
Finance income and costs Finance income and costs
 For the three months ended March 31,
20242023
 €m€m
Finance income
Interest income1.8 1.1 
Net financing gain recognized on debt transactions (a)4.1 — 
Total finance income5.9 1.1 
Interest expense (b)(22.7)(21.5)
Net foreign exchange losses arising on translation of financial assets and liabilities(10.2)(5.8)
Net pension interest costs(1.2)(1.1)
Amortization of debt discounts and borrowing costs(1.7)(1.6)
Net fair value losses on derivatives held at fair value through profit or loss(0.2)(0.1)
Total finance costs(36.0)(30.1)
Net finance costs(30.1)(29.0)
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Taxation
3 Months Ended
Mar. 31, 2024
Income Taxes [Abstract]  
Taxation Taxation
Income tax expense of €7.4 million for the three months ended March 31, 2024 (2023: €9.4 million) is provided for based on management’s estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the periods. This estimate reflects the tax impact of exceptional items accounted for in the periods. The UK statutory rate of corporation tax increased from 19% to 25% with effect from April 1, 2023.
The Company’s subsidiaries, which are subject to tax, operate in many different jurisdictions and, in some of these, certain tax matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments appeals and refunds. The Company actively seeks to manage the associated risks by proactively engaging with tax authorities and applying for Advanced Pricing Agreements where appropriate. Provisions for uncertain tax positions require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision, including releases of provisions when those exposures become time-barred.
Notwithstanding this, management believes that the Company’s tax position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings per share
3 Months Ended
Mar. 31, 2024
Earnings per share [abstract]  
Earnings per share Earnings per share
 For the three months ended March 31,
 20242023
Basic earnings per share
Profit for the period attributable to equity owners of the parent (€m)
34.5 41.2 
Weighted average Ordinary Shares and shares issuable solely after the passage of time in millions163.2 174.5 
Basic earnings per share0.21 0.24 

For the three months period ended March 31, 2024, the number of shares in both basic and diluted earnings per share calculations has been adjusted to include 292,687 shares to be issued in future periods as performance conditions have been met. The diluted earnings per share calculation also includes an estimate of 109,322 potential ordinary shares, calculated using the treasury method, on long term incentive plans contingent on service only. There are no adjustments to the profit for the period attributable to equity owners of the parent.
 For the three months ended March 31,
20242023
Diluted earnings per share
Profit for the period attributable to equity owners of the parent (€m)34.5 41.2 
Weighted average Ordinary Shares, shares issuable solely after the passage of time and potential ordinary shares in millions163.3 174.5 
Diluted earnings per share0.21 0.24 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial instruments
3 Months Ended
Mar. 31, 2024
Financial Instruments [Abstract]  
Financial instruments Financial instruments
The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 “Financial Instruments”.
Financial assets at amortized costFinancial assets at fair value through profit or lossDerivatives designated in hedge relationshipsFinancial
liabilities at
amortized
cost
Total
March 31, 2024€m€m€m€m€m
Assets
Derivative financial instruments— — 7.4 — 7.4 
Trade and other receivables292.3 — — — 292.3 
Cash and cash equivalents255.5 135.2 — — 390.7 
Liabilities
Derivative financial instruments— — (78.7)— (78.7)
Trade and other payables excluding non-financial liabilities— — — (755.7)(755.7)
Loans and borrowings— — — (2,153.1)(2,153.1)
Total547.8 135.2 (71.3)(2,908.8)(2,297.1)
Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €227.6 million.

Loans and borrowings includes €84.1 million relating to lease liabilities.

Financial assets at amortized costFinancial assets at fair value through profit or lossDerivatives designated in hedge relationships Financial
liabilities at
amortized
cost
Total
December 31, 2023€m€m€m€m€m
Assets
Derivative financial instruments— — 1.9 — 1.9 
Trade and other receivables226.9 — — — 226.9 
Cash and cash equivalents275.1 137.8 — — 412.9 
Liabilities
Derivative financial instruments— — (110.0)— (110.0)
Trade and other payables excluding non-financial liabilities— — — (719.1)(719.1)
Loans and borrowings— — — (2,135.1)(2,135.1)
Total502.0 137.8 (108.1)(2,854.2)(2,322.5)
Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €231.4 million.
Loans and borrowings includes €78.8 million relating to lease liabilities.
The Company has determined that the carrying amounts of trade receivables, trade payables and cash and cash equivalents are a reasonable approximation of fair value.
Derivative financial instruments
The financial instruments are not traded in an active market and so the fair value of these instruments is determined from the implied forward rate. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 “Fair value measurement”.
Interest bearing loans and borrowings
The fair value of the senior secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the period end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities.
Syndicated loans includes the Senior U.S. Dollar debt of $700.0 million (€642.3 million) (the “Senior USD Loan”) and Senior EUR debt of €130.0 million (a "Senior EUR Loan") both repayable in November 2029, as well as the Senior EUR debt of €553.2 million (a "Senior EUR Loan") repayable in June 2028. The Senior USD Loan includes an annual amortization repayment, equivalent to 1.0% of the original issuance value or $7.0 million (€6.5 million) in October each year until maturity. The Senior EUR Loans are repayable only upon maturity. As required under the Senior Facilities Agreement, the Company is also required to undertake an annual excess cash flow calculation whereby additional principal could be repaid.
On November 8, 2022, the Company amended and restated the Senior Facilities Agreement to issue both a $700.0 million (€700.6 million) term loan bearing interest at a rate per annum equal to the term SOFR rate plus 3.75% with a 0.5% floor and a €130.0 million term loan bearing interest at a rate per annum equal to EURIBOR plus 3.5% with a zero floor, both due November 10, 2029. The net proceeds from these loans were used to repay and extinguish the Company's existing Senior Secured U.S. Dollar term loan due in 2024 in full, and for transaction expenses and general corporate purposes. The new term loans were issued at a discount of €31.3 million, which together with eligible transaction costs of €5.1 million have been capitalized and are being amortized over the life of the debt. Concurrently with the closing of this refinancing, the Company closed out its existing cross currency interest rate swaps and has entered into a number of new 5-year cross-currency and interest rate swaps for the new Term Loans.
On September 22, 2023, the Company completed a repricing of its $693.0 million term loan due 2029 which reduced the interest rate from SOFR plus 3.75% to SOFR plus 3.00%. There are no changes to the maturity of the Term Loan as a result of this repricing. The repricing represents a modification of a financial liability, such that a modification gain of €17.2 million has been recognized, representing the difference between the remaining original contractual cash flows and the modified cash flows, both discounted at the original effective interest rate. Eligible transaction costs associated with the modification of €2.4 million were added to the loan carrying amount and amortized over the remaining loan term. The carrying amount of the loan was revised to reflect the new cash outflows at the date of modification. In October 2023, our cross-currency and interest rate swaps were amended, effective October 10, 2023 to align more closely with the amended cash flows of our USD term loan following the repricing.
On February 2, 2024, the Company completed on the repricing of its existing EUR denominated Term Loan B of €130.0 million principal due 2029 (the “Term Loan”). Following the closing, the margin on the Term Loan has been reduced by 75 basis points to EURIBOR plus 2.75%. There are no changes to the maturity of the Term Loan as a result of this repricing. The repricing represents a modification of a financial liability, such that a net modification gain of €4.1 million has been recognized, representing the difference between the remaining original contractual cash flows and the modified cash flows, both discounted at the original effective interest rate. On April 10, 2024, our interest rate swaps were amended to align more closely with the amended cash flows of our EUR term loan following the repricing.
On April 29, 2024, the Company completed on the repricing of its existing USD denominated Term Loan B of €693.0 million principal due 2029 (the “Term Loan”), subject to customary closing conditions. Following the closing, the margin on the Term Loan will be reduced by 50 basis points to SOFR plus 2.5% effective from May 7, 2024. There are no changes to the maturity of the Term Loan as a result of this repricing. Our cross currency interest rate swaps have also been amended to more closely align with this change, also taking effect in May 2024.
The Senior Loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries.
 
 Fair valueCarrying value
March 31, 2024December 31, 2023March 31, 2024December 31, 2023
 €m€m€m€m
Senior EUR/USD loans1,328.5 1,314.5 1,304.8 1,293.8 
Other external debt0.3 0.3 0.3 0.3 
2028 fixed rate senior secured notes748.0 752.8 800.0 800.0 
Less capitalized debt discounts and borrowing costs— — (36.1)(37.8)
2,076.8 2,067.6 2,069.0 2,056.3 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Provisions
3 Months Ended
Mar. 31, 2024
Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]  
Provisions Provisions
RestructuringProvisions
related to
other taxes
OtherTotal
€m€m€m€m
Balance as of January 1, 202412.7 7.6 16.2 36.5 
Additional provision in the period0.6 — 0.8 1.4 
Release of provision(0.5)(0.2)(0.7)(1.4)
Utilization of provision(3.6)— (0.1)(3.7)
Foreign exchange(0.1)— 0.2 0.1 
Balance as of March 31, 20249.1 7.4 16.4 32.9 
Analysis of total provisions:March 31, 2024December 31, 2023
Current31.5 35.1 
Non-current1.4 1.4 
Total32.9 36.5 
Updates since December 31, 2023
Restructuring
The €9.1 million (December 31, 2023: €12.7 million) provision relates to committed plans for certain restructuring activities of an exceptional nature. The increase in the provision during the period relates to the business transformation program as detailed in Note 6, which are due to be completed within the next 12 months. €3.6 million has been utilized in the three months ended March 31, 2024, which relates to reorganizational activities across the Company.
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Employee benefits
3 Months Ended
Mar. 31, 2024
Employee Benefits [Abstract]  
Employee benefits Employee benefits
The Company operates partially funded defined benefit pension plans in Germany and Austria, an unfunded defined benefit pension plan in Sweden and defined benefit indemnity arrangements in Italy and Austria, as well as various contribution plans in other countries. Pension benefits in Switzerland are met via a contract with a collective foundation that offers a fully insured solution to provide a contribution-based cash balance retirement plan, which is classified as a defined benefit plan. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy, long term service awards are in operation and various other countries provide other employee benefits. There were no changes in the nature of any schemes in the three months ended March 31, 2024.
The total net employee benefit obligations as at March 31, 2024 is as follows:
 €m
Balance as of January 1, 2024158.3 
Service cost0.5 
Net interest expense1.2 
Actuarial gain on pension scheme valuations(3.9)
Benefits paid(0.9)
Other movements(1.0)
Foreign exchange differences on translation(2.1)
Balance as of March 31, 2024152.1 
The principal assumptions applied for the valuation at March 31, 2024 were the same as those applied at December 31, 2023, except for the German plan, which is the most significant in terms of plan assets and liabilities to the Company. The discount rate applied to the German defined benefit obligations increased from 3.4% to 3.5%
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related parties
3 Months Ended
Mar. 31, 2024
Related Party [Abstract]  
Related parties Related parties
As of January 1, 2022, the Company amended its Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of Sir Martin Franklin, and TOMS Capital LLC, an affiliate of Mr. Gottesman. Pursuant to the terms of the Amended and Restated Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC will continue to provide high-level strategic advice and guidance to the Company for an aggregate annual fee equal to $4.0 million, payable in quarterly installments.

Key management personnel comprise the Directors and Executive Officers. The Executive Officers continue to be remunerated for their services to the Company through their employment contracts. Non-executive Directors continue to receive fees for their services as board members and to certain committees and are settled through payroll. Director fees are payable quarterly in arrears. Total non-executive Director fees and expenses for the three months ended March 31, 2024 were €0.1 million (three months ended March 31, 2023: €0.1 million). In addition, certain non-executive Directors received grants under the LTIP as discussed in Note 14.
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of preparation (Policies)
3 Months Ended
Mar. 31, 2024
Common Domain Members [Abstract]  
Basis of Presentation
The accounting policies used by management in preparing these condensed consolidated financial statements were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023, except for taxes on income. Taxes on income are provided for based on management's estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the period. It also reflects the tax impact of exceptional items accounted for in the period.
The preparation of our consolidated interim financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as supply chain disruptions, high inflation and ongoing conflicts, including that between Ukraine and Russia. Actual results could differ from these estimates. The Directors, at the time of approving these interim financial statements, have a reasonable expectation that the Company has adequate resources to continue in operational existence for at least 12 months from the date of signing these interim financial statements given the cash funds available and the current forecast cash flows. In preparing cash flow forecasts, management considers severe but plausible downside scenarios taking into consideration the Company's key risks, including the current economic climate which may adversely impact the Company. Having considered these risks the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these interim financial statements.
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment reporting (Tables)
3 Months Ended
Mar. 31, 2024
Operating Segments [Abstract]  
Segment As Adjusted EBITDA
The Chief Operating Decision Maker (“CODM”) of the Company considers there to be one reporting and operating segment, being “Frozen” and is reflected in the segment presentation below for the periods presented. The CODM primarily uses “Adjusted EBITDA”, as the key measure of the segment’s results, which is considered non-IFRS financial information.

Segment Adjusted EBITDA
  For the three months ended March 31,
20242023
 Note€m€m
Profit for the period34.5 41.2 
Taxation7.4 9.4 
Net financing costs730.1 29.0 
Depreciation & amortization23.1 22.3 
Exceptional items623.5 30.1 
Other add-backs3.7 14.3 
Adjusted EBITDA122.3 146.3 
External Revenue by Geography
For the three months ended March 31,
20242023
 €m€m
United Kingdom225.3216.4
Germany112.6117.6
Italy110.6109.1
France53.952.9
Sweden35.838.1
Croatia20.819.6
Austria38.537.9
Norway30.833.7
Serbia19.018.4
Spain22.320.6
Switzerland21.621.2
Rest of Europe92.589.6
Total external revenue by geography783.7775.1
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Exceptional items (Tables)
3 Months Ended
Mar. 31, 2024
Analysis of income and expense [abstract]  
Schedule of Exceptional Items
 For the three months ended March 31,
 20242023
€m€m
Business transformation program (1)20.5 28.1 
Fortenova Acquisition integration costs (2)— 1.8 
Information Technology transformation program (3)— 0.2 
Settlement of legacy matters (4)3.0 — 
Total exceptional items23.5 30.1 
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Finance income and costs (Tables)
3 Months Ended
Mar. 31, 2024
Analysis of income and expense [abstract]  
Schedule of Finance income and costs
 For the three months ended March 31,
20242023
 €m€m
Finance income
Interest income1.8 1.1 
Net financing gain recognized on debt transactions (a)4.1 — 
Total finance income5.9 1.1 
Interest expense (b)(22.7)(21.5)
Net foreign exchange losses arising on translation of financial assets and liabilities(10.2)(5.8)
Net pension interest costs(1.2)(1.1)
Amortization of debt discounts and borrowing costs(1.7)(1.6)
Net fair value losses on derivatives held at fair value through profit or loss(0.2)(0.1)
Total finance costs(36.0)(30.1)
Net finance costs(30.1)(29.0)
(a) Net income for the three months ended March 31, 2024 of €4.1 million has been recognized from the repricing of the EUR denominated Term Loan B of €130.0 million in February 2024, representing a modification gain net of transaction costs.
(b) Interest expense includes interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss and is shown net of gains recycled from the cash flow hedge reserve on cross currency interest rate swaps.
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings per share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings per share [abstract]  
Schedule of Earnings per Share
 For the three months ended March 31,
 20242023
Basic earnings per share
Profit for the period attributable to equity owners of the parent (€m)
34.5 41.2 
Weighted average Ordinary Shares and shares issuable solely after the passage of time in millions163.2 174.5 
Basic earnings per share0.21 0.24 
Schedule of Diluted Earnings per Share
 For the three months ended March 31,
20242023
Diluted earnings per share
Profit for the period attributable to equity owners of the parent (€m)34.5 41.2 
Weighted average Ordinary Shares, shares issuable solely after the passage of time and potential ordinary shares in millions163.3 174.5 
Diluted earnings per share0.21 0.24 
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial instruments (Tables)
3 Months Ended
Mar. 31, 2024
Financial Instruments [Abstract]  
Disclosure of Financial Assets
Financial assets at amortized costFinancial assets at fair value through profit or lossDerivatives designated in hedge relationshipsFinancial
liabilities at
amortized
cost
Total
March 31, 2024€m€m€m€m€m
Assets
Derivative financial instruments— — 7.4 — 7.4 
Trade and other receivables292.3 — — — 292.3 
Cash and cash equivalents255.5 135.2 — — 390.7 
Liabilities
Derivative financial instruments— — (78.7)— (78.7)
Trade and other payables excluding non-financial liabilities— — — (755.7)(755.7)
Loans and borrowings— — — (2,153.1)(2,153.1)
Total547.8 135.2 (71.3)(2,908.8)(2,297.1)
Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €227.6 million.

Loans and borrowings includes €84.1 million relating to lease liabilities.

Financial assets at amortized costFinancial assets at fair value through profit or lossDerivatives designated in hedge relationships Financial
liabilities at
amortized
cost
Total
December 31, 2023€m€m€m€m€m
Assets
Derivative financial instruments— — 1.9 — 1.9 
Trade and other receivables226.9 — — — 226.9 
Cash and cash equivalents275.1 137.8 — — 412.9 
Liabilities
Derivative financial instruments— — (110.0)— (110.0)
Trade and other payables excluding non-financial liabilities— — — (719.1)(719.1)
Loans and borrowings— — — (2,135.1)(2,135.1)
Total502.0 137.8 (108.1)(2,854.2)(2,322.5)
Disclosure of Financial Liabilities
Financial assets at amortized costFinancial assets at fair value through profit or lossDerivatives designated in hedge relationshipsFinancial
liabilities at
amortized
cost
Total
March 31, 2024€m€m€m€m€m
Assets
Derivative financial instruments— — 7.4 — 7.4 
Trade and other receivables292.3 — — — 292.3 
Cash and cash equivalents255.5 135.2 — — 390.7 
Liabilities
Derivative financial instruments— — (78.7)— (78.7)
Trade and other payables excluding non-financial liabilities— — — (755.7)(755.7)
Loans and borrowings— — — (2,153.1)(2,153.1)
Total547.8 135.2 (71.3)(2,908.8)(2,297.1)
Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €227.6 million.

Loans and borrowings includes €84.1 million relating to lease liabilities.

Financial assets at amortized costFinancial assets at fair value through profit or lossDerivatives designated in hedge relationships Financial
liabilities at
amortized
cost
Total
December 31, 2023€m€m€m€m€m
Assets
Derivative financial instruments— — 1.9 — 1.9 
Trade and other receivables226.9 — — — 226.9 
Cash and cash equivalents275.1 137.8 — — 412.9 
Liabilities
Derivative financial instruments— — (110.0)— (110.0)
Trade and other payables excluding non-financial liabilities— — — (719.1)(719.1)
Loans and borrowings— — — (2,135.1)(2,135.1)
Total502.0 137.8 (108.1)(2,854.2)(2,322.5)
 Fair valueCarrying value
March 31, 2024December 31, 2023March 31, 2024December 31, 2023
 €m€m€m€m
Senior EUR/USD loans1,328.5 1,314.5 1,304.8 1,293.8 
Other external debt0.3 0.3 0.3 0.3 
2028 fixed rate senior secured notes748.0 752.8 800.0 800.0 
Less capitalized debt discounts and borrowing costs— — (36.1)(37.8)
2,076.8 2,067.6 2,069.0 2,056.3 
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Provisions (Tables)
3 Months Ended
Mar. 31, 2024
Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]  
Summary of Provisions
RestructuringProvisions
related to
other taxes
OtherTotal
€m€m€m€m
Balance as of January 1, 202412.7 7.6 16.2 36.5 
Additional provision in the period0.6 — 0.8 1.4 
Release of provision(0.5)(0.2)(0.7)(1.4)
Utilization of provision(3.6)— (0.1)(3.7)
Foreign exchange(0.1)— 0.2 0.1 
Balance as of March 31, 20249.1 7.4 16.4 32.9 
Analysis of total provisions:March 31, 2024December 31, 2023
Current31.5 35.1 
Non-current1.4 1.4 
Total32.9 36.5 
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Employee benefits (Tables)
3 Months Ended
Mar. 31, 2024
Employee Benefits [Abstract]  
Schedule of Net Employee Benefit Obligations
The total net employee benefit obligations as at March 31, 2024 is as follows:
 €m
Balance as of January 1, 2024158.3 
Service cost0.5 
Net interest expense1.2 
Actuarial gain on pension scheme valuations(3.9)
Benefits paid(0.9)
Other movements(1.0)
Foreign exchange differences on translation(2.1)
Balance as of March 31, 2024152.1 
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share based compensation reserve (Tables)
3 Months Ended
Mar. 31, 2024
Share Capital, Reserves and Other Equity Interest [Abstract]  
Summary of Management Share Awards
As part of its long term incentive initiatives, the Company has awarded restricted shares to the management team (the “Management Share Awards”) as of the following award dates.

 January 1, 2021 AwardJanuary 1, 2022 AwardJanuary 1, 2023 AwardJanuary 1, 2024 AwardOther AwardsTotal
Number of awards outstanding at January 1, 2024605,600730,5941,003,808  163,000 2,503,002
New awards granted in the period— — — 1,112,4601,112,460
Forfeitures in the period(9,222)(11,301)(7,000)(27,523)
Awards lapsed in the period(129,048)— — (129,048)
Number of awards outstanding at March 31, 2024476,552721,372992,5071,112,460156,0003,458,891
Summary of Management Share Award Inputs and Assumptions Based on the latest revision to schemes, the inputs and assumptions underlying the Monte Carlo models for all awards outstanding as of valuation date are as follows:
 January 1, 2021 AwardJanuary 1, 2022 Award *January 1, 2023 Award *January 1, 2024 Award *
Grant date price$25.42 $25.39 $17.24 $16.95 
Exercise price$— $— $— $— 
Expected life of restricted share3.00 years3.00 years3.00 years3.00 years
Expected volatility of the share price30.0 %28.0 %N/AN/A
Dividend yield expected— %— %N/AN/A
Risk free rate0.24 %1.15 %N/AN/A
Employee exit rate14.0 %14.0 %18.0 %15.0 %
EBITDA Performance Target Conditions35.0 %35.0 %75.0 %75.0 %
*Note: The table above does not include details on awards that only require continued employment over the vesting period and have only non-company wide specific performance conditions.
Schedule of Reserves within Equity
Share based compensation reserve
20242023
 €m€m
Balance as of January 131.4 13.8 
Non-Executive Directors' restricted share awards charge0.1 0.1 
Directors' and Senior Management share awards charge3.0 12.2 
Reclassification of awards for settlement of tax liabilities— (4.0)
Balance as of March 3134.5 22.1 
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share Capital and Capital reserve (Tables)
3 Months Ended
Mar. 31, 2024
Share Capital, Reserves and Other Equity Interest [Abstract]  
Schedule of Share Capital and Capital Reserve
 SharesMarch 31, 2024December 31, 2023
March 31, 2024December 31, 2023€m€m
Authorized Share Capital issued and fully paid:
Ordinary Shares with nil nominal value162,719,172 163,167,134 1,446.3 1,453.4 
Total share capital and capital reserve1,446.3 1,453.4 
Listing and share transaction costs(27.3)(27.3)
Total net share capital and capital reserve1,419.0 1,426.1 
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of preparation (Details)
€ in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
EUR (€)
Mar. 31, 2023
EUR (€)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
Nov. 08, 2022
EUR (€)
Nov. 08, 2022
USD ($)
Common Table Line Items [Line Items]              
Other reserves € (11.8)     € (24.6)      
Translation reserve € 104.6     101.0      
Description of nature of impending change in accounting policy Recently issued and not yet adopted accounting pronouncements under IFRSOn April 9, 2024, the IASB issued IFRS 18 'Presentation and Disclosure in Financial Statements'. IFRS 18 replaces IAS 1 'Presentation of Financial Statements'. The new Accounting Standard introduces a number of changes to the structure of the Statement of Profit or Loss, more transparency in the presentation of management's own performance measures and more granularity in reporting of financial information. The main impacts of the new Accounting Standard include:•    Improved comparability in the Statement of Profit or Loss by introducing a set of clearly defined categories based on main business activities (i.e. operating, investing and financing);•    Requiring disclosure about management-defined performance measures; and•    Adding new principles for aggregation and disaggregation of information. IFRS 18 applies for annual reporting periods beginning on or after January 1, 2027. Earlier application is permitted. The Company is still assessing the full impact of the standard.There are no other accounting pronouncements with a material impact on the Company.            
Cash flow hedges              
Common Table Line Items [Line Items]              
Other reserves € (14.8)     € (27.5)      
Senior EURO Debt              
Common Table Line Items [Line Items]              
Notional amount € 553.2            
Interest rate 3.50%   3.50%        
Senior USD Debt              
Common Table Line Items [Line Items]              
Notional amount € 642.3   $ 693.0     € 700.6 $ 700.0
Interest rate 2.50%   2.50% 3.00% 3.75%    
Other reserves              
Common Table Line Items [Line Items]              
Deferred hedging losses and costs of hedging transferred to the carrying value of inventory € 4.3 € (0.1)          
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment reporting - Segment as Adjusted EBITDA (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disclosure of operating segments [line items]    
Profit for the period € 34.5 € 41.2
Taxation 7.4 9.4
Net financing costs 30.1 29.0
Depreciation & amortization 23.1 22.3
Exceptional items 23.5 30.1
Material reconciling items    
Disclosure of operating segments [line items]    
Exceptional items 23.5 30.1
Other add-backs 3.7 14.3
Adjusted EBITDA € 122.3 € 146.3
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment reporting - Additional Information (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Segments [Abstract]    
Adjustments for share based payments including employer tax € 3.4 € 13.9
Acquisition related costs € 0.3 € 0.4
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segment reporting - Geographical information (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disclosure of geographical areas [line items]    
Revenue € 783.7 € 775.1
United Kingdom    
Disclosure of geographical areas [line items]    
Revenue 225.3 216.4
Germany    
Disclosure of geographical areas [line items]    
Revenue 112.6 117.6
Italy    
Disclosure of geographical areas [line items]    
Revenue 110.6 109.1
France    
Disclosure of geographical areas [line items]    
Revenue 53.9 52.9
Sweden    
Disclosure of geographical areas [line items]    
Revenue 35.8 38.1
CROATIA    
Disclosure of geographical areas [line items]    
Revenue 20.8 19.6
Austria    
Disclosure of geographical areas [line items]    
Revenue 38.5 37.9
Norway    
Disclosure of geographical areas [line items]    
Revenue 30.8 33.7
SERBIA    
Disclosure of geographical areas [line items]    
Revenue 19.0 18.4
Spain    
Disclosure of geographical areas [line items]    
Revenue 22.3 20.6
SWITZERLAND    
Disclosure of geographical areas [line items]    
Revenue 21.6 21.2
Rest of Europe    
Disclosure of geographical areas [line items]    
Revenue € 92.5 € 89.6
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Exceptional Items - Schedule (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Analysis of income and expense [abstract]    
Business transformation program (1) € 20.5 € 28.1
Fortenova Acquisition integration costs (2) 0.0 1.8
Information Technology transformation program (3) 0.0 0.2
Settlement of legacy matters (4) 3.0 0.0
Exceptional items € 23.5 € 30.1
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Exceptional items - Additional Information (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Analysis of income and expense [abstract]    
Business transformation program (1) € 20.5 € 28.1
Exceptional Items, Tax Expense (Income), Continuing Operations (5.7) (7.0)
Payments relating to exceptional items € (24.0) € (14.0)
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Finance income and costs (Details) - EUR (€)
€ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Analysis of income and expense [abstract]      
Interest income € 1.8 € 1.1  
Net gain on refinancing 4.1 0.0 € 17.2
Total finance income 5.9 1.1  
Interest expense (b) (22.7) (21.5)  
Net foreign exchange losses arising on translation of financial assets and liabilities (10.2) (5.8)  
Net pension interest costs (1.2) (1.1)  
Amortization of debt discounts and borrowing costs (1.7) (1.6)  
Net fair value losses on derivatives held at fair value through profit or loss (0.2) (0.1)  
Total finance costs (36.0) (30.1)  
Net financing costs € (30.1) € (29.0)  
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Taxation (Details) - EUR (€)
€ in Millions
3 Months Ended
Apr. 01, 2023
Mar. 31, 2024
Mar. 31, 2023
Income Taxes [Abstract]      
Tax expense   € 7.4 € 9.4
Applicable tax rate 2500.00% 1900.00%  
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings per share - Computation (Details) - EUR (€)
€ / shares in Units, € in Millions, shares in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Basic earnings per share    
Profit for the period attributable to equity owners of the parent (€m) € 34.5 € 41.2
Weighted average Ordinary Shares and shares issuable solely after the passage of time in millions 163.2 174.5
Basic earnings per share € 0.21 € 0.24
Diluted earnings per share    
Profit for the period attributable to equity owners of the parent (€m) € 34.5 € 41.2
Weighted average Ordinary Shares, shares issuable solely after the passage of time and potential ordinary shares in millions 163.3 174.5
Diluted earnings per share € 0.21 € 0.24
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Earnings per share - Additional Information (Details)
3 Months Ended 12 Months Ended
Jul. 06, 2023
Mar. 31, 2024
shares
Dec. 31, 2023
Non-Executive Director      
Earnings per share [line items]      
Number of other equity instruments exercised or vested in share-based payment arrangement 29,676   18,450
Key management personnel of entity or parent      
Earnings per share [line items]      
Dilutive effect of restricted share awards on number of ordinary shares (in shares)   292,687  
Dilutive effect of share options on number of ordinary shares   109,322  
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial instruments - Categories of financial instruments (Details) - EUR (€)
€ in Millions
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2023
Dec. 31, 2022
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]        
Financial assets at amortized cost € 390.7 € 412.9 € 370.9 € 366.8
Financial assets at amortised cost 547.8 502.0    
Financial assets at fair value through profit or loss 135.2 137.8    
Financial liabilities at amortised cost (2,908.8) (2,854.2)    
Financial assets (liabilities) at fair value through other comprehensive income (71.3) (108.1)    
Total (2,297.1) (2,322.5)    
Derivative financial instruments        
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]        
Financial liabilities at amortised cost 0.0 0.0    
Financial liabilities (78.7) (110.0)    
Financial Liabilities At Fair Value Through Other Comprehensive Income (78.7) (110.0)    
Trade and other payables excluding non-financial liabilities        
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]        
Financial liabilities at amortised cost (755.7) (719.1)    
Financial liabilities (755.7) (719.1)    
Financial Liabilities At Fair Value Through Other Comprehensive Income 0.0 0.0    
Loans and borrowings        
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]        
Financial liabilities at amortised cost (2,153.1) (2,135.1)    
Financial liabilities (2,153.1) (2,135.1)    
Financial Liabilities At Fair Value Through Other Comprehensive Income 0.0 0.0    
Derivative financial instruments        
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]        
Financial assets 7.4 1.9    
Derivative financial assets held for hedging 7.4 1.9    
Trade and other receivables        
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]        
Financial assets at amortised cost 292.3 226.9    
Financial assets 292.3 226.9    
Cash and cash equivalents        
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]        
Financial assets at amortised cost 255.5 275.1    
Financial assets at fair value through profit or loss 135.2 137.8    
Financial assets € 390.7 € 412.9    
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Instruments - Additional Information (Details)
€ in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
EUR (€)
Mar. 31, 2024
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
Nov. 08, 2022
EUR (€)
Nov. 08, 2022
USD ($)
Disclosure of detailed information about borrowings [line items]              
Contract liabilities € 227.6     € 231.4      
Liability relating to IFRS 16              
Disclosure of detailed information about borrowings [line items]              
Lease liabilities 84.1     € 78.8      
Senior EURO Debt              
Disclosure of detailed information about borrowings [line items]              
Notional amount € 553.2            
Interest rate 3.50%   3.50%        
Senior USD Debt              
Disclosure of detailed information about borrowings [line items]              
Notional amount € 642.3   $ 693.0     € 700.6 $ 700.0
Repayments of non-current borrowings € 6.5 $ 7.0          
Interest rate 2.50%   2.50% 3.00% 3.75%    
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial Instruments - Interest bearing loans and borrowings (Details)
€ in Millions, $ in Millions
3 Months Ended 12 Months Ended
Nov. 08, 2022
EUR (€)
Mar. 31, 2024
EUR (€)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
EUR (€)
Dec. 31, 2023
EUR (€)
Mar. 31, 2024
USD ($)
Dec. 31, 2022
Nov. 08, 2022
USD ($)
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Discount on issuance of debt € 31.3              
Borrowing costs capitalised         € 2.4      
Net gain on refinancing   € 4.1   € 0.0 € 17.2      
Senior USD Debt                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Notional amount 700.6 € 642.3       $ 693.0   $ 700.0
Interest rate   2.50%     3.00% 2.50% 3.75%  
Repayments of non-current borrowings   € 6.5 $ 7.0          
Repayments Of Non-current Borrowings - percentage of original issued notional   1.00%       1.00%    
Interest rate floor   0.50%       0.50%    
Senior EURO Debt                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Notional amount   € 553.2            
Interest rate   3.50%       3.50%    
Borrowing costs capitalised € 5.1              
Senior Eur Debt                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Notional amount   € 130.0            
Interest rate   2.75%       2.75%    
Loans and Borrowings                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Fair value   € 2,076.8     € 2,067.6      
Carrying value   2,069.0     2,056.3      
Loans and Borrowings | Deferred borrowing costs                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Fair value   0.0     0.0      
Carrying value   (36.1)     (37.8)      
Loans and Borrowings | Senior EUR/USD loans                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Carrying value   1,304.8     1,293.8      
Loans and Borrowings | Senior EUR/USD loans | Level 2                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Fair value   1,328.5     1,314.5      
Loans and Borrowings | Other borrowings [Domain]                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Fair value   0.3     0.3      
Carrying value   0.3     0.3      
Loans and Borrowings | Twenty Twenty-Eight Fixed Rate Senior Secured Notes                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Carrying value   800.0     800.0      
Loans and Borrowings | Twenty Twenty-Eight Fixed Rate Senior Secured Notes | Level 1                
Disclosure Of Financial Assets And Liabilities [Table] [Line Items]                
Fair value   € 748.0     € 752.8      
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Provisions - Schedule (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Disclosure of other provisions [line items]    
Other provisions at beginning of period € 36.5  
Additional provision in the period 1.4  
Release of provision (1.4)  
Utilization of provision (3.7)  
Foreign exchange 0.1  
Other provisions at end of period 32.9  
Current 31.5 € 35.1
Non-current 1.4 1.4
Provisions 32.9 € 36.5
Restructuring    
Disclosure of other provisions [line items]    
Other provisions at beginning of period 12.7  
Additional provision in the period 0.6  
Release of provision (0.5)  
Utilization of provision (3.6)  
Foreign exchange (0.1)  
Other provisions at end of period 9.1  
Provisions related to other taxes    
Disclosure of other provisions [line items]    
Other provisions at beginning of period 7.6  
Additional provision in the period 0.0  
Release of provision (0.2)  
Utilization of provision 0.0  
Foreign exchange 0.0  
Other provisions at end of period 7.4  
Other    
Disclosure of other provisions [line items]    
Other provisions at beginning of period 16.2  
Additional provision in the period 0.8  
Release of provision (0.7)  
Utilization of provision (0.1)  
Foreign exchange 0.2  
Other provisions at end of period € 16.4  
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Provisions - Additional Information (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Disclosure of other provisions [line items]    
Other provisions € 32.9 € 36.5
Provision used, other provisions 3.7  
Restructuring    
Disclosure of other provisions [line items]    
Other provisions € 9.1 12.7
Estimated completion of activities 12 months  
Provision used, other provisions € 3.6  
Other    
Disclosure of other provisions [line items]    
Other provisions 16.4 16.2
Provision used, other provisions 0.1  
Provisions related to other taxes    
Disclosure of other provisions [line items]    
Other provisions 7.4 € 7.6
Provision used, other provisions € 0.0  
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Employee Benefits (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Employee Benefits [Abstract]    
Net defined benefit liability (asset) at beginning of period € 158.3  
Service cost 0.5  
Net interest expense 1.2  
Actuarial gain on pension scheme valuations (3.9)  
Benefits paid (0.9)  
Increase (decrease) in net defined benefit liability (asset) resulting from other changes (1.0)  
Foreign exchange differences on translation (2.1)  
Net defined benefit liability (asset) at end of period € 152.1  
Germany    
Disclosure of defined benefit plans [line items]    
Actuarial assumption of discount rates 3.50% 3.40%
Sweden    
Disclosure of defined benefit plans [line items]    
Actuarial assumption of discount rates 3.20%  
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share based compensation reserve - Director and Senior Management Share Awards (Details) - Restricted shares - shares
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 01, 2023
Jan. 01, 2023
Jan. 01, 2022
Jan. 31, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period   2,699,157     2,503,002 2,699,157 2,699,157
New awards granted in the period (in shares)         1,112,460    
Forfeitures in the period (in shares)         (27,523) (209,938)  
Number of other equity instruments expired in share-based payment arrangement         129,048 171,579  
Awards vested and issued in period (in shares)           (761,544)  
Number of other equity instruments outstanding (in shares) at end of period         3,458,891 1,556,096 2,503,002
New awards granted in the period (in shares)         1,112,460    
Management Award 2019              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Awards vested and issued in period (in shares)   (152,695)          
Liabilities from share-based payment transactions (in shares)   73,120          
January 1, 2021              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
New awards granted in the period (in shares)       820,202      
New awards granted in the period (in shares)       820,202      
January 1, 2022              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
New awards granted in the period (in shares)     1,140,518        
New awards granted in the period (in shares)     1,140,518        
Management Award 2020              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Awards vested and issued in period (in shares) (414,859)            
Liabilities from share-based payment transactions (in shares) 192,079            
January 1, 2018              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period   193,990       193,990 193,990
Forfeitures in the period (in shares)           0  
Number of other equity instruments expired in share-based payment arrangement           0  
Awards vested and issued in period (in shares)           (193,990)  
Number of other equity instruments outstanding (in shares) at end of period           0  
January 1, 2019              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period   152,695       152,695 152,695
Forfeitures in the period (in shares)           0  
Number of other equity instruments expired in share-based payment arrangement           0  
Awards vested and issued in period (in shares)           (152,695)  
Number of other equity instruments outstanding (in shares) at end of period           0  
January 1, 2020              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period   598,173       598,173 598,173
Forfeitures in the period (in shares)           (11,735)  
Number of other equity instruments expired in share-based payment arrangement           171,579  
Awards vested and issued in period (in shares)           (414,859)  
Number of other equity instruments outstanding (in shares) at end of period           0  
January 1, 2021              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period   683,549     605,600 683,549 683,549
New awards granted in the period (in shares)         0    
Forfeitures in the period (in shares)         0 (40,620)  
Number of other equity instruments expired in share-based payment arrangement         129,048 0  
Awards vested and issued in period (in shares)           0  
Number of other equity instruments outstanding (in shares) at end of period         476,552 642,929 605,600
New awards granted in the period (in shares)         0    
January 1, 2022              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period   894,750     730,594 894,750 894,750
New awards granted in the period (in shares)         0    
Forfeitures in the period (in shares)         (9,222) (92,583)  
Number of other equity instruments expired in share-based payment arrangement         0 0  
Awards vested and issued in period (in shares)           0  
Number of other equity instruments outstanding (in shares) at end of period         721,372 802,167 730,594
New awards granted in the period (in shares)         0    
Other Awards              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period   176,000     163,000 176,000 176,000
New awards granted in the period (in shares)         0    
Forfeitures in the period (in shares)         (7,000) (65,000)  
Number of other equity instruments expired in share-based payment arrangement         0 0  
Awards vested and issued in period (in shares)           0  
Number of other equity instruments outstanding (in shares) at end of period         156,000 111,000 163,000
New awards granted in the period (in shares)         0    
January 1, 2023              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period         1,003,808    
New awards granted in the period (in shares)         0    
Forfeitures in the period (in shares)         (11,301)    
Number of other equity instruments expired in share-based payment arrangement         0    
Number of other equity instruments outstanding (in shares) at end of period         992,507   1,003,808
New awards granted in the period (in shares)         0    
January 1, 2024              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments outstanding (in shares) at beginning of period         0    
New awards granted in the period (in shares)         1,112,460    
Forfeitures in the period (in shares)         0    
Number of other equity instruments expired in share-based payment arrangement         0    
Number of other equity instruments outstanding (in shares) at end of period         1,112,460   0
New awards granted in the period (in shares)         1,112,460    
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share based compensation reserve - Director and Senior Management Share Awards (Narrative) (Details)
$ / shares in Units, € in Millions, $ in Millions
1 Months Ended 3 Months Ended
Mar. 01, 2024
shares
$ / shares
Jan. 01, 2024
USD ($)
shares
Feb. 01, 2023
shares
$ / shares
Jan. 01, 2023
USD ($)
shares
$ / shares
Jan. 01, 2022
USD ($)
shares
Jan. 31, 2021
shares
Mar. 31, 2024
USD ($)
shares
$ / shares
Mar. 31, 2024
EUR (€)
shares
Mar. 31, 2023
EUR (€)
shares
Jan. 01, 2024
EUR (€)
Dec. 31, 2023
$ / shares
Jan. 01, 2023
EUR (€)
Dec. 31, 2022
$ / shares
Jan. 01, 2022
EUR (€)
Dec. 31, 2021
$ / shares
Jan. 01, 2021
USD ($)
Jan. 01, 2021
EUR (€)
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Key management personnel compensation | €               € 3.0 € 12.2                
Ordinary shares                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Shares issued, price per share (in dollars per share) | $ / shares             $ 17.31       $ 16.33   $ 26.23   $ 24.5    
January 1, 2021                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Weighted average fair value at measurement date, other equity instruments granted                               $ 16.0 € 15.1
January 1, 2022                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Weighted average fair value at measurement date, other equity instruments granted         $ 19.0                 € 17.9      
Other Awards                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Weighted average fair value at measurement date, other equity instruments granted       $ 3.8               € 3.4          
January 1, 2023                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Weighted average fair value at measurement date, other equity instruments granted   $ 8.8   $ 7.5           € 8.0   € 7.0          
Restricted shares                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)                 761,544                
New awards granted in the period (in shares)             1,112,460 1,112,460                  
New awards granted in the period (in shares)             1,112,460 1,112,460                  
Restricted shares | Management Award 2019                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)       152,695                          
Liabilities from share-based payment transactions (in shares)       73,120                          
Shares issued, price per share (in dollars per share) | $ / shares       $ 17.24                          
Restricted shares | Management Award 2019 | Ordinary shares                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)       79,575                          
Restricted shares | Management Award 2020                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)     414,859                            
Liabilities from share-based payment transactions (in shares)     192,079                            
Shares issued, price per share (in dollars per share) | $ / shares     $ 17.77                            
Restricted shares | Management Award 2020 | Ordinary shares                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 256,687   222,780                            
Restricted shares | January 1, 2018                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)       193,990                          
Liabilities from share-based payment transactions (in shares)       83,209                          
Shares issued, price per share (in dollars per share) | $ / shares       $ 17.24                          
Restricted shares | January 1, 2018 | Ordinary shares                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)       110,781                          
Restricted shares | January 1, 2021                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Award vesting period             3 years 3 years                  
EBITDA and cumulative net sales tranches as percent of total award                               3750.00% 3750.00%
Share price tranche as percent of total award                               2500.00% 2500.00%
Incremental fair value granted, modified share-based payment arrangements             $ 9.0 € 8.5                  
New awards granted in the period (in shares)           820,202                      
New awards granted in the period (in shares)           820,202                      
Restricted shares | January 1, 2022                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Incremental fair value granted, modified share-based payment arrangements             $ 11.4 € 10.8                  
New awards granted in the period (in shares)         1,140,518                        
New awards granted in the period (in shares)         1,140,518                        
Restricted shares | January 1, 2023                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
New awards granted in the period (in shares)       1,209,137                          
New awards granted in the period (in shares)       1,209,137                          
Restricted shares | Other Awards                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
New awards granted in the period (in shares)       87,000                          
New awards granted in the period (in shares)       87,000                          
Restricted shares | January 1, 2024                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
New awards granted in the period (in shares)   1,112,460                              
New awards granted in the period (in shares)   1,112,460                              
Restricted shares | Management Award 2021                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 476,552                                
Liabilities from share-based payment transactions (in shares) 219,865                                
Shares issued, price per share (in dollars per share) | $ / shares $ 18.89                                
Restricted shares | January 1, 2018                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)                 193,990                
Restricted shares | January 1, 2020                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)                 414,859                
Restricted shares | January 1, 2021                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)                 0                
New awards granted in the period (in shares)             0 0                  
New awards granted in the period (in shares)             0 0                  
Restricted shares | January 1, 2022                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)                 0                
New awards granted in the period (in shares)             0 0                  
New awards granted in the period (in shares)             0 0                  
Restricted shares | Other Awards                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)                 0                
New awards granted in the period (in shares)             0 0                  
New awards granted in the period (in shares)             0 0                  
Restricted shares | January 1, 2023                                  
Disclosure of terms and conditions of share-based payment arrangement [line items]                                  
New awards granted in the period (in shares)             0 0                  
New awards granted in the period (in shares)             0 0                  
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share based compensation reserve - Valuation Assumptions (Details) - Restricted shares
3 Months Ended
Mar. 31, 2024
$ / shares
January 1, 2021  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Grant date price $ 25.42
Exercise price $ 0
Expected life of restricted share 3 years
Expected volatility of the share price 30.00%
Dividend yield expected 0.00%
Risk free rate 0.24%
Employee exit rate 14.00%
EBITDA Performance Target Conditions 35.00%
January 1, 2022  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Grant date price $ 25.39
Exercise price $ 0
Expected life of restricted share 3 years
Expected volatility of the share price 28.00%
Dividend yield expected 0.00%
Risk free rate 1.15%
Employee exit rate 14.00%
EBITDA Performance Target Conditions 35.00%
January 1, 2023  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Grant date price $ 17.24
Exercise price $ 0
Expected life of restricted share 3 years
Employee exit rate 18.00%
EBITDA Performance Target Conditions 75.00%
January 1, 2024  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Grant date price $ 16.95
Exercise price $ 0
Expected life of restricted share 3 years
Employee exit rate 15.00%
EBITDA Performance Target Conditions 75.00%
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share based compensation reserve - Non-Executive Director Restricted Share Awards (Details)
$ / shares in Units, € in Millions
3 Months Ended 12 Months Ended
Jul. 06, 2023
$ / shares
shares
Jul. 01, 2022
$ / shares
Mar. 31, 2024
USD ($)
shares
Mar. 31, 2024
EUR (€)
shares
Mar. 31, 2023
EUR (€)
shares
Dec. 31, 2023
shares
Dec. 31, 2022
shares
Non-Executive Director              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) 29,676         18,450  
New awards granted in the period (in shares) 35,082 29,676          
Liabilities from share-based payment transactions (in shares) 11,226            
Restricted shares              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)         761,544    
New awards granted in the period (in shares)     1,112,460 1,112,460      
Number of other equity instruments outstanding (in shares)     3,458,891 3,458,891 1,556,096 2,503,002 2,699,157
Restricted shares | Non-Executive Director              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Other equity instruments granted in share-based payment arrangement, per director | $     $ 100,000        
Expense from share-based payment transactions with employees | €       € 0.1 € 0.1    
Shares issued, price per share (in dollars per share) | $ / shares $ 17.1 $ 20.22          
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share based compensation reserve - Reserve Summary (Details) - EUR (€)
€ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Reserve of share-based payments € 31.4  
Reserve of share-based payments 34.5  
Share based compensation reserve    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Reserve of share-based payments 31.4 € 13.8
Reserve of share-based payments 34.5 22.1
Share based compensation reserve | Non-Executive Director    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Share based payment charge 0.1 0.1
Share based compensation reserve | Key Management Personnel Of Entity Or Parent, Reclassification to tax liability    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Reclassification of awards for settlement of tax liabilities 0.0 (4.0)
Share based compensation reserve | Key management personnel of entity or parent    
Disclosure of terms and conditions of share-based payment arrangement [line items]    
Share based payment charge € 3.0 € 12.2
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share Capital and Capital reserve - Narrative (Details)
3 Months Ended 5 Months Ended 12 Months Ended
Nov. 06, 2023
USD ($)
Aug. 05, 2021
USD ($)
Mar. 31, 2024
EUR (€)
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Mar. 31, 2023
EUR (€)
Dec. 31, 2021
EUR (€)
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2023
EUR (€)
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
EUR (€)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Mar. 31, 2024
$ / shares
Dec. 31, 2023
$ / shares
Disclosure of classes of share capital [line items]                          
Other reserves     € (11,800,000)         € (24,600,000)          
Purchase of treasury shares | $ $ 500 $ 500,000,000                      
Payments to acquire or redeem entity's shares     7,100,000   € 0                
Dividends paid, ordinary shares per share | $ / shares       $ 0.15                  
Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share | $ / shares       $ 0.15                  
Dividends paid, ordinary shares     22,300,000 $ 24,400,000                  
Cash flow hedges                          
Disclosure of classes of share capital [line items]                          
Other reserves     (14,800,000)         (27,500,000)          
Cost of hedging reserve                          
Disclosure of classes of share capital [line items]                          
Reserve of change in value of forward elements of forward contracts     € 3,000,000         2,900,000          
Ordinary shares                          
Disclosure of classes of share capital [line items]                          
Shares issued, price per share (in dollars per share) | $ / shares             $ 24.5       $ 26.23 $ 17.31 $ 16.33
Transaction costs           € 0.1   € 0.2          
Number of shares repurchased | shares     447,962 447,962   3,090,082 3,090,082 11,314,705 11,314,705 1,160,547 1,160,547    
Payments to acquire or redeem entity's shares     € 7.1 $ 7.8   € 67.1 $ 75.8 € 170.9 $ 185 € 26.8 $ 30.5    
Ordinary shares | Issued Capital and Capital Reserve                          
Disclosure of classes of share capital [line items]                          
Par value per share (in usd per share) | $ / shares                       $ 10.00  
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share Capital and Capital reserve - Schedule (Details) - EUR (€)
€ in Millions
Mar. 31, 2024
Dec. 31, 2023
Disclosure of classes of share capital [line items]    
Total share capital and capital reserve € 1,446.3 € 1,453.4
Listing and share transaction costs (27.3) (27.3)
Total net share capital and capital reserve 1,419.0 1,426.1
Ordinary shares    
Disclosure of classes of share capital [line items]    
Total share capital and capital reserve € 1,446.3 € 1,453.4
Issued Capital and Capital Reserve | Ordinary shares    
Disclosure of classes of share capital [line items]    
Issued and fully paid (in shares) 162,719,172 163,167,134
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related parties (Details)
€ in Millions
3 Months Ended
Jan. 01, 2022
USD ($)
Mar. 31, 2024
EUR (€)
Mar. 31, 2023
EUR (€)
Non-Executive Director      
Disclosure of transactions between related parties [line items]      
Fees and expenses | €   € 0.1 € 0.1
Mariposa Capital and TOMS Capital | Affiliate of Founder Entities      
Disclosure of transactions between related parties [line items]      
Services Agreement, Annual Fee, Related Party Transactions | $ $ 4    
EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 76 nomd-20240331_htm.xml IDEA: XBRL DOCUMENT 0001651717 2024-01-01 2024-03-31 0001651717 2024-03-31 0001651717 2023-12-31 0001651717 2023-01-01 2023-03-31 0001651717 ifrs-full:CapitalReserveMember 2023-12-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001651717 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-12-31 0001651717 ifrs-full:ReserveOfCashFlowHedgesMember 2023-12-31 0001651717 ifrs-full:RetainedEarningsMember 2023-12-31 0001651717 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-12-31 0001651717 ifrs-full:RetainedEarningsMember 2024-01-01 2024-03-31 0001651717 ifrs-full:EquityAttributableToOwnersOfParentMember 2024-01-01 2024-03-31 0001651717 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-01-01 2024-03-31 0001651717 ifrs-full:ReserveOfCashFlowHedgesMember 2024-01-01 2024-03-31 0001651717 ifrs-full:CapitalReserveMember 2024-01-01 2024-03-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-01-01 2024-03-31 0001651717 ifrs-full:CapitalReserveMember 2024-03-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-03-31 0001651717 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2024-03-31 0001651717 ifrs-full:ReserveOfCashFlowHedgesMember 2024-03-31 0001651717 ifrs-full:RetainedEarningsMember 2024-03-31 0001651717 ifrs-full:EquityAttributableToOwnersOfParentMember 2024-03-31 0001651717 ifrs-full:CapitalReserveMember 2022-12-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001651717 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001651717 ifrs-full:ReserveOfCashFlowHedgesMember 2022-12-31 0001651717 ifrs-full:RetainedEarningsMember 2022-12-31 0001651717 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-12-31 0001651717 ifrs-full:RetainedEarningsMember 2023-01-01 2023-03-31 0001651717 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-01-01 2023-03-31 0001651717 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-01-01 2023-03-31 0001651717 ifrs-full:ReserveOfCashFlowHedgesMember 2023-01-01 2023-03-31 0001651717 ifrs-full:CapitalReserveMember 2023-01-01 2023-03-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-03-31 0001651717 ifrs-full:CapitalReserveMember 2023-03-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-03-31 0001651717 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-03-31 0001651717 ifrs-full:ReserveOfCashFlowHedgesMember 2023-03-31 0001651717 ifrs-full:RetainedEarningsMember 2023-03-31 0001651717 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-03-31 0001651717 2022-12-31 0001651717 2023-03-31 0001651717 ifrs-full:MaterialReconcilingItemsMember 2024-01-01 2024-03-31 0001651717 ifrs-full:MaterialReconcilingItemsMember 2023-01-01 2023-03-31 0001651717 country:GB 2024-01-01 2024-03-31 0001651717 country:GB 2023-01-01 2023-03-31 0001651717 country:DE 2024-01-01 2024-03-31 0001651717 country:DE 2023-01-01 2023-03-31 0001651717 country:IT 2024-01-01 2024-03-31 0001651717 country:IT 2023-01-01 2023-03-31 0001651717 country:FR 2024-01-01 2024-03-31 0001651717 country:FR 2023-01-01 2023-03-31 0001651717 country:SE 2024-01-01 2024-03-31 0001651717 country:SE 2023-01-01 2023-03-31 0001651717 country:HR 2024-01-01 2024-03-31 0001651717 country:HR 2023-01-01 2023-03-31 0001651717 country:AT 2024-01-01 2024-03-31 0001651717 country:AT 2023-01-01 2023-03-31 0001651717 country:NO 2024-01-01 2024-03-31 0001651717 country:NO 2023-01-01 2023-03-31 0001651717 country:RS 2024-01-01 2024-03-31 0001651717 country:RS 2023-01-01 2023-03-31 0001651717 country:ES 2024-01-01 2024-03-31 0001651717 country:ES 2023-01-01 2023-03-31 0001651717 country:CH 2024-01-01 2024-03-31 0001651717 country:CH 2023-01-01 2023-03-31 0001651717 nomd:RestOfEuropeMember 2024-01-01 2024-03-31 0001651717 nomd:RestOfEuropeMember 2023-01-01 2023-03-31 0001651717 nomd:SeniorEurDebtMember 2024-03-31 0001651717 2023-04-01 2023-04-01 0001651717 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2024-01-01 2024-03-31 0001651717 ifrs-full:DerivativesMember 2024-03-31 0001651717 ifrs-full:TradeReceivablesMember 2024-03-31 0001651717 nomd:CashAndCashEquivalents1Member 2024-03-31 0001651717 ifrs-full:DerivativesMember 2024-03-31 0001651717 nomd:TradePayablesMember 2024-03-31 0001651717 nomd:LoansandBorrowingsExcludingDeferredBorrowingCostsMember 2024-03-31 0001651717 nomd:LiabilityrelatingtoIFRS16Member 2024-03-31 0001651717 ifrs-full:DerivativesMember 2023-12-31 0001651717 ifrs-full:TradeReceivablesMember 2023-12-31 0001651717 nomd:CashAndCashEquivalents1Member 2023-12-31 0001651717 ifrs-full:DerivativesMember 2023-12-31 0001651717 nomd:TradePayablesMember 2023-12-31 0001651717 nomd:LoansandBorrowingsExcludingDeferredBorrowingCostsMember 2023-12-31 0001651717 nomd:LiabilityrelatingtoIFRS16Member 2023-12-31 0001651717 nomd:SeniorUSDDebtMember 2022-11-08 0001651717 nomd:SeniorUSDDebtMember 2024-03-31 0001651717 nomd:SeniorEURODebtMember 2024-03-31 0001651717 nomd:SeniorUSDDebtMember 2024-01-01 2024-03-31 0001651717 nomd:SeniorUSDDebtMember 2022-12-31 0001651717 2022-11-08 0001651717 nomd:SeniorEURODebtMember 2022-11-08 2022-11-08 0001651717 nomd:SeniorUSDDebtMember 2023-12-31 0001651717 2023-01-01 2023-12-31 0001651717 nomd:SeniorEURUSDLoansMember nomd:LoansandBorrowingsMember ifrs-full:Level2OfFairValueHierarchyMember 2024-03-31 0001651717 nomd:SeniorEURUSDLoansMember nomd:LoansandBorrowingsMember ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001651717 nomd:SeniorEURUSDLoansMember nomd:LoansandBorrowingsMember 2024-03-31 0001651717 nomd:SeniorEURUSDLoansMember nomd:LoansandBorrowingsMember 2023-12-31 0001651717 nomd:OtherborrowingsDomain nomd:LoansandBorrowingsMember 2024-03-31 0001651717 nomd:OtherborrowingsDomain nomd:LoansandBorrowingsMember 2023-12-31 0001651717 nomd:TwentyTwentyEightFixedRateSeniorSecuredNotesMember nomd:LoansandBorrowingsMember ifrs-full:Level1OfFairValueHierarchyMember 2024-03-31 0001651717 nomd:TwentyTwentyEightFixedRateSeniorSecuredNotesMember nomd:LoansandBorrowingsMember ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001651717 nomd:TwentyTwentyEightFixedRateSeniorSecuredNotesMember nomd:LoansandBorrowingsMember 2024-03-31 0001651717 nomd:TwentyTwentyEightFixedRateSeniorSecuredNotesMember nomd:LoansandBorrowingsMember 2023-12-31 0001651717 nomd:DeferredFinancingCostsMember nomd:LoansandBorrowingsMember 2024-03-31 0001651717 nomd:DeferredFinancingCostsMember nomd:LoansandBorrowingsMember 2023-12-31 0001651717 nomd:LoansandBorrowingsMember 2024-03-31 0001651717 nomd:LoansandBorrowingsMember 2023-12-31 0001651717 ifrs-full:RestructuringProvisionMember 2023-12-31 0001651717 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2023-12-31 0001651717 ifrs-full:MiscellaneousOtherProvisionsMember 2023-12-31 0001651717 ifrs-full:RestructuringProvisionMember 2024-01-01 2024-03-31 0001651717 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2024-01-01 2024-03-31 0001651717 ifrs-full:MiscellaneousOtherProvisionsMember 2024-01-01 2024-03-31 0001651717 ifrs-full:RestructuringProvisionMember 2024-03-31 0001651717 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2024-03-31 0001651717 ifrs-full:MiscellaneousOtherProvisionsMember 2024-03-31 0001651717 country:DE 2023-12-31 0001651717 country:DE 2024-03-31 0001651717 country:SE 2024-03-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2023-12-31 0001651717 nomd:January12022Member nomd:RestrictedStock1Member 2023-12-31 0001651717 nomd:January12023Member nomd:RestrictedStock1Member 2023-12-31 0001651717 nomd:January12024Member nomd:RestrictedStock1Member 2023-12-31 0001651717 nomd:OtherAwardsMember nomd:RestrictedStock1Member 2023-12-31 0001651717 nomd:RestrictedStock1Member 2023-12-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:January12022Member nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:January12023Member nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:January12024Member nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:OtherAwardsMember nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2024-03-31 0001651717 nomd:January12022Member nomd:RestrictedStock1Member 2024-03-31 0001651717 nomd:January12023Member nomd:RestrictedStock1Member 2024-03-31 0001651717 nomd:January12024Member nomd:RestrictedStock1Member 2024-03-31 0001651717 nomd:OtherAwardsMember nomd:RestrictedStock1Member 2024-03-31 0001651717 nomd:RestrictedStock1Member 2024-03-31 0001651717 nomd:January12018Member nomd:RestrictedStock1Member 2022-12-31 0001651717 nomd:January12019Member nomd:RestrictedStock1Member 2022-12-31 0001651717 nomd:January12020Member nomd:RestrictedStock1Member 2022-12-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2022-12-31 0001651717 nomd:January12022Member nomd:RestrictedStock1Member 2022-12-31 0001651717 nomd:OtherAwardsMember nomd:RestrictedStock1Member 2022-12-31 0001651717 nomd:RestrictedStock1Member 2022-12-31 0001651717 nomd:January12018Member nomd:RestrictedStock1Member 2023-01-01 2023-03-31 0001651717 nomd:January12019Member nomd:RestrictedStock1Member 2023-01-01 2023-03-31 0001651717 nomd:January12020Member nomd:RestrictedStock1Member 2023-01-01 2023-03-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2023-01-01 2023-03-31 0001651717 nomd:January12022Member nomd:RestrictedStock1Member 2023-01-01 2023-03-31 0001651717 nomd:OtherAwardsMember nomd:RestrictedStock1Member 2023-01-01 2023-03-31 0001651717 nomd:RestrictedStock1Member 2023-01-01 2023-03-31 0001651717 nomd:January12018Member nomd:RestrictedStock1Member 2023-03-31 0001651717 nomd:January12019Member nomd:RestrictedStock1Member 2023-03-31 0001651717 nomd:January12020Member nomd:RestrictedStock1Member 2023-03-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2023-03-31 0001651717 nomd:January12022Member nomd:RestrictedStock1Member 2023-03-31 0001651717 nomd:OtherAwardsMember nomd:RestrictedStock1Member 2023-03-31 0001651717 nomd:RestrictedStock1Member 2023-03-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2021-01-01 2021-01-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:January12021Member nomd:RestrictedStock1Member 2021-01-01 0001651717 nomd:January12022Member nomd:RestrictedStock1Member 2022-01-01 2022-01-01 0001651717 nomd:January12022Member nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:January12023Member nomd:RestrictedStock1Member 2023-01-01 2023-01-01 0001651717 nomd:OtherAwardsMember nomd:RestrictedStock1Member 2023-01-01 2023-01-01 0001651717 nomd:January12024Member nomd:RestrictedStock1Member 2024-01-01 2024-01-01 0001651717 nomd:January12018Member nomd:RestrictedStock1Member 2023-01-01 2023-01-01 0001651717 nomd:January12018Member nomd:RestrictedStock1Member 2023-01-01 0001651717 nomd:January12018Member ifrs-full:OrdinarySharesMember nomd:RestrictedStock1Member 2023-01-01 2023-01-01 0001651717 nomd:ManagementAward2019Member nomd:RestrictedStock1Member 2023-01-01 2023-01-01 0001651717 nomd:ManagementAward2019Member nomd:RestrictedStock1Member 2023-01-01 0001651717 nomd:ManagementAward2019Member ifrs-full:OrdinarySharesMember nomd:RestrictedStock1Member 2023-01-01 2023-01-01 0001651717 nomd:ManagementAward2020Member nomd:RestrictedStock1Member 2023-02-01 2023-02-01 0001651717 nomd:ManagementAward2020Member nomd:RestrictedStock1Member 2023-02-01 0001651717 nomd:ManagementAward2020Member ifrs-full:OrdinarySharesMember nomd:RestrictedStock1Member 2023-02-01 2023-02-01 0001651717 nomd:ManagementAward2021Member nomd:RestrictedStock1Member 2024-03-01 2024-03-01 0001651717 nomd:ManagementAward2021Member nomd:RestrictedStock1Member 2024-03-01 0001651717 nomd:ManagementAward2020Member ifrs-full:OrdinarySharesMember nomd:RestrictedStock1Member 2024-03-01 2024-03-01 0001651717 nomd:January12021Member 2021-01-01 0001651717 nomd:January12022Member 2022-01-01 0001651717 nomd:January12023Member 2023-01-01 0001651717 nomd:January12023Member 2024-01-01 0001651717 nomd:OtherAwardsMember 2023-01-01 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember nomd:RestrictedStock1Member 2024-01-01 2024-03-31 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember 2022-07-01 2022-07-01 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember nomd:RestrictedStock1Member 2022-07-01 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember 2023-01-01 2023-12-31 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember 2023-07-06 2023-07-06 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember nomd:RestrictedStock1Member 2023-07-06 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember nomd:RestrictedStock1Member 2023-01-01 2023-03-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember ifrs-full:ReserveOfSharebasedPaymentsMember 2024-01-01 2024-03-31 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-03-31 0001651717 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember ifrs-full:ReserveOfSharebasedPaymentsMember 2024-01-01 2024-03-31 0001651717 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-03-31 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentReclassificationToTaxLiabilityMember ifrs-full:ReserveOfSharebasedPaymentsMember 2024-01-01 2024-03-31 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentReclassificationToTaxLiabilityMember ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-03-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2024-03-31 0001651717 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-03-31 0001651717 2021-08-05 2021-08-05 0001651717 ifrs-full:OrdinarySharesMember 2021-08-05 2021-12-31 0001651717 ifrs-full:OrdinarySharesMember 2021-12-31 0001651717 ifrs-full:OrdinarySharesMember 2022-01-01 2022-12-31 0001651717 ifrs-full:OrdinarySharesMember 2022-12-31 0001651717 ifrs-full:OrdinarySharesMember 2023-01-01 2023-12-31 0001651717 ifrs-full:OrdinarySharesMember 2023-12-31 0001651717 2023-11-06 2023-11-06 0001651717 ifrs-full:OrdinarySharesMember 2024-01-01 2024-03-31 0001651717 ifrs-full:OrdinarySharesMember 2024-03-31 0001651717 ifrs-full:OrdinarySharesMember nomd:IssuedCapitalAndCapitalReserveMember 2024-03-31 0001651717 ifrs-full:OrdinarySharesMember nomd:IssuedCapitalAndCapitalReserveMember 2023-12-31 0001651717 ifrs-full:CashFlowHedgesMember 2024-03-31 0001651717 ifrs-full:CashFlowHedgesMember 2023-12-31 0001651717 nomd:CostOfHedgingReserveMember 2024-03-31 0001651717 nomd:CostOfHedgingReserveMember 2023-12-31 0001651717 nomd:AffiliateOfFounderEntitiesMember nomd:MariposaCapitalandTOMSCapitalMember 2022-01-01 2022-01-01 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember 2024-01-01 2024-03-31 0001651717 nomd:KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember 2023-01-01 2023-03-31 iso4217:EUR iso4217:EUR shares utr:Rate shares iso4217:USD pure iso4217:USD shares 6-K false 2024-03-31 2024 Q1 Nomad Foods Ltd. 0001651717 --12-31 2103200000 2105000000 2467000000 2468200000 563400000 563700000 7300000 7100000 1400000 700000 106100000 106900000 5248400000 5251600000 390700000 412900000 432600000 446400000 343800000 263400000 39700000 40700000 500000 500000 6000000.0 1200000 1213300000 1165100000 6461700000 6416700000 810300000 769800000 189300000 189500000 31500000 35100000 26200000 21400000 8900000 12200000 1066200000 1028000000 2126900000 2113700000 152100000 158300000 500000 500000 1400000 1400000 69800000 97800000 425600000 425100000 2776300000 2796800000 3842500000 3824800000 2619200000 2591900000 1419000000 1426100000 34500000 31400000 104600000 101000000.0 -11800000 -24600000 1072900000 1058000000 2619200000 2591900000 783700000 775100000 572800000 550900000 210900000 224200000 -115400000 -114500000 23500000 30100000 72000000.0 79600000 5900000 1100000 36000000.0 30100000 -30100000 -29000000.0 41900000 50600000 7400000 9400000 34500000 41200000 0.21 0.21 0.24 0.24 34500000 41200000 3900000 -4300000 1200000 -1700000 2700000 -2600000 3600000 0 12300000 -13600000 3800000 -4700000 12100000 -8900000 14800000 -11500000 49300000 29700000 1426100000 31400000 101000000.0 -24600000 1058000000 2591900000 34500000 34500000 3600000 8500000 2700000 14800000 0 0 3600000 8500000 37200000 49300000 -4300000 -4300000 3100000 3100000 7100000 7100000 22300000 22300000 -7100000 3100000 0 0 -22300000 -26300000 1419000000 34500000 104600000 -11800000 1072900000 2619200000 1596700000 13800000 89300000 19800000 886600000 2606200000 41200000 41200000 0 -8900000 -2600000 -11500000 0 -8900000 38600000 29700000 100000 100000 0 12300000 12300000 -4000000.0 -500000 -4500000 0 8300000 0 0 -500000 7800000 1596700000 22100000 89300000 10800000 924700000 2643600000 34500000 41200000 23500000 30100000 3100000 12300000 23100000 22300000 -400000 -500000 30100000 29000000.0 7400000 9400000 122100000 144800000 14200000 -34300000 -81300000 -53700000 77100000 20600000 -200000 1900000 131900000 79300000 -24000000.0 -14000000.0 -8900000 -10000000.0 99000000.0 55300000 18800000 20600000 2000000.0 1100000 -16800000 -19500000 7100000 0 22300000 0 7200000 7000000.0 500000 500000 50400000 19300000 -87500000 -26800000 -5300000 9000000.0 399700000 366800000 -3700000 -4900000 390700000 370900000 General information<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated interim financial statements (“interim financial statements”) as at and for the three months ended March 31, 2024 comprise the results and financial position of Nomad Foods Limited and its subsidiaries (together referred to as the “Company” or “Nomad”). Nomad (NYSE: NOMD) is Europe's leading frozen foods company. Nomad's portfolio of iconic brands, which includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Birds Eye</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Findus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">iglo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ledo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Frikom</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, have been a part of consumers’ meals for generations, standing for great tasting food that is convenient, high quality and nutritious. Nomad is headquartered in the United Kingdom. Additional information may be found at www.nomadfoods.com.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s sales and working capital levels have historically been affected to a limited extent by seasonality. In general, sales volumes for savory frozen food are slightly higher in colder or winter months and variable production costs and working capital will vary depending on the harvesting and buying periods of seasonal raw materials, in particular vegetable crops. For example, inventory levels typically peak in August to September just after the pea harvest and as a result, more working capital is required during those months. The one exception to this is in our Adriatic business, which follows a different seasonality pattern with stronger performance through the summer months behind the ice-cream business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nomad is a company registered in the British Virgin Islands and domiciled for tax in the United Kingdom.</span></div> Basis of preparation<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated interim financial statements for the three months ended March 31, 2024 have been prepared in accordance with International Accounting Standard 34, Interim Financial Reporting, as issued by the IASB. They do not include all the information required for a complete set of IFRS financial statements. The financial information consolidates the Company and the subsidiaries it controls and includes selected notes to explain events and transactions that are significant to an understanding of the changes in Nomad’s financial position and performance since the last annual consolidated financial statements. Therefore the unaudited condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended December 31, 2023, which have been prepared in accordance with International Financial Reporting Standards as issued by the IASB.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated interim financial statements were authorized for issue by the Company’s Board of Directors on May 7, 2024. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies used by management in preparing these condensed consolidated financial statements were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023, except for taxes on income. Taxes on income are provided for based on management's estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the period. It also reflects the tax impact of exceptional items accounted for in the period.</span></div>The preparation of our consolidated interim financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as supply chain disruptions, high inflation and ongoing conflicts, including that between Ukraine and Russia. Actual results could differ from these estimates. The Directors, at the time of approving these interim financial statements, have a reasonable expectation that the Company has adequate resources to continue in operational existence for at least 12 months from the date of signing these interim financial statements given the cash funds available and the current forecast cash flows. In preparing cash flow forecasts, management considers severe but plausible downside scenarios taking into consideration the Company's key risks, including the current economic climate which may adversely impact the Company. Having considered these risks the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these interim financial statements. <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accounting policies used by management in preparing these condensed consolidated financial statements were the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023, except for taxes on income. Taxes on income are provided for based on management's estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the period. It also reflects the tax impact of exceptional items accounted for in the period.</span></div>The preparation of our consolidated interim financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as supply chain disruptions, high inflation and ongoing conflicts, including that between Ukraine and Russia. Actual results could differ from these estimates. The Directors, at the time of approving these interim financial statements, have a reasonable expectation that the Company has adequate resources to continue in operational existence for at least 12 months from the date of signing these interim financial statements given the cash funds available and the current forecast cash flows. In preparing cash flow forecasts, management considers severe but plausible downside scenarios taking into consideration the Company's key risks, including the current economic climate which may adversely impact the Company. Having considered these risks the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus, they continue to adopt the going concern basis in preparing these interim financial statements. Recently issued and not yet adopted accounting pronouncements under IFRSOn April 9, 2024, the IASB issued IFRS 18 'Presentation and Disclosure in Financial Statements'. IFRS 18 replaces IAS 1 'Presentation of Financial Statements'. The new Accounting Standard introduces a number of changes to the structure of the Statement of Profit or Loss, more transparency in the presentation of management's own performance measures and more granularity in reporting of financial information. The main impacts of the new Accounting Standard include:•    Improved comparability in the Statement of Profit or Loss by introducing a set of clearly defined categories based on main business activities (i.e. operating, investing and financing);•    Requiring disclosure about management-defined performance measures; and•    Adding new principles for aggregation and disaggregation of information. IFRS 18 applies for annual reporting periods beginning on or after January 1, 2027. Earlier application is permitted. The Company is still assessing the full impact of the standard.There are no other accounting pronouncements with a material impact on the Company. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of financial statements in accordance with IFRS requires the use of judgment in applying the accounting policies and estimation that affect the reported amounts of assets and liabilities and results. Actual results could differ from those estimates and the financial statements will be impacted by key judgments taken. In preparing the condensed consolidated interim financial statements, the key sources of estimation uncertainty for the interim period ended March 31, 2024, continue to be the same as those that applied to the consolidated financial statements as at and for the year ended December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Judgments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgments are made in the process of applying accounting policies. Those judgments which are considered key are listed below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a)     Business Combinations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Business combinations are recognized using the acquisition method. At the acquisition date, the Company is required to recognize separately the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves judgment over whether intangible assets can be separately identified, the useful economic life of assets and in selecting an appropriate valuation methodology. Furthermore, judgment is applied in allocating business combinations to operating segments, as well as allocating Goodwill to cash generating units</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b)     Discounts and trade promotions</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses judgment when considering when accruals for discounts and trade promotions can be released. Management makes the judgment based on the principle that accruals are reversed only to the extent that it is highly probable that a significant reversal will not occur. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c)    Uncertain tax positions</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management uses judgment when identifying and determining whether it is appropriate to provide for uncertain tax positions and for how long provisions for uncertain tax positions are retained, based on assessment as to whether it is probable that a risk would crystallize or not. Management considers tax laws which are in place in making that assessment determining whether it is appropriate to release. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d)    Cash generating units</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">When performing goodwill impairment testing, management applies judgment to the allocation of goodwill to cash generating units. Management has determined goodwill is monitored at the operating segment level of “Frozen”.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e)    Operating segments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Management applies judgment in determining the Chief Operating Decision Maker (“CODM”), and the nature and extent of the financial information which is reviewed by the CODM. Management has considered how resources are allocated in determining the single reporting and operating segment of “Frozen”. Please refer to Note 5 for further information. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant estimates</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Information about estimates and assumptions that have significant effects on the amounts reported in the condensed consolidated interim financial statements are listed below. In forming these estimates, management has taken into account the impact and potential future impact of supply chain disruptions, high inflation as well as the ongoing conflict between Ukraine and Russia. Management will continue to assess the impact of future developments in relation to these matters as it relates to estimates, especially around the carrying value of goodwill, brands and other intangibles, as well as on property, plant and equipment. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In particular, management will focus on the impact of a long-term conflict in Ukraine. While we do not have any direct operations or sales in either Russia or Ukraine, these countries are responsible for many commonly used raw materials and resources such as fish, wheat and energy. The ongoing conflict and economic sanctions could see considerable reductions in the availability or increase in cost of such raw materials and resources. At this time it is not possible to predict the extent or nature of future impacts on our business although we expect the current conflict to continue for some time. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a)    Discounts and trade promotions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Discounts given by the Company include rebates, price reductions and incentives given to customers, promotional couponing and trade communication costs. Each customer has bespoke agreements that are governed by a combination of observable and unobservable performance conditions. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trade promotions comprise of amounts paid to retailers for programs designed to promote Company products and include pricing allowances, merchandising funds and customer coupons, which are offered through various programs to customers and consumers. The ultimate costs of these programs can depend upon retailer performance and is the subject of significant management estimates. The estimated ultimate cost of the program is based upon the programs offered, timing of those offers, estimated retailer performance based on history, management’s experience and current economic trends.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At each financial year end date, any discount or trade promotion incurred but not yet invoiced is estimated and accrued for. In certain cases, the estimate for discounts and trade promotions requires the use of forecast information for future trading periods and therefore a degree of estimation uncertainty exists. These estimates are sensitive to variances between actual results and forecasts. The estimate is based on accumulated experience. It is impracticable to disclose the extent of the possible effects of estimation uncertainty, however, it is reasonably possible that outcomes within the next financial period from these agreements are materially different in aggregate to those estimated.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accruals are presented as ‘trade terms’ and offset against trade receivables due to the same customer, or as trade term payables where there is no receivable to be offset. The balance of the reduction in trade receivables for trade terms as of March 31, 2024 is disclosed in Note 11. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b)    Employee benefit obligations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group operates a number of defined benefit pension schemes and post-employment benefit schemes which are valued by estimating the amount of future benefit that employees have earned in return for their service in the current and prior periods. Each scheme has an actuarial valuation performed and is dependent on a series of assumptions to estimate the projected obligations. The assumptions include variables which are revised periodically, that include discount rates, expected salary increases, inflation, employee turnover, retirement age, mortality and medical care costs. Our assumptions reflect historical experience and management's best judgment regarding future obligations. The assumptions used affect the current service cost and interest expense as well as changes in the obligation recognized. Net actuarial gains or losses arising from changes in assumptions and from experience are recognized in other comprehensive income/(loss). </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since defined benefit pension schemes and post-employment benefit schemes are measured on a discounted basis, the discount rate applied has an impact on the expense and obligation recognized. These discount rates are determined by reference to market yields at the end of the reporting period on high quality corporate bonds, except for Sweden where a deep market does not exist, where mortgage bonds are used. See Note 13 for details of material changes, if any, to assumptions since December 31, 2023.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c)    Provisions for uncertain tax positions</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in many different jurisdictions and in some of these there are certain tax matters which are under discussion with local tax authorities, including as part of tax audits. Management considers these tax audits and discussions with local tax authorities as well as the local tax legislation relative to their tax positions in those jurisdictions when identifying uncertain tax positions. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments, appeals and refunds.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Where tax exposures can be quantified, and management assesses that the risk of an exposure crystallizing is probable, a provision for uncertain tax positions is made based on management's estimates which include judgments with regard to the amounts expected to be paid to the relevant tax authority. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these provisions. The factors considered in estimating the provision include the progress of discussions with the tax authorities, the complexity of respective tax legislation, valuations of assets for tax purposes and the level of documentary support for historical positions taken by previous owners. The provisions are made on the basis of a probability-weighted average of potential outcomes. Given the inherent uncertainties in assessing the outcomes of these exposures, the Company could in future periods experience adjustments to these provisions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other estimates</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a)    Carrying value of goodwill and brands</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's goodwill and indefinite life brand values have been allocated based on the enterprise value at acquisition of each cash generating unit. Goodwill is monitored at an operating segment level for which the Company has one reporting and operating segment. Determining whether goodwill and indefinite life brands are impaired requires an estimation of the value in use. The review is performed using a discounted cash flow model to calculate the value in use of the Frozen segment. The value in use calculation requires the entity to estimate the future cash flows expected to arise from the cash generating unit and a suitable discount rate in order to calculate present value. This requires us to make assumptions and estimates regarding historical information, future plans and external sources. Future cash flows for the purposes of the value in use calculation are taken from approved budgets. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b)    Business combinations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to recognize separately, at the acquisition date, the identifiable assets, liabilities and contingent liabilities acquired or assumed in a business combination at their fair values. This involves an estimate of fair value of all assets and liabilities acquired. Such estimates are based on valuation techniques, which require considerable estimation in forecasting future cash flows and developing other assumptions. These estimates are based on information available on the acquisition date and assumptions that have been deemed reasonable by management. The following estimates and assumptions can materially affect our financial position and profit:</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•    The fair value and expected useful economic life of acquired intangible and tangible assets that are subject to depreciation or amortization in future periods.</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•    Future changes to the assumptions over forecast future profitability used in estimating the value of intangible assets and goodwill may result in additional expenses or income.</span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•    Future changes to the assumptions used in estimating the value of uncertain tax positions may result in additional expenses or income.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value of derivative financial instruments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 11 includes details of the fair value of the derivative instruments that the Company holds at each balance sheet period. Management has estimated the fair value of these instruments by using valuations based on discounted cash flow calculations. These inputs may be readily observable, market corroborated, or generally unobservable inputs and are further discussed in Note 11.</span></div> None Segment reporting<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Chief Operating Decision Maker (“CODM”) of the Company considers there to be one reporting and operating segment, being “Frozen” and is reflected in the segment presentation below for the periods presented. The CODM primarily uses “Adjusted EBITDA”, as the key measure of the segment’s results, which is considered non-IFRS financial information</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Segment Adjusted EBITDA</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.027%"><tr><td style="width:1.0%"></td><td style="width:72.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.633%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profit for the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net financing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exceptional items</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other add-backs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other add-backs include the elimination of share-based payment expense and related employer payroll tax expense of €3.4 million for the three months ended March 31, 2024 (2023: €13.9 million), as well as the elimination of non-operating M&amp;A related costs, professional fees and transaction costs of €0.3 million for the three months ended March 31, 2024 (2023: €0.4 million). We exclude these costs because we do not believe they are indicative of our normal operating costs, can vary significantly in amount and frequency, and are unrelated to our underlying operating performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No information on segment assets or liabilities is presented to the CODM.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">External revenue by geography</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:78.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.637%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.4</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total external revenue by geography</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">783.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">775.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Chief Operating Decision Maker (“CODM”) of the Company considers there to be one reporting and operating segment, being “Frozen” and is reflected in the segment presentation below for the periods presented. The CODM primarily uses “Adjusted EBITDA”, as the key measure of the segment’s results, which is considered non-IFRS financial information</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Segment Adjusted EBITDA</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.027%"><tr><td style="width:1.0%"></td><td style="width:72.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.071%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.062%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.632%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.510%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.633%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Note</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Profit for the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net financing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exceptional items</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other add-backs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">146.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 34500000 41200000 7400000 9400000 -30100000 -29000000.0 23100000 22300000 23500000 30100000 3700000 14300000 122300000 146300000 3400000 13900000 300000 400000 <div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:78.084%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.637%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216.4</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.9</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sweden</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Croatia</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Austria</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.9</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Norway</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Serbia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.2</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of Europe</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total external revenue by geography</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">783.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">775.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 225300000 216400000 112600000 117600000 110600000 109100000 53900000 52900000 35800000 38100000 20800000 19600000 38500000 37900000 30800000 33700000 19000000.0 18400000 22300000 20600000 21600000 21200000 92500000 89600000 783700000 775100000 Exceptional items<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:78.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business transformation program (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fortenova Acquisition integration costs (2)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Technology transformation program (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of legacy matters (4)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total exceptional items</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not consider these items to be indicative of our ongoing operating performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1)    Business transformation program</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, the Company launched the first phase of a multi-year, enterprise-wide transformation and optimization program which continued to progress in the current year. Over the next few years, additional transformation phases will be implemented. Progress of the project is ongoing and there remain certain phases to be implemented. The program aims to standardize, simplify and automate end-to-end business processes. This will enable key decision making and analytical capability, building a platform and organization to support future growth and provide better value for shareholders. Execution of the business transformation program includes the evaluation and implementation of a new ERP system.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses incurred to date consist of restructuring, severance and transformational project costs, including business technology transformation initiative costs and related professional fees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2)    Fortenova Acquisition integration costs</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed the acquisition of the Fortenova Group’s Frozen Food Business Group on September 30, 2021, following which the Company began an integration project which was completed in 2023. Integration expenses incurred relate to external consultancy costs, organizational structure alignment to Nomad design, systems configuration and roll-out of our controls environment to the acquired business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(3)    Information Technology transformation program</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2021, the Company launched a program to transform the Information Technology (“IT”) operating model, specifically to modernize the end-to-end technology estate to support current and future complex and evolving business needs driven by acquisitions and organic growth. Among the many changes made, the program moved our operating model to a cloud-hosted solution, which better deploys new services to the business and end user, including application management, supporting a diverse workforce across multiple locations and languages, as well as deploying artificial Intelligence assisted tools. Other key components of the program included the Company’s cyber security services to adapt to rapidly changing threats and a change of IT service partners to enable one-off renovation and uplift of capabilities across the business. The program was completed in 2023.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(4)    Settlement of legacy matters</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A net expense has been recognized associated with the release of acquired provisions relating to periods prior to acquisition by the Company and other gains or charges associated with items that were originally recognized as exceptional.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Tax impact of exceptional items</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he tax impact of the exceptional items for the three months ended March 31, 2024 amounted to a credit of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">€5.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2023: €7.0 million).</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash flow impact of exceptional items</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Condensed Consolidated Interim Statements of Cash Flows for the three months ended March 31, 2024 is €24.0 million (2023: €14.0 million) of cash outflows relating to exceptional items. This includes cash flows related to the above items in addition to the cash impact of the settlement of provisions brought forward from previous accounting periods.</span></div> <div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:78.365%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business transformation program (1)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fortenova Acquisition integration costs (2)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Information Technology transformation program (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of legacy matters (4)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total exceptional items</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 20500000 28100000 0 1800000 0 200000 3000000.0 0 23500000 30100000 -5700000 -7000000 -24000000 -14000000 Finance income and costs<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.055%"><tr><td style="width:1.0%"></td><td style="width:80.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net financing gain recognized on debt transactions (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total finance income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (b)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange losses arising on translation of financial assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension interest costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discounts and borrowing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net fair value losses on derivatives held at fair value through profit or loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total finance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net finance costs</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.055%"><tr><td style="width:1.0%"></td><td style="width:80.061%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Finance income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net financing gain recognized on debt transactions (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total finance income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (b)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net foreign exchange losses arising on translation of financial assets and liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension interest costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt discounts and borrowing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net fair value losses on derivatives held at fair value through profit or loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total finance costs</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net finance costs</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(30.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Net income for the three months ended March 31, 2024 of €4.1 million has been recognized from the repricing of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EUR denominated Term Loan B of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">€130.0 million in February 2024, representing a modification gain net of transaction costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Interest expense includes interest and finance charges paid/payable for lease liabilities and financial liabilities not at fair value through profit or loss and is shown net of gains recycled from the cash flow hedge reserve on cross currency interest rate swaps.</span></div> 1800000 1100000 4100000 0 5900000 1100000 22700000 21500000 10200000 5800000 1200000 1100000 1700000 1600000 200000 100000 36000000.0 30100000 -30100000 -29000000.0 4100000 130000000 Taxation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Income tax expense of €7.4 million for the three months ended March 31, 2024 (2023: €9.4 million) is provided for based on management’s estimate of the average annual effective income tax rate on profits excluding exceptional items, applied to the pre-tax income excluding exceptional items of the periods. This estimate reflects the tax impact of exceptional items accounted for in the periods. The UK statutory rate of corporation tax increased from 19% to 25% with effect from April 1, 2023. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s subsidiaries, which are subject to tax, operate in many different jurisdictions and, in some of these, certain tax matters are under discussion with local tax authorities. These discussions are often complex and can take many years to resolve, and are in different stages with respect to assessments appeals and refunds. The Company actively seeks to manage the associated risks by proactively engaging with tax authorities and applying for Advanced Pricing Agreements where appropriate. Provisions for uncertain tax positions require management to make estimates and judgments with respect to the ultimate outcome of a tax audit, and actual results could vary from these estimates. Where tax exposures can be quantified, a provision is made based on best estimates and management’s judgments. Given the inherent uncertainties in assessing the outcomes of these exposures (which can sometimes be binary in nature), the Company could, in future years, experience adjustments to this provision, including releases of provisions when those exposures become time-barred.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding this, management believes that the Company’s tax position on all open matters including those in current discussion with local tax authorities is robust and that the Company is appropriately provided.</span></div> 7400000 9400000 19 25 Earnings per share<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.055%"><tr><td style="width:1.0%"></td><td style="width:78.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings per share </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit for the period attributable to equity owners of the parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(€m)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Ordinary Shares and shares issuable solely after the passage of time in millions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">€</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">€</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the three months period ended March 31, 2024, the number of shares in both basic and diluted earnings per share calculations has been adjusted to include 292,687 shares to be issued in future periods as performance conditions have been met. The diluted earnings per share calculation also includes an estimate of 109,322 potential ordinary shares, calculated using the treasury method, on long term incentive plans contingent on service only. There are no adjustments to the profit for the period attributable to equity owners of the parent.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:78.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.314%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit for the period attributable to equity owners of the parent (€m)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Ordinary Shares, shares issuable solely after the passage of time and potential ordinary shares in millions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">€</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">€</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.055%"><tr><td style="width:1.0%"></td><td style="width:78.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.408%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings per share </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit for the period attributable to equity owners of the parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(€m)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Ordinary Shares and shares issuable solely after the passage of time in millions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">€</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">€</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 34500000 41200000 163200000 174500000 0.21 0.24 292687 109322 <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:78.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.314%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit for the period attributable to equity owners of the parent (€m)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average Ordinary Shares, shares issuable solely after the passage of time and potential ordinary shares in millions</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.3 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per share</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">€</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">€</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 34500000 41200000 163300000 174500000 0.21 0.24 Cash and cash equivalents<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents in the Statement of Financial Position</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">390.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">412.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank overdraft</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents per Statement of Cash Flows</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">390.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">399.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>‘Cash and cash equivalents’ comprise cash balances and deposits. <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents in the Statement of Financial Position</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">390.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">412.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bank overdraft</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents per Statement of Cash Flows</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">390.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">399.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 390700000 412900000 0 13200000 390700000 399700000 Financial instruments<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the carrying amount of each Statement of Financial Position class split into the relevant category of financial instrument as defined in IFRS 9 “Financial Instruments”.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value through profit or loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated in hedge relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>liabilities at<br/>amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other payables excluding non-financial liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans and borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,153.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,153.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">547.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(71.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,908.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,297.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €227.6 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans and borrowings includes €84.1 million relating to lease liabilities.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value through profit or loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated in hedge relationships </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>liabilities at<br/>amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other payables excluding non-financial liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans and borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(108.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,854.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,322.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €231.4 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans and borrowings includes €78.8 million relating to lease liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the carrying amounts of trade receivables, trade payables and cash and cash equivalents are a reasonable approximation of fair value.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Derivative financial instruments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial instruments are not traded in an active market and so the fair value of these instruments is determined from the implied forward rate. The valuation technique utilized by the Company maximizes the use of observable market data where it is available. All significant inputs required to fair value the instrument are observable. The Company has classified its derivative financial instruments as level 2 instruments as defined in IFRS 13 “Fair value measurement”.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest bearing loans and borrowings</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the senior secured notes is determined by reference to price quotations in the active market in which they are traded. They are classified as level 1 instruments. The fair value of the senior loans is calculated by discounting the expected future cash flows at the period end’s prevailing interest rates. They are classified as level 2 instruments. There is no requirement to determine or disclose the fair value of lease liabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Syndicated loans includes the Senior U.S. Dollar debt of $700.0 million (€642.3 million) (the “Senior USD Loan”) and Senior EUR debt of €130.0 million (a "Senior EUR Loan") both repayable in November 2029, as well as the Senior EUR debt of €553.2 million (a "Senior EUR Loan") repayable in June 2028. The Senior USD Loan includes an annual amortization repayment, equivalent to 1.0% of the original issuance value or $7.0 million (€6.5 million) in October each year until maturity. The Senior EUR Loans are repayable only upon maturity. As required under the Senior Facilities Agreement, the Company is also required to undertake an annual excess cash flow calculation whereby additional principal could be repaid.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 8, 2022, the Company amended and restated the Senior Facilities Agreement to issue both a $700.0 million (€700.6 million) term loan bearing interest at a rate per annum equal to the term SOFR rate plus 3.75% with a 0.5% floor and a €130.0 million term loan bearing interest at a rate per annum equal to EURIBOR plus 3.5% with a zero floor, both due November 10, 2029. The net proceeds from these loans were used to repay and extinguish the Company's existing Senior Secured U.S. Dollar term loan due in 2024 in full, and for transaction expenses and general corporate purposes. The new term loans were issued at a discount of €31.3 million, which together with eligible transaction costs of €5.1 million have been capitalized and are being amortized over the life of the debt. Concurrently with the closing of this refinancing, the Company closed out its existing cross currency interest rate swaps and has entered into a number of new 5-year cross-currency and interest rate swaps for the new Term Loans.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22, 2023, the Company completed a repricing of its $693.0 million term loan due 2029 which reduced the interest rate from SOFR plus 3.75% to SOFR plus 3.00%. There are no changes to the maturity of the Term Loan as a result of this repricing. The repricing represents a modification of a financial liability, such that a modification gain of €17.2 million has been recognized, representing the difference between the remaining original contractual cash flows and the modified cash flows, both discounted at the original effective interest rate. Eligible transaction costs associated with the modification of €2.4 million were added to the loan carrying amount and amortized over the remaining loan term. The carrying amount of the loan was revised to reflect the new cash outflows at the date of modification. In October 2023, our cross-currency and interest rate swaps were amended, effective October 10, 2023 to align more closely with the amended cash flows of our USD term loan following the repricing.</span></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 2, 2024, the Company completed on the repricing of its existing EUR denominated Term Loan B of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">€130.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> principal due 2029 (the “Term Loan”). Following the closing, the margin on the Term Loan has been reduced by 75 basis points to EURIBOR plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.75%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There are no changes to the maturity of the Term Loan as a result of this repricing. The repricing represents a modification of a financial liability, such that a net modification gain of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">€4.1 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has been recognized, representing the difference between the remaining original contractual cash flows and the modified cash flows, both discounted at the original effective interest rate. On</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> April 10, 2024, our interest rate swaps were amended to align more closely with the amended cash flows of our EUR term loan following the repricing.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 29, 2024, the Company completed on the repricing of its existing USD denominated Term Loan B of €693.0 million principal due 2029 (the “Term Loan”), subject to customary closing conditions. Following the closing, the margin on the Term Loan will be reduced by 50 basis points to SOFR plus 2.5% effective from May 7, 2024. There are no changes to the maturity of the Term Loan as a result of this repricing. Our cross currency interest rate swaps have also been amended to more closely align with this change, also taking effect in May 2024.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Loans, Senior Secured Notes and any drawn balances of the Revolving Credit Facility are secured with equal ranking against assets of the Company and specified subsidiaries. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior EUR/USD loans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 fixed rate senior secured notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less capitalized debt discounts and borrowing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,076.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,067.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,069.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,056.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value through profit or loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated in hedge relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>liabilities at<br/>amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other payables excluding non-financial liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans and borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,153.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,153.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">547.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(71.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,908.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,297.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €227.6 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans and borrowings includes €84.1 million relating to lease liabilities.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value through profit or loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated in hedge relationships </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>liabilities at<br/>amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other payables excluding non-financial liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans and borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(108.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,854.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,322.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value through profit or loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated in hedge relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>liabilities at<br/>amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.5 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135.2 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390.7 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other payables excluding non-financial liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans and borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,153.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,153.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">547.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">135.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(71.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,908.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,297.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade receivables disclosed in the table above are net of contract liabilities related to discounts and trade marketing expenses of €227.6 million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans and borrowings includes €84.1 million relating to lease liabilities.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.500%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.166%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.219%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial assets at fair value through profit or loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives designated in hedge relationships </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial<br/>liabilities at<br/>amortized<br/>cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226.9 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.1 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412.9 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other payables excluding non-financial liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans and borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,135.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">502.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">137.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(108.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,854.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,322.5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Carrying value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior EUR/USD loans</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,328.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,314.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,293.8 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 fixed rate senior secured notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">748.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less capitalized debt discounts and borrowing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,076.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,067.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,069.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,056.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 7400000 7400000 292300000 292300000 255500000 135200000 390700000 78700000 0 78700000 0 755700000 755700000 0 2153100000 2153100000 547800000 135200000 -71300000 2908800000 -2297100000 227600000 84100000 1900000 1900000 226900000 226900000 275100000 137800000 412900000 110000000.0 0 110000000.0 0 719100000 719100000 0 2135100000 2135100000 502000000.0 137800000 -108100000 2854200000 -2322500000 231400000 78800000 700000000 642300000 130000000 553200000 0.010 7000000 6500000 700000000 700600000 0.0375 0.005 130000000 0.035 31300000 5100000 693000000 0.0375 0.0300 17200000 2400000 130000000 0.0275 4100000 693000000 0.025 1328500000 1314500000 1304800000 1293800000 300000 300000 300000 300000 748000000.0 752800000 800000000.0 800000000.0 0 0 -36100000 -37800000 2076800000 2067600000 2069000000 2056300000 Provisions<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restructuring</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions<br/>related to<br/>other taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional provision in the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization of provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Analysis of total provisions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Updates since December 31, 2023</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restructuring</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The €9.1 million (December 31, 2023: €12.7 million) provision relates to committed plans for certain restructuring activities of an exceptional nature. The increase in the provision during the period relates to the business transformation program as detailed in Note 6, which are due to be completed within the next 12 months. €3.6 million has been utilized in the three months ended March 31, 2024, which relates to reorganizational activities across the Company.</span></div> <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.043%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restructuring</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions<br/>related to<br/>other taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional provision in the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Release of provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utilization of provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Analysis of total provisions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 12700000 7600000 16200000 36500000 600000 0 800000 1400000 500000 200000 700000 1400000 3600000 0 100000 3700000 -100000 0 200000 100000 9100000 7400000 16400000 32900000 31500000 35100000 1400000 1400000 32900000 36500000 9100000 12700000 P12M 3600000 Employee benefits<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates partially funded defined benefit pension plans in Germany and Austria, an unfunded defined benefit pension plan in Sweden and defined benefit indemnity arrangements in Italy and Austria, as well as various contribution plans in other countries. Pension benefits in Switzerland are met via a contract with a collective foundation that offers a fully insured solution to provide a contribution-based cash balance retirement plan, which is classified as a defined benefit plan. In addition, an unfunded post-retirement medical plan is operated in Austria. In Germany and Italy, long term service awards are in operation and various other countries provide other employee benefits. There were no changes in the nature of any schemes in the three months ended March 31, 2024.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total net employee benefit obligations as at March 31, 2024 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:89.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain on pension scheme valuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange differences on translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The principal assumptions applied for the valuation at March 31, 2024 were the same as those applied at December 31, 2023, except for the German plan, which is the most significant in terms of plan assets and liabilities to the Company. The discount rate applied to the German defined benefit obligations increased from 3.4% to 3.5% <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total net employee benefit obligations as at March 31, 2024 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:89.336%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">158.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gain on pension scheme valuations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange differences on translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 158300000 500000 1200000 3900000 900000 -1000000.0 -2100000 152100000 0.034 0.035 0.032 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of its long term incentive initiatives, the Company has awarded restricted shares to the management team (the “Management Share Awards”) as of the following award dates. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.777%"><tr><td style="width:1.0%"></td><td style="width:19.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2021 Award</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022 Award</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023 Award</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2024 Award</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of awards outstanding at January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">605,600</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">730,594</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,003,808</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">—</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">163,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,503,002</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New awards granted in the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112,460</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112,460</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeitures in the period</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,222)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,301)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,523)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Awards lapsed in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,048)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129,048)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of awards outstanding at March 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">476,552</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">721,372</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">992,507</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,112,460</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,458,891</span></td></tr></table></div> 605600 730594 1003808 0 163000 2503002 0 0 0 1112460 0 1112460 0 9222 11301 0 7000 27523 129048 0 0 0 0 129048 476552 721372 992507 1112460 156000 3458891 193990 152695 598173 683549 894750 176000 2699157 0 0 11735 40620 92583 65000 209938 0 0 171579 0 0 0 171579 193990 152695 414859 0 0 0 761544 0 0 0 642929 802167 111000 1556096 820202 P3Y 37.5 25 1140518 9000000 8500000 11400000 10800000 1209137 87000 1112460 193990 17.24 110781 83209 152695 17.24 79575 73120 414859 17.77 222780 192079 476552 18.89 256687 219865 3000000 12200000 Based on the latest revision to schemes, the inputs and assumptions underlying the Monte Carlo models for all awards outstanding as of valuation date are as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.555%"><tr><td style="width:1.0%"></td><td style="width:33.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.452%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.452%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.452%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2021 Award</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2022 Award *</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2023 Award *</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">January 1, 2024 Award *</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant date price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.42 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.39 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.24 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.95 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of restricted share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00 years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility of the share price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield expected</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.24 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee exit rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA Performance Target Conditions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.0 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*Note: The table above does not include details on awards that only require continued employment over the vesting period and have only non-company wide specific performance conditions.</span></td></tr></table></div> 25.42 25.39 17.24 16.95 0 0 0 0 P3Y P3Y P3Y P3Y 0.300 0.280 0 0 0.0024 0.0115 0.140 0.140 0.180 0.150 0.350 0.350 0.750 0.750 16000000 15100000 19000000 17900000 7500000 7000000 8800000 8000000 3800000 3400000 100000 29676 20.22 18450 29676 11226 35082 17.1 100000 100000 <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share based compensation reserve</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:77.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Executive Directors' restricted share awards charge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors' and Senior Management share awards charge</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of awards for settlement of tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 31400000 13800000 100000 100000 3000000.0 12200000 0 -4000000.0 34500000 22100000 500000000 3090082 24.5 75.8 67.1 0.1 1160547 26.23 30.5 26.8 11314705 16.33 185 170.9 0.2 500 447962 17.31 7.8 7.1 10.00 <div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">€m</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Authorized Share Capital issued and fully paid:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary Shares with nil nominal value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,719,172 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,167,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,446.3 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total share capital and capital reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,446.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,453.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Listing and share transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total net share capital and capital reserve</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,419.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,426.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 162719172 163167134 1446300000 1453400000 1446300000 1453400000 27300000 27300000 1419000000 1426100000 -14800000 -27500000 3000000 2900000 0.15 24400000 22300000 0.15 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Related parties</span><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 1, 2022, the Company amended its Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of Sir Martin Franklin, and TOMS Capital LLC, an affiliate of Mr. Gottesman. Pursuant to the terms of the Amended and Restated Advisory Services Agreement, Mariposa Capital, LLC and TOMS Capital LLC will continue to provide high-level strategic advice and guidance to the Company for an aggregate annual fee equal to $4.0 million, payable in quarterly installments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key management personnel comprise the Directors and Executive Officers. The Executive Officers continue to be remunerated for their services to the Company through their employment contracts. Non-executive Directors continue to receive fees for their services as board members and to certain committees and are settled through payroll. Director fees are payable quarterly in arrears. Total non-executive Director fees and expenses for the three months ended March 31, 2024 were €0.1 million (three months ended March 31, 2023: €0.1 million). In addition, certain non-executive Directors received grants under the LTIP as discussed in Note 14.</span></div> 4 100000 100000

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end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 71 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 220 229 1 false 67 0 false 7 false false R1.htm 0000001 - Document - Cover Sheet http://www.nomadfoods.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Unaudited Condensed Consolidated Interim Statements of Financial Position Sheet http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition Unaudited Condensed Consolidated Interim Statements of Financial Position Statements 2 false false R3.htm 0000003 - Statement - Unaudited Condensed Consolidated Interim Statements of Profit or Loss Sheet http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss Unaudited Condensed Consolidated Interim Statements of Profit or Loss Statements 3 false false R4.htm 0000004 - Statement - Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss) Sheet http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss) Statements 4 false false R5.htm 0000005 - Statement - Unaudited Condensed Consolidated Interim Statements of Changes in Equity Sheet http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity Unaudited Condensed Consolidated Interim Statements of Changes in Equity Statements 5 false false R6.htm 0000006 - Statement - Unaudited Condensed Consolidated Interim Statements of Cash Flows Sheet http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows Unaudited Condensed Consolidated Interim Statements of Cash Flows Statements 6 false false R7.htm 0000007 - Statement - Cash and cash equivalents Sheet http://www.nomadfoods.com/role/Cashandcashequivalents Cash and cash equivalents Statements 7 false false R8.htm 0000008 - Statement - Cash and cash equivalents (Tables) Sheet http://www.nomadfoods.com/role/CashandcashequivalentsTables Cash and cash equivalents (Tables) Statements 8 false false R9.htm 0000009 - Statement - Cash and cash equivalents (Details) Sheet http://www.nomadfoods.com/role/CashandcashequivalentsDetails Cash and cash equivalents (Details) Statements 9 false false R10.htm 0000010 - Disclosure - General information Sheet http://www.nomadfoods.com/role/Generalinformation General information Notes 10 false false R11.htm 0000011 - Disclosure - Basis of preparation Sheet http://www.nomadfoods.com/role/Basisofpreparation Basis of preparation Notes 11 false false R12.htm 0000012 - Disclosure - Accounting estimates and judgments Sheet http://www.nomadfoods.com/role/Accountingestimatesandjudgments Accounting estimates and judgments Notes 12 false false R13.htm 0000013 - Disclosure - Acquisitions Sheet http://www.nomadfoods.com/role/Acquisitions Acquisitions Notes 13 false false R14.htm 0000014 - Disclosure - Segment reporting Sheet http://www.nomadfoods.com/role/Segmentreporting Segment reporting Notes 14 false false R15.htm 0000015 - Disclosure - Exceptional items Sheet http://www.nomadfoods.com/role/Exceptionalitems Exceptional items Notes 15 false false R16.htm 0000016 - Disclosure - Finance income and costs Sheet http://www.nomadfoods.com/role/Financeincomeandcosts Finance income and costs Notes 16 false false R17.htm 0000017 - Disclosure - Taxation Sheet http://www.nomadfoods.com/role/Taxation Taxation Notes 17 false false R18.htm 0000018 - Disclosure - Earnings per share Sheet http://www.nomadfoods.com/role/Earningspershare Earnings per share Notes 18 false false R19.htm 0000019 - Disclosure - Financial instruments Sheet http://www.nomadfoods.com/role/Financialinstruments Financial instruments Notes 19 false false R20.htm 0000020 - Disclosure - Provisions Sheet http://www.nomadfoods.com/role/Provisions Provisions Notes 20 false false R21.htm 0000021 - Disclosure - Employee benefits Sheet http://www.nomadfoods.com/role/Employeebenefits Employee benefits Notes 21 false false R22.htm 0000024 - Disclosure - Related parties Sheet http://www.nomadfoods.com/role/Relatedparties Related parties Notes 22 false false R23.htm 9954471 - Disclosure - Basis of preparation (Policies) Sheet http://www.nomadfoods.com/role/BasisofpreparationPolicies Basis of preparation (Policies) Policies http://www.nomadfoods.com/role/Accountingestimatesandjudgments 23 false false R24.htm 9954473 - Disclosure - Segment reporting (Tables) Sheet http://www.nomadfoods.com/role/SegmentreportingTables Segment reporting (Tables) Tables http://www.nomadfoods.com/role/Segmentreporting 24 false false R25.htm 9954474 - Disclosure - Exceptional items (Tables) Sheet http://www.nomadfoods.com/role/ExceptionalitemsTables Exceptional items (Tables) Tables http://www.nomadfoods.com/role/Exceptionalitems 25 false false R26.htm 9954475 - Disclosure - Finance income and costs (Tables) Sheet http://www.nomadfoods.com/role/FinanceincomeandcostsTables Finance income and costs (Tables) Tables http://www.nomadfoods.com/role/Financeincomeandcosts 26 false false R27.htm 9954476 - Disclosure - Earnings per share (Tables) Sheet http://www.nomadfoods.com/role/EarningspershareTables Earnings per share (Tables) Tables http://www.nomadfoods.com/role/Earningspershare 27 false false R28.htm 9954477 - Disclosure - Financial instruments (Tables) Sheet http://www.nomadfoods.com/role/FinancialinstrumentsTables Financial instruments (Tables) Tables http://www.nomadfoods.com/role/Financialinstruments 28 false false R29.htm 9954478 - Disclosure - Provisions (Tables) Sheet http://www.nomadfoods.com/role/ProvisionsTables Provisions (Tables) Tables http://www.nomadfoods.com/role/Provisions 29 false false R30.htm 9954479 - Disclosure - Employee benefits (Tables) Sheet http://www.nomadfoods.com/role/EmployeebenefitsTables Employee benefits (Tables) Tables http://www.nomadfoods.com/role/Employeebenefits 30 false false R31.htm 9954480 - Disclosure - Share based compensation reserve (Tables) Sheet http://www.nomadfoods.com/role/SharebasedcompensationreserveTables Share based compensation reserve (Tables) Tables 31 false false R32.htm 9954481 - Disclosure - Share Capital and Capital reserve (Tables) Sheet http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveTables Share Capital and Capital reserve (Tables) Tables 32 false false R33.htm 9954483 - Disclosure - Basis of preparation (Details) Sheet http://www.nomadfoods.com/role/BasisofpreparationDetails Basis of preparation (Details) Details http://www.nomadfoods.com/role/BasisofpreparationPolicies 33 false false R34.htm 9954485 - Disclosure - Segment reporting - Segment as Adjusted EBITDA (Details) Sheet http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails Segment reporting - Segment as Adjusted EBITDA (Details) Details 34 false false R35.htm 9954486 - Disclosure - Segment reporting - Additional Information (Details) Sheet http://www.nomadfoods.com/role/SegmentreportingAdditionalInformationDetails Segment reporting - Additional Information (Details) Details 35 false false R36.htm 9954487 - Disclosure - Segment reporting - Geographical information (Details) Sheet http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails Segment reporting - Geographical information (Details) Details 36 false false R37.htm 9954488 - Disclosure - Exceptional Items - Schedule (Details) Sheet http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails Exceptional Items - Schedule (Details) Details 37 false false R38.htm 9954489 - Disclosure - Exceptional items - Additional Information (Details) Sheet http://www.nomadfoods.com/role/ExceptionalitemsAdditionalInformationDetails Exceptional items - Additional Information (Details) Details 38 false false R39.htm 9954490 - Disclosure - Finance income and costs (Details) Sheet http://www.nomadfoods.com/role/FinanceincomeandcostsDetails Finance income and costs (Details) Details http://www.nomadfoods.com/role/FinanceincomeandcostsTables 39 false false R40.htm 9954491 - Disclosure - Taxation (Details) Sheet http://www.nomadfoods.com/role/TaxationDetails Taxation (Details) Details http://www.nomadfoods.com/role/Taxation 40 false false R41.htm 9954492 - Disclosure - Earnings per share - Computation (Details) Sheet http://www.nomadfoods.com/role/EarningspershareComputationDetails Earnings per share - Computation (Details) Details 41 false false R42.htm 9954493 - Disclosure - Earnings per share - Additional Information (Details) Sheet http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails Earnings per share - Additional Information (Details) Details 42 false false R43.htm 9954494 - Disclosure - Financial instruments - Categories of financial instruments (Details) Sheet http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails Financial instruments - Categories of financial instruments (Details) Details 43 false false R44.htm 9954495 - Disclosure - Financial Instruments - Additional Information (Details) Sheet http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails Financial Instruments - Additional Information (Details) Details 44 false false R45.htm 9954496 - Disclosure - Financial Instruments - Interest bearing loans and borrowings (Details) Sheet http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails Financial Instruments - Interest bearing loans and borrowings (Details) Details 45 false false R46.htm 9954497 - Disclosure - Provisions - Schedule (Details) Sheet http://www.nomadfoods.com/role/ProvisionsScheduleDetails Provisions - Schedule (Details) Details 46 false false R47.htm 9954498 - Disclosure - Provisions - Additional Information (Details) Sheet http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails Provisions - Additional Information (Details) Details 47 false false R48.htm 9954499 - Disclosure - Employee Benefits (Details) Sheet http://www.nomadfoods.com/role/EmployeeBenefitsDetails Employee Benefits (Details) Details 48 false false R49.htm 9954500 - Disclosure - Share based compensation reserve - Director and Senior Management Share Awards (Details) Sheet http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails Share based compensation reserve - Director and Senior Management Share Awards (Details) Details 49 false false R50.htm 9954501 - Disclosure - Share based compensation reserve - Director and Senior Management Share Awards (Narrative) (Details) Sheet http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails Share based compensation reserve - Director and Senior Management Share Awards (Narrative) (Details) Details 50 false false R51.htm 9954502 - Disclosure - Share based compensation reserve - Valuation Assumptions (Details) Sheet http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails Share based compensation reserve - Valuation Assumptions (Details) Details 51 false false R52.htm 9954503 - Disclosure - Share based compensation reserve - Non-Executive Director Restricted Share Awards (Details) Sheet http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails Share based compensation reserve - Non-Executive Director Restricted Share Awards (Details) Details 52 false false R53.htm 9954504 - Disclosure - Share based compensation reserve - Reserve Summary (Details) Sheet http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails Share based compensation reserve - Reserve Summary (Details) Details 53 false false R54.htm 9954505 - Disclosure - Share Capital and Capital reserve - Narrative (Details) Sheet http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails Share Capital and Capital reserve - Narrative (Details) Details 54 false false R55.htm 9954506 - Disclosure - Share Capital and Capital reserve - Schedule (Details) Sheet http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails Share Capital and Capital reserve - Schedule (Details) Details 55 false false R56.htm 9954508 - Disclosure - Related parties (Details) Sheet http://www.nomadfoods.com/role/RelatedpartiesDetails Related parties (Details) Details http://www.nomadfoods.com/role/Relatedparties 56 false false All Reports Book All Reports nomd-20240331.htm nomd-20240331.xsd nomd-20240331_cal.xml nomd-20240331_def.xml nomd-20240331_lab.xml nomd-20240331_pre.xml http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 73 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "nomd-20240331.htm": { "nsprefix": "nomd", "nsuri": "http://www.nomadfoods.com/20240331", "dts": { "inline": { "local": [ "nomd-20240331.htm" ] }, "schema": { "local": [ "nomd-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "nomd-20240331_cal.xml" ] }, "definitionLink": { "local": [ "nomd-20240331_def.xml" ] }, "labelLink": { "local": [ "nomd-20240331_lab.xml" ] }, "presentationLink": { "local": [ "nomd-20240331_pre.xml" ] } }, "keyStandard": 169, "keyCustom": 60, "axisStandard": 15, "axisCustom": 1, "memberStandard": 28, "memberCustom": 31, "hidden": { "total": 8, "http://xbrl.sec.gov/dei/2023": 8 }, "contextCount": 220, "entityCount": 1, "segmentCount": 67, "elementCount": 519, "unitCount": 7, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 565, "http://xbrl.sec.gov/dei/2023": 8 }, "report": { "R1": { "role": "http://www.nomadfoods.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": null, "uniqueAnchor": null }, "R2": { "role": "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition", "longName": "0000002 - Statement - Unaudited Condensed Consolidated Interim Statements of Financial Position", "shortName": "Unaudited Condensed Consolidated Interim Statements of Financial Position", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-2", "name": "ifrs-full:Goodwill", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "ifrs-full:Goodwill", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss", "longName": "0000003 - Statement - Unaudited Condensed Consolidated Interim Statements of Profit or Loss", "shortName": "Unaudited Condensed Consolidated Interim Statements of Profit or Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:Revenue", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:CostOfSales", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R4": { "role": "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss", "longName": "0000004 - Statement - Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss)", "shortName": "Unaudited Condensed Consolidated Interim Statements of Comprehensive Income/(Loss)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLoss", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R5": { "role": "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity", "longName": "0000005 - Statement - Unaudited Condensed Consolidated Interim Statements of Changes in Equity", "shortName": "Unaudited Condensed Consolidated Interim Statements of Changes in Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-23", "name": "nomd:Equityattributabletoownersoftheparentrestated", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-30", "name": "ifrs-full:AmountRemovedFromReserveOfCashFlowHedgesAndIncludedInInitialCostOrOtherCarryingAmountOfNonfinancialAssetLiabilityOrFirmCommitmentForWhichFairValueHedgeAccountingIsApplied", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R6": { "role": "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows", "longName": "0000006 - Statement - Unaudited Condensed Consolidated Interim Statements of Cash Flows", "shortName": "Unaudited Condensed Consolidated Interim Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLoss", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:AdjustmentsForSharebasedPayments", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R7": { "role": "http://www.nomadfoods.com/role/Cashandcashequivalents", "longName": "0000007 - Statement - Cash and cash equivalents", "shortName": "Cash and cash equivalents", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.nomadfoods.com/role/CashandcashequivalentsTables", "longName": "0000008 - Statement - Cash and cash equivalents (Tables)", "shortName": "Cash and cash equivalents (Tables)", "isDefault": "false", "groupType": "statement", "subGroupType": "tables", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "nomd:DisclosureofCashandCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:DisclosureofCashandCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.nomadfoods.com/role/CashandcashequivalentsDetails", "longName": "0000009 - Statement - Cash and cash equivalents (Details)", "shortName": "Cash and cash equivalents (Details)", "isDefault": "false", "groupType": "statement", "subGroupType": "details", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c-2", "name": "nomd:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "nomd:DisclosureofCashandCashEquivalentsTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "ifrs-full:BankOverdraftsClassifiedAsCashEquivalents", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "nomd:DisclosureofCashandCashEquivalentsTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R10": { "role": "http://www.nomadfoods.com/role/Generalinformation", "longName": "0000010 - Disclosure - General information", "shortName": "General information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.nomadfoods.com/role/Basisofpreparation", "longName": "0000011 - Disclosure - Basis of preparation", "shortName": "Basis of preparation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.nomadfoods.com/role/Accountingestimatesandjudgments", "longName": "0000012 - Disclosure - Accounting estimates and judgments", "shortName": "Accounting estimates and judgments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.nomadfoods.com/role/Acquisitions", "longName": "0000013 - Disclosure - Acquisitions", "shortName": "Acquisitions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.nomadfoods.com/role/Segmentreporting", "longName": "0000014 - Disclosure - Segment reporting", "shortName": "Segment reporting", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.nomadfoods.com/role/Exceptionalitems", "longName": "0000015 - Disclosure - Exceptional items", "shortName": "Exceptional items", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "nomd:DisclosureOfExceptionalItemsExplanatoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:DisclosureOfExceptionalItemsExplanatoryTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.nomadfoods.com/role/Financeincomeandcosts", "longName": "0000016 - Disclosure - Finance income and costs", "shortName": "Finance income and costs", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.nomadfoods.com/role/Taxation", "longName": "0000017 - Disclosure - Taxation", "shortName": "Taxation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.nomadfoods.com/role/Earningspershare", "longName": "0000018 - Disclosure - Earnings per share", "shortName": "Earnings per share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.nomadfoods.com/role/Financialinstruments", "longName": "0000019 - Disclosure - Financial instruments", "shortName": "Financial instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.nomadfoods.com/role/Provisions", "longName": "0000020 - Disclosure - Provisions", "shortName": "Provisions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfProvisionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfProvisionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.nomadfoods.com/role/Employeebenefits", "longName": "0000021 - Disclosure - Employee benefits", "shortName": "Employee benefits", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.nomadfoods.com/role/Relatedparties", "longName": "0000024 - Disclosure - Related parties", "shortName": "Related parties", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.nomadfoods.com/role/BasisofpreparationPolicies", "longName": "9954471 - Disclosure - Basis of preparation (Policies)", "shortName": "Basis of preparation (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "nomd:DescriptionofaccountingpolicyforchangesinaccountingpoliciesaccountingestimatesanderrorsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:DescriptionofaccountingpolicyforchangesinaccountingpoliciesaccountingestimatesanderrorsPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.nomadfoods.com/role/SegmentreportingTables", "longName": "9954473 - Disclosure - Segment reporting (Tables)", "shortName": "Segment reporting (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.nomadfoods.com/role/ExceptionalitemsTables", "longName": "9954474 - Disclosure - Exceptional items (Tables)", "shortName": "Exceptional items (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "nomd:DisclosureOfDetailedInformationForExceptionalItemsExplanatoryTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:DisclosureOfDetailedInformationForExceptionalItemsExplanatoryTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.nomadfoods.com/role/FinanceincomeandcostsTables", "longName": "9954475 - Disclosure - Finance income and costs (Tables)", "shortName": "Finance income and costs (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "nomd:DisclosureofFinanceIncomeandCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:DisclosureofFinanceIncomeandCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.nomadfoods.com/role/EarningspershareTables", "longName": "9954476 - Disclosure - Earnings per share (Tables)", "shortName": "Earnings per share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.nomadfoods.com/role/FinancialinstrumentsTables", "longName": "9954477 - Disclosure - Financial instruments (Tables)", "shortName": "Financial instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.nomadfoods.com/role/ProvisionsTables", "longName": "9954478 - Disclosure - Provisions (Tables)", "shortName": "Provisions (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.nomadfoods.com/role/EmployeebenefitsTables", "longName": "9954479 - Disclosure - Employee benefits (Tables)", "shortName": "Employee benefits (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.nomadfoods.com/role/SharebasedcompensationreserveTables", "longName": "9954480 - Disclosure - Share based compensation reserve (Tables)", "shortName": "Share based compensation reserve (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveTables", "longName": "9954481 - Disclosure - Share Capital and Capital reserve (Tables)", "shortName": "Share Capital and Capital reserve (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.nomadfoods.com/role/BasisofpreparationDetails", "longName": "9954483 - Disclosure - Basis of preparation (Details)", "shortName": "Basis of preparation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-2", "name": "ifrs-full:ReserveOfCashFlowHedges", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DescriptionOfNatureOfImpendingChangeInAccountingPolicy", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R34": { "role": "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails", "longName": "9954485 - Disclosure - Segment reporting - Segment as Adjusted EBITDA (Details)", "shortName": "Segment reporting - Segment as Adjusted EBITDA (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLoss", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:DepreciationAndAmortisationExpense", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R35": { "role": "http://www.nomadfoods.com/role/SegmentreportingAdditionalInformationDetails", "longName": "9954486 - Disclosure - Segment reporting - Additional Information (Details)", "shortName": "Segment reporting - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "nomd:Adjustmentsforsharebasedpaymentsincludingemployertax", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:Adjustmentsforsharebasedpaymentsincludingemployertax", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails", "longName": "9954487 - Disclosure - Segment reporting - Geographical information (Details)", "shortName": "Segment reporting - Geographical information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:Revenue", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-45", "name": "ifrs-full:Revenue", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfGeographicalAreasExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R37": { "role": "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails", "longName": "9954488 - Disclosure - Exceptional Items - Schedule (Details)", "shortName": "Exceptional Items - Schedule (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "nomd:BusinessTransformationProgram", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "nomd:DisclosureOfDetailedInformationForExceptionalItemsExplanatoryTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:FortenovaGroupIntegrationCosts", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "nomd:DisclosureOfDetailedInformationForExceptionalItemsExplanatoryTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R38": { "role": "http://www.nomadfoods.com/role/ExceptionalitemsAdditionalInformationDetails", "longName": "9954489 - Disclosure - Exceptional items - Additional Information (Details)", "shortName": "Exceptional items - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "nomd:BusinessTransformationProgram", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "nomd:DisclosureOfDetailedInformationForExceptionalItemsExplanatoryTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:ExceptionalItemsTaxExpenseIncomeContinuingOperations", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R39": { "role": "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails", "longName": "9954490 - Disclosure - Finance income and costs (Details)", "shortName": "Finance income and costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:RevenueFromInterest", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "nomd:DisclosureofFinanceIncomeandCostsTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:RevenueFromInterest", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "nomd:DisclosureofFinanceIncomeandCostsTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.nomadfoods.com/role/TaxationDetails", "longName": "9954491 - Disclosure - Taxation (Details)", "shortName": "Taxation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:IncomeTaxExpenseContinuingOperations", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-70", "name": "ifrs-full:ApplicableTaxRate", "unitRef": "rate", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R41": { "role": "http://www.nomadfoods.com/role/EarningspershareComputationDetails", "longName": "9954492 - Disclosure - Earnings per share - Computation (Details)", "shortName": "Earnings per share - Computation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "nomd:DilutedearningspershareTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "nomd:WeightedAverageNumberOfOrdinaryandPreferredSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:EarningsPerShareExplanatory", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R42": { "role": "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "longName": "9954493 - Disclosure - Earnings per share - Additional Information (Details)", "shortName": "Earnings per share - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-189", "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-71", "name": "nomd:DilutiveEffectofRestrictedShareAwardsonNumberofOrdinaryShares", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R43": { "role": "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails", "longName": "9954494 - Disclosure - Financial instruments - Categories of financial instruments (Details)", "shortName": "Financial instruments - Categories of financial instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-2", "name": "nomd:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "nomd:DisclosureofCashandCashEquivalentsTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "ifrs-full:FinancialAssetsAtAmortisedCost", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialAssetsExplanatory", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R44": { "role": "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "longName": "9954495 - Disclosure - Financial Instruments - Additional Information (Details)", "shortName": "Financial Instruments - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-2", "name": "ifrs-full:ContractLiabilities", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "ifrs-full:ContractLiabilities", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails", "longName": "9954496 - Disclosure - Financial Instruments - Interest bearing loans and borrowings (Details)", "shortName": "Financial Instruments - Interest bearing loans and borrowings (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-91", "name": "nomd:DiscountOnIssuanceOfDebt", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-91", "name": "nomd:DiscountOnIssuanceOfDebt", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.nomadfoods.com/role/ProvisionsScheduleDetails", "longName": "9954497 - Disclosure - Provisions - Schedule (Details)", "shortName": "Provisions - Schedule (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:OtherProvisions", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:AdditionalProvisionsOtherProvisions", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R47": { "role": "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "longName": "9954498 - Disclosure - Provisions - Additional Information (Details)", "shortName": "Provisions - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-2", "name": "ifrs-full:OtherProvisions", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-112", "name": "nomd:OtherProvisionsEstimatedCompletionOfActivities", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R48": { "role": "http://www.nomadfoods.com/role/EmployeeBenefitsDetails", "longName": "9954499 - Disclosure - Employee Benefits (Details)", "shortName": "Employee Benefits (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "longName": "9954500 - Disclosure - Share based compensation reserve - Director and Senior Management Share Awards (Details)", "shortName": "Share based compensation reserve - Director and Senior Management Share Awards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-145", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-132", "name": "ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R50": { "role": "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "longName": "9954501 - Disclosure - Share based compensation reserve - Director and Senior Management Share Awards (Narrative) (Details)", "shortName": "Share based compensation reserve - Director and Senior Management Share Awards (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-1", "name": "ifrs-full:KeyManagementPersonnelCompensation", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ifrs-full:KeyManagementPersonnelCompensation", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails", "longName": "9954502 - Disclosure - Share based compensation reserve - Valuation Assumptions (Details)", "shortName": "Share based compensation reserve - Valuation Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-127", "name": "nomd:GrantDatePriceOtherEquityInstrumentsGranted", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-127", "name": "nomd:GrantDatePriceOtherEquityInstrumentsGranted", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "longName": "9954503 - Disclosure - Share based compensation reserve - Non-Executive Director Restricted Share Awards (Details)", "shortName": "Share based compensation reserve - Non-Executive Director Restricted Share Awards (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-189", "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-189", "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R53": { "role": "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails", "longName": "9954504 - Disclosure - Share based compensation reserve - Reserve Summary (Details)", "shortName": "Share based compensation reserve - Reserve Summary (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-3", "name": "ifrs-full:ReserveOfSharebasedPayments", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-192", "name": "ifrs-full:ReserveOfSharebasedPayments", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "nomd:DisclosureOfDetailedInformationAboutReservesWithinEquityTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R54": { "role": "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "longName": "9954505 - Disclosure - Share Capital and Capital reserve - Narrative (Details)", "shortName": "Share Capital and Capital reserve - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-2", "name": "ifrs-full:ReserveOfCashFlowHedges", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-209", "name": "ifrs-full:PurchaseOfTreasuryShares", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "unique": true } }, "R55": { "role": "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails", "longName": "9954506 - Disclosure - Share Capital and Capital reserve - Schedule (Details)", "shortName": "Share Capital and Capital reserve - Schedule (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-2", "name": "nomd:IssuedCapitalandCapitalReserveGross", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-2", "name": "nomd:IssuedCapitalandCapitalReserveGross", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "div", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.nomadfoods.com/role/RelatedpartiesDetails", "longName": "9954508 - Disclosure - Related parties (Details)", "shortName": "Related parties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-219", "name": "nomd:FeesAndExpensesRelatedPartyTransactions", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-219", "name": "nomd:FeesAndExpensesRelatedPartyTransactions", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "nomd-20240331.htm", "first": true, "unique": true } } }, "tag": { "country_AT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AT", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Austria", "label": "AUSTRIA" } } }, "auth_ref": [] }, "nomd_AccountingPoliciesChangesinAccountingEstimatesandErrorsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AccountingPoliciesChangesinAccountingEstimatesandErrorsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]", "label": "Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]", "documentation": "Accounting Policies, Changes in Accounting Estimates and Errors [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitionsThroughBusinessCombinationsOtherProvisions", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired through business combinations", "label": "Acquisitions through business combinations, other provisions" } }, "en": { "role": { "documentation": "The increase in other provisions resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Other provisions]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_ActuarialAssumptionOfDiscountRates": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfDiscountRates", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Actuarial assumption of discount rates", "label": "Actuarial assumption of discount rates" } }, "en": { "role": { "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } } }, "auth_ref": [ "r241" ] }, "ifrs-full_AdditionalProvisionsOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionalProvisionsOtherProvisions", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional provision in the period", "label": "Additional provisions, other provisions" } }, "en": { "role": { "documentation": "The amount of additional other provisions made. [Refer: Other provisions]" } } }, "auth_ref": [ "r82" ] }, "nomd_AdjustmentsForAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AdjustmentsForAcquisitionRelatedCosts", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition related costs", "label": "Adjustments For Acquisition Related Costs", "documentation": "Adjustments For Acquisition Related Costs" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "nomd_NetCashFlowsFromUsedInOperatingActivitiesBeforeIncomeTaxesPaidAndCashFlowsRelatedToExceptionalItems", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Decrease/(increase) in inventories", "label": "Adjustments for decrease (increase) in inventories" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } } }, "auth_ref": [ "r246" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "nomd_NetCashFlowsFromUsedInOperatingActivitiesBeforeIncomeTaxesPaidAndCashFlowsRelatedToExceptionalItems", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in trade and other receivables", "label": "Adjustments for decrease (increase) in trade and other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Adjustments for depreciation and amortisation expense" } }, "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } } }, "auth_ref": [ "r247" ] }, "nomd_AdjustmentsForExceptionalItems": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AdjustmentsForExceptionalItems", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 7.0 }, "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails", "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Exceptional items", "totalLabel": "Exceptional items", "label": "Adjustments For Exceptional Items", "documentation": "Adjustments For Exceptional Items" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForFinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForFinanceCosts", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Net finance costs", "label": "Adjustments for finance costs" } }, "en": { "role": { "documentation": "Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]" } } }, "auth_ref": [ "r248" ] }, "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss on disposal and impairment of property, plant and equipment", "label": "Adjustments for gain (loss) on disposals, property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_AdjustmentsForIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncomeTaxExpense", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Taxation", "label": "Adjustments for income tax expense" } }, "en": { "role": { "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r102" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "nomd_NetCashFlowsFromUsedInOperatingActivitiesBeforeIncomeTaxesPaidAndCashFlowsRelatedToExceptionalItems", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "(Decrease)/increase in employee benefits and other provisions", "label": "Adjustments for increase (decrease) in employee benefit liabilities" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r249" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "nomd_NetCashFlowsFromUsedInOperatingActivitiesBeforeIncomeTaxesPaidAndCashFlowsRelatedToExceptionalItems", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in trade and other payables", "label": "Adjustments for increase (decrease) in trade and other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r249" ] }, "nomd_AdjustmentsForOtherItems": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AdjustmentsForOtherItems", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other add-backs", "label": "Adjustments For Other Items", "documentation": "Adjustments For Other Items" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments for:", "label": "Adjustments to reconcile profit (loss) [abstract]" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Share based payments expense", "label": "Adjustments for share-based payments" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r247" ] }, "nomd_Adjustmentsforsharebasedpaymentsincludingemployertax": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Adjustmentsforsharebasedpaymentsincludingemployertax", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments for share based payments including employer tax", "label": "adjustments for share based payments including employer tax", "documentation": "adjustments for share based payments including employer tax" } } }, "auth_ref": [] }, "nomd_AffiliateOfFounderEntitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AffiliateOfFounderEntitiesMember", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Affiliate of Founder Entities", "label": "Affiliate Of Founder Entities [Member]", "documentation": "Affiliate Of Founder Entities [Member]" } } }, "auth_ref": [] }, "srt_AircraftTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AircraftTypeAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aircraft Type [Axis]", "label": "Aircraft Type [Axis]" } } }, "auth_ref": [] }, "srt_AircraftTypeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AircraftTypeMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aircraft [Domain]", "label": "Aircraft [Domain]" } } }, "auth_ref": [] }, "currency_AllCurrenciesDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/currency/2023", "localname": "AllCurrenciesDomain", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All Currencies [Domain]", "label": "All Currencies [Domain]" } } }, "auth_ref": [] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "All levels of fair value hierarchy [member]", "label": "All levels of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r65", "r129" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.nomadfoods.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "nomd_AmortizationOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AmortizationOfDebtIssuanceCosts", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amortization of debt discounts and borrowing costs", "label": "Amortization Of Debt Issuance Costs", "documentation": "Amortization Of Debt Issuance Costs" } } }, "auth_ref": [] }, "ifrs-full_AmountRemovedFromReserveOfCashFlowHedgesAndIncludedInInitialCostOrOtherCarryingAmountOfNonfinancialAssetLiabilityOrFirmCommitmentForWhichFairValueHedgeAccountingIsApplied": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountRemovedFromReserveOfCashFlowHedgesAndIncludedInInitialCostOrOtherCarryingAmountOfNonfinancialAssetLiabilityOrFirmCommitmentForWhichFairValueHedgeAccountingIsApplied", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Deferred hedging losses and costs of hedging transferred to the carrying value of inventory", "label": "Amount removed from reserve of cash flow hedges and included in initial cost or other carrying amount of non-financial asset (liability) or firm commitment for which fair value hedge accounting is applied" } }, "en": { "role": { "documentation": "The amount removed from reserve of cash flow hedges and included in the initial cost or other carrying amount of a non-financial asset (liability) or a firm commitment for which fair value hedge accounting is applied. [Refer: Reserve of cash flow hedges]" } } }, "auth_ref": [ "r152", "r189" ] }, "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AnalysisOfIncomeAndExpenseAbstract", "lang": { "en-us": { "role": { "terseLabel": "Analysis of income and expense [abstract]", "label": "Analysis of income and expense [abstract]" } } }, "auth_ref": [] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ApplicableTaxRate", "presentation": [ "http://www.nomadfoods.com/role/TaxationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Applicable tax rate", "label": "Applicable tax rate" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r52" ] }, "nomd_AssetRetirementObligationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AssetRetirementObligationMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asset retirement obligation", "label": "Asset retirement obligation [Member]", "documentation": "Asset retirement obligation" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NetAssetsLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r21", "r128", "r129", "r131", "r177", "r180" ] }, "nomd_AuntBessiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AuntBessiesMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aunt Bessie's", "label": "Aunt Bessie's [Member]", "documentation": "Aunt Bessie's" } } }, "auth_ref": [] }, "nomd_AwardDate1Axis": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AwardDate1Axis", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Date1 [Axis]", "label": "Award Date1 [Axis]", "documentation": "Award Date1 [Axis]" } } }, "auth_ref": [] }, "nomd_AwardDate1Domain": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AwardDate1Domain", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Date1 [Domain]", "label": "Award Date1 [Domain]", "documentation": "Award Date1 [Domain]" } } }, "auth_ref": [] }, "nomd_AwardType1Axis": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AwardType1Axis", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type1 [Axis]", "label": "Award Type1 [Axis]", "documentation": "Award Type1 [Axis]" } } }, "auth_ref": [] }, "nomd_AwardType1Domain": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "AwardType1Domain", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type1 [Domain]", "label": "Award Type1 [Domain]", "documentation": "Award Type1 [Domain]" } } }, "auth_ref": [] }, "ifrs-full_BankOverdraftsClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BankOverdraftsClassifiedAsCashEquivalents", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/CashandcashequivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/CashandcashequivalentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Bank overdraft", "label": "Bank overdrafts" } }, "en": { "role": { "documentation": "The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r250" ] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareComputationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Basic earnings per share", "label": "Basic earnings (loss) per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r75", "r76" ] }, "ifrs-full_BasicEarningsLossPerShareFromContinuingOperations": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShareFromContinuingOperations", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Basic earnings (loss) per share from continuing operations", "label": "Basic earnings (loss) per share from continuing operations" } }, "en": { "role": { "documentation": "Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations [member]]" } } }, "auth_ref": [ "r75", "r76" ] }, "ifrs-full_BasicEarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsPerShareAbstract", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic earnings per share", "label": "Basic earnings per share [abstract]" } } }, "auth_ref": [] }, "nomd_BasisOfPresentationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "BasisOfPresentationAbstract", "lang": { "en-us": { "role": { "terseLabel": "Basis Of Presentation [Abstract]", "label": "Basis Of Presentation [Abstract]", "documentation": "Basis Of Presentation" } } }, "auth_ref": [] }, "ifrs-full_BorrowingCostsCapitalised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingCostsCapitalised", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowing costs capitalised", "label": "Borrowing costs capitalised" } }, "en": { "role": { "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset." } } }, "auth_ref": [ "r69" ] }, "ifrs-full_Borrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Borrowings", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings", "label": "Borrowings" } }, "en": { "role": { "documentation": "The amount of outstanding funds that the entity is obligated to repay." } } }, "auth_ref": [ "r235" ] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings by name [axis]", "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r252" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Borrowings by name [member]", "label": "Borrowings by name [member]" } }, "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r252" ] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Borrowings, interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r252" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bottom of range", "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r132", "r137", "r140", "r217", "r219", "r252" ] }, "nomd_BusinessCombinationPurchasePriceAdjustmentInventoryStepUp": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "BusinessCombinationPurchasePriceAdjustmentInventoryStepUp", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisition purchase price adjustments", "label": "Business Combination, Purchase Price Adjustment, Inventory Step Up", "documentation": "Business Combination, Purchase Price Adjustment, Inventory Step Up" } } }, "auth_ref": [] }, "nomd_BusinessCombinations1Abstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "BusinessCombinations1Abstract", "lang": { "en-us": { "role": { "terseLabel": "Business Combinations1 [Abstract]", "label": "Business Combinations1 [Abstract]", "documentation": "Business Combinations1 [Abstract]" } } }, "auth_ref": [] }, "nomd_BusinessTransformationProgram": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "BusinessTransformationProgram", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": "nomd_AdjustmentsForExceptionalItems", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails", "http://www.nomadfoods.com/role/ExceptionalitemsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business transformation program (1)", "label": "Business transformation program", "documentation": "Business transformation program" } } }, "auth_ref": [] }, "country_CH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CH", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SWITZERLAND", "label": "SWITZERLAND" } } }, "auth_ref": [] }, "ifrs-full_CapitalReserve": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CapitalReserve", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Share capital and capital reserve", "label": "Capital reserve" } }, "en": { "role": { "documentation": "A component of equity representing the capital reserves." } } }, "auth_ref": [ "r235" ] }, "ifrs-full_CapitalReserveMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CapitalReserveMember", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Share capital and capital reserve", "label": "Capital reserve [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing capital reserves." } } }, "auth_ref": [ "r231" ] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]", "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r55", "r56", "r86", "r87", "r91", "r92", "r93", "r94", "r95", "r145", "r155", "r156" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying amount [member]", "label": "Carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r56", "r87", "r91", "r93", "r94", "r145", "r155", "r156" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/CashandcashequivalentsDetails": { "parentTag": "nomd_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/CashandcashequivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash balances and deposits", "label": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r15", "r104", "r123" ] }, "nomd_CashAndCashEquivalents1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "CashAndCashEquivalents1Member", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash And Cash Equivalents1 [Member]", "documentation": "Cash And Cash Equivalents [Member]" } } }, "auth_ref": [] }, "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/CashandcashequivalentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/CashandcashequivalentsDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents at beginning of period", "totalLabel": "Cash and cash equivalents per Statement of Cash Flows", "label": "Cash and cash equivalents if different from statement of financial position" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r250" ] }, "nomd_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 }, "http://www.nomadfoods.com/role/CashandcashequivalentsDetails": { "parentTag": "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/CashandcashequivalentsDetails", "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "totalLabel": "Cash and cash equivalents in the Statement of Financial Position", "verboseLabel": "Financial assets at amortized cost", "label": "Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents1", "documentation": "Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents1" } } }, "auth_ref": [] }, "ifrs-full_CashFlowHedgesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowHedgesMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedges", "label": "Cash flow hedges [member]" } }, "en": { "role": { "documentation": "This member stands for hedges of the exposure to variability in cash flows that (a) are attributable to a particular risk associated with a recognised asset or liability (such as all or some future interest payments on variable rate debt) or a highly probable forecast transaction; and (b) could affect profit or loss. [Refer: Hedges [member]]" } } }, "auth_ref": [ "r89", "r149", "r150", "r151" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r96", "r105" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities", "label": "Cash flows from (used in) financing activities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash used in investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r96", "r105" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities", "label": "Cash flows from (used in) investing activities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash generated from operating activities", "label": "Cash flows from (used in) operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r96", "r105" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities", "label": "Cash flows from (used in) operating activities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "nomd_NetCashFlowsFromUsedInOperatingActivitiesBeforeIncomeTaxesPaidAndCashFlowsRelatedToExceptionalItems", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Operating cash flow before changes in working capital, provisions and exceptional items", "label": "Cash flows from (used in) operations before changes in working capital" } }, "en": { "role": { "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital." } } }, "auth_ref": [ "r212", "r249" ] }, "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of subsidiaries, net of cash acquired", "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities" } }, "en": { "role": { "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r103" ] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/RelatedpartiesDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Categories of related parties [axis]", "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r72" ] }, "ifrs-full_ClassesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialAssetsAxis", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of financial assets [axis]", "label": "Classes of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r138", "r162", "r164", "r193", "r194" ] }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of financial instruments [axis]", "label": "Classes of financial instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r155", "r157", "r159", "r160" ] }, "ifrs-full_ClassesOfFinancialInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial instruments, class [member]", "label": "Financial instruments, class [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r155", "r157", "r159", "r160" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails", "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of financial liabilities [axis]", "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r162", "r164", "r193", "r194" ] }, "ifrs-full_ClassesOfOrdinarySharesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfOrdinarySharesAxis", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of ordinary shares [axis]", "label": "Classes of ordinary shares [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_ClassesOfProvisionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfProvisionsAxis", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of other provisions [axis]", "label": "Classes of other provisions [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Classes of share capital [axis]", "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r32" ] }, "ifrs-full_ClassesOfShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalMember", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share capital [member]", "label": "Share capital [member]" } }, "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r32" ] }, "srt_CommonDomainMembersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CommonDomainMembersAbstract", "lang": { "en-us": { "role": { "label": "Common Domain Members [Abstract]" } } }, "auth_ref": [] }, "srt_CommonTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CommonTable", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common [Table]", "label": "Common [Table]" } } }, "auth_ref": [] }, "nomd_CommonTableLineItemsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "CommonTableLineItemsLineItems", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Table Line Items [Line Items]", "label": "Common Table Line Items [Line Items]", "documentation": "Common Table Line Items" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Components of equity [axis]", "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income for the period", "terseLabel": "Comprehensive income", "label": "Comprehensive income" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r2", "r37", "r112", "r114", "r120", "r215" ] }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income for the period", "terseLabel": "Equity owners of the parent", "label": "Comprehensive income, attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } } }, "auth_ref": [ "r2", "r40" ] }, "nomd_ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDateReleaseofProvision": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDateReleaseofProvision", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": "nomd_AdjustmentsForExceptionalItems", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Release of indemnification assets (4)", "label": "Contingent Consideration Arrangements And Indemnification Assets Recognised As Of Acquisition Date, Release of Provision", "documentation": "Contingent Consideration Arrangements And Indemnification Assets Recognised As Of Acquisition Date, Release of Provision" } } }, "auth_ref": [] }, "ifrs-full_ContractLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContractLiabilities", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liabilities", "label": "Contract liabilities" } }, "en": { "role": { "documentation": "The amount of an entity\u2019s obligation to transfer goods or services to a customer for which the entity has received consideration (or the amount is due) from the customer." } } }, "auth_ref": [ "r133", "r134" ] }, "nomd_CostOfHedgingReserveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "CostOfHedgingReserveMember", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of hedging reserve", "label": "Cost of hedging reserve [Member]", "documentation": "Cost of hedging reserve" } } }, "auth_ref": [] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cost of sales", "label": "Cost of sales" } }, "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } } }, "auth_ref": [ "r0", "r48" ] }, "ifrs-full_CounterpartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesAxis", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparties [axis]", "label": "Counterparties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r170" ] }, "ifrs-full_CounterpartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesMember", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Counterparties [member]", "label": "Counterparties [member]" } }, "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "auth_ref": [ "r170" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "srt_CreditRatingFitchAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CreditRatingFitchAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Rating, Fitch [Axis]", "label": "Credit Rating, Fitch [Axis]" } } }, "auth_ref": [] }, "srt_CreditRatingMoodysAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CreditRatingMoodysAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Rating, Moody's [Axis]", "label": "Credit Rating, Moody's [Axis]" } } }, "auth_ref": [] }, "srt_CreditRatingStandardPoorsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CreditRatingStandardPoorsAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Rating, Standard & Poor's [Axis]", "label": "Credit Rating, Standard & Poor's [Axis]" } } }, "auth_ref": [] }, "nomd_CumulativeTranslationDifferenceOnCroatiaAdoptingTheEuro": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "CumulativeTranslationDifferenceOnCroatiaAdoptingTheEuro", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative translation difference on Croatia adopting the Euro", "label": "Cumulative translation difference on Croatia adopting the Euro", "documentation": "Cumulative translation difference on Croatia adopting the Euro" } } }, "auth_ref": [] }, "srt_CurrencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "CurrencyAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency [Axis]", "label": "Currency [Axis]" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r23", "r116", "r215" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Current assets [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CurrentDerivativeFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDerivativeFinancialAssets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial instruments", "label": "Current derivative financial assets" } }, "en": { "role": { "documentation": "The amount of current derivative financial assets. [Refer: Derivative financial assets]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_CurrentDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial instruments", "label": "Current derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r235" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.nomadfoods.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r24", "r118", "r215" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Current liabilities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_CurrentPortionOfLongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPortionOfLongtermBorrowings", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Loans and borrowings", "label": "Current portion of non-current borrowings" } }, "en": { "role": { "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_CurrentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentProvisions", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/ProvisionsScheduleDetails": { "parentTag": "ifrs-full_Provisions", "weight": 1.0, "order": 1.0 }, "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ProvisionsScheduleDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Provisions", "terseLabel": "Current", "label": "Current provisions" } }, "en": { "role": { "documentation": "The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r17" ] }, "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Increase in net defined benefit liability (asset) resulting from current service cost" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r59" ] }, "ifrs-full_CurrentTaxAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxAssetsCurrent", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Current tax receivable", "label": "Current tax assets, current" } }, "en": { "role": { "documentation": "The current amount of current tax assets. [Refer: Current tax assets]" } } }, "auth_ref": [ "r18" ] }, "ifrs-full_CurrentTaxLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Current tax payable", "label": "Current tax liabilities, current" } }, "en": { "role": { "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]" } } }, "auth_ref": [ "r18" ] }, "country_DE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "DE", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails", "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Germany", "label": "GERMANY" } } }, "auth_ref": [] }, "nomd_DeferredFinancingCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DeferredFinancingCostsMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred borrowing costs", "label": "Deferred Financing Costs [Member]", "documentation": "Deferred Financing Costs [Member]" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r19", "r22", "r53" ] }, "ifrs-full_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Deferred tax liabilities" } }, "en": { "role": { "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r19", "r22", "r53" ] }, "ifrs-full_DepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationAndAmortisationExpense", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation & amortization", "label": "Depreciation and amortisation expense" } }, "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } } }, "auth_ref": [ "r1", "r48", "r124", "r175", "r182", "r195" ] }, "ifrs-full_DerivativeFinancialAssetsHeldForHedging": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativeFinancialAssetsHeldForHedging", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": "ifrs-full_FinancialAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial assets held for hedging", "label": "Derivative financial assets held for hedging" } }, "en": { "role": { "documentation": "The amount of derivative financial assets held for hedging. [Refer: Derivative financial assets]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_DerivativesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativesMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives", "verboseLabel": "Derivative financial instruments", "label": "Derivatives [member]" } }, "en": { "role": { "documentation": "This member stands for financial instruments or other contracts within the scope of IFRS 9 with all three of the following characteristics: (a) Their value changes in response to the change in a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index of prices or rates, credit rating or credit index, or other variable, provided in the case of a non-financial variable that the variable is not specific to a party to the contract (sometimes called the \u2018underlying\u2019); (b) They require no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; (c) They are settled at a future date. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r216", "r218", "r224", "r225" ] }, "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/AccountingestimatesandjudgmentsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combinations", "label": "Description of accounting policy for business combinations [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for business combinations. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DescriptionOfAccountingPolicyForDiscountsAndRebatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForDiscountsAndRebatesExplanatory", "presentation": [ "http://www.nomadfoods.com/role/AccountingestimatesandjudgmentsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Discounts and trade promotions", "label": "Description of accounting policy for discounts and rebates [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for discounts and rebates." } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/AccountingestimatesandjudgmentsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Employee benefit obligation", "label": "Description of accounting policy for employee benefits [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment." } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory", "presentation": [ "http://www.nomadfoods.com/role/AccountingestimatesandjudgmentsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivative financial instruments", "label": "Description of accounting policy for fair value measurement [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/AccountingestimatesandjudgmentsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of property, plant and equipment", "label": "Description of accounting policy for impairment of assets [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the impairment of assets." } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "presentation": [ "http://www.nomadfoods.com/role/AccountingestimatesandjudgmentsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax positions", "label": "Description of accounting policy for income tax [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for income tax." } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory", "presentation": [ "http://www.nomadfoods.com/role/AccountingestimatesandjudgmentsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Carrying value of goodwill and brands", "label": "Description of accounting policy for intangible assets and goodwill [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]" } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/AccountingestimatesandjudgmentsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payments", "label": "Description of accounting policy for share-based payment transactions [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r233" ] }, "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of expected impact of initial application of new standards or interpretations [text block]", "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]" } }, "en": { "role": { "documentation": "The disclosure of the known or reasonably estimable information relevant to assessing the possible impact that the application of a new IFRS, that has been issued but is not yet effective, will have." } } }, "auth_ref": [ "r109" ] }, "ifrs-full_DescriptionOfNatureOfImpendingChangeInAccountingPolicy": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfNatureOfImpendingChangeInAccountingPolicy", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Description of nature of impending change in accounting policy", "label": "Description of nature of impending change in accounting policy" } }, "en": { "role": { "documentation": "The description of the nature of the impending change or changes in accounting policy due to a new IFRS that has been issued but is not yet effective." } } }, "auth_ref": [ "r213" ] }, "nomd_DescriptionofaccountingpolicyforchangesinaccountingpoliciesaccountingestimatesanderrorsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DescriptionofaccountingpolicyforchangesinaccountingpoliciesaccountingestimatesanderrorsPolicyTextBlock", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Description of accounting policy for changes in accounting policies, accounting estimates and errors [Policy Text Block]", "documentation": "Description of accounting policy for changes in accounting policies, accounting estimates and errors" } } }, "auth_ref": [] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareComputationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted earnings per share", "label": "Diluted earnings (loss) per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r75", "r76" ] }, "ifrs-full_DilutedEarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsPerShareAbstract", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted earnings per share", "label": "Diluted earnings per share [abstract]" } } }, "auth_ref": [] }, "nomd_DilutedearningspershareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DilutedearningspershareTextBlock", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Diluted Earnings per Share", "label": "diluted earnings per share [Text Block]", "documentation": "diluted earnings per share [Text Block]" } } }, "auth_ref": [] }, "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of share options on number of ordinary shares", "label": "Dilutive effect of share options on weighted average number of ordinary shares" } }, "en": { "role": { "documentation": "The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed exercise of the entity's share options." } } }, "auth_ref": [ "r242" ] }, "nomd_DilutiveEffectofRestrictedShareAwardsonNumberofOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DilutiveEffectofRestrictedShareAwardsonNumberofOrdinaryShares", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of restricted share awards on number of ordinary shares (in shares)", "label": "Dilutive Effect of Restricted Share Awards on Number of Ordinary Shares", "documentation": "Dilutive Effect of Restricted Share Awards on Number of Ordinary Shares" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Accountingestimatesandjudgments" ], "lang": { "en-us": { "role": { "terseLabel": "Accounting estimates and judgments", "label": "Disclosure of accounting judgements and estimates [text block]" } }, "en": { "role": { "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r229" ] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Basisofpreparation" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of preparation", "label": "Disclosure of basis of preparation of financial statements [text block]" } }, "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } } }, "auth_ref": [ "r229" ] }, "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBusinessCombinationsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Acquisitions" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions", "label": "Disclosure of business combinations [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for business combinations." } } }, "auth_ref": [ "r146" ] }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBusinessCombinationsTable", "presentation": [ "http://www.nomadfoods.com/role/AcquisitionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about business combination [table]", "label": "Disclosure of detailed information about business combination [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } } }, "auth_ref": [ "r144" ] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Cashandcashequivalents" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Disclosure of cash and cash equivalents [text block]" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r229" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share Capital and Capital Reserve", "label": "Disclosure of classes of share capital [text block]" } }, "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } } }, "auth_ref": [ "r32" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalLineItems", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of classes of share capital [line items]", "label": "Disclosure of classes of share capital [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfClassesOfShareCapitalTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalTable", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of classes of share capital [table]", "label": "Disclosure of classes of share capital [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to classes of share capital." } } }, "auth_ref": [ "r32" ] }, "ifrs-full_DisclosureOfDefinedBenefitPlansLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDefinedBenefitPlansLineItems", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of defined benefit plans [line items]", "label": "Disclosure of defined benefit plans [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDefinedBenefitPlansTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDefinedBenefitPlansTable", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of defined benefit plans [table]", "label": "Disclosure of defined benefit plans [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to defined benefit plans." } } }, "auth_ref": [ "r57" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about borrowings [line items]", "label": "Disclosure of detailed information about borrowings [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about borrowings [table]", "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r252" ] }, "nomd_DisclosureOfDetailedInformationAboutReservesWithinEquityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureOfDetailedInformationAboutReservesWithinEquityTableTextBlock", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reserves within Equity", "label": "Disclosure Of Detailed Information About Reserves Within Equity [Table Text Block]", "documentation": "Disclosure Of Detailed Information About Reserves Within Equity [Table Text Block]" } } }, "auth_ref": [] }, "nomd_DisclosureOfDetailedInformationForExceptionalItemsExplanatoryTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureOfDetailedInformationForExceptionalItemsExplanatoryTableTextBlock", "presentation": [ "http://www.nomadfoods.com/role/ExceptionalitemsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Exceptional Items", "label": "Disclosure Of Detailed Information For Exceptional Items Explanatory [Table Text Block]", "documentation": "Disclosure Of Detailed Information For Exceptional Items Explanatory [Table Text Block]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Earningspershare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share", "label": "Disclosure of earnings per share [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r77" ] }, "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEmployeeBenefitsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Employeebenefits" ], "lang": { "en-us": { "role": { "terseLabel": "Employee benefits", "label": "Disclosure of employee benefits [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for employee benefits." } } }, "auth_ref": [ "r66" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Segmentreporting" ], "lang": { "en-us": { "role": { "terseLabel": "Segment reporting", "label": "Disclosure of entity's operating segments [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r188" ] }, "nomd_DisclosureOfExceptionalItemsExplanatoryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureOfExceptionalItemsExplanatoryTextBlock", "presentation": [ "http://www.nomadfoods.com/role/Exceptionalitems" ], "lang": { "en-us": { "role": { "terseLabel": "Exceptional items", "label": "Disclosure Of Exceptional Items Explanatory [Text Block]", "documentation": "Disclosure Of Exceptional Items Explanatory [Text Block]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Financeincomeandcosts" ], "lang": { "en-us": { "role": { "terseLabel": "Finance income and costs", "label": "Disclosure of finance income (cost) [text block]" } }, "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } } }, "auth_ref": [ "r229" ] }, "nomd_DisclosureOfFinancialAssetsAndLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureOfFinancialAssetsAndLiabilitiesTable", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails", "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure Of Financial Assets And Liabilities [Table]", "label": "Disclosure Of Financial Assets And Liabilities [Table]", "documentation": "Disclosure Of Financial Assets And Liabilities [Table]" } } }, "auth_ref": [] }, "nomd_DisclosureOfFinancialAssetsAndLiabilitiesTableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureOfFinancialAssetsAndLiabilitiesTableLineItems", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails", "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure Of Financial Assets And Liabilities [Table] [Line Items]", "label": "Disclosure Of Financial Assets And Liabilities [Table] [Line Items]", "documentation": "[Line Items] for Disclosure Of Financial Assets And Liabilities [Table] [Table]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of Financial Assets", "label": "Disclosure of financial assets [text block]" } }, "en": { "role": { "documentation": "The disclosure of financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r165" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Disclosure of detailed information about financial instruments [abstract]", "label": "Disclosure of detailed information about financial instruments [abstract]" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Financialinstruments" ], "lang": { "en-us": { "role": { "terseLabel": "Financial instruments", "label": "Disclosure of financial instruments [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r171" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of Financial Liabilities", "label": "Disclosure of financial liabilities [text block]" } }, "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r165" ] }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Generalinformation" ], "lang": { "en-us": { "role": { "terseLabel": "General information", "label": "Disclosure of general information about financial statements [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } } }, "auth_ref": [ "r10" ] }, "ifrs-full_DisclosureOfGeographicalAreasExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeographicalAreasExplanatory", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingTables" ], "lang": { "en-us": { "role": { "verboseLabel": "External Revenue by Geography", "label": "Disclosure of geographical areas [text block]" } }, "en": { "role": { "documentation": "The disclosure of geographical information." } } }, "auth_ref": [ "r186" ] }, "ifrs-full_DisclosureOfGeographicalAreasLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeographicalAreasLineItems", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of geographical areas [line items]", "label": "Disclosure of geographical areas [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfGeographicalAreasTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeographicalAreasTable", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of geographical areas [table]", "label": "Disclosure of geographical areas [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to geographical areas." } } }, "auth_ref": [ "r186" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Taxation" ], "lang": { "en-us": { "role": { "terseLabel": "Taxation", "label": "Disclosure of income tax [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r54" ] }, "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Management Share Award Inputs and Assumptions", "label": "Disclosure of indirect measurement of fair value of goods or services received, other equity instruments granted during period [text block]" } }, "en": { "role": { "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's other equity instruments (ie other than share options)." } } }, "auth_ref": [ "r142" ] }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "presentation": [ "http://www.nomadfoods.com/role/EmployeebenefitsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Employee Benefit Obligations", "label": "Disclosure of net defined benefit liability (asset) [text block]" } }, "en": { "role": { "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r58" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Management Share Awards", "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)." } } }, "auth_ref": [ "r251" ] }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingTables" ], "lang": { "en-us": { "role": { "terseLabel": "Segment As Adjusted EBITDA", "label": "Disclosure of operating segments [text block]" } }, "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r177" ] }, "ifrs-full_DisclosureOfOperatingSegmentsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsLineItems", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of operating segments [line items]", "label": "Disclosure of operating segments [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOperatingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsTable", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of operating segments [table]", "label": "Disclosure of operating segments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to operating segments." } } }, "auth_ref": [ "r177" ] }, "ifrs-full_DisclosureOfOtherProvisionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Provisions", "label": "Disclosure of other provisions [text block]" } }, "en": { "role": { "documentation": "The disclosure of other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_DisclosureOfOtherProvisionsLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsLineItems", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of other provisions [line items]", "label": "Disclosure of other provisions [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherProvisionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsTable", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of other provisions [table]", "label": "Disclosure of other provisions [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to other provisions." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_DisclosureOfProvisionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfProvisionsExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Provisions" ], "lang": { "en-us": { "role": { "terseLabel": "Provisions", "label": "Disclosure of provisions [text block]" } }, "en": { "role": { "documentation": "The disclosure of provisions. [Refer: Provisions]" } } }, "auth_ref": [ "r229" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Relatedparties" ], "lang": { "en-us": { "role": { "terseLabel": "Related parties", "label": "Disclosure of related party [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r73" ] }, "ifrs-full_DisclosureOfReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://www.nomadfoods.com/role/Sharebasedcompensationreserve" ], "lang": { "en-us": { "role": { "netLabel": "Share based compensation reserve", "label": "Disclosure of reserves within equity [text block]" } }, "en": { "role": { "documentation": "The disclosure of reserves within equity. [Refer: Other reserves [member]]" } } }, "auth_ref": [ "r33" ] }, "nomd_DisclosureOfShareBasedCompensationReserveTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureOfShareBasedCompensationReserveTextBlock", "presentation": [ "http://www.nomadfoods.com/role/Sharebasedcompensationreserve" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of Share Based Compensation Reserve", "label": "Disclosure of Share Based Compensation Reserve [Text Block]", "documentation": "Disclosure of Share Based Compensation Reserve" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserve" ], "lang": { "en-us": { "role": { "terseLabel": "Share Capital and Capital reserve", "label": "Disclosure of share capital, reserves and other equity interest [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r34" ] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [line items]", "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [table]", "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } } }, "auth_ref": [ "r141" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of transactions between related parties [line items]", "label": "Disclosure of transactions between related parties [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disclosure of transactions between related parties [table]", "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r72" ] }, "nomd_DisclosureofCashandCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureofCashandCashEquivalentsTableTextBlock", "presentation": [ "http://www.nomadfoods.com/role/CashandcashequivalentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Cash and Cash Equivalents", "label": "Disclosure of Cash and Cash Equivalents [Table Text Block]", "documentation": "Disclosure of Cash and Cash Equivalents" } } }, "auth_ref": [] }, "nomd_DisclosureofFinanceIncomeandCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureofFinanceIncomeandCostsTableTextBlock", "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finance income and costs", "label": "Disclosure of Finance Income and Costs [Table Text Block]", "documentation": "Disclosure of Finance Income and Costs" } } }, "auth_ref": [] }, "nomd_DisclosureofotherprovisionscontingentliabilitiesandcontingentassetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureofotherprovisionscontingentliabilitiesandcontingentassetsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Disclosure of other provisions, contingent liabilities and contingent assets [Abstract]", "label": "Disclosure of other provisions, contingent liabilities and contingent assets [Abstract]", "documentation": "Disclosure of other provisions, contingent liabilities and contingent assets [Abstract]" } } }, "auth_ref": [] }, "nomd_DisclosureofsharecapitalreservesandotherequityinterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DisclosureofsharecapitalreservesandotherequityinterestAbstract", "lang": { "en-us": { "role": { "terseLabel": "Disclosure of share capital, reserves and other equity interest [Abstract]", "label": "Disclosure of share capital, reserves and other equity interest [Abstract]", "documentation": "Disclosure of share capital, reserves and other equity interest [Abstract]" } } }, "auth_ref": [] }, "nomd_DiscountOnIssuanceOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DiscountOnIssuanceOfDebt", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Discount on issuance of debt", "label": "Discount on issuance of debt", "documentation": "Discount on issuance of debt" } } }, "auth_ref": [] }, "nomd_DistributionNetworkIntegration": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DistributionNetworkIntegration", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": "nomd_AdjustmentsForExceptionalItems", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalitemsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Organizational Design (5)", "label": "Distribution network integration", "documentation": "Distribution network integration" } } }, "auth_ref": [] }, "ifrs-full_DividendsPaid": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaid", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity": { "parentTag": "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends", "label": "Dividends recognised as distributions to owners" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } } }, "auth_ref": [ "r8" ] }, "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Dividends paid, classified as financing activities", "label": "Dividends paid, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities." } } }, "auth_ref": [ "r101" ] }, "ifrs-full_DividendsPaidOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaidOrdinaryShares", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends paid, ordinary shares", "label": "Dividends paid, ordinary shares" } }, "en": { "role": { "documentation": "The amount of dividends paid by the entity on ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r78" ] }, "ifrs-full_DividendsPaidOrdinarySharesPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaidOrdinarySharesPerShare", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends paid, ordinary shares per share", "label": "Dividends paid, ordinary shares per share" } }, "en": { "role": { "documentation": "The amount of dividends paid per ordinary share." } } }, "auth_ref": [ "r78" ] }, "ifrs-full_DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsProposedOrDeclaredBeforeFinancialStatementsAuthorisedForIssueButNotRecognisedAsDistributionToOwnersPerShare", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share", "label": "Dividends proposed or declared before financial statements authorised for issue but not recognised as distribution to owners per share" } }, "en": { "role": { "documentation": "The amount, per share, of dividends proposed or declared before financial statements were authorised for issue but not recognised as distribution to owners." } } }, "auth_ref": [ "r9" ] }, "ifrs-full_DividendsRecognisedAsDistributionsToOwnersPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsRecognisedAsDistributionsToOwnersPerShare", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends recognised as distributions to owners per share (in dollars per share)", "label": "Dividends recognised as distributions to owners per share" } }, "en": { "role": { "documentation": "The amount, per share, of dividends recognised as distributions to owners." } } }, "auth_ref": [ "r8" ] }, "nomd_DividendsRecognisedAsDistributionsToOwnersShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "DividendsRecognisedAsDistributionsToOwnersShares", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Founder preferred shares annual dividend amount (in shares)", "label": "Dividends Recognised As Distributions To Owners, Shares", "documentation": "Dividends Recognised As Distributions To Owners, Shares" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.nomadfoods.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.nomadfoods.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.nomadfoods.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.nomadfoods.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "nomd_EBITDAAndCumulativeNetSalesTranchesAsPercentOfTotalAward": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "EBITDAAndCumulativeNetSalesTranchesAsPercentOfTotalAward", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBITDA and cumulative net sales tranches as percent of total award", "label": "EBITDA and Cumulative Net Sales tranches as Percent of Total Award", "documentation": "EBITDA and Cumulative Net Sales tranches as Percent of Total Award" } } }, "auth_ref": [] }, "nomd_EBITDAPerformanceTargetConditionOtherEquityInstrumentsGranted": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "EBITDAPerformanceTargetConditionOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "EBITDA Performance Target Conditions", "label": "EBITDA Performance Target Condition, Other Equity Instruments Granted", "documentation": "EBITDA Performance Target Condition, Other Equity Instruments Granted" } } }, "auth_ref": [] }, "country_ES": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "ES", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Spain", "label": "SPAIN" } } }, "auth_ref": [] }, "nomd_EarningsBeforeInterestTaxDepreciationandAmortizationAdjusted": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "EarningsBeforeInterestTaxDepreciationandAmortizationAdjusted", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjusted EBITDA", "label": "Earnings Before Interest, Tax, Depreciation and Amortization, Adjusted", "documentation": "Earnings Before Interest, Tax, Depreciation and Amortization, Adjusted" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share", "label": "Earnings per share [abstract]" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings per Share", "label": "Earnings per share [text block]" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_EarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareLineItems", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share [line items]", "label": "Earnings per share [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareTable", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share [table]", "label": "Earnings per share [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to earnings per share." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate fluctuations", "label": "Effect of exchange rate changes on cash and cash equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r99", "r100" ] }, "nomd_EmployeeBenefitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "EmployeeBenefitsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Employee Benefits [Abstract]", "label": "Employee Benefits [Abstract]", "documentation": "Employee Benefits [Abstract]" } } }, "auth_ref": [] }, "nomd_EmployeeExitRateOtherEquityInstrumentsGranted": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "EmployeeExitRateOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee exit rate", "label": "Employee Exit Rate, Other Equity Instruments Granted", "documentation": "Employee Exit Rate, Other Equity Instruments Granted" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.nomadfoods.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r228" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.nomadfoods.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r228" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/RelatedpartiesDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity's total for related parties [member]", "label": "Entity's total for related parties [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r72" ] }, "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSegmentConsolidationItemsMember", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Entity's total for segment consolidation items [member]", "label": "Entity's total for segment consolidation items [member]" } }, "en": { "role": { "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used." } } }, "auth_ref": [ "r183" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Equity", "periodEndLabel": "Equity", "terseLabel": "Equity", "label": "Equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r21", "r28", "r111", "r113", "r128", "r129", "r131" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Equity attributable to equity holders", "label": "Equity [abstract]" } } }, "auth_ref": [] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Equity attributable to owners of parent", "periodStartLabel": "Equity attributable to owners, beginning balance", "periodEndLabel": "Equity attributable to owners, ending balance", "label": "Equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r20" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Total equity", "label": "Equity attributable to owners of parent [member]" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity [member]", "label": "Equity [member]" } }, "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r7" ] }, "nomd_Equityattributabletoownersoftheparentrestated": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Equityattributabletoownersoftheparentrestated", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Equity attributable to owners of the parent (restated)", "terseLabel": "Equity attributable to owners of the parent (restated)", "label": "Equity attributable to owners of the parent (restated)", "documentation": "Equity attributable to owners of the parent (restated)" } } }, "auth_ref": [] }, "nomd_Equityrestated": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Equityrestated", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Equity (restated)", "terseLabel": "Equity (restated)", "label": "Equity (restated)", "documentation": "Equity (restated)" } } }, "auth_ref": [] }, "nomd_EventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "EventsAfterReportingPeriodAxis", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Events after Reporting Period [Axis]", "label": "Events after Reporting Period [Axis]", "documentation": "Events after Reporting Period" } } }, "auth_ref": [] }, "nomd_EventsAfterReportingPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "EventsAfterReportingPeriodDomain", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Events after Reporting Period [Domain]", "label": "Events after Reporting Period [Domain]", "documentation": "Events after Reporting Period" } } }, "auth_ref": [] }, "nomd_EventsAfterReportingPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "EventsAfterReportingPeriodMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Events after Reporting Period", "label": "Events after Reporting Period [Member]", "documentation": "Events after Reporting Period" } } }, "auth_ref": [] }, "nomd_ExceptionalItems": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ExceptionalItems", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exceptional items", "label": "Exceptional Items", "documentation": "Exceptional Items" } } }, "auth_ref": [] }, "nomd_ExceptionalItemsTaxExpenseIncomeContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ExceptionalItemsTaxExpenseIncomeContinuingOperations", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/ExceptionalitemsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exceptional Items, Tax Expense (Income), Continuing Operations", "label": "Exceptional Items, Tax Expense (Income), Continuing Operations", "documentation": "Exceptional Items, Tax Expense (Income), Continuing Operations" } } }, "auth_ref": [] }, "nomd_ExercisePriceOtherEquityInstrumentsGranted": { "xbrltype": "perShareItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ExercisePriceOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price", "label": "Exercise Price, Other Equity Instruments Granted", "documentation": "Exercise Price, Other Equity Instruments Granted" } } }, "auth_ref": [] }, "nomd_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ExpectedDividendAsPercentageOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend yield expected", "label": "Expected Dividend As Percentage, Other Equity Instruments Granted", "documentation": "Expected Dividend As Percentage, Other Equity Instruments Granted" } } }, "auth_ref": [] }, "nomd_ExpectedVolatilityOtherEquityInstrumentsGranted": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ExpectedVolatilityOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility of the share price", "label": "Expected Volatility, Other Equity Instruments Granted", "documentation": "Expected Volatility, Other Equity Instruments Granted" } } }, "auth_ref": [] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expense from share-based payment transactions with employees", "label": "Expense from share-based payment transactions with employees" } }, "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } } }, "auth_ref": [ "r232" ] }, "nomd_ExpensesFromSupplyChainReconfiguration": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ExpensesFromSupplyChainReconfiguration", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/ExceptionalitemsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Information Technology transformation program (3)", "label": "Expenses From Supply Chain Reconfiguration", "documentation": "Expenses From Supply Chain Reconfiguration" } } }, "auth_ref": [] }, "srt_ExternalCreditRatingFitchMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ExternalCreditRatingFitchMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating, Fitch [Domain]", "label": "External Credit Rating, Fitch [Domain]" } } }, "auth_ref": [] }, "srt_ExternalCreditRatingMoodysMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ExternalCreditRatingMoodysMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating, Moody's [Domain]", "label": "External Credit Rating, Moody's [Domain]" } } }, "auth_ref": [] }, "srt_ExternalCreditRatingStandardPoorsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ExternalCreditRatingStandardPoorsMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "External Credit Rating, Standard & Poor's [Domain]", "label": "External Credit Rating, Standard & Poor's [Domain]" } } }, "auth_ref": [] }, "country_FR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "FR", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "France", "label": "FRANCE" } } }, "auth_ref": [] }, "nomd_FactoryOptimization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FactoryOptimization", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": "nomd_AdjustmentsForExceptionalItems", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails", "http://www.nomadfoods.com/role/ExceptionalitemsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Factory optimization (6)", "label": "Factory Optimization", "documentation": "Factory Optimization" } } }, "auth_ref": [] }, "ifrs-full_FairValueGainLossThatWouldHaveBeenRecognisedInProfitOrLossOrOtherComprehensiveIncomeIfFinancialAssetsHadNotBeenReclassifiedFirstApplicationOfIFRS9": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FairValueGainLossThatWouldHaveBeenRecognisedInProfitOrLossOrOtherComprehensiveIncomeIfFinancialAssetsHadNotBeenReclassifiedFirstApplicationOfIFRS9", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value gain (loss) that would have been recognised in profit or loss or other comprehensive income if financial assets had not been reclassified as measured at amortised cost, initial application of IFRS 9", "label": "Fair value gain (loss) that would have been recognised in profit or loss or other comprehensive income if financial assets had not been reclassified as measured at amortised cost, initial application of IFRS 9" } }, "en": { "role": { "documentation": "The fair value gain (loss) that would have been recognised in profit or loss or other comprehensive income if financial assets had not been reclassified so that they are measured at amortised cost as a result of the transition to IFRS 9. [Refer: Financial assets]" } } }, "auth_ref": [ "r163" ] }, "srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "FederalHomeLoanBankAdvancesBranchOfFHLBBankAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Home Loan Bank Branch [Axis]", "label": "Federal Home Loan Bank Branch [Axis]" } } }, "auth_ref": [] }, "srt_FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "FederalHomeLoanBankAdvancesBranchOfFHLBBankStateDomain", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal Home Loan Bank Branch [Domain]", "label": "Federal Home Loan Bank Branch [Domain]" } } }, "auth_ref": [] }, "nomd_FeesAndExpensesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FeesAndExpensesRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fees and expenses", "label": "Fees And Expenses, Related Party Transactions", "documentation": "Fees And Expenses, Related Party Transactions" } } }, "auth_ref": [] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": -1.0, "order": 2.0 }, "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Finance costs", "negatedTotalLabel": "Total finance costs", "label": "Finance costs" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r42" ] }, "ifrs-full_FinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncome", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0, "order": 1.0 }, "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Finance income", "totalLabel": "Total finance income", "label": "Finance income" } }, "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r238" ] }, "ifrs-full_FinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncomeCost", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails", "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net financing costs", "negatedTerseLabel": "Net financing costs", "label": "Finance income (cost)" } }, "en": { "role": { "documentation": "The amount of income or cost associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r238" ] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Financial assets", "label": "Financial assets" } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } } }, "auth_ref": [ "r153", "r155", "r156", "r159", "r223" ] }, "ifrs-full_FinancialAssetsAtAmortisedCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsAtAmortisedCost", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": "ifrs-full_FinancialAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets at amortised cost", "label": "Financial assets at amortised cost" } }, "en": { "role": { "documentation": "The amount of financial assets at amortised cost. The amortised cost is the amount at which financial assets are measured at initial recognition minus principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount, and adjusted for any impairment. [Refer: Financial assets]" } } }, "auth_ref": [ "r168" ] }, "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsAtFairValueThroughProfitOrLoss", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": "nomd_FinancialAssetsLiabilitiesNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets at fair value through profit or loss", "label": "Financial assets at fair value through profit or loss" } }, "en": { "role": { "documentation": "The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]" } } }, "auth_ref": [ "r166" ] }, "nomd_FinancialAssetsFinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FinancialAssetsFinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncome", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": "nomd_FinancialAssetsLiabilitiesNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets (liabilities) at fair value through other comprehensive income", "label": "Financial Assets (Financial Liabilities) At Fair Value Through Other Comprehensive Income", "documentation": "Financial Assets (Financial Liabilities) At Fair Value Through Other Comprehensive Income" } } }, "auth_ref": [] }, "nomd_FinancialAssetsFinancialLiabilitiesAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FinancialAssetsFinancialLiabilitiesAtFairValueThroughProfitOrLoss", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": "nomd_FinancialAssetsLiabilitiesNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets (liabilities) at fair value through profit or loss", "label": "Financial Assets (Financial Liabilities) At Fair Value Through Profit Or Loss", "documentation": "Financial Assets (Financial Liabilities) At Fair Value Through Profit Or Loss" } } }, "auth_ref": [] }, "nomd_FinancialAssetsLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FinancialAssetsLiabilitiesNet", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Financial Assets (Liabilities), Net", "documentation": "Financial Assets (Liabilities), Net" } } }, "auth_ref": [] }, "ifrs-full_FinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial assets, class [member]", "label": "Financial assets, class [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r138", "r162", "r164", "r193", "r194" ] }, "ifrs-full_FinancialEffectOfChangesInAccountingPolicyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialEffectOfChangesInAccountingPolicyMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) due to changes in accounting policy [member]", "label": "Increase (decrease) due to changes in accounting policy [member]" } }, "en": { "role": { "documentation": "This member stands for the financial effect of changes in accounting policy." } } }, "auth_ref": [ "r106", "r107" ] }, "nomd_FinancialInstrumentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FinancialInstrumentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Abstract]", "label": "Financial Instruments [Abstract]", "documentation": "Financial Instruments [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails", "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Financial liabilities", "terseLabel": "Carrying value", "label": "Financial liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r153" ] }, "ifrs-full_FinancialLiabilitiesAtAmortisedCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtAmortisedCost", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": "nomd_FinancialAssetsLiabilitiesNet", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Financial liabilities at amortised cost", "label": "Financial liabilities at amortised cost" } }, "en": { "role": { "documentation": "The amount of financial liabilities at amortised cost. The amortised cost is the amount at which financial liabilities are measured at initial recognition minus principal repayments, plus or minus the cumulative amortisation using the effective interest method of any difference between that initial amount and the maturity amount. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r169" ] }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValue", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Fair value", "label": "Financial liabilities, at fair value" } }, "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } } }, "auth_ref": [ "r153" ] }, "nomd_FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FinancialLiabilitiesAtFairValueThroughOtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Financial Liabilities At Fair Value Through Other Comprehensive Income", "label": "Financial Liabilities At Fair Value Through Other Comprehensive Income", "documentation": "Financial Liabilities At Fair Value Through Other Comprehensive Income" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLoss", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails": { "parentTag": "ifrs-full_FinancialLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Financial liabilities at fair value through profit or loss", "label": "Financial liabilities at fair value through profit or loss" } }, "en": { "role": { "documentation": "The amount of financial liabilities that meet either of the following conditions: (a) they meet the definition of held for trading; or (b) upon initial recognition they are designated by the entity as at fair value through profit or loss. An entity may use this designation only when permitted by paragraph 4.3.5 of IFRS 9 (embedded derivatives) or when doing so results in more relevant information, because either: (a) it eliminates or significantly reduces a measurement or recognition inconsistency (sometimes referred to as \u2018an accounting mismatch\u2019) that would otherwise arise from measuring assets or liabilities or recognising the gains and losses on them on different bases; or (b) a group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the group is provided internally on that basis to the entity\u2019s key management personnel (as defined in IAS 24). [Refer: At fair value [member]; Key management personnel of entity or parent [member]; Derivatives [member]; Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r167" ] }, "ifrs-full_FinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails", "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial liabilities, class [member]", "label": "Financial liabilities, class [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r162", "r164", "r193", "r194" ] }, "nomd_FindusSwitzerlandIntegrationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FindusSwitzerlandIntegrationCosts", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": "nomd_AdjustmentsForExceptionalItems", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Findus Switzerland integration costs (2)", "label": "Findus Switzerland Integration Costs", "documentation": "Findus Switzerland Integration Costs" } } }, "auth_ref": [] }, "nomd_FortenovaGroupIntegrationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FortenovaGroupIntegrationCosts", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": "nomd_AdjustmentsForExceptionalItems", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fortenova Acquisition integration costs (2)", "label": "Fortenova Group Integration Costs", "documentation": "Fortenova Group Integration Costs" } } }, "auth_ref": [] }, "nomd_FounderEntitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FounderEntitiesMember", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Founder Entities", "label": "Founder Entities [Member]", "documentation": "Founder Entities [Member]" } } }, "auth_ref": [] }, "nomd_FounderPreferredSharesDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FounderPreferredSharesDomain", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Founder preferred shares [Domain]", "label": "Founder preferred shares [Domain]", "documentation": "Founder preferred shares [Domain]" } } }, "auth_ref": [] }, "nomd_FounderpreferredsharesAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "FounderpreferredsharesAxis", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Founder preferred shares [Axis]", "label": "Founder preferred shares [Axis]", "documentation": "Founder preferred shares [Axis]" } } }, "auth_ref": [] }, "country_GB": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "GB", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United Kingdom", "label": "UNITED KINGDOM" } } }, "auth_ref": [] }, "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Actuarial gain on pension scheme valuations", "label": "Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income" } }, "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r61" ] }, "nomd_GainsLossesOnRestructuringOfPreviousDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "GainsLossesOnRestructuringOfPreviousDebt", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gains (Losses) on Restructuring of previous debt", "label": "Gains (Losses) on Restructuring of previous debt", "documentation": "Gains (Losses) on Restructuring of previous debt" } } }, "auth_ref": [] }, "nomd_GainsLossesonRestructuringofDebt1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "GainsLossesonRestructuringofDebt1", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing costs incurred on new or amended debt (d)", "label": "Gains (Losses) on Restructuring of Debt1", "documentation": "Gains (Losses) on Restructuring of Debt1" } } }, "auth_ref": [] }, "nomd_GeneralInformationAboutFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "GeneralInformationAboutFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "General Information About Financial Statements [Abstract]", "label": "General Information About Financial Statements [Abstract]", "documentation": "General Information About Financial Statements [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails", "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical areas [axis]", "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r186", "r202", "r220", "r222" ] }, "ifrs-full_GeographicalAreasMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasMember", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails", "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical areas [member]", "label": "Geographical areas [member]" } }, "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r186", "r202", "r220", "r222" ] }, "nomd_GoodfellasPizzaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "GoodfellasPizzaMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodfella's Pizza [Member]", "label": "Goodfella's Pizza [Member]", "documentation": "Goodfella's Pizza [Member]" } } }, "auth_ref": [] }, "ifrs-full_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill" } }, "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r12", "r79", "r80", "r145" ] }, "nomd_GrantDatePriceOtherEquityInstrumentsGranted": { "xbrltype": "perShareItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "GrantDatePriceOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant date price", "label": "Grant Date Price, Other Equity Instruments Granted", "documentation": "Grant Date Price, Other Equity Instruments Granted" } } }, "auth_ref": [] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross profit" } }, "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } } }, "auth_ref": [ "r196" ] }, "country_HR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "HR", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "CROATIA", "label": "CROATIA" } } }, "auth_ref": [] }, "ifrs-full_HedgesOfNetInvestmentInForeignOperationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "HedgesOfNetInvestmentInForeignOperationsMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedges of net investment in foreign operations", "label": "Hedges of net investment in foreign operations [member]" } }, "en": { "role": { "documentation": "This member stands for hedges of the entity's monetary items that are receivable from or payable to a foreign operation, for which settlement is neither planned nor likely to occur in the foreseeable future. A foreign operation is an entity that is a subsidiary, associate, joint venture or branch of a reporting entity, the activities of which are based or conducted in a country or currency other than those of the reporting entity." } } }, "auth_ref": [ "r90", "r149", "r150", "r151" ] }, "ifrs-full_HedgingInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "HedgingInstrumentsAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging instruments [axis]", "label": "Hedging instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r148", "r149" ] }, "ifrs-full_HedgingInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "HedgingInstrumentsMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging instruments [member]", "label": "Hedging instruments [member]" } }, "en": { "role": { "documentation": "This member stands for hedging instruments. A hedging instrument can be a designated: (a) derivative measured at fair value through profit or loss, except for some written options (see paragraph B6.2.4 of IFRS 9); (b) non-derivative financial asset or non-derivative financial liability measured at fair value through profit or loss, unless it is a financial liability designated as at fair value through profit or loss for which the amount of its change in fair value that is attributable to changes in the credit risk of that liability is presented in other comprehensive income in accordance with paragraph 5.7.7 of IFRS 9. For a hedge of foreign currency risk, the foreign currency risk component of a non-derivative financial asset or a non-derivative financial liability may be designated as a hedging instrument provided that it is not an investment in an equity instrument for which an entity has elected to present changes in fair value in other comprehensive income in accordance with paragraph 5.7.5 of IFRS 9. This member also represents the standard value for the 'Hedging instruments' axis if no other member is used." } } }, "auth_ref": [ "r148", "r149" ] }, "country_IT": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "IT", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Italy", "label": "ITALY" } } }, "auth_ref": [] }, "ifrs-full_ImpairmentLossRecognisedInProfitOrLossLoansAndAdvances": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ImpairmentLossRecognisedInProfitOrLossLoansAndAdvances", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net impairment loss on short term investments", "label": "Impairment loss recognised in profit or loss, loans and advances" } }, "en": { "role": { "documentation": "The amount of impairment loss recognised in profit or loss for loans and advances. [Refer: Impairment loss recognised in profit or loss]" } } }, "auth_ref": [ "r238" ] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Profit or loss [abstract]", "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss_1": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails", "http://www.nomadfoods.com/role/TaxationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Taxation", "terseLabel": "Taxation", "verboseLabel": "Tax expense", "label": "Tax expense (income)" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r43", "r49", "r51", "r52", "r74", "r127", "r176" ] }, "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Taxation (charge)/credit relating to components of other comprehensive income", "label": "Income tax relating to components of other comprehensive income that will be reclassified to profit or loss" } }, "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]" } } }, "auth_ref": [ "r47" ] }, "ifrs-full_IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxRelatingToRemeasurementsOfDefinedBenefitPlansOfOtherComprehensiveIncome", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Taxation (charge)/credit on measurement of defined benefit pension plans", "label": "Income tax relating to remeasurements of defined benefit plans included in other comprehensive income" } }, "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to remeasurements of defined benefit plans. [Refer: Other comprehensive income; Reserve of remeasurements of defined benefit plans; Defined benefit plans [member]]" } } }, "auth_ref": [ "r44", "r50" ] }, "nomd_IncomeTaxesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IncomeTaxesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Taxes [Abstract]", "label": "Income Taxes [Abstract]", "documentation": "Income Taxes [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxesPaidRefundClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxesPaidRefundClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Payments related to shares withheld for taxes", "label": "Income taxes paid (refund), classified as financing activities" } }, "en": { "role": { "documentation": "The cash flows from income taxes paid or refunded, classified as financing activities. [Refer: Income taxes paid (refund)]" } } }, "auth_ref": [ "r102", "r206" ] }, "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Tax paid", "label": "Income taxes paid (refund), classified as operating activities" } }, "en": { "role": { "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]" } } }, "auth_ref": [ "r102", "r206" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net (decrease)/increase in cash and cash equivalents", "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r104" ] }, "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInNumberOfSharesOutstanding", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) in number of shares outstanding", "label": "Increase (decrease) in number of shares outstanding" } }, "en": { "role": { "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]" } } }, "auth_ref": [ "r31" ] }, "ifrs-full_IncreaseDecreaseThroughAcquisitionOfSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughAcquisitionOfSubsidiary", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) through acquisition of subsidiary, equity", "label": "Increase (decrease) through acquisition of subsidiary, equity" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the acquisition of subsidiaries. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r230" ] }, "ifrs-full_IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquired through business combinations", "label": "Increase (decrease) in net defined benefit liability (asset) resulting from business combinations and disposals" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from business combinations and disposals. [Refer: Business combinations [member]; Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r64" ] }, "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange differences on translation", "label": "Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r62" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange", "label": "Increase (decrease) through net exchange differences, other provisions" } }, "en": { "role": { "documentation": "The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_IncreaseDecreaseThroughOtherChangesNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughOtherChangesNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) in net defined benefit liability (asset) resulting from other changes", "label": "Increase (decrease) in net defined benefit liability (asset) resulting from other changes" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r240" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity": { "parentTag": "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Share based payment charge", "label": "Increase (decrease) through share-based payment transactions, equity" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r6" ] }, "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTransactionsWithOwners", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total transactions with owners, recognized directly in equity", "label": "Increase (decrease) through transactions with owners, equity" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from transactions with owners." } } }, "auth_ref": [ "r230" ] }, "ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) through transfers, intangible assets other than goodwill", "label": "Increase (decrease) through transfers, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r244" ] }, "nomd_IncreaseDecreaseThroughVestingOfOtherEquityInstrumentsInShareBasedPaymentTransactionsEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IncreaseDecreaseThroughVestingOfOtherEquityInstrumentsInShareBasedPaymentTransactionsEquity", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity": { "parentTag": "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity", "label": "Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity", "documentation": "Increase (Decrease) Through Vesting Of Other Equity Instruments In Share-Based Payment Transactions, Equity" } } }, "auth_ref": [] }, "nomd_IncreaseinreservesrecognizedofapplyingIFRS16": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IncreaseinreservesrecognizedofapplyingIFRS16", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in reserves recognized of applying IFRS 16", "label": "Increase in reserves recognized of applying IFRS 16", "documentation": "Increase in reserves recognized of applying IFRS 16" } } }, "auth_ref": [] }, "ifrs-full_IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental fair value granted, modified share-based payment arrangements", "label": "Incremental fair value granted, modified share-based payment arrangements" } }, "en": { "role": { "documentation": "The difference, for modified share-based payment arrangements, between the fair value of the modified equity instrument and that of the original equity instrument, both estimated as at the date of the modification. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r143" ] }, "nomd_IndemnificationAssetLiabilityWithCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IndemnificationAssetLiabilityWithCustomersMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification asset liability with customers", "label": "Indemnification asset liability with customers [Member]", "documentation": "Indemnification asset liability with customers" } } }, "auth_ref": [] }, "nomd_IndemnificationAssetsRecognizedAsOfAcquisitionDate": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IndemnificationAssetsRecognizedAsOfAcquisitionDate", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification assets", "label": "Indemnification assets recognized as of acquisition date", "documentation": "Indemnification assets recognized as of acquisition date" } } }, "auth_ref": [] }, "nomd_InflowsOutflowsOfCashDueToExceptionalItemsClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "InflowsOutflowsOfCashDueToExceptionalItemsClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalitemsAdditionalInformationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Payments relating to exceptional items", "label": "Inflows (Outflows) Of Cash Due To Exceptional Items, Classified As Operating Activities", "documentation": "Inflows (Outflows) Of Cash Due To Exceptional Items, Classified As Operating Activities" } } }, "auth_ref": [] }, "nomd_InformationTechnologyTransformationProgram": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "InformationTechnologyTransformationProgram", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": "nomd_AdjustmentsForExceptionalItems", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Information Technology transformation program (3)", "label": "Information Technology Transformation program", "documentation": "Information Technology Transformation program" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Intangibles", "label": "Intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r12", "r87" ] }, "ifrs-full_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense (b)", "label": "Interest expense" } }, "en": { "role": { "documentation": "The amount of expense arising from interest." } } }, "auth_ref": [ "r126", "r174", "r182" ] }, "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net interest expense", "label": "Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r60" ] }, "ifrs-full_InterestPaidClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestPaidClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest paid", "label": "Interest paid, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as financing activities." } } }, "auth_ref": [ "r101" ] }, "nomd_InterestRateFloor": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "InterestRateFloor", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate floor", "label": "Interest rate floor", "documentation": "Interest rate floor" } } }, "auth_ref": [] }, "ifrs-full_InterestReceivedClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestReceivedClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Interest received", "label": "Interest received, classified as investing activities" } }, "en": { "role": { "documentation": "The cash inflow from interest received, classified as investing activities." } } }, "auth_ref": [ "r101" ] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Current inventories" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r13", "r67", "r198" ] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity": { "parentTag": "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issue of ordinary shares", "label": "Issue of equity" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r6" ] }, "nomd_IssuedCapitalAndCapitalReserveMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IssuedCapitalAndCapitalReserveMember", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued Capital and Capital Reserve", "label": "Issued Capital And Capital Reserve [Member]", "documentation": "Issued Capital And Capital Reserve [Member]" } } }, "auth_ref": [] }, "nomd_IssuedCapitalandCapitalReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IssuedCapitalandCapitalReserve", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total net share capital and capital reserve", "label": "Issued Capital and Capital Reserve", "documentation": "Issued Capital and Capital Reserve" } } }, "auth_ref": [] }, "nomd_IssuedCapitalandCapitalReserveGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IssuedCapitalandCapitalReserveGross", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails": { "parentTag": "nomd_IssuedCapitalandCapitalReserve", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total share capital and capital reserve", "label": "Issued Capital and Capital Reserve, Gross", "documentation": "Issued Capital and Capital Reserve, Gross" } } }, "auth_ref": [] }, "nomd_IssuedPriceOfSeniorSecuredNotes2028": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "IssuedPriceOfSeniorSecuredNotes2028", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued price of Senior Secured Notes (2028)", "label": "Issued price of Senior Secured Notes (2028)", "documentation": "Issued price of Senior Secured Notes (2028)" } } }, "auth_ref": [] }, "nomd_January12016Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12016Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2016", "label": "January 1, 2016 [Member]", "documentation": "January 1, 2016 [Member]" } } }, "auth_ref": [] }, "nomd_January12017Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12017Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2017", "label": "January 1, 2017 [Member]", "documentation": "January 1, 2017 [Member]" } } }, "auth_ref": [] }, "nomd_January12018Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12018Member", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2018", "label": "January 1, 2018 [Member]", "documentation": "January 1, 2018" } } }, "auth_ref": [] }, "nomd_January12019Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12019Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2019", "label": "January 1, 2019 [Member]", "documentation": "January 1, 2019" } } }, "auth_ref": [] }, "nomd_January12020Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12020Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2020", "label": "January 1, 2020 [Member]", "documentation": "January 1, 2020" } } }, "auth_ref": [] }, "nomd_January12021Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12021Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2021", "label": "January 1, 2021 [Member]", "documentation": "January 1, 2021" } } }, "auth_ref": [] }, "nomd_January12022Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12022Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2022", "label": "January 1, 2022 [Member]", "documentation": "January 1, 2022" } } }, "auth_ref": [] }, "nomd_January12023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12023Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2023", "label": "January 1, 2023 [Member]", "documentation": "January 1, 2023" } } }, "auth_ref": [] }, "nomd_January12024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "January12024Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "January 1, 2024", "label": "January 1, 2024 [Member]", "documentation": "January 1, 2024" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Key management personnel compensation", "label": "Key management personnel compensation" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r70" ] }, "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelOfEntityOrParentMember", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Key management personnel of entity or parent", "label": "Key management personnel of entity or parent [member]" } }, "en": { "role": { "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity." } } }, "auth_ref": [ "r71" ] }, "nomd_KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "KeyManagementPersonnelOfEntityOrParentNonExecutiveDirectorMember", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/RelatedpartiesDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-Executive Director", "label": "Key Management Personnel Of Entity Or Parent, Non-Executive Director [Member]", "documentation": "Key Management Personnel Of Entity Or Parent, Non-Executive Director [Member]" } } }, "auth_ref": [] }, "nomd_KeyManagementPersonnelOfEntityOrParentReclassificationToTaxLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "KeyManagementPersonnelOfEntityOrParentReclassificationToTaxLiabilityMember", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Key Management Personnel Of Entity Or Parent, Reclassification to tax liability", "label": "Key Management Personnel Of Entity Or Parent, Reclassification to tax liability [Member]", "documentation": "Key Management Personnel Of Entity Or Parent, Reclassification to tax liability" } } }, "auth_ref": [] }, "nomd_LTIPVestingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "LTIPVestingMember", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "LTIP vesting", "label": "LTIP vesting [Member]", "documentation": "LTIP vesting" } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r135" ] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r65", "r129" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r129" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Levels of fair value hierarchy [axis]", "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r65", "r129" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NetAssetsLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r21", "r128", "r129", "r131", "r177", "r181" ] }, "nomd_LiabilitiesFromSharebasedPaymentTransactionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "LiabilitiesFromSharebasedPaymentTransactionsShares", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities from share-based payment transactions (in shares)", "label": "Liabilities From Share-based Payment Transactions, Shares", "documentation": "Liabilities From Share-based Payment Transactions, Shares" } } }, "auth_ref": [] }, "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilityAssetOfDefinedBenefitPlans", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Net defined benefit liability (asset) at beginning of period", "periodEndLabel": "Net defined benefit liability (asset) at end of period", "label": "Net defined benefit liability (asset)" } }, "en": { "role": { "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]" } } }, "auth_ref": [ "r58" ] }, "nomd_LiabilityrelatingtoIFRS16Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "LiabilityrelatingtoIFRS16Member", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability relating to IFRS 16", "label": "Liability relating to IFRS 16 [Member]", "documentation": "Liability relating to IFRS 16 [Member]" } } }, "auth_ref": [] }, "nomd_LineofCreditFacilityMaximumBorrowingCapacity1": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "LineofCreditFacilityMaximumBorrowingCapacity1", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit facility, maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity1", "documentation": "Line of Credit Facility, Maximum Borrowing Capacity" } } }, "auth_ref": [] }, "nomd_LoansandBorrowingsExcludingDeferredBorrowingCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "LoansandBorrowingsExcludingDeferredBorrowingCostsMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans and borrowings", "label": "Loans and Borrowings Excluding Deferred Borrowing Costs [Member]", "documentation": "Loans and Borrowings Excluding Deferred Borrowing Costs [Member]" } } }, "auth_ref": [] }, "nomd_LoansandBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "LoansandBorrowingsMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Loans and Borrowings", "label": "Loans and Borrowings [Member]", "documentation": "Loans and Borrowings [Member]" } } }, "auth_ref": [] }, "ifrs-full_LongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LongtermBorrowings", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Loans and borrowings", "label": "Non-current portion of non-current borrowings" } }, "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_LossesOnChangeInFairValueOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LossesOnChangeInFairValueOfDerivatives", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net fair value losses on derivatives held at fair value through profit or loss", "label": "Losses on change in fair value of derivatives" } }, "en": { "role": { "documentation": "The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r238" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]" } } }, "auth_ref": [] }, "nomd_ManagementAward2016Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ManagementAward2016Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Management Award 2016", "label": "Management Award 2016 [Member]", "documentation": "Management Award 2016 [Member]" } } }, "auth_ref": [] }, "nomd_ManagementAward2017Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ManagementAward2017Member", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Management Award 2017", "terseLabel": "Management Award 2017 [Member]", "label": "Management Award 2017 [Member]", "documentation": "Management Award 2017 [Member]" } } }, "auth_ref": [] }, "nomd_ManagementAward2019Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ManagementAward2019Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Management Award 2019", "label": "Management Award 2019 [Member]", "documentation": "Management Award 2019" } } }, "auth_ref": [] }, "nomd_ManagementAward2020Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ManagementAward2020Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Management Award 2020", "label": "Management Award 2020 [Member]", "documentation": "Management Award 2020" } } }, "auth_ref": [] }, "nomd_ManagementAward2021Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ManagementAward2021Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Management Award 2021", "label": "Management Award 2021 [Member]", "documentation": "Management Award 2021" } } }, "auth_ref": [] }, "nomd_MariposaCapitalandTOMSCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "MariposaCapitalandTOMSCapitalMember", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mariposa Capital and TOMS Capital", "label": "Mariposa Capital and TOMS Capital [Member]", "documentation": "Mariposa Capital and TOMS Capital [Member]" } } }, "auth_ref": [] }, "ifrs-full_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Material reconciling items", "label": "Material reconciling items [member]" } }, "en": { "role": { "documentation": "This member stands for material adjustments used to reconcile items in the entity's financial statements." } } }, "auth_ref": [ "r183" ] }, "ifrs-full_MiscellaneousOtherProvisionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MiscellaneousOtherProvisionsMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Miscellaneous other provisions [member]" } }, "en": { "role": { "documentation": "This member stands for miscellaneous other provisions. [Refer: Other provisions [member]]" } } }, "auth_ref": [ "r85" ] }, "country_NO": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "NO", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Norway", "label": "NORWAY" } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]" } } }, "auth_ref": [] }, "ifrs-full_NetAssetsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetAssetsLiabilities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Net assets", "label": "Assets (liabilities)" } }, "en": { "role": { "documentation": "The amount of assets less the amount of liabilities." } } }, "auth_ref": [ "r214", "r232" ] }, "nomd_NetCashFlowsFromUsedInOperatingActivitiesBeforeIncomeTaxesPaidAndCashFlowsRelatedToExceptionalItems": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "NetCashFlowsFromUsedInOperatingActivitiesBeforeIncomeTaxesPaidAndCashFlowsRelatedToExceptionalItems", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash generated from operations before tax and exceptional items", "label": "Net Cash Flows From (Used In) Operating Activities, Before Income Taxes Paid And Cash Flows Related To Exceptional Items", "documentation": "Net Cash Flows From (Used In) Operating Activities, Before Income Taxes Paid And Cash Flows Related To Exceptional Items" } } }, "auth_ref": [] }, "nomd_NetForeignExchangeGainsOnFinancialAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "NetForeignExchangeGainsOnFinancialAssetsAndLiabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net foreign exchange gains on translation of financial assets and liabilities", "label": "Net Foreign Exchange Gains On Financial Assets And Liabilities", "documentation": "Net Foreign Exchange Gains On Financial Assets And Liabilities" } } }, "auth_ref": [] }, "nomd_NetForeignExchangeLossesOnFinancialAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "NetForeignExchangeLossesOnFinancialAssetsAndLiabilities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net foreign exchange losses arising on translation of financial assets and liabilities", "label": "Net Foreign Exchange Losses On Financial Assets And Liabilities", "documentation": "Net Foreign Exchange Losses On Financial Assets And Liabilities" } } }, "auth_ref": [] }, "nomd_NetGainOnRefinancing": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "NetGainOnRefinancing", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net gain on refinancing", "label": "Net gain on refinancing", "documentation": "Net gain on refinancing" } } }, "auth_ref": [] }, "nomd_NetPensionInterestCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "NetPensionInterestCosts", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceCosts", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Net pension interest costs", "label": "Net Pension Interest Costs", "documentation": "Net Pension Interest Costs" } } }, "auth_ref": [] }, "nomd_NonCashLossRecognizedInRelationToCrossCurrencyInterestRateSwaps": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "NonCashLossRecognizedInRelationToCrossCurrencyInterestRateSwaps", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash loss recognized in relation to cross currency interest rate swaps", "label": "Non-cash loss recognized in relation to cross currency interest rate swaps", "documentation": "Non-cash loss recognized in relation to cross currency interest rate swaps" } } }, "auth_ref": [] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling interests", "label": "Non-controlling interests [member]" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r7" ] }, "nomd_Noncontrollinginterestthroughacquisitionofsubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Noncontrollinginterestthroughacquisitionofsubsidiary", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity": { "parentTag": "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Non controlling interest through acquisition of subsidiary", "label": "Non controlling interest through acquisition of subsidiary", "documentation": "Non controlling interest through acquisition of subsidiary" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Non-current assets" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r23", "r117", "r215" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets", "label": "Non-current assets [abstract]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentDerivativeFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentDerivativeFinancialAssets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial instruments", "label": "Non-current derivative financial assets" } }, "en": { "role": { "documentation": "The amount of non-current derivative financial assets. [Refer: Derivative financial assets]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_NoncurrentDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentDerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative financial instruments", "label": "Non-current derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Non-current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r24", "r119", "r215" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current liabilities", "label": "Non-current liabilities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentProvisions", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/ProvisionsScheduleDetails": { "parentTag": "ifrs-full_Provisions", "weight": 1.0, "order": 2.0 }, "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ProvisionsScheduleDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Provisions", "verboseLabel": "Non-current", "label": "Non-current provisions" } }, "en": { "role": { "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r17" ] }, "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentRecognisedLiabilitiesDefinedBenefitPlan", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Employee benefits", "label": "Non-current net defined benefit liability" } }, "en": { "role": { "documentation": "The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_NotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotionalAmount", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional amount", "label": "Notional amount" } }, "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } } }, "auth_ref": [ "r232" ] }, "nomd_NumberOfCountriesInWhichEntityOperates1": { "xbrltype": "integerItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "NumberOfCountriesInWhichEntityOperates1", "presentation": [ "http://www.nomadfoods.com/role/GeneralinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of countries in which entity operates", "label": "Number Of Countries In Which Entity Operates1", "documentation": "Number Of Countries In Which Entity Operates1" } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New awards granted in the period (in shares)", "label": "Number of other equity instruments granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r142", "r251" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of other equity instruments exercised or vested in share-based payment arrangement", "negatedLabel": "Awards vested and issued in period (in shares)", "verboseLabel": "Number of other equity instruments exercised or vested in share-based payment arrangement (in shares)", "label": "Number of other equity instruments exercised or vested in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } } }, "auth_ref": [ "r251" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of other equity instruments expired in share-based payment arrangement", "label": "Number of other equity instruments expired in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement." } } }, "auth_ref": [ "r251" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeitures in the period (in shares)", "label": "Number of other equity instruments forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r251" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of other equity instruments outstanding (in shares) at beginning of period", "periodEndLabel": "Number of other equity instruments outstanding (in shares) at end of period", "terseLabel": "Number of other equity instruments outstanding (in shares)", "label": "Number of other equity instruments outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r251" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued (in shares)", "label": "Number of shares issued" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r230" ] }, "ifrs-full_NumberOfSharesIssuedAndFullyPaid": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssuedAndFullyPaid", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued and fully paid (in shares)", "label": "Number of shares issued and fully paid" } }, "en": { "role": { "documentation": "The number of shares issued by the entity, for which full payment has been received." } } }, "auth_ref": [ "r29" ] }, "nomd_NumberOfSharesRepurchased": { "xbrltype": "sharesItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "NumberOfSharesRepurchased", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares repurchased", "label": "Number of shares repurchased", "documentation": "Number of shares repurchased" } } }, "auth_ref": [] }, "ifrs-full_OnerousContractsProvisionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OnerousContractsProvisionMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Onerous/ unfavorable contracts", "label": "Onerous contracts provision [member]" } }, "en": { "role": { "documentation": "This member stands for a provision for onerous contracts. [Refer: Onerous contracts provision]" } } }, "auth_ref": [ "r204" ] }, "nomd_OperatingSegmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "OperatingSegmentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Operating Segments [Abstract]", "label": "Operating Segments [Abstract]", "documentation": "Operating Segments [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ordinary shares", "label": "Ordinary shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r75", "r237" ] }, "nomd_OtherAwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "OtherAwardsMember", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Awards", "label": "Other Awards [Member]", "documentation": "Other Awards" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive income/(loss) for the period, net of tax", "terseLabel": "Other comprehensive income for the period", "label": "Other comprehensive income" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r5", "r36", "r45", "r122" ] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income:", "label": "Other comprehensive income [abstract]" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeBeforeTaxCashFlowHedges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeBeforeTaxCashFlowHedges", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flow hedges", "label": "Other comprehensive income, before tax, cash flow hedges" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, before tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income, before tax]" } } }, "auth_ref": [ "r25", "r46" ] }, "ifrs-full_OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Actuarial gains/(losses) on defined benefit pension plans", "label": "Other comprehensive income, before tax, gains (losses) on remeasurements of defined benefit plans" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, before tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [member]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]" } } }, "auth_ref": [ "r25", "r46", "r239" ] }, "ifrs-full_OtherComprehensiveIncomeBeforeTaxHedgesOfNetInvestmentsInForeignOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeBeforeTaxHedgesOfNetInvestmentsInForeignOperations", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange differences on translation of foreign operations", "label": "Other comprehensive income, before tax, hedges of net investments in foreign operations" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, before tax, after reclassification adjustments, related to hedges of net investments in foreign operations. [Refer: Other comprehensive income, before tax]" } } }, "auth_ref": [ "r46", "r88", "r191" ] }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Items that may be subsequently reclassified to the Statement of Profit or Loss", "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r200", "r201" ] }, "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Items not reclassified to the Statement of Profit or Loss", "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r200", "r201" ] }, "nomd_OtherEquityInstrumentsGrantedInSharebasedPaymentArrangementPerDirector": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "OtherEquityInstrumentsGrantedInSharebasedPaymentArrangementPerDirector", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other equity instruments granted in share-based payment arrangement, per director", "label": "Other Equity Instruments Granted In Share-based Payment Arrangement, Per Director", "documentation": "Other Equity Instruments Granted In Share-based Payment Arrangement, Per Director" } } }, "auth_ref": [] }, "nomd_OtherEquityInstrumentsLifeOtherEquityInstrumentsGranted": { "xbrltype": "durationItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "OtherEquityInstrumentsLifeOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected life of restricted share", "label": "Other Equity Instruments Life, Other Equity Instruments Granted", "documentation": "Other Equity Instruments Life, Other Equity Instruments Granted" } } }, "auth_ref": [] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other financing cash flows", "label": "Other inflows (outflows) of cash, classified as financing activities" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as financing activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r98" ] }, "ifrs-full_OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption of investments", "label": "Other inflows (outflows) of cash, classified as investing activities" } }, "en": { "role": { "documentation": "Inflows (outflows) of cash, classified as investing activities, that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r98" ] }, "ifrs-full_OtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current assets", "label": "Other non-current assets" } }, "en": { "role": { "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_OtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentLiabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities", "label": "Other non-current liabilities" } }, "en": { "role": { "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]" } } }, "auth_ref": [ "r235" ] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating expenses", "label": "Other operating income (expense)" } }, "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r238" ] }, "ifrs-full_OtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherProvisions", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Other provisions at beginning of period", "periodEndLabel": "Other provisions at end of period", "terseLabel": "Other provisions", "label": "Other provisions" } }, "en": { "role": { "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r27", "r81" ] }, "nomd_OtherProvisionsContingentLiabilitiesandContingentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "OtherProvisionsContingentLiabilitiesandContingentAssetsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]", "label": "Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]", "documentation": "Other Provisions, Contingent Liabilities and Contingent Assets [Abstract]" } } }, "auth_ref": [] }, "nomd_OtherProvisionsEstimatedCompletionOfActivities": { "xbrltype": "durationItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "OtherProvisionsEstimatedCompletionOfActivities", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated completion of activities", "label": "Other Provisions, Estimated Completion Of Activities", "documentation": "Other Provisions, Estimated Completion Of Activities" } } }, "auth_ref": [] }, "ifrs-full_OtherProvisionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherProvisionsMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other provisions [member]", "label": "Other provisions [member]" } }, "en": { "role": { "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]" } } }, "auth_ref": [ "r85" ] }, "ifrs-full_OtherReserves": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherReserves", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other reserves", "label": "Other reserves" } }, "en": { "role": { "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]" } } }, "auth_ref": [ "r199" ] }, "ifrs-full_OtherReservesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherReservesMember", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other reserves [member]", "label": "Other reserves [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. It also represents the standard value for the 'Reserves within equity' axis if no other member is used. [Refer: Retained earnings]" } } }, "auth_ref": [ "r7", "r33" ] }, "nomd_OtherborrowingsDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "OtherborrowingsDomain", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other borrowings [Domain]", "label": "Other borrowings [Domain]", "documentation": "Other borrowings [Domain]" } } }, "auth_ref": [] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Par value per share (in usd per share)", "label": "Par value per share" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r30" ] }, "ifrs-full_PaymentsForDebtIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsForDebtIssueCosts", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of financing fees", "label": "Payments for debt issue costs" } }, "en": { "role": { "documentation": "The cash outflow for debt issue costs." } } }, "auth_ref": [ "r245" ] }, "ifrs-full_PaymentsForShareIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsForShareIssueCosts", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Share issuance costs", "label": "Payments for share issue costs" } }, "en": { "role": { "documentation": "The cash outflow for share issue costs." } } }, "auth_ref": [ "r245" ] }, "ifrs-full_PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsInRespectOfSettlementsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Benefits paid", "label": "Decrease (increase) in net defined benefit liability (asset) resulting from payments in respect of settlements" } }, "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan in respect of settlements. [Refer: Decrease (increase) in net defined benefit liability (asset) resulting from gains (losses) arising from settlements; Net defined benefit liability (asset); Defined benefit plans [member]]" } } }, "auth_ref": [ "r63" ] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of lease liabilities", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r211" ] }, "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsToAcquireOrRedeemEntitysShares", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repurchase of ordinary shares", "terseLabel": "Payments to acquire or redeem entity's shares", "label": "Payments to acquire or redeem entity's shares" } }, "en": { "role": { "documentation": "The cash outflow to acquire or redeem entity's shares." } } }, "auth_ref": [ "r208" ] }, "nomd_PreferenceSharesDividendPaymentTermsWeightedAverageSharePriceMinimumTermRequired": { "xbrltype": "durationItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "PreferenceSharesDividendPaymentTermsWeightedAverageSharePriceMinimumTermRequired", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareAdditionalInformationDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preference shares, dividend payment terms, weighted average share price, minimum term required", "label": "Preference Shares, Dividend Payment Terms, Weighted Average Share Price, Minimum Term Required", "documentation": "Preference Shares, Dividend Payment Terms, Weighted Average Share Price, Minimum Term Required" } } }, "auth_ref": [] }, "nomd_PreferenceSharesDividendRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "PreferenceSharesDividendRatePercentage", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage increase in dividend price", "label": "Preference Shares, Dividend Rate, Percentage", "documentation": "Preference Shares, Dividend Rate, Percentage" } } }, "auth_ref": [] }, "ifrs-full_PreferenceSharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PreferenceSharesMember", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Founder Preferred shares", "label": "Preference shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r237" ] }, "nomd_PreferredStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "PreferredStockSharesIssued1", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock, Shares Issued1", "label": "Preferred Stock, Shares Issued1", "documentation": "Preferred Stock, Shares Issued1" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of new loan principal", "label": "Proceeds from borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r209" ] }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of ordinary shares", "label": "Proceeds from issue of ordinary shares" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_ProceedsFromSaleOrIssueOfTreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromSaleOrIssueOfTreasuryShares", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale or issue of treasury shares", "label": "Proceeds from sale or issue of treasury shares" } }, "en": { "role": { "documentation": "The cash inflow from the sale or issuing of treasury shares. [Refer: Sale or issue of treasury shares; Treasury shares]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 5.0 }, "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofComprehensiveIncomeLoss", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Profit for the period", "terseLabel": "Profit for the period", "label": "Profit (loss)" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r4", "r35", "r97", "r112", "r114", "r177", "r179", "r215", "r221" ] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Non-controlling interests", "label": "Profit (loss), attributable to non-controlling interests" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r38", "r115" ] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/EarningspershareComputationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Equity owners of the parent", "verboseLabel": "Profit for the period attributable to equity owners of the parent (\u20acm)", "label": "Profit (loss), attributable to owners of parent" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r39" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss_1": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 }, "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Profit before tax", "label": "Profit (loss) before tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r147", "r195", "r196", "r226", "r227" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Operating profit", "label": "Profit (loss) from operating activities" } }, "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r203", "r238" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment", "label": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r11", "r56" ] }, "ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProvisionForTaxesOtherThanIncomeTaxMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provisions related to other\u00a0taxes", "label": "Provision for taxes other than income tax [member]" } }, "en": { "role": { "documentation": "This member stands for a provision for taxes other than income tax. Income taxes include all domestic and foreign taxes which are based on taxable profits. Income taxes also include taxes, such as withholding taxes, which are payable by a subsidiary, associate or joint arrangement on distributions to the reporting entity. [Refer: Other provisions [member]]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_ProvisionUsedOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProvisionUsedOtherProvisions", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Utilization of provision", "terseLabel": "Provision used, other provisions", "label": "Provision used, other provisions" } }, "en": { "role": { "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r83" ] }, "nomd_ProvisionforemployertaxesonsharebasedpaymentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ProvisionforemployertaxesonsharebasedpaymentsMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for employer taxes on share based payments", "label": "Provision for employer taxes on share based payments [Member]", "documentation": "Provision for employer taxes on share based payments [Member]" } } }, "auth_ref": [] }, "ifrs-full_Provisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Provisions", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/ProvisionsScheduleDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Provisions", "label": "Provisions" } }, "en": { "role": { "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits." } } }, "auth_ref": [ "r17" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchase of property, plant and equipment and intangibles", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r207" ] }, "ifrs-full_PurchaseOfTreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfTreasuryShares", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase of treasury shares", "label": "Purchase of treasury shares" } }, "en": { "role": { "documentation": "The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]" } } }, "auth_ref": [ "r230" ] }, "ifrs-full_PurchasesFairValueMeasurementAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchasesFairValueMeasurementAssets", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash fair value purchase price adjustment of inventory", "label": "Purchases, fair value measurement, assets" } }, "en": { "role": { "documentation": "The increase in the fair value measurement of assets resulting from purchases of those assets. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r130" ] }, "country_RS": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "RS", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SERBIA", "label": "SERBIA" } } }, "auth_ref": [] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Range [axis]", "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r132", "r137", "r140", "r217", "r219", "r252" ] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ranges [member]", "label": "Ranges [member]" } }, "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r132", "r137", "r140", "r217", "r219", "r252" ] }, "nomd_Reclassificationofawardsforsettlementoftaxliabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Reclassificationofawardsforsettlementoftaxliabilities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity": { "parentTag": "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Reclassification of awards for settlement of tax liabilities", "label": "Reclassification of awards for settlement of tax liabilities", "documentation": "Reclassification of awards for settlement of tax liabilities" } } }, "auth_ref": [] }, "ifrs-full_RecognisedAssetsRepresentingContinuingInvolvementInDerecognisedFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RecognisedAssetsRepresentingContinuingInvolvementInDerecognisedFinancialAssets", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recognised assets representing continuing involvement in derecognised financial assets", "label": "Recognised assets representing continuing involvement in derecognised financial assets" } }, "en": { "role": { "documentation": "The amount of assets recognised in the statement of financial position representing the entity's continuing involvement in derecognised financial assets." } } }, "auth_ref": [ "r161" ] }, "ifrs-full_ReductionOfIssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReductionOfIssuedCapital", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity": { "parentTag": "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Reduction of issued capital", "terseLabel": "Repurchase of ordinary shares", "label": "Reduction of issued capital" } }, "en": { "role": { "documentation": "The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]" } } }, "auth_ref": [ "r230" ] }, "nomd_RelatedPartyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "RelatedPartyAbstract", "lang": { "en-us": { "role": { "terseLabel": "Related Party [Abstract]", "label": "Related Party [Abstract]", "documentation": "Related Party [Abstract]" } } }, "auth_ref": [] }, "nomd_RelationshiptoEntity1Domain": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "RelationshiptoEntity1Domain", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Relationship to Entity1 [Domain]", "label": "Relationship to Entity1 [Domain]", "documentation": "Relationship to Entity1 [Domain]" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayment of loan principal", "label": "Repayments of borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r210" ] }, "nomd_RepaymentsOfNonCurrentBorrowingsPercentageOfOriginalIssuedNotional": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "RepaymentsOfNonCurrentBorrowingsPercentageOfOriginalIssuedNotional", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments Of Non-current Borrowings - percentage of original issued notional", "label": "Repayments Of Non-current Borrowings - percentage of original issued notional", "documentation": "Repayments Of Non-current Borrowings - percentage of original issued notional" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfNoncurrentBorrowings", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of non-current borrowings", "label": "Repayments of non-current borrowings" } }, "en": { "role": { "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_ReserveOfCashFlowHedges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfCashFlowHedges", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Other reserves", "label": "Reserve of cash flow hedges" } }, "en": { "role": { "documentation": "A component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]" } } }, "auth_ref": [ "r190", "r236" ] }, "ifrs-full_ReserveOfCashFlowHedgesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfCashFlowHedgesMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Other reserves", "label": "Reserve of cash flow hedges [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing the accumulated portion of gain (loss) on a hedging instrument that is determined to be an effective hedge for cash flow hedges. [Refer: Cash flow hedges [member]]" } } }, "auth_ref": [ "r190", "r197" ] }, "ifrs-full_ReserveOfChangeInValueOfForwardElementsOfForwardContracts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfChangeInValueOfForwardElementsOfForwardContracts", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserve of change in value of forward elements of forward contracts", "label": "Reserve of change in value of forward elements of forward contracts" } }, "en": { "role": { "documentation": "A component of equity representing the accumulated change in the value of the forward elements of forward contracts when separating the forward element and spot element of a forward contract and designating as the hedging instrument only the changes in the spot element." } } }, "auth_ref": [ "r192", "r236" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Translation reserve", "label": "Reserve of exchange differences on translation" } }, "en": { "role": { "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r68" ] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslationMember", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Translation reserve", "label": "Reserve of exchange differences on translation [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing accumulated exchange differences on the translation of financial statements recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r68", "r197" ] }, "nomd_ReserveOfPreferenceSharesDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ReserveOfPreferenceSharesDividend", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 6.0 } }, "auth_ref": [] }, "ifrs-full_ReserveOfSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfSharebasedPayments", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation reserve", "periodStartLabel": "Reserve of share-based payments", "periodEndLabel": "Reserve of share-based payments", "label": "Reserve of share-based payments" } }, "en": { "role": { "documentation": "A component of equity resulting from share-based payments." } } }, "auth_ref": [ "r236" ] }, "ifrs-full_ReserveOfSharebasedPaymentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfSharebasedPaymentsMember", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation reserve", "label": "Reserve of share-based payments [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity resulting from share-based payments." } } }, "auth_ref": [ "r197" ] }, "ifrs-full_ReservesWithinEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReservesWithinEquityAxis", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveReserveSummaryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reserves within equity [axis]", "label": "Reserves within equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r33" ] }, "nomd_RestOfEuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "RestOfEuropeMember", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rest of Europe", "label": "Rest Of Europe [Member]", "documentation": "Rest Of Europe [Member]" } } }, "auth_ref": [] }, "ifrs-full_RestatedMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestatedMember", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Currently stated [member]", "label": "Currently stated [member]" } }, "en": { "role": { "documentation": "This member stands for the information currently stated in the financial statements. It also represents the standard value for the 'Retrospective application and retrospective restatement' and 'Departure from requirement of IFRS' axes if no other member is used." } } }, "auth_ref": [ "r3", "r106", "r107", "r110", "r136", "r234" ] }, "ifrs-full_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/CashandcashequivalentsDetails": { "parentTag": "nomd_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/CashandcashequivalentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r235" ] }, "nomd_RestrictedStock1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "RestrictedStock1Member", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted shares", "label": "Restricted Stock1 [Member]", "documentation": "Restricted Stock1 [Member]" } } }, "auth_ref": [] }, "ifrs-full_RestructuringProvisionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestructuringProvisionMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring", "label": "Restructuring provision [member]" } }, "en": { "role": { "documentation": "This member stands for a provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Other provisions [member]]" } } }, "auth_ref": [ "r205" ] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained earnings" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r199", "r201" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r7", "r197" ] }, "ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetrospectiveApplicationAndRetrospectiveRestatementAxis", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retrospective application and retrospective restatement [axis]", "label": "Retrospective application and retrospective restatement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r3", "r106", "r107", "r110" ] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails", "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofProfitorLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenue" } }, "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } } }, "auth_ref": [ "r41", "r121", "r147", "r172", "r178", "r184", "r185", "r187", "r195", "r196", "r215" ] }, "ifrs-full_RevenueFromInterest": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromInterest", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Interest income" } }, "en": { "role": { "documentation": "The amount of income arising from interest." } } }, "auth_ref": [ "r125", "r173", "r182", "r232" ] }, "ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLossLoansAndAdvances": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReversalOfImpairmentLossRecognisedInProfitOrLossLoansAndAdvances", "calculation": { "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/FinanceincomeandcostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Reversal of impairment loss on short term investments (a)", "label": "Reversal of impairment loss recognised in profit or loss, loans and advances" } }, "en": { "role": { "documentation": "The amount of reversal of impairment loss recognised in profit or loss for loans and advances. [Refer: Reversal of impairment loss recognised in profit or loss]" } } }, "auth_ref": [ "r238" ] }, "nomd_RevolvingCreditFacilityExistingReplacedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "RevolvingCreditFacilityExistingReplacedMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility (existing - replaced) [Member]", "documentation": "Revolving Credit Facility [Member]" } } }, "auth_ref": [] }, "nomd_RevolvingCreditFacilityNewMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "RevolvingCreditFacilityNewMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility (new)", "label": "Revolving Credit Facility (new) [Member]", "documentation": "Revolving Credit Facility (new)" } } }, "auth_ref": [] }, "nomd_RiskFreeInterestRateOtherEquityInstrumentsGranted": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "RiskFreeInterestRateOtherEquityInstrumentsGranted", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk free rate", "label": "Risk Free Interest Rate, Other Equity Instruments Granted", "documentation": "Risk Free Interest Rate, Other Equity Instruments Granted" } } }, "auth_ref": [] }, "country_SE": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "SE", "presentation": [ "http://www.nomadfoods.com/role/EmployeeBenefitsDetails", "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sweden", "label": "SWEDEN" } } }, "auth_ref": [] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Domain]", "label": "Scenario [Domain]" } } }, "auth_ref": [] }, "ifrs-full_SegmentConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentConsolidationItemsAxis", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingSegmentasAdjustedEBITDADetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment consolidation items [axis]", "label": "Segment consolidation items [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r177" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [] }, "nomd_SeniorEURODebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SeniorEURODebtMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior EURO Debt", "label": "Senior EURO Debt [Member]", "documentation": "Senior EURO Debt [Member]" } } }, "auth_ref": [] }, "nomd_SeniorEURUSDLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SeniorEURUSDLoansMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior EUR/USD loans", "label": "Senior EUR/USD Loans [Member]", "documentation": "Senior EUR/USD Loans [Member]" } } }, "auth_ref": [] }, "nomd_SeniorEurDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SeniorEurDebtMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior Eur Debt", "label": "Senior Eur Debt [Member]", "documentation": "Senior Eur Debt" } } }, "auth_ref": [] }, "nomd_SeniorUSDDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SeniorUSDDebtMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior USD Debt", "label": "Senior USD Debt [Member]", "documentation": "Senior USD Debt [Member]" } } }, "auth_ref": [] }, "nomd_ServicesAgreementAnnualFeeRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ServicesAgreementAnnualFeeRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/RelatedpartiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Services Agreement, Annual Fee, Related Party Transactions", "label": "Services Agreement, Annual Fee, Related Party Transactions", "documentation": "Services Agreement, Annual Fee, Related Party Transactions" } } }, "auth_ref": [] }, "nomd_SettlementOfLegacyMatters": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SettlementOfLegacyMatters", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails": { "parentTag": "nomd_AdjustmentsForExceptionalItems", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ExceptionalItemsScheduleDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement of legacy matters (4)", "label": "Settlement Of Legacy Matters", "documentation": "Settlement Of Legacy Matters" } } }, "auth_ref": [] }, "nomd_ShareCapitalReservesandOtherEquityInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ShareCapitalReservesandOtherEquityInterestAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share Capital, Reserves and Other Equity Interest [Abstract]", "label": "Share Capital, Reserves and Other Equity Interest [Abstract]", "documentation": "Share Capital, Reserves and Other Equity Interest [Abstract]" } } }, "auth_ref": [] }, "nomd_ShareIssueRelatedCostAccumulated": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ShareIssueRelatedCostAccumulated", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails": { "parentTag": "nomd_IssuedCapitalandCapitalReserve", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveScheduleDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Listing and share transaction costs", "label": "Share Issue Related Cost, Accumulated", "documentation": "Share Issue Related Cost, Accumulated" } } }, "auth_ref": [] }, "nomd_SharePriceTrancheAsPercentOfTotalAward": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SharePriceTrancheAsPercentOfTotalAward", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share price tranche as percent of total award", "label": "Share Price Tranche as Percent of Total Award", "documentation": "Share Price Tranche as Percent of Total Award" } } }, "auth_ref": [] }, "nomd_ShareRepurchaseProgramme": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ShareRepurchaseProgramme", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share repurchase programme", "label": "Share repurchase programme", "documentation": "Share repurchase programme" } } }, "auth_ref": [] }, "nomd_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingPeriod2": { "xbrltype": "durationItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingPeriod2", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting period", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Period2", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period" } } }, "auth_ref": [] }, "nomd_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage1", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting rights, percentage", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Percentage1", "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Award Vesting Rights, Percentage1" } } }, "auth_ref": [] }, "nomd_SharebasedCompensationAwardTrancheOne1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SharebasedCompensationAwardTrancheOne1Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Award, Tranche One", "label": "Share-based Compensation Award, Tranche One1 [Member]", "documentation": "Share-based Compensation Award, Tranche One1 [Member]" } } }, "auth_ref": [] }, "nomd_SharebasedCompensationAwardTrancheTwo1Member": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SharebasedCompensationAwardTrancheTwo1Member", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Award, Tranche Two", "label": "Share-based Compensation Award, Tranche Two1 [Member]", "documentation": "Share-based Compensation Award, Tranche Two1 [Member]" } } }, "auth_ref": [] }, "ifrs-full_SharebasedPaymentArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharebasedPaymentArrangementsMember", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangements [member]", "label": "Share-based payment arrangements [member]" } }, "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "auth_ref": [ "r141" ] }, "nomd_SharesIssuedPricePerShare1": { "xbrltype": "perShareItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "SharesIssuedPricePerShare1", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued, price per share (in dollars per share)", "label": "Shares Issued, Price Per Share1", "documentation": "Shares Issued, Price Per Share1" } } }, "auth_ref": [] }, "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments", "label": "Short-term deposits, not classified as cash equivalents" } }, "en": { "role": { "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r235" ] }, "nomd_ShortterminvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "ShortterminvestmentsMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term investments [Member]", "label": "Short-term investments [Member]", "documentation": "Short-term deposits [Member]" } } }, "auth_ref": [] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.nomadfoods.com/role/SegmentreportingGeographicalinformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of cash flows [abstract]", "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of changes in equity [abstract]", "label": "Statement of changes in equity [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityLineItems": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityLineItems", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement of changes in equity [line items]", "label": "Statement of changes in equity [line items]" } }, "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofChangesinEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement of changes in equity [table]", "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_StatementOfComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of comprehensive income [abstract]", "label": "Statement of comprehensive income [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of financial position [abstract]", "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementScenarioAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Scenario [Axis]", "label": "Scenario [Axis]" } } }, "auth_ref": [] }, "ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Subclassifications of assets, liabilities and equities [abstract]", "label": "Subclassifications of assets, liabilities and equities [abstract]" } } }, "auth_ref": [] }, "ifrs-full_SwapContractMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SwapContractMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Swap contract", "label": "Swap contract [member]" } }, "en": { "role": { "documentation": "This member stands for a derivative financial instrument that involves the exchange of cash flow streams between the parties of the contract over a specified period. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r232" ] }, "nomd_TitleofIndividual1Axis": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "TitleofIndividual1Axis", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual1 [Axis]", "label": "Title of Individual1 [Axis]", "documentation": "Title of Individual1 [Axis]" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Top of range", "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r132", "r137", "r140", "r217", "r219", "r252" ] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Trade and other payables", "label": "Trade and other current payables" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r16" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "calculation": { "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.nomadfoods.com/role/UnauditedCondensedConsolidatedInterimStatementsofFinancialPosition" ], "lang": { "en-us": { "role": { "terseLabel": "Trade and other receivables", "label": "Trade and other current receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r14", "r26" ] }, "nomd_TradePayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "TradePayablesMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade and other payables excluding non-financial liabilities", "label": "Trade Payables [Member]", "documentation": "Trade Payable [Member]" } } }, "auth_ref": [] }, "ifrs-full_TradeReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeReceivablesMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialinstrumentsCategoriesoffinancialinstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade and other receivables", "label": "Trade receivables [member]" } }, "en": { "role": { "documentation": "This member stands for trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r154", "r158", "r223", "r232" ] }, "nomd_TransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "TransactionCosts", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction costs", "label": "Transaction costs", "documentation": "Transaction costs incurred with regards to share repurchase" } } }, "auth_ref": [] }, "ifrs-full_TreasurySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TreasurySharesMember", "presentation": [ "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury shares", "label": "Treasury shares [member]" } }, "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r7" ] }, "nomd_TwentyTwentyEightFixedRateSeniorSecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "TwentyTwentyEightFixedRateSeniorSecuredNotesMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Twenty Twenty-Eight Fixed Rate Senior Secured Notes", "label": "Twenty Twenty-Eight Fixed Rate Senior Secured Notes [Member]", "documentation": "Twenty Twenty-Eight Fixed Rate Senior Secured Notes" } } }, "auth_ref": [] }, "nomd_TwentyTwentyFourFixedRateSeniorSecuredNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "TwentyTwentyFourFixedRateSeniorSecuredNotesMember", "presentation": [ "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsInterestbearingloansandborrowingsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024 fixed rate senior secured notes", "label": "Twenty Twenty-Four Fixed Rate Senior Secured Notes [Member]", "documentation": "Twenty Twenty-Four Fixed Rate Senior Secured Notes [Member]" } } }, "auth_ref": [] }, "ifrs-full_TypesOfHedgesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfHedgesAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Types of hedges [axis]", "label": "Types of hedges [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r149", "r150", "r151" ] }, "ifrs-full_TypesOfHedgesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfHedgesMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails", "http://www.nomadfoods.com/role/FinancialInstrumentsAdditionalInformationDetails", "http://www.nomadfoods.com/role/ShareCapitalandCapitalreserveNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedges [member]", "label": "Hedges [member]" } }, "en": { "role": { "documentation": "This member stands for all types of hedges. It also represents the standard value for the 'Types of hedges' axis if no other member is used." } } }, "auth_ref": [ "r149", "r150", "r151" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsAxis", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsAdditionalInformationDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails", "http://www.nomadfoods.com/role/SharebasedcompensationreserveValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Types of share-based payment arrangements [axis]", "label": "Types of share-based payment arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r141" ] }, "ifrs-full_UnusedProvisionReversedOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedProvisionReversedOtherProvisions", "crdr": "debit", "presentation": [ "http://www.nomadfoods.com/role/ProvisionsScheduleDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Release of provision", "label": "Unused provision reversed, other provisions" } }, "en": { "role": { "documentation": "The amount reversed for unused other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r84" ] }, "nomd_Vesting1Axis": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Vesting1Axis", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting1 [Axis]", "label": "Vesting1 [Axis]", "documentation": "Vesting1 [Axis]" } } }, "auth_ref": [] }, "nomd_Vesting1Domain": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Vesting1Domain", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting1 [Domain]", "label": "Vesting1 [Domain]", "documentation": "[Domain] for Vesting1 [Axis]" } } }, "auth_ref": [] }, "nomd_Vesting2AxisAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Vesting2AxisAxis", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting 2 [Axis] [Axis]", "label": "Vesting 2 [Axis] [Axis]", "documentation": "Vesting 2 [Axis] [Axis]" } } }, "auth_ref": [] }, "nomd_Vesting2AxisDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "Vesting2AxisDomain", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting 2 [Axis] [Domain]", "label": "Vesting 2 [Axis] [Domain]", "documentation": "[Domain] for Vesting 2 [Axis] [Axis]" } } }, "auth_ref": [] }, "ifrs-full_VoluntaryChangesInAccountingPolicyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "VoluntaryChangesInAccountingPolicyAxis", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Voluntary changes in accounting policy [axis]", "label": "Voluntary changes in accounting policy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r108" ] }, "ifrs-full_VoluntaryChangesInAccountingPolicyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "VoluntaryChangesInAccountingPolicyMember", "presentation": [ "http://www.nomadfoods.com/role/BasisofpreparationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Voluntary changes in accounting policy [member]", "label": "Voluntary changes in accounting policy [member]" } }, "en": { "role": { "documentation": "This member stands for changes in accounting policy that result in the financial statements providing reliable and more relevant information about the effects of transactions, other events or conditions on the entity\u2019s financial position, financial performance or cash flows. Early application of an IFRS is not considered a voluntary change in accounting policy. It also represents the standard value for the 'Voluntary changes in accounting policy' axis if no other member is used." } } }, "auth_ref": [ "r108" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveNonExecutiveDirectorRestrictedShareAwardsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement", "label": "Weighted average exercise price of other equity instruments granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r251" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise price of share options exercised in share-based payment arrangement", "label": "Weighted average exercise price of share options exercised in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r139" ] }, "ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted", "crdr": "credit", "presentation": [ "http://www.nomadfoods.com/role/SharebasedcompensationreserveDirectorandSeniorManagementShareAwardsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average fair value at measurement date, other equity instruments granted", "label": "Weighted average fair value at measurement date, other equity instruments granted" } }, "en": { "role": { "documentation": "The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r142" ] }, "nomd_WeightedAverageNumberOfOrdinaryandPreferredSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "WeightedAverageNumberOfOrdinaryandPreferredSharesOutstandingBasic", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareComputationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average Ordinary Shares and shares issuable solely after the passage of time in millions", "label": "Weighted Average Number Of Ordinary and Preferred Shares Outstanding, Basic", "documentation": "Weighted Average Number Of Ordinary and Preferred Shares Outstanding, Basic" } } }, "auth_ref": [] }, "nomd_WeightedAverageNumberOfOrdinaryandPreferredSharesOutstandingDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://www.nomadfoods.com/20240331", "localname": "WeightedAverageNumberOfOrdinaryandPreferredSharesOutstandingDiluted", "presentation": [ "http://www.nomadfoods.com/role/EarningspershareComputationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average Ordinary Shares, shares issuable solely after the passage of time and potential ordinary shares in millions", "label": "Weighted Average Number Of Ordinary and Preferred Shares Outstanding, Diluted", "documentation": "Weighted Average Number Of Ordinary and Preferred Shares Outstanding, Diluted" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_b&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_107&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "137", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_137_a&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "l", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_l&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "n", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_n&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_b&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "90", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_90&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_b&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "ab", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_ab&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "140", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_140_a&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_a&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_b&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_e&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_g&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_h&doctype=Standard", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "23", "IssueDate": "2023-01-01", "Paragraph": "26", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=23&code=ifrs-tx-2023-en-r&anchor=para_26_a&doctype=Standard", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_f&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "34", "IssueDate": "2023-01-01", "Paragraph": "16A", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=34&code=ifrs-tx-2023-en-r&anchor=para_16A_f&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_a&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_b&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_c&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_d&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "39", "IssueDate": "2023-01-01", "Paragraph": "102", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2023-en-r&anchor=para_102_a&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "39", "IssueDate": "2023-01-01", "Paragraph": "86", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2023-en-r&anchor=para_86_b&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "39", "IssueDate": "2023-01-01", "Paragraph": "86", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2023-en-r&anchor=para_86_c&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "39", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_f_i&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "29", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_29_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "29", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_29&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "30", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_30_b&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "49", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_49_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "105", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_105&doctype=Standard", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "116", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_116_a&doctype=Standard", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "C32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C32&doctype=Appendix&subtype=C", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS03_g59-63_TI", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23A&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24A&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24B&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24C&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24E", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24E_a&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_36&doctype=Standard", "URIDate": "2023-03-23" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42E", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_a&doctype=Standard", "URIDate": "2023-03-23" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2023-03-23" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42M", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42M_b&doctype=Standard", "URIDate": "2023-03-23" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_a&doctype=Standard", "URIDate": "2023-03-23" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_e&doctype=Standard", "URIDate": "2023-03-23" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_f&doctype=Standard", "URIDate": "2023-03-23" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_g&doctype=Standard", "URIDate": "2023-03-23" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2023-03-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2023-03-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_c&doctype=Standard", "URIDate": "2023-03-23" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2023-03-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2023-03-23" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2023-03-23" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2023-03-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "6.5.11", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_6.5.11_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "6.5.11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_6.5.11&doctype=Standard", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "6.5.13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_6.5.13_a&doctype=Standard", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "6.5.16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_6.5.16&doctype=Standard", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "14", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_14_f&doctype=Standard", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "31", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_31_b&doctype=Standard", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG63&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE60", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r220": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r221": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r222": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2023-03-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG40B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_20_d&doctype=Standard", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141&doctype=Standard", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "144", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_144&doctype=Standard", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84&doctype=Standard", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r246": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r247": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r248": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_c&doctype=Standard", "URIDate": "2023-03-23" }, "r249": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r250": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r251": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r252": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" } } } ZIP 74 0001651717-24-000031-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001651717-24-000031-xbrl.zip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g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